
<html lang="en"     class="pb-page"  data-request-id="03310b61-d9bf-40cd-be21-6bd9811abfbf"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-22;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b00834;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Novel Flavonoid Dimers To Reverse Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediated Drug Resistance in Cancers Using a High Throughput Platform with “Click Chemistry”" /></meta><meta name="dc.Creator" content="Iris L.&#xA;K.  Wong" /></meta><meta name="dc.Creator" content="Xuezhen  Zhu" /></meta><meta name="dc.Creator" content="Kin-Fai  Chan" /></meta><meta name="dc.Creator" content="Man Chun  Law" /></meta><meta name="dc.Creator" content="Aya M. Y.  Lo" /></meta><meta name="dc.Creator" content="Xuesen  Hu" /></meta><meta name="dc.Creator" content="Larry M. C.  Chow" /></meta><meta name="dc.Creator" content="Tak Hang  Chan" /></meta><meta name="dc.Description" content="A 300-member flavonoid dimer library of multidrug resistance-associated protein 1 (MRP1, ABCC1) modulators was rapidly assembled using “click chemistry”. Subsequent high-throughput screening has le..." /></meta><meta name="Description" content="A 300-member flavonoid dimer library of multidrug resistance-associated protein 1 (MRP1, ABCC1) modulators was rapidly assembled using “click chemistry”. Subsequent high-throughput screening has le..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 23, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00834" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00834" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00834" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00834" /></link>
        
    
    

<title>Discovery of Novel Flavonoid Dimers To Reverse Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediated Drug Resistance in Cancers Using a High Throughput Platform with “Click Chemistry” | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00834" /></meta><meta property="og:title" content="Discovery of Novel Flavonoid Dimers To Reverse Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediated Drug Resistance in Cancers Using a High Throughput Platform with “Click Chemistry”" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0016.jpeg" /></meta><meta property="og:description" content="A 300-member flavonoid dimer library of multidrug resistance-associated protein 1 (MRP1, ABCC1) modulators was rapidly assembled using “click chemistry”. Subsequent high-throughput screening has led to the discovery of highly potent (EC50 ranging from 53 to 298 nM) and safe (selective indexes ranging from &gt;190 to &gt;1887) MRP1 modulators. Some dimers have potency about 6.5- to 36-fold and 64- to 358-fold higher than the well-known MRP1 inhibitors, verapamil, and MK571, respectively. They inhibited DOX efflux and restored intracellular DOX concentration. The most potent modulator, Ac3Az11, was predicted to bind to the bipartite substrate-binding site of MRP1 in a competitive manner. Moreover, it provided sufficient concentration to maintain its plasma level above its in vitro EC50 (53 nM for DOX) for about 90 min. Overall, we demonstrate that “click chemistry” coupled with high throughput screening is a rapid, reliable, and efficient tool in the discovery of compounds having potent MRP1-modualting activity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00834"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00834">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00834&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00834&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00834&amp;href=/doi/10.1021/acs.jmedchem.8b00834" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9931-9951</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00639" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00883" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Novel Flavonoid Dimers To Reverse Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediated Drug Resistance in Cancers Using a High Throughput Platform with “Click Chemistry”</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Iris L. K. Wong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Iris L. K. Wong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Iris+L.%0AK.++Wong">Iris L. K. Wong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xuezhen Zhu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xuezhen Zhu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xuezhen++Zhu">Xuezhen Zhu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kin-Fai Chan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kin-Fai Chan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kin-Fai++Chan">Kin-Fai Chan</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1475-288X" title="Orcid link">http://orcid.org/0000-0003-1475-288X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Man Chun Law</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Man Chun Law</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Man+Chun++Law">Man Chun Law</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aya M. Y. Lo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aya M. Y. Lo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aya+M.+Y.++Lo">Aya M. Y. Lo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xuesen Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xuesen Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xuesen++Hu">Xuesen Hu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Larry M. C. Chow</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Larry M. C. Chow</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</div></div><span class="conrtib-corresp"><strong>*</strong>L.M.C.C.: phone, (852) 34008662; fax, (852) 23649932; e-mail, <a href="/cdn-cgi/l/email-protection#b2ded3c0c0cb9cd1daddc5f2c2dddecbc79cd7d6c79cdad9"><span class="__cf_email__" data-cfemail="9ff3feedede6b1fcf7f0e8dfeff0f3e6eab1fafbeab1f7f4">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Larry+M.+C.++Chow">Larry M. C. Chow</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Tak Hang Chan</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tak Hang Chan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</div><div class="loa-info-affiliations-info">Department of Chemistry, McGill University, Montreal, Quebec H3A 2K6, Canada</div></div><span class="conrtib-corresp"><strong>*</strong>T.H.C.: phone, (852) 34008670; fax, (852) 23649932; e-mail, <a href="/cdn-cgi/l/email-protection#7004111b5d18111e175e1318111e30001f1c09055e1514055e181b"><span class="__cf_email__" data-cfemail="0672676d2b6e67686128656e67684676696a7f7328636273286e6d">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tak+Hang++Chan">Tak Hang Chan</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8702-4499" title="Orcid link">http://orcid.org/0000-0002-8702-4499</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00834&amp;href=/doi/10.1021%2Facs.jmedchem.8b00834" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9931–9951</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 23, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 May 2018</li><li><span class="item_label"><b>Published</b> online</span>23 October 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 21 November 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00834" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00834</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9931%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DIris%2BL.%250AK.%2BWong%252C%2BXuezhen%2BZhu%252C%2BKin-Fai%2BChan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D22%26contentID%3Dacs.jmedchem.8b00834%26title%3DDiscovery%2Bof%2BNovel%2BFlavonoid%2BDimers%2BTo%2BReverse%2BMultidrug%2BResistance%2BProtein%2B1%2B%2528MRP1%252C%2BABCC1%2529%2BMediated%2BDrug%2BResistance%2Bin%2BCancers%2BUsing%2Ba%2BHigh%2BThroughput%2BPlatform%2Bwith%2B%25E2%2580%259CClick%2BChemistry%25E2%2580%259D%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9951%26publicationDate%3DNovember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00834"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1642</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00834" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Novel Flavonoid Dimers To Reverse Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediated Drug Resistance in Cancers Using a High Throughput Platform with “Click Chemistry”&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Iris&quot;,&quot;last_name&quot;:&quot;L.\nK. Wong&quot;},{&quot;first_name&quot;:&quot;Xuezhen&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Kin-Fai&quot;,&quot;last_name&quot;:&quot;Chan&quot;},{&quot;first_name&quot;:&quot;Man&quot;,&quot;last_name&quot;:&quot;Chun Law&quot;},{&quot;first_name&quot;:&quot;Aya&quot;,&quot;last_name&quot;:&quot;M. Y. Lo&quot;},{&quot;first_name&quot;:&quot;Xuesen&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Larry&quot;,&quot;last_name&quot;:&quot;M. C. Chow&quot;},{&quot;first_name&quot;:&quot;Tak&quot;,&quot;last_name&quot;:&quot;Hang Chan&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;9931-9951&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00834&quot;},&quot;abstract&quot;:&quot;A 300-member flavonoid dimer library of multidrug resistance-associated protein 1 (MRP1, ABCC1) modulators was rapidly assembled using “click chemistry”. Subsequent high-throughput screening has led to the discovery of highly potent (EC50 ranging from 53 to 298 nM) and safe (selective indexes ranging from &gt;190 to &gt;1887) MRP1 modulators. Some dimers have potency about 6.5- to 36-fold and 64- to 358-fold higher than the well-known MRP1 inhibitors, verapamil, and MK571, respectively. They inhibited DOX efflux and restored intracellular DOX concentration. The most potent modulator, Ac3Az11, was predicted to bind to the bipartite substrate-binding site of MRP1 in a competitive manner. Moreover, it provided sufficient concentration to maintain its plasma level above its in vitro EC50 (53 nM for DOX) for about 90 min. Overall, we demonstrate that “click chemistry” coupled with high throughput screening is a rapid, reliable, and efficient tool in the discovery of compounds having potent MRP1-modualting activity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00834&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00834" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00834&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00834" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00834&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00834" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00834&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00834&amp;href=/doi/10.1021/acs.jmedchem.8b00834" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00834" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00834" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00834%26sid%3Dliteratum%253Aachs%26pmid%3D30351934%26genre%3Darticle%26aulast%3DWong%26date%3D2018%26atitle%3DDiscovery%2Bof%2BNovel%2BFlavonoid%2BDimers%2BTo%2BReverse%2BMultidrug%2BResistance%2BProtein%2B1%2B%2528MRP1%252C%2BABCC1%2529%2BMediated%2BDrug%2BResistance%2Bin%2BCancers%2BUsing%2Ba%2BHigh%2BThroughput%2BPlatform%2Bwith%2B%25E2%2580%259CClick%2BChemistry%25E2%2580%259D%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D22%26spage%3D9931%26epage%3D9951%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291829" title="Flavonoids">Flavonoids</a>,</li><li><a href="/action/doSearch?ConceptID=291456" title="Hydrocarbons">Hydrocarbons</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291631" title="Modulators">Modulators</a>,</li><li><a href="/action/doSearch?ConceptID=292425" title="Oligomers">Oligomers</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/jmcmar.2018.61.issue-22/20181121/jmcmar.2018.61.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A 300-member flavonoid dimer library of multidrug resistance-associated protein 1 (MRP1, ABCC1) modulators was rapidly assembled using “click chemistry”. Subsequent high-throughput screening has led to the discovery of highly potent (EC<sub>50</sub> ranging from 53 to 298 nM) and safe (selective indexes ranging from >190 to >1887) MRP1 modulators. Some dimers have potency about 6.5- to 36-fold and 64- to 358-fold higher than the well-known MRP1 inhibitors, verapamil, and MK571, respectively. They inhibited DOX efflux and restored intracellular DOX concentration. The most potent modulator, <b>Ac3Az11</b>, was predicted to bind to the bipartite substrate-binding site of MRP1 in a competitive manner. Moreover, it provided sufficient concentration to maintain its plasma level above its in vitro EC<sub>50</sub> (53 nM for DOX) for about 90 min. Overall, we demonstrate that “click chemistry” coupled with high throughput screening is a rapid, reliable, and efficient tool in the discovery of compounds having potent MRP1-modualting activity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36222" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36222" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Multidrug resistance (MDR) is a major impediment to successful treatment of many forms of malignant cancers. MDR is often associated with overexpression of an ATP-binding cassette (ABC) transporter which can extrude a wide variety of structurally unrelated anticancer drugs and decrease intracellular drug accumulation below toxic levels. P-gp/ABCB1, MRP1/ABCC1, and BCRP/ABCG2 are the three major ABC members that confer cancer MDR. Multidrug resistance-associated protein 1 (MRP1/ABCC1) was first identified in 1992 in a drug-selected human small lung cancer cell line H69AR.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> It pumps out organic anions, glutathione-, glucuronate-, or sulfate-conjugated drugs, or unconjugated drugs in concert with free glutathione, including the chemotherapeutic agents vincristine, doxorubicin, and etoposide.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7 ref8">(3−8)</a> Its elevated protein and mRNA levels have been reported in many tumors and is correlated with poor patient outcome including non-small-cell lung cancer, gastrointestinal carcinoma, melanoma, neuroblastoma, and cancers of the breast, ovary, and prostate.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a> Similar to P-gp/ABCB1, MRP1 contains an internally duplicated structure of two transmembrane domains (TMD1 and TMD2) and two cytosolic nucleotide binding domains (NBD). However, MRP1 has an extra N-terminal transmembrane domain containing five membrane-spanning helices (TMD0). The functional role of this third TMD0 is currently unclear.<a onclick="showRef(event, 'ref3 ref4 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref7 ref8">(3,4,7,8)</a></div><div class="NLM_p">Considerable efforts have been placed to overcome MDR by designing modulators that can inhibit the function of ABC transporter and restore intracellular accumulation of drugs. A large number of modulators have been identified for P-gp/ABCB1 (verapamil, cyclosporine A, PSC-833, biricodar, zosuquidar, tariquidar, elacridar, and ontogen)<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> and BCRP/ABCG2 (elacridar, ko143, pantoprazole, tariquidar, and biricodar),<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20">(16−20)</a> some with high potencies having low nM range of EC<sub>50</sub> (effective concentration that can lower the IC<sub>50</sub> of a drug to resistant cancer cells by 50%) in vitro. In contrast, there are fewer MRP1 inhibitors including probenecid and MK-571.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> These MRP1 inhibitors are far from satisfactory because of their relatively high EC<sub>50</sub> which may cause toxicity and side effects in clinical trials. Therefore, development of modulators that are potent and safe against MRP1 is highly desirable.</div><div class="NLM_p">We have previously synthesized some potent and safe P-gp and MRP1 modulators using flavonoid as the structural motif.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27 ref28">(23−28)</a> Many natural flavonoids are known to be modest modulators of these ABC transporters.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Flavonoids are commonly found in fruits, vegetables, and plant-derived products of human diet and generally considered as safe compounds. Because of the pseudodimeric structure of many ABC transporters, we reasoned that a bivalent approach by combining two flavonoid moieties linked with different polyethylene glycol linkers would yield selective and potent modulators. Indeed, we discovered that some flavonoid dimers showed effectiveness to inhibit P-gp and MRP1 transporters with nanomolar EC<sub>50</sub> values (<170 nM).<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27 ref28">(23−28)</a> The flavonoid dimer <b>FD</b>-<b>4e</b>, with PEG linker length <i>n</i> = 5, displayed a low EC<sub>50</sub> value of 73 nM in reversing DOX resistance in a MRP1 overexpressing ovarian (2008/MRP1) cell line (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> However, its relatively low aqueous solubility rendered it a poor candidate for further in vivo animal study.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of <b>FD-4e</b>, MK571, and verapamil used in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Triazoles are amphoteric in nature, acting as both acids and bases. Such properties make them usually soluble in aqueous medium. In order to rapidly generate a large number of diverse and dimeric MRP1 modulators which may have better physiochemical properties as potential drug candidates, we employed the copper(I) catalyzed Huisgen 1,3-dipolar cycloaddition reaction between azides and alkynes to yield 1,4-disubstituted 1,2,3 triazoles (commonly known as CuAAC reaction).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The reaction belongs to a class of reactions known as “click chemistry”. The features of these reactions include high efficiency (∼100% reaction yield), chemoselectivity, and modularity. They have been found to be useful as a rapid method to assemble compound libraries and allow direct in vitro screening of the clicked products without the need of purification.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> Click-chemistry-based high throughput screening platform has been developed in cases where the target enzyme is available as reported for the Ras palmitoylation<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and various other enzymes.<a onclick="showRef(event, 'ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36">(33−36)</a> Click chemistry has also been employed to synthesize bivalent ligands in the study of P-gp-mediated cellular efflux.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37−39)</a> Because whole cells, instead of a pure enzyme, have to be used for the bioassay of ABC transporter-mediated cellular efflux, no high throughput screening platform was developed and only a small library of pure click products was prepared and studied. Herein, we report a 300-member flavonoid dimer library synthesized using the “click chemistry” approach and coupled that with a high throughput screening platform to discover novel MRP1/ABCC1 modulators with favorable physiochemical properties.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  Library Generation by Click Chemistry</h3><div class="NLM_p">Previously, we synthesized a series of bivalent ligands by coupling two flavonoid moieties with PEG linkers. <b>FD-4e</b> was demonstrated to be a potent MPR1 inhibitor for reversing DOX resistance with EC<sub>50</sub> of 73 nM.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In terms of chemical structures, our previous dimers contain mainly symmetrical structures with two identical flavonoid moieties. On the basis of the previous synthetic routes, it was difficult to generate a large number of unsymmetrical dimers with two different flavonoids.</div><div class="NLM_p">In this work, we take advantage of the appealing ease and chemoselectivity of the Cu(I)-catalyzed azide–alkyne cycloaddition as the key dimerizing approach for the construction of a library of triazole bridged flavonoid bearing molecules. At first, we designed 25 terminal alkynes comprising monoacetylenes (<b>Ac1</b>–<b>13</b>, <b>Ac16</b>, <b>Ac19</b>, <b>Ac27</b>, <b>Ac33</b>, <b>Ac35</b>, <b>Ac42</b>), diacetylenes (<b>Ac15</b>, <b>Ac22</b>, <b>Ac23</b>, <b>Ac29</b>, <b>Ac31</b>), and the triacetylene <b>Ac17</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) and 12 flavonoids bearing azido groups (<b>Az1</b>–<b>5</b>, <b>Az7</b>, <b>Az10</b>–<b>13</b>, <b>Az17</b>, and <b>Az18</b>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of various alkynes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of various azides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5">2.1.1.  Synthesis of Alkynes</h4><div class="NLM_p">The flavonoids bearing alkynes <b>Ac1</b>–<b>5</b>, <b>Ac12</b>, <b>Ac35</b>, and <b>Ac42</b> were prepared by treating 4′ or 7-hydroxyflavones <b>1a</b>–<b>g</b> with various haloalkynes in high yield (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). <b>Ac33</b> was easily prepared by treating <i>p</i>-hydroxybenzaldehyde <b>4d</b> with 6-chloro-1-hexyne (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Base-catalyzed aldol condensation of aldehyde <b>Ac33</b> with various 2-hydroxyl acetophenones <b>3a</b>–<b>e</b> afforded the chalcones <b>Ac6</b>–<b>10</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). 2-Phenylquinazolin-4(3<i>H</i>)-one derivative <b>Ac11</b> was prepared by treatment of 2-aminobenzamide with aldehyde <b>2a</b> in the presence of catalytic amount of iodine (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Acetylene <b>Ac13</b> was simply obtained in two steps: (1) alkylation of hydroxyl flavone <b>1e</b> with bromoethanol; (2) alkylation of the hydroxyl group with propargyl bromide in the presence of sodium hydride (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Acetylenes bearing flavonoid <b>Ac16</b> were easily prepared through ligation of flavone <b>1e</b> with 2-(benzyl(prop-2-yn-1-yl)amino)ethanol under Mitsunobu condition (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Treatment of aniline (<b>4a</b>), piperazine (<b>4b</b>) and <i>N</i><sup>1</sup>,<i>N</i><sup>2</sup>-dimethylethane-1,2-diamine (<b>4c</b>) with propargyl bromide easily furnished monoacetylene <b>Ac27</b>, diacetylene <b>Ac29</b> and <b>Ac31</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Acetylene <b>Ac15</b>, triacetylene <b>Ac17</b>, monoacetylene <b>Ac19</b>, diacetylene <b>Ac22</b> and <b>Ac23</b> are commercially available.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Acetylenes <b>Ac1</b>–<b>5</b>, <b>Ac12</b>, and <b>Ac42</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and condition: (i) K<sub>2</sub>CO<sub>3</sub>, 6-chloro-1-hexyne or 5-chloro-1-pentyne, DMF, reflux.</p></p></figure><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Acetylenes <b>Ac6</b>–<b>Ac11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and condition: (i) KOH, EtOH, rt; (ii) I<sub>2</sub>, DMSO, 150 °C.</p></p></figure><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Acetylenes <b>Ac13</b> and <b>Ac16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and condition: (i) (a) K<sub>2</sub>CO<sub>3</sub>, 2-bromoethanol, DMF, reflux; (b) NaH, propargyl bromide solution, THF; (ii) 2-(benzyl(prop-2-yn-1-yl)amino)ethanol, PPh<sub>3</sub>, DIAD, THF.</p></p></figure><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Acetylenes <b>Ac27</b>, <b>Ac29</b>, <b>Ac31</b>, and <b>Ac33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and condition: (i) K<sub>2</sub>CO<sub>3</sub>, propargyl bromide, DMF, rt; (ii) K<sub>2</sub>CO<sub>3</sub>, propargyl bromide, acetone, rt; (iii) K<sub>2</sub>CO<sub>3</sub>, propargyl bromide, DMF, 10 °C; (iv) K<sub>2</sub>CO<sub>3</sub>, 6-chloro-1-hexyne, KI, DMF, 80 °C.</p></p></figure></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">2.1.2.  Synthesis of Azides</h4><div class="NLM_p">The synthesis of the required azide bearing flavonoids is shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. The azides <b>Az1</b>–<b>7</b>, <b>Az10</b>–<b>13</b>, <b>Az17</b>, and <b>Az18</b> were conveniently prepared from 4′- or 7-hydroxyflavones (<b>1a</b>,<b>d</b>,<b>f</b>–<b>i</b>) with high yield by the following three steps: (1) treatment of 4′- or 7-hydroxyflavones with various hydroxyl halides such as bromoethanol, 2-(2-chloroethoxy)ethanol, and 2-(2-(2-chloroethoxy)ethoxy)ethanol in the presence of sodium carbonate; (2) conversion of hydroxyl to methanesulfonate group by methanesulfonyl chloride; and (3) treatment of the mesylated flavones with excess sodium azide.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Azides <b>Az1</b>–<b>5</b>, <b>Az7</b>–<b>13</b>, <b>Az17</b>, and <b>Az18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and condition: (i) K<sub>2</sub>CO<sub>3</sub>, 2-bromoethanol (<i>n</i> = 0) or 2-(2-chloroethoxy)ethanol (<i>n</i> = 1) or 2-(2-(2-chloroethoxy)ethoxy)ethanol (<i>n</i> = 2), DMF, reflux; (ii) (a) methanesulfonyl chloride, NEt<sub>3</sub>, DCM, 0 °C; (b) NaN<sub>3</sub>, ACN.</p></p></figure></div><div id="sec2_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">2.1.3.  The Click Reaction</h4><div class="NLM_p last">By use of the CuAAC reactions, a 300-member “clicked” flavonoid dimers library was constructed in microtiter plates and in millimolar scale. In general, 1 mM of each acetylene (AcN) was mixed with each of 1 mM azides (AzM) in 100 μL of THF solvent, followed by addition of catalytic amount of bromotris(triphenylphosphine)copper(I) to yield about 1 mM triazole bridged products (AcN-AzM) without purification. For diacetylenes <b>Ac15</b>, <b>Ac22</b>, <b>Ac23</b>, <b>Ac29</b>, <b>Ac 31</b> and triacetylene <b>Ac17</b>, 2 mM and 3 mM of azides (AzM) were used, respectively. The reactions were carried out overnight in microplate heater (70 °C). We generated 300 triazole compounds in such identical reaction condition. After overnight reaction, all THF solvent in each well was removed by evaporation and the 300 triazole compounds were then dissolved in DMSO. Without any further purification of the assembled products, they were directly screened for MRP1 modulating activity in 96-well plates containing 2008/MRP1 cells and anticancer drug doxorubicin.</div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">2.2.  Biological Assay Results</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">2.2.1.  Primary and Secondary Screening of MRP1-Modulating Activity of Clicked Flavonoid Dimers</h4><div class="NLM_p">Each of the unpurified 300-member of the clicked homo- and heteroflavonoid dimer library contained at least four components: (1) the alkyne AcN, (2) the azide AzM, (3) the catalyst bromotris(triphenylphosphine)copper(I) and (4) the product AcN-AzM. This library was used for primary screening (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) at 2 μM of the product AcN-AzM by assuming a nearly 100% yield of the click reaction. 100 nM DOX was employed for the assay, a concentration at which it showed no toxicity toward 2008/MRP1 cells (100% of survival, data not shown). The relative potency of MRP1-modulating activity of the clicked dimers was determined by MTS proliferation assay and presented as % of survival normalized to those with DOX but without unpurified clicked dimer. The active clicked dimers would result in a relatively lower % of cell survival. Controlled experiments with the pure alkyne, with the pure azide, or with the catalyst were also performed (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). At 2 μM, all pure alkynes, azides and catalyst showed no or low MRP1-modulating activity with % of survival ranging from 57% to 103% (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Primary Screening of Clicked Flavonoid Dimers To Reverse DOX Resistance in 2008/MRP1 Cells<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0015.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">A total of 300 clicked dimers were used to screen for the MRP1-modulating activity. 2008/MRP1 cells were incubated with 100 nM DOX and 2 μM crude clicked dimers together. The % of survival was determined using MTS assay after 72 h incubation and normalized to the control containing no DOX and any clicked dimer. Each clicked dimer was tested in triplicate in each experiment. <i>N</i> = 3 independent experiment. The % of survivors was presented as the mean here. Percentage survival less than 50% was bolded and underlined. These dimers displaying potential MRP1-modulating activity were picked up for further cytotoxicity test.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. MRP1-Modulating Activity of Pure Alkyne, Pure Azide, or Cu(I) Catalyst in 2008/MRP1 Cells<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">% survival</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac1</b></td><td class="colsep0 rowsep0" align="left">74 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac2</b></td><td class="colsep0 rowsep0" align="left">85 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac3</b></td><td class="colsep0 rowsep0" align="left">79 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac4</b></td><td class="colsep0 rowsep0" align="left">67 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac5</b></td><td class="colsep0 rowsep0" align="left">88 ± 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac6</b></td><td class="colsep0 rowsep0" align="left">102 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac7</b></td><td class="colsep0 rowsep0" align="left">103 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac8</b></td><td class="colsep0 rowsep0" align="left">100 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac9</b></td><td class="colsep0 rowsep0" align="left">100 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac10</b></td><td class="colsep0 rowsep0" align="left">99 ± 0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac11</b></td><td class="colsep0 rowsep0" align="left">86 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac12</b></td><td class="colsep0 rowsep0" align="left">99 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac13</b></td><td class="colsep0 rowsep0" align="left">98 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac15</b></td><td class="colsep0 rowsep0" align="left">81 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac16</b></td><td class="colsep0 rowsep0" align="left">86 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac17</b></td><td class="colsep0 rowsep0" align="left">84 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac19</b></td><td class="colsep0 rowsep0" align="left">83 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac22</b></td><td class="colsep0 rowsep0" align="left">84 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac23</b></td><td class="colsep0 rowsep0" align="left">86 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac27</b></td><td class="colsep0 rowsep0" align="left">87 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac29</b></td><td class="colsep0 rowsep0" align="left">81 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac31</b></td><td class="colsep0 rowsep0" align="left">87 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac33</b></td><td class="colsep0 rowsep0" align="left">86 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac35</b></td><td class="colsep0 rowsep0" align="left">71 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac42</b></td><td class="colsep0 rowsep0" align="left">81 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Az1</b></td><td class="colsep0 rowsep0" align="left">78 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Az2</b></td><td class="colsep0 rowsep0" align="left">85 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Az3</b></td><td class="colsep0 rowsep0" align="left">84 ± 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Az4</b></td><td class="colsep0 rowsep0" align="left">85 ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Az5</b></td><td class="colsep0 rowsep0" align="left">74 ± 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Az7</b></td><td class="colsep0 rowsep0" align="left">90 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Az10</b></td><td class="colsep0 rowsep0" align="left">72 ± 9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Az11</b></td><td class="colsep0 rowsep0" align="left">91 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Az12</b></td><td class="colsep0 rowsep0" align="left">90 ± 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Az13</b></td><td class="colsep0 rowsep0" align="left">79 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Az17</b></td><td class="colsep0 rowsep0" align="left">57 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Az18</b></td><td class="colsep0 rowsep0" align="left">86 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cu(I) catalyst</td><td class="colsep0 rowsep0" align="left">103 ± 3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">A total of 25 pure alkynes, 12 pure azides, and Cu(I) catalyst were tested for their MRP1-modulating activity. 2008/MRP1 cells were incubated with 100 nM DOX and 2 μM each monomer or catalyst together. Percentage survival was determined using MTS assay after 5-day incubation and normalized to the control containing no DOX or monomers. Each monomer was tested in triplicate in each experiment. <i>N</i> = 3 independent experiment. Percentage survival was presented as the mean ± SEM here. Percentage survival below 50% indicates that the compound showed promising MRP1-modulating activity.</p></div></div></div><div class="NLM_p">In the primary screening, the relative MRP1-modulating activity of each clicked dimer was measured and presented as in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Out of the 300-member library, 53 members were considered as “hit” compounds with % of survival ranging from 20% to 49% (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, bolded and underlined). Among these 53 flavonoid dimer “hits”, 18 of them exhibited cytotoxicity toward 2008/MRP1 cells at 2 μM with % of survival less than 70% (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Interestingly, 7 out of the 12 dimers in the <b>Ac19</b> sublibrary showed cytotoxic effect, suggesting that <b>Ac19</b> is a poor building block for making MRP1 modulators (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). After exclusion of these 18 cytotoxic flavonoid dimers, the remaining 35 “hit” compounds were further differentiated by testing them at a lower concentration of 1 μM. A total of 21 compounds consistently maintained promising activity with <51% of survival (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Cytotoxicity of 53 Clicked Dimers Alone toward 2008/MRP1 Cells<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="2" align="center">compd</th><th class="rowsep1 colsep0" colspan="2" align="center">% survival</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>Ac</b></th><th class="colsep0 rowsep0" align="center"><b>Az</b></th><th class="colsep0 rowsep0" align="center">2 μM dimers + 100 nM DOX, 2008/MRP1</th><th class="colsep0 rowsep0" align="center">2 μM dimers alone, 2008/MRP1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">20 ± 1</td><td class="colsep0 rowsep0" align="left">85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">21 ± 2</td><td class="colsep0 rowsep0" align="left">91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">23 ± 3</td><td class="colsep0 rowsep0" align="left">92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">26 ± 3</td><td class="colsep0 rowsep0" align="left">97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>19</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>2</b></i></td><td class="colsep0 rowsep0" align="left"><i>28 ± 19</i></td><td class="colsep0 rowsep0" align="left"><i>4</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>19</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>4</b></i></td><td class="colsep0 rowsep0" align="left"><i>28 ± 18</i></td><td class="colsep0 rowsep0" align="left"><i>10</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">29 ± 0</td><td class="colsep0 rowsep0" align="left">81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>15</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>2</b></i></td><td class="colsep0 rowsep0" align="left"><i>29 ± 3</i></td><td class="colsep0 rowsep0" align="left"><i>49</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">30 ± 2</td><td class="colsep0 rowsep0" align="left">99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">30 ± 6</td><td class="colsep0 rowsep0" align="left">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">31 ± 1</td><td class="colsep0 rowsep0" align="left">97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>35</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>5</b></i></td><td class="colsep0 rowsep0" align="left"><i>33 ± 12</i></td><td class="colsep0 rowsep0" align="left"><i>53</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">33 ± 1</td><td class="colsep0 rowsep0" align="left">89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>19</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>5</b></i></td><td class="colsep0 rowsep0" align="left"><i>34 ± 13</i></td><td class="colsep0 rowsep0" align="left"><i>16</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">34 ± 1</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">34 ± 2</td><td class="colsep0 rowsep0" align="left">93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">36 ± 17</td><td class="colsep0 rowsep0" align="left">87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">37 ± 3</td><td class="colsep0 rowsep0" align="left">97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>19</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>1</b></i></td><td class="colsep0 rowsep0" align="left"><i>37 ± 15</i></td><td class="colsep0 rowsep0" align="left"><i>18</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>19</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>13</b></i></td><td class="colsep0 rowsep0" align="left"><i>37 ± 20</i></td><td class="colsep0 rowsep0" align="left"><i>11</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">38 ± 2</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>1</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>7</b></i></td><td class="colsep0 rowsep0" align="left"><i>39 ± 2</i></td><td class="colsep0 rowsep0" align="left"><i>43</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>1</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>11</b></i></td><td class="colsep0 rowsep0" align="left"><i>39 ± 2</i></td><td class="colsep0 rowsep0" align="left"><i>39</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>19</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>7</b></i></td><td class="colsep0 rowsep0" align="left"><i>39 ± 13</i></td><td class="colsep0 rowsep0" align="left"><i>14</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">39 ± 4</td><td class="colsep0 rowsep0" align="left">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">39 ± 3</td><td class="colsep0 rowsep0" align="left">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>5</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>2</b></i></td><td class="colsep0 rowsep0" align="left"><i>39 ± 3</i></td><td class="colsep0 rowsep0" align="left"><i>68</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">40 ± 2</td><td class="colsep0 rowsep0" align="left">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>35</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>1</b></i></td><td class="colsep0 rowsep0" align="left"><i>40 ± 13</i></td><td class="colsep0 rowsep0" align="left"><i>63</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">40 ± 9</td><td class="colsep0 rowsep0" align="left">105</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">41 ± 3</td><td class="colsep0 rowsep0" align="left">93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>19</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>12</b></i></td><td class="colsep0 rowsep0" align="left"><i>41 ± 21</i></td><td class="colsep0 rowsep0" align="left"><i>23</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>1</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>12</b></i></td><td class="colsep0 rowsep0" align="left"><i>42 ± 3</i></td><td class="colsep0 rowsep0" align="left"><i>49</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">42 ± 2</td><td class="colsep0 rowsep0" align="left">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">42 ± 2</td><td class="colsep0 rowsep0" align="left">90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">44 ± 3</td><td class="colsep0 rowsep0" align="left">93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">44 ± 7</td><td class="colsep0 rowsep0" align="left">72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>1</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>5</b></i></td><td class="colsep0 rowsep0" align="left"><i>45 ± 5</i></td><td class="colsep0 rowsep0" align="left"><i>39</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">45 ± 5</td><td class="colsep0 rowsep0" align="left">98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">45 ± 2</td><td class="colsep0 rowsep0" align="left">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">45 ± 3</td><td class="colsep0 rowsep0" align="left">99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">45 ± 5</td><td class="colsep0 rowsep0" align="left">74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">45 ± 6</td><td class="colsep0 rowsep0" align="left">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>1</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>4</b></i></td><td class="colsep0 rowsep0" align="left"><i>46 ± 3</i></td><td class="colsep0 rowsep0" align="left"><i>44</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">46 ± 6</td><td class="colsep0 rowsep0" align="left">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>35</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>3</b></i></td><td class="colsep0 rowsep0" align="left"><i>46 ± 13</i></td><td class="colsep0 rowsep0" align="left"><i>50</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">46 ± 5</td><td class="colsep0 rowsep0" align="left">85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">47 ± 8</td><td class="colsep0 rowsep0" align="left">88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">47 ± 3</td><td class="colsep0 rowsep0" align="left">92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">48 ± 2</td><td class="colsep0 rowsep0" align="left">88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>11</b></i></td><td class="colsep0 rowsep0" align="left"><i><b>11</b></i></td><td class="colsep0 rowsep0" align="left"><i>49 ± 5</i></td><td class="colsep0 rowsep0" align="left"><i>65</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">49 ± 2</td><td class="colsep0 rowsep0" align="left">82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">49 ± 1</td><td class="colsep0 rowsep0" align="left">92</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">After primary screening, a total of 53 promising clicked dimers were tested for their cytotoxicity toward 2008/MRP1 cells. The clicked dimers were ranked from highest to the lowest according to their MRP1-modulating activity from the primary screening. Each clicked dimer was tested in triplicate and performed in three independent experiments. In cytotoxicity toward 2008/MRP1 cells, the % survival was presented as the mean. The % survival below 70% is in italics, indicating that these dimers alone showed cytotoxicity toward 2008/MRP1 cells and were excluded from the secondary screening.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Secondary Screening of 35 Promising Clicked Dimers in Reversing DOX Resistance in 2008/MRP1 Cells<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="2" align="center">compd</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>Ac</b></th><th class="colsep0 rowsep0" align="center"><b>Az</b></th><th class="colsep0 rowsep0" align="center">% survival, 1 μM dimers + 100 nM DOX, 2008/MRP1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">25 ± 0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">29 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">29 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">30 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">38 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">41 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">42 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">46 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">46 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">46 ± 14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">48 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">48 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">48 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">49 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">49 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">49 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">50 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">50 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">50 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">51 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">51 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">53 ± 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">53 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">54 ± 14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">54 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">55 ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">56 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">56 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">59 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">62 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">63 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">64 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">65 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">66 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">66 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">70 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">71 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">79 ± 3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">A total of 35 dimers showing low cytotoxicity toward 2008/MRP1 cells were selected for secondary screening of MRP1-modulating activity. The cells were incubated with 100 nM DOX and 1 μM clicked dimers together. These dimers were ranked from the highest to the lowest according to the MRP1-modulating activity as determined by % survival. Each dimer was tested in triplicate and performed in three independent experiments. The % survival was presented as the mean here. In the presence of 100 nM DOX, the clicked dimers showing 25–51% survival were selected for determining EC<sub>50</sub> and cytotoxicity toward L929 cells.</p></div></div></div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">2.2.2.  Effective Concentration (EC<sub>50</sub>) and Therapeutic Indexes of Potent Clicked Flavonoid Dimers</h4><div class="NLM_p">After the secondary screening, the top 21 “hit” compounds (% survival of <51% at 1 μM) were resynthesized, purified, and tested for their MRP1-modulating activity. EC<sub>50</sub> values were found to be in nanomolar range from 53 nM to 298 nM and did not show cytotoxicity toward L929 with IC<sub>50</sub> > 50 μM (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Among them, <b>Ac3Az11</b> has the lowest EC<sub>50</sub> in reversing DOX resistance in 2008/MRP1 cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). In contrast, under identical protocol, the EC<sub>50</sub> values of well-established MRP1 inhibitors verapamil (EC<sub>50</sub> = 1925 nM) and MK571 (EC<sub>50</sub> = 19 000 nM) were in micromolar range (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). The potencies of these clicked dimers were about 6.5- to 36-fold and 64- to 358-fold higher than verapamil and MK571, respectively. Moreover, our compounds are relatively nontoxic toward L929 cells. Their selective indexes ranged from >190 to >1887. Selective index was calculated by dividing the IC<sub>50</sub> of modulators toward L929 cells by the EC<sub>50</sub> of modulators in reversing DOX resistance. EC<sub>50</sub> values of pure dimers are in general consistent with the data from the primary and secondary screening using unpurified clicked dimers, indicating that the CuAAC reaction coupled with the high throughput screening is a reliable platform for rapid discovery of MRP1 modulators.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effective Concentrations (EC<sub>50</sub>) of 21 Potent Pure Clicked Dimers and Their Selective Indexes<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">pure clicked dimer</th><th class="colsep0 rowsep0" align="center">L929 (IC<sub>50</sub>, μM)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM) for reversing Dox resistance in 2008/MRP1</th><th class="colsep0 rowsep0" align="center" char=".">selective index</th><th class="colsep0 rowsep0" align="center">linker conjugation site</th><th class="colsep0 rowsep0" align="center" char=".">no. of carbon atoms in linker</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac3Az11</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">53 ± 2</td><td class="colsep0 rowsep0" align="char" char=".">>1887</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac16Az1</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">78 ± 17</td><td class="colsep0 rowsep0" align="char" char=".">>1282</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac12Az1</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">87 ± 17</td><td class="colsep0 rowsep0" align="char" char=".">>1149</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac2Az4</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">95 ± 5</td><td class="colsep0 rowsep0" align="char" char=".">>1053</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac16Az2</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">99 ± 18</td><td class="colsep0 rowsep0" align="char" char=".">>1010</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac5Az1</b></td><td class="colsep0 rowsep0" align="left">>57</td><td class="colsep0 rowsep0" align="left">103 ± 15</td><td class="colsep0 rowsep0" align="char" char=".">>553</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac3Az4</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">103 ± 6</td><td class="colsep0 rowsep0" align="char" char=".">>971</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac1Az1</b></td><td class="colsep0 rowsep0" align="left">60 ± 16</td><td class="colsep0 rowsep0" align="left">113 ± 49</td><td class="colsep0 rowsep0" align="char" char=".">531</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac3Az3</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">121 ± 13</td><td class="colsep0 rowsep0" align="char" char=".">>826</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac5Az3</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">137 ± 12</td><td class="colsep0 rowsep0" align="char" char=".">>365</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac3Az1</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">140 ± 40</td><td class="colsep0 rowsep0" align="char" char=".">>714</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac2Az1</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">151 ± 14</td><td class="colsep0 rowsep0" align="char" char=".">>662</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac16Az7</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">155 ± 33</td><td class="colsep0 rowsep0" align="char" char=".">>645</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac16Az4</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">156 ± 27</td><td class="colsep0 rowsep0" align="char" char=".">>641</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac5Az11</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">175 ± 18</td><td class="colsep0 rowsep0" align="char" char=".">>571</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac13Az5</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">193 ± 13</td><td class="colsep0 rowsep0" align="char" char=".">>518</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac3Az2</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">208 ± 48</td><td class="colsep0 rowsep0" align="char" char=".">>481</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac5Az4</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">217 ± 25</td><td class="colsep0 rowsep0" align="char" char=".">>461</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac5Az7</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">250 ± 31</td><td class="colsep0 rowsep0" align="char" char=".">>400</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac13Az1</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">263 ± 7</td><td class="colsep0 rowsep0" align="char" char=".">>190</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ac2Az11</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">298 ± 44</td><td class="colsep0 rowsep0" align="char" char=".">>336</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>FD-4e</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">73 ± 13</td><td class="colsep0 rowsep0" align="char" char=".">>1370</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">verapamil</td><td class="colsep0 rowsep0" align="left">88 ± 7</td><td class="colsep0 rowsep0" align="left">1925 ± 677</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="char" char=".">/</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MK571</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">19000 ± 1000</td><td class="colsep0 rowsep0" align="char" char=".">>5</td><td class="colsep0 rowsep0" align="left">/</td><td class="colsep0 rowsep0" align="char" char=".">/</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">A total of 21 pure clicked dimers were resynthesized and their EC<sub>50</sub> values determined. EC<sub>50</sub> values were presented as the mean ± standard error of the mean. <i>N</i> = 3–7 independent experiments. Selective index = (IC<sub>50</sub> of modulators toward L929)/(EC<sub>50</sub> of modulators for reversing DOX resistance). L929 is normal mouse fibroblast cell line. These pure clicked dimers can be divided into three classes according to the linker conjugation site: (A) linker conjugated at C7 of A-ring and C4′ of B-ring of flavones, (B) linker conjugated at C4′ of both B-rings of flavones, and (C) linker conjugated at C7 of both A-rings of flavones. “/” means verapamil and MK571 do not contain linker. The chemical structures of these potent pure clicked dimers are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_001.pdf" class="ext-link">Supporting Information (Figure S7–S27)</a>.</p></div></div></div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. EC<sub>50</sub> of <b>Ac3Az11</b> for reversing DOX resistance in 2008/MRP1 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">2.2.3.  Dimeric Clicked Alkyne–Azide Modulator Is Much More Potent than Monomeric Alkyne or Azide in Reversing DOX Resistance in 2008/MRP1 Cells</h4><div class="NLM_p">To illustrate the effect of dimerization in improving the MRP1-modulating activity, we determine the potency of the dimers and monomers. 1 μM clicked dimers <b>Ac3Az11</b> and <b>Ac12Az1</b> showed promising MRP1-modulating activity with RF = 13.5 and 12.2, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). In contrary, their constituent monomers <b>Ac3</b>, <b>Az11</b>, <b>Ac12</b>, and <b>Az1</b> were not active with RF values below 1.8 even when they were used at double the concentration (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). A combination of <b>Ac3</b> and <b>Az11</b> or <b>Ac12</b> and <b>Az1</b> also displayed no activity with RF = 1.3 and 1.5, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). This observation of MRP1 being strongly inhibited by dimeric AcN-AzM modulator, but not by the constituent monomeric AcN or AzM, highlights the importance of dimerization of constituent flavonoid monomers in modulating MRP1.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Comparing MRP1-Modulating Activity of Pure <b>Ac3Az11</b> and <b>Ac12Az1</b> and Their Respective Monomers in 2008/MRP1 Cells<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">mean IC<sub>50</sub> of DOX (nM) in 2008/MRP1 cells</th><th class="colsep0 rowsep0" align="center" char=".">RF</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac3Az11</b></td><td class="colsep0 rowsep0" align="left">31 ± 10</td><td class="colsep0 rowsep0" align="char" char=".">13.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2 μM <b>Ac3</b></td><td class="colsep0 rowsep0" align="left">541 ± 189</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2 μM <b>Az11</b></td><td class="colsep0 rowsep0" align="left">487 ± 108</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac3</b> + 1 μM <b>Az11</b></td><td class="colsep0 rowsep0" align="left">444 ± 101</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac12Az1</b></td><td class="colsep0 rowsep0" align="left">51 ± 16</td><td class="colsep0 rowsep0" align="char" char=".">12.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2 μM <b>Ac12</b></td><td class="colsep0 rowsep0" align="left">566 ± 132</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2 μM <b>Az1</b></td><td class="colsep0 rowsep0" align="left">338 ± 87</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac12</b> + 1 μM <b>Az1</b></td><td class="colsep0 rowsep0" align="left">400 ± 105</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.1% DMSO</td><td class="colsep0 rowsep0" align="left">597 ± 165</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.1% DMSO</td><td class="colsep0 rowsep0" align="left">63 ± 5<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">9.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">2008/MRP1 cells were incubated with either 1 μM clicked dimer or 2 μM alkyne or azide monomers or a mixture of 1 μM each of alkyne and azide monomers in the presence of DOX for 5 days. After incubation, percentage survival was determined by MTS proliferation assay. Relative fold (RF) was determined by dividing the IC<sub>50</sub> value without modulators by IC<sub>50</sub> value with modulators.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">2008 wild type ovarian cancer cells were used. 2008/MRP1 is MRP1 overexpressing ovarian cancer cell line. Each compound was tested in triplicate and performed in three independent experiments. 0.1% DMSO was used as a solvent control.</p></div></div></div></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">2.2.4.  Effect on Intracellular DOX Accumulation in 2008/MRP1 Cells</h4><div class="NLM_p">The above results showed that these triazole linked flavonoid dimers are effective MRP1 modulators. DOX is a fluorescent MRP1substrate that can be used to monitor intracellular drug accumulation. We determined whether the modulation of MRP1-mediated drug resistance is associated with a concomitant increase in drug accumulation. Since <b>Ac3Az11</b>, <b>Ac12Az1</b>, and <b>Ac16Az1</b> are effective MRP1 modulators according to their EC<sub>50</sub> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), we selected these compounds for further characterization. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, treatment of 2008/MRP1 cells with 2 μM compounds <b>Ac3Az11</b>, <b>Ac12Az1</b>, and <b>Ac16Az1</b> resulted in 2.0-fold increase in intracellular DOX accumulation. Verapamil, being a less potent MRP1 modulator, only increased the DOX accumulation by about 1.6-fold (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). MK571, an even less potent modulator, did not increase DOX accumulation in 2008/MRP1 cells at 2 μM (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The result suggests that these flavonoid dimers inhibit transport activity of MRP1 and restore the intracellular DOX concentration to a level similar to that of parental 2008/P cells.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of pure clicked flavonoid dimers on intracellular DOX accumulation in 2008/MRP1 cells. 2008/MRP1 cells were incubated with 5 μM DOX for 120 min at 37 °C with or without 2 μM <b>Ac3Az11</b>, <b>Ac12Az1</b>, <b>Ac16Az1</b>, <b>FD</b>-4e, verapamil, or MK571. 0.2% of DMSO was used as negative control. After incubation, cells were washed and intracellular accumulation of DOX was measured by flow cytometry. Experiments were performed in duplicate and repeated thrice. The florescence level of each sample was normalized to the 0.2% DMSO negative control and presented as a fold-difference. The results were presented as mean ± standard error of mean. Student paired <i>t</i> test was conducted relative to 2008/MRP1 cells incubated with 0.2% DMSO: (∗) <i>P</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">2.2.5.  Effect on MRP1 Protein Expression Level</h4><div class="NLM_p">We characterized the effect of <b>Ac3Az11</b> on MRP1 protein expression by flow cytometry (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). 2008/MRP1 cells has 7.8-fold (<i>P</i> < 0.001) higher levels of MRP1 than the parental 2008/P cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). After incubating with 1, 2, or 5 μM <b>Ac3Az11</b> for 3 days, the high expression level of MRP1 in 2008/MRP1 cells remained unchanged, indicating that <b>Ac3Az11</b> does not affect the protein expression. After co-incubation with <b>Ac3Az11</b>, the increased DOX accumulation level observed in 2008/MRP1 cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) might be due to the loss of functionality of MRP1.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of <b>Ac3Az11</b> on MRP1 protein expression. The 2008/MRP1 cells were incubated with 1, 2, or 5 μM <b>Ac3Az11</b> for 3 days. Total MRP1 level was measured by flow cytometer at FL1 channel. (A) Flow cytometry result of total MRP1 protein expression in 2008/P or 2008/MRP1 cells after incubating with 0.25% DMSO. (B) Total MRP1 protein level of 2008/MRP1 cells after incubating with 1, 2, or 5 μM <b>Ac3Az11</b> for 3 days. <i>N</i> = 3 independent experiments. The fluorescence units were presented as the mean ± standard error of the mean. 0.25% DMSO was used as a solvent control. Student paired <i>t</i> test was conducted between 2008/P and 2008/MRP1 cells after incubating with 0.25% of DMSO for 3 days: (∗∗) <i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">2.2.6.  Effect on DOX Efflux and DOX Influx</h4><div class="NLM_p">We studied if <b>Ac3Ac11</b> increased DOX accumulation in 2008/MRP1 cells by increasing DOX influx or inhibiting DOX efflux. When influx was measured, both 2008/P and 2008/MRP1 cells can influx DOX at almost identical rate with or without <b>Ac3Az11</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). When efflux was measured, 2008/MRP1 cells showed significantly higher efflux rate of DOX than 2008/P cells, with DOX fluorescence dropping to 64% of the original level in 105 min compared to 81% in 2008/P (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). Importantly, addition of <b>Ac3Ac11</b> completely inhibited DOX efflux in 2008/MRP1 cells (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). This result demonstrates that reversal of DOX resistance by <b>Ac3Az11</b> is due to an inhibition of MRP1-mediated drug efflux, leading to an increased drug accumulation and thus restoring the drug sensitivity.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0007.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of <b>Ac3Az11</b> on DOX influx and DOX efflux in 2008/MRP1 cells. In the influx experiments (A), cells were co-incubated with DOX (5 μM) and <b>Ac3Az11</b> (2 μM) in supplemented RPMI1640 medium at 37 °C. 0.25% of DMSO was used as a negative control. The cells were harvested after 0, 15, 30, 45, and 60 min for determining the intracellular DOX concentration. To measure DOX efflux (B), cells were incubated in supplemented RPMI1640 containing 20 μM DOX for 1 h at 37 °C. Cells were then washed and further incubated with or without compound <b>Ac3Az11</b> (2 μM). At 0, 15, 30, 45, 60, 75, 90, and 105 min, cells were harvested and intracellular DOX concentration was measured. The values were presented as the mean ± standard error of the mean. Student paired <i>t</i> test was conducted at each time point in 2008/MRP1 cells after incubating with or without <b>Ac3Az11</b>: (∗∗∗) <i>P</i> < 0.0001 and (∗) <i>P</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">2.2.7.  Preliminary Pharmacokinetics Study of Ac3Az11 in Mice</h4><div class="NLM_p">The previous generation of flavonoid dimer <b>FD</b>-<b>4e</b> has low solubility in many formulations, therefore hampering it from in vivo efficacy study despite its high potency. The present series of flavonoid dimers contain a basic triazole ring, and their hydrochloride salts can be readily prepared. Here we have dissolved <b>Ac3Az11·HCl</b> in a formulation (NMP/Cremorphol/Tween 80/H<sub>2</sub>O = 5:5:4.5:85.5) at 1.5 mg/mL and used it to study intravenous (iv) pharmacokinetics in Balb/c mice (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). <b>Ac3Az11</b> was dosed at 10 mg/kg, and its plasma level in Balb/c mice was monitored up to 360 min after administration. <b>Ac3Az11</b> could be detected in plasma, and its plasma level was maintained above its in vitro EC<sub>50</sub> (53 nM for DOX) for about 90 min (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). In contrast, <b>FD-4e</b> was completely insoluble in the same formulation. When <b>FD-4e</b> was dissolved in DMSO and administered to mice by iv injection, it precipitated very quickly and the concentration of <b>FD-4e</b> in plasma was below the detection limit. Further in vivo efficacy studies of these compounds are in progress.</div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0008.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Pharmacokinetics study of <b>Ac3Az11·HCl</b> in Balb/c mice. <b>Ac3Az11.2·HCl</b> at 10 mg/kg was injected intravenously to the Balb/c mice. At each time point indicated (15, 30, 60, 120, 240, and 360 min), three mice were sacrificed and blood was collected. The plasma level of <b>Ac3Az11</b> was quantified by LC–MS/MS. The data were presented as the mean ± standard error of the mean. In vitro EC<sub>50</sub> (nM) for reversing DOX resistance was 53 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">2.2.8.  In Silico Docking Studies</h4><div class="NLM_p">The electron cryomicroscopy (cryo-EM) structures of bovine MRP1 in two different inward-facing conformations, including an apo form at 3.5 Å resolution without any substrate and a complex form at 3.3 Å resolution with one substrate leukotriene C<sub>4</sub> (LTC<sub>4</sub>), and an outward-facing conformation with an ATP-bound at 3.1 Å resolution have been determined recently.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> These cryo-EM structures suggest that the bovine MRP1 recognizes a wide range of chemicals by forming a single bipartite substrate binding site of higher substrate-binding affinity and extrudes them through reconfiguring substrate binding site to a lower substrate-binding affinity upon ATP binding. More importantly, both bovine MRP1 and human MRP1 share a high level of similarity not only in their physiological functions of xenobiotics extrusion but also in their amino acid sequence identities (91% identical, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_001.pdf" class="ext-link">Figure S27</a>). Therefore, these cryo-EM structures of bovine MRP1 are good homology models that can be employed to perform in silico docking studies for providing more insights into the potential molecular interactions between selected compounds and human MRP1. In the present docking studies, the bovine MRP1 in the inward-facing conformation with LTC4-bound (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UJA">5UJA</a>) was selected as the docking model. Flavonoid dimers <b>Ac3Az11</b>, <b>FD-4e</b>, and DOX, a MRP1 substrate, were docked into this cryo-EM structure, respectively. As shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A1, the highest docking scores of <b>Ac3Az11</b>, <b>FD-4e</b>, and DOX predicted that they all bind to the bipartite binding site of MRP1 and occupy the central translocation pathway in which they share similar interactions with bovine MRP1 as LTC<sub>4</sub> does. The predicted binding poses for <b>Ac3Az11</b>, <b>FD-4e</b>, and DOX are shown in parts A2, A3, and A4 of <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, respectively. Docking results suggested that extensive networks of hydrogen bonding interactions, π–π interactions, and van der Waals contacts are formed inside the bipartite binding site between these ligands and several amino acid residues including His335, Lys332, Leu381, Phe385, Asn1244, Trp1245, Met1092, Ser1096, Thr550, Tyr1242, Trp553, Phe594, Arg1248, and Arg1196. In particular, the “tryptophan sandwich” formed by Trp1245 and Trp553 in the bipartite binding site, is potentially the major interacting amino acid residues as flavonoid dimers <b>Ac3Az11</b>, <b>FD-4e</b>, and DOX were predicted to have strong π–π interactions between the aromatic moieties of these compounds and the indole moieties of Trp. Such π–π interactions were also predicted to occur between the aromatic moieties of these compounds and the phenyl rings of Phe385 and Phe594, respectively. Moreover, extensive networks of hydrogen bonding interactions were predicted to exist between these compounds and the amino acid residues of bovine MRP1. For example, the carbonyl groups of flavonoid dimer <b>Ac3Az11</b> formed hydrogen bonding interactions with Tyr1242 and Ser1096, respectively (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A2); the carbonyl groups and oxygen atoms of flavonoid dimer <b>FD-4e</b> formed hydrogen bonding interactions with Gln1238, Thr1241, and Tyr440, respectively (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A3); the amine group and hydroxyl group of DOX formed hydrogen bonding interactions with Tyr1242 and Tyr440, respectively (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A4). In addition, the linker portion of both flavonoid dimers may form van der Waals contacts with amino acid residues including Tyr1242, Met1092, Glu1088, Thr550, Val554, and Trp553. From the docking studies, the highest docking scores of <b>Ac3Az11</b> (score −114) and <b>FD4e</b> (score −110) were more energetically favorable than that of DOX (score −82) or LTC<sub>4</sub> (score −95), implying that both flavonoid dimers may have stronger binding affinity to bovine MRP1 than that of the substrate DOX or LTC<sub>4</sub>, therefore capable of inhibiting their transportation.</div><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0009.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. In silico docking. (A1) Representation of bovine MRP1 with labeled TMD0, TMD1, TMD2, NBD1, and NBD2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UJA">5UJA</a>). The red square indicates the bipartite binding site with zoomed in view of (A2) <b>Ac3Az11</b> (violet color), (A3) <b>FD-4e</b> (blue color), and (A4) DOX (brown color) in the same binding site with important amino acids highlighted in black and hydrogen bonding interactions indicated as dotted blue lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28">2.2.9.  Modulation Activity of Promising Flavonoid Dimers toward P-gp and BCRP Transporters</h4><div class="NLM_p">Other than MRP1-modulating activity, we also examined the ability of promising clicked flavonoid dimers (listed in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) to reverse P-gp and BCRP-mediated drug resistance. It was found that the P-gp-mediated paclitaxel resistance in LCC6MDR cells and BCRP-mediated topotecan resistance in HEK293/R2 cells were substantially reversed by the clicked dimers at 1 μM, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Compared to cyclosporine A (RF = 79.4), <b>Ac3Az11</b> (RF = 40.7) was about 2-fold lower in P-gp modulating activity (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). On the other hand, the BCRP-modulating activity of <b>Ac3Az11</b> (RF = 18.2) was as potent as Ko143 (RF = 20.7) in reversing topotecan resistance in HEK293/R2 cells. It demonstrates that <b>Ac3Az11</b> and many of the dimers in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> can modulate MRP1-, P-gp-, and BCRP-mediated drug resistance.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Modulating Activity of Promising Clicked Flavonoid Dimers toward P-gp and BCRP Transporters<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">P-gp-expressing LCC6MDR, mean IC<sub>50</sub> of paclitaxel (nM)</th><th class="colsep0 rowsep0" align="center" char=".">RF</th><th class="colsep0 rowsep0" align="center">BCRP-expressing HEK293/R2, mean IC<sub>50</sub> of toptoecan (nM)</th><th class="colsep0 rowsep0" align="center" char=".">RF</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac3Az11</b></td><td class="colsep0 rowsep0" align="left">3.9 ± 1.3</td><td class="colsep0 rowsep0" align="char" char=".">40.7</td><td class="colsep0 rowsep0" align="left">27.3 ± 7.3</td><td class="colsep0 rowsep0" align="char" char=".">18.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac16Az1</b></td><td class="colsep0 rowsep0" align="left">4.1 ± 0.8</td><td class="colsep0 rowsep0" align="char" char=".">38.7</td><td class="colsep0 rowsep0" align="left">39.9 ± 4.0</td><td class="colsep0 rowsep0" align="char" char=".">12.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac12Az1</b></td><td class="colsep0 rowsep0" align="left">8.0 ± 2.1</td><td class="colsep0 rowsep0" align="char" char=".">19.8</td><td class="colsep0 rowsep0" align="left">25.8 ± 4.5</td><td class="colsep0 rowsep0" align="char" char=".">19.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac2Az4</b></td><td class="colsep0 rowsep0" align="left">9.9 ± 0.7</td><td class="colsep0 rowsep0" align="char" char=".">16.0</td><td class="colsep0 rowsep0" align="left">32.6 ± 6.6</td><td class="colsep0 rowsep0" align="char" char=".">15.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac16Az2</b></td><td class="colsep0 rowsep0" align="left">5.0 ± 0.4</td><td class="colsep0 rowsep0" align="char" char=".">31.7</td><td class="colsep0 rowsep0" align="left">47.9 ± 2.5</td><td class="colsep0 rowsep0" align="char" char=".">10.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac5Az1</b></td><td class="colsep0 rowsep0" align="left">2.3 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">69.0</td><td class="colsep0 rowsep0" align="left">47.9 ± 1.8</td><td class="colsep0 rowsep0" align="char" char=".">10.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac3Az4</b></td><td class="colsep0 rowsep0" align="left">7.0 ± 1.4</td><td class="colsep0 rowsep0" align="char" char=".">22.7</td><td class="colsep0 rowsep0" align="left">27.0 ± 5.5</td><td class="colsep0 rowsep0" align="char" char=".">18.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac1Az1</b></td><td class="colsep0 rowsep0" align="left">5.0 ± 1.1</td><td class="colsep0 rowsep0" align="char" char=".">31.7</td><td class="colsep0 rowsep0" align="left">23.1 ± 6.1</td><td class="colsep0 rowsep0" align="char" char=".">21.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac3Az3</b></td><td class="colsep0 rowsep0" align="left">4.3 ± 1.1</td><td class="colsep0 rowsep0" align="char" char=".">36.9</td><td class="colsep0 rowsep0" align="left">30.6 ± 3.3</td><td class="colsep0 rowsep0" align="char" char=".">16.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac5Az3</b></td><td class="colsep0 rowsep0" align="left">2.7 ± 0.7</td><td class="colsep0 rowsep0" align="char" char=".">58.8</td><td class="colsep0 rowsep0" align="left">41.5 ± 2.1</td><td class="colsep0 rowsep0" align="char" char=".">12.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac3Az1</b></td><td class="colsep0 rowsep0" align="left">2.5 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">63.5</td><td class="colsep0 rowsep0" align="left">24.1 ± 9.5</td><td class="colsep0 rowsep0" align="char" char=".">20.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac2Az1</b></td><td class="colsep0 rowsep0" align="left">8.3 ± 1.1</td><td class="colsep0 rowsep0" align="char" char=".">19.1</td><td class="colsep0 rowsep0" align="left">32.0 ± 11.3</td><td class="colsep0 rowsep0" align="char" char=".">15.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac16Az7</b></td><td class="colsep0 rowsep0" align="left">6.0 ± 1.0</td><td class="colsep0 rowsep0" align="char" char=".">26.5</td><td class="colsep0 rowsep0" align="left">40.0 ± 5.7</td><td class="colsep0 rowsep0" align="char" char=".">12.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac16Az4</b></td><td class="colsep0 rowsep0" align="left">9.4 ± 2.5</td><td class="colsep0 rowsep0" align="char" char=".">16.9</td><td class="colsep0 rowsep0" align="left">32.8 ± 12.4</td><td class="colsep0 rowsep0" align="char" char=".">15.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac5Az11</b></td><td class="colsep0 rowsep0" align="left">2.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">54.7</td><td class="colsep0 rowsep0" align="left">20.3 ± 0.8</td><td class="colsep0 rowsep0" align="char" char=".">24.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac13Az5</b></td><td class="colsep0 rowsep0" align="left">3.4 ± 0.3</td><td class="colsep0 rowsep0" align="char" char=".">46.7</td><td class="colsep0 rowsep0" align="left">18.4 ± 3.2</td><td class="colsep0 rowsep0" align="char" char=".">27.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac3Az2</b></td><td class="colsep0 rowsep0" align="left">40.1 ± 5.7</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="left">39.3 ± 5.6</td><td class="colsep0 rowsep0" align="char" char=".">12.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac5Az4</b></td><td class="colsep0 rowsep0" align="left">1.6 ± 0.3</td><td class="colsep0 rowsep0" align="char" char=".">99.2</td><td class="colsep0 rowsep0" align="left">28.8 ± 3.7</td><td class="colsep0 rowsep0" align="char" char=".">17.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac5Az7</b></td><td class="colsep0 rowsep0" align="left">1.6 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">99.2</td><td class="colsep0 rowsep0" align="left">32.0 ± 5.8</td><td class="colsep0 rowsep0" align="char" char=".">15.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac13Az1</b></td><td class="colsep0 rowsep0" align="left">48.7 ± 9.8</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="left">47.9 ± 3.7</td><td class="colsep0 rowsep0" align="char" char=".">10.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM <b>Ac2Az11</b></td><td class="colsep0 rowsep0" align="left">39.9 ± 3.5</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="left">42.6 ± 7.5</td><td class="colsep0 rowsep0" align="char" char=".">11.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM cyclosporine A</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">79.4</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM Ko143</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">24.0 ± 1.9</td><td class="colsep0 rowsep0" align="char" char=".">20.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.1% DMSO</td><td class="colsep0 rowsep0" align="left">158.7 ± 6.1</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">496.7 ± 31.1</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LCC6 + 0.1% DMSO</td><td class="colsep0 rowsep0" align="left">1.6 ± 0.3</td><td class="colsep0 rowsep0" align="char" char=".">99.2</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HEK293/pcDNA3.1 + 0.1% DMSO</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">15.8 ± 1.5</td><td class="colsep0 rowsep0" align="char" char=".">31.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">All promising clicked flavonoid dimers were tested for their modulating activity toward P-gp and BCRP. LCC6MDR is a P-gp transfected breast cancer cell line and was incubated with different concentrations of paclitaxel (0, 1.6, 5, 15, 44, 133, 400 nM) and 1 μM dimers or the known P-gp inhibitor cyclosporine A. HEK293/R2 is a BCRP-transfected human embryonic kidney cell line. It was co-incubated with different doses of topotecan (0, 12, 37, 111, 333, 1000, 3000 nM) and 1 μM of dimers or known BCRP inhibitor Ko143. After 5-day incubation, percentage of survivors was determined by MTS proliferation assay, and the IC<sub>50</sub> of drug was determined. Relative fold (RF) was determined by dividing the IC<sub>50</sub> value without modulators by the IC<sub>50</sub> value with modulators. LCC6 and HEK293/pcDNA3.1 were parental cell line of LCC6MDR and HEK293/R2, respectively. Each compound was tested in triplicate and performed in three independent experiments. 0.1% DMSO was used as a solvent control. ND = not determined.</p></div></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">3.  Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02455" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02455" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Overexpression of MRP1 transporter has been associated with tumor MDR and poor patient outcome. To circumvent MRP1-mediated MDR, combination of MRP1 modulator and anticancer drugs has been considered as a potential treatment. To date, no potent and safe MRP1 modulator has been developed. Herein, we have successfully applied “click chemistry” to construct a 300-member homo- and heteroflavonoid dimer library without the need for purification. With the use of high throughput screening of the unpurified flavonoid dimer library, we were able to rapidly identify the active members of the library. Of the 300 members, we only needed to synthesize and purify 21 members of the flavonoid dimers. The EC<sub>50</sub> of and the selective index of these 21 pure dimers can be further characterized to confirm the validity of such high throughput platform. It is also possible to draw some information regarding the structure–activity relation for MRP1 modulation. Our preliminary conclusion regarding the pharmacophore of active MRP1 modulator is that it should have (1) dimeric structure, (2) unsubstitution or fluoro or methyl substitution at A-ring of flavone, (3) unsubstitution at C-ring of flavone, (4) flavone phenyl A, B, and C rings on both flavonoid moieties, (5) one triazole ring on the linker, and (6) linker length of <i>n</i> = 4–9 atoms on either side of the triazole ring.</div><div class="NLM_p">Among the 21 active pure clicked dimers, all of them possess the above six criteria. The much higher potency of the dimer over the corresponding monomeric units (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>) is in conformity with the divalent approach of design of modulators due to the pseudodimeric structures of MRP1 and ABC transporters in general.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27 ref28">(23−28)</a> Previously, we found that the flavonoid dimer <b>FD</b>-<b>4e</b>, with PEG linker length <i>n</i> = 5 having 15 atoms between the two flavonoid moieties, displayed a low EC<sub>50</sub> value of 73 nM in reversing DOX resistance in a MRP1 overexpressing ovarian (2008/MRP1) cell line, whereas flavonoid dimers with shorter (<i>n</i> ≤ 4) or longer (<i>n</i> ≥ 6) PEG linkers were less potent.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> It is interesting to note that of the 21 active compounds discovered in here, all have linkers with 13–17 atoms between the two flavonoid moieties. Linker conjugation site at the phenyl rings appears to influence the MRP1-modulating activity (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). The top five “hit” compounds, <b>Ac3Az11</b>, <b>Ac16Az1</b>, <b>Ac12Az1</b>, <b>Ac2Az4</b>, and <b>Ac16Az2</b> showed the highest potency (EC<sub>50</sub> ranged from 53 to 99 nM). Their triazole-bridged linkers were conjugated at C7 position of A-ring of one flavonoid moiety and the C4′ position of B-ring of the other flavonoid moiety. Compounds with linkers conjugated at C4′ position of B-rings of both flavonoid moieties showed slightly weaker potency with EC<sub>50</sub> ranging from 103 to 250 nM. Compounds with linker conjugated at C7 position of both A-rings displayed the lowest potency with EC<sub>50</sub> of 298 nM among the 21 compounds. On the other hand, the presence of the triazole group confers different physiochemical properties to the active compounds. Thus, compound <b>Ac3Az11</b> and its hydrochloride salt have much better aqueous solubility than <b>FD-4e</b>. Preliminary pharmacokinetics study showed that <b>Ac3Az11</b> can be administered to mice with sufficient plasma concentration above its EC<sub>50</sub> level (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). In an effort to understand the mechanism of action of these compounds, we demonstrated that <b>Ac3Az11</b> did not affect the protein expression level of MRP1 when 2008/MRP1 cells were incubated with 1, 2, and 5 μM <b>Ac3Az11</b> for 3 days (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). On the other hand, <b>Ac3Az11</b> was found to inhibit DOX efflux in 2008/MRP1 cells (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), leading to an increased drug accumulation (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) and thus restoring the drug sensitivity.</div><div class="NLM_p">Recently, the electron cryomicroscopy structures of bovine MRP1 in the apo form, the substrate added form, and an ATP-bound outward facing form have been reported.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> The high similarities in amino acid sequences and functional properties between bovine and human MRP1 implied that the structure of bovine MRP1 would be a reasonable starting point for structural studies of human MRP1. By comparing the two inward facing structures, it is possible to conclude that the substrate LTC<sub>4</sub> binds to two pockets (H and P) of bMRP1, with one pocket in TMD1 and the other pocket in TMD2.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Furthermore, large conformational change is induced by substrate binding, bringing the two halves of the transporter together. Such a bipartite substrate binding is consistent with the fact that MRP1 can recognize a spectrum of substrates with different chemical structures.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> It is likely that our flavonoid dimer modulators bind to the same bipartite substrate binding site.</div><div class="NLM_p">In our in silico study, the bovine MRP1 in complex with substrate LTC<sub>4</sub> was used to perform the docking studies with flavonoid dimers <b>Ac3Az11</b>, <b>FD-4e</b>, and DOX using CLC Drug Discovery Workbench software. The physiological substrate LTC<sub>4</sub> was used as reference compound to compare the molecular interactions of flavonoid dimers with the bovine MRP1. Compounds <b>Ac3Az11</b>, <b>FD-4e</b>, LTC<sub>4</sub>, and DOX interact with bovine MRP1 in the same binding site with a score of −114, −110, −89, and −82, respectively (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Considering the scores, both flavonoid dimers are expected to bind stronger than LTC<sub>4</sub> or DOX and function as competitive inhibitor. Previously, we demonstrated that <b>FD-4e</b> is a competitive inhibitor of DOX transport by MRP1, presumably by binding to the same binding site as the substrate.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">Other than MRP1-modulating activity, we also examined the ability of <b>Ac3Az11</b> and other dimers to reverse P-gp and BCRP-mediated drug resistance. It appeared that these flavonoid dimers can modulate MRP1- as well as P-gp- and BCRP-mediated drug resistance (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). In the literature, some modulators are known to have activity against two ABC transporters. For example, Ko143 has been reported to have inhibitory effect on the transport activity of both P-gp and MRP1 at concentrations of >1 μM,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and HM30181 was reported to be potent inhibitors of both P-gp and the breast cancer resistance protein (BCRP/ABCG2).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> As far as we are aware, there are few compounds that can inhibit all three ABC transporters. We will further investigate such pan-transporter activities.</div><div class="NLM_p last">To our knowledge, this is the first click-chemistry-derived library coupled with high throughput screening platform for transmembrane transporters. It appears that discovery of potent MRP1 modulators can be achieved effectively and with much less synthetic effort required. The size of the library can be easily expanded by simply increasing the number of monomeric units. We are cognizant of the possibility that such an approach could lead to false negatives in that potentially active compounds may have been missed because the CuAAC reaction is inefficient for some specific alkynes or azides. The platform however can be readily modified by changing the reaction conditions if necessary. This approach can be easily applied to screen for active modulators of other membrane transporters, and this will be pursued.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">4.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62675" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62675" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32">4.1.  Materials and Methods</h3><div class="NLM_p last">All NMR spectra were recorded on a Bruker Advance-III 400 MHz spectrometer at 400 MHz for <sup>1</sup>H and 100 MHz for <sup>13</sup>C, Varian Unity Inova 500 MHz NMR spectrometer at 500 MHz for <sup>1</sup>H and 125 MHz for <sup>13</sup>C, or Bruker Advance-III 600 MHz spectrometer at 600 MHz for <sup>1</sup>H and 151 MHz for <sup>13</sup>C. All NMR measurements were carried out at room temperature, and the chemical shifts are reported as parts per million (ppm) in unit relative to the resonance of CDCl<sub>3</sub> (7.26 ppm in the <sup>1</sup>H, 77.0 ppm for the central line of the triplet in the <sup>13</sup>C modes, respectively). Low-resolution and high-resolution mass spectra were obtained on a Micromass Q-TOF-2 by electron spray ionization (ESI) mode or on Finnigan MAT95 ST by electron ionization (EI) mode. All reagents and solvents were reagent grade and were used without further purification unless otherwise stated. The plates used for thin-layer chromatography (TLC) were E. Merck silica gel 60F<sub>254</sub> (0.25 mm thickness), and they were visualized under short (254 nm) and long (365 nm) UV light. Chromatographic purifications were carried out using MN silica gel 60 (230–400 mesh). Substituted 4′- or 7-hydroxyflavones <b>1a</b>–<b>i</b> were prepared as reported previously.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The purity of tested compounds was determined by HPLC, which was performed by using Agilent 1100 series installed with an analytic column of Agilent Prep-Sil scalar column (4.6 mm × 250 mm, 5 μm) at UV detection of 320 nm (reference at 450 nm) with isocratic elution of hexane (50%)/ethyl acetate (25%)/methanol (25%) at a flow rate of 1.0 mL/min. All tested compounds were shown to have >95% purity according to HPLC.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33">4.2.  Synthesis of Alkynes</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">4.2.1.  General Procedure for the Synthesis of <b>Ac1</b>–<b>Ac5</b>, <b>Ac12</b>, <b>Ac35</b>, and <b>Ac42</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>)</h4><div class="NLM_p last">A round-bottom flask was charged with corresponding 4′-hydroxyflavones or 7-hydroxyflavones <b>1a</b>–<b>e</b> (1 equiv), 5-chloropent-1-yne or 6-chlorohex-1-yne (1.2 equiv), K<sub>2</sub>CO<sub>3</sub> (1.5 equiv), and DMF (3 mL per equiv (mmol)). The reaction mixture was stirred at refluxing temperature for 2 h. When TLC indicated complete consumption of starting material, the reaction mixture was poured into a separating funnel containing water. The mixture was continuously extracted with DCM. If the mixture could not be separated into two layers, a small amount of 1 M HCl was added. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and evaporated to give a brown crude reaction mixture. Purification was performed by flash column chromatography on silica gel with acetone in DCM as eluent to furnish desired product.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">4.2.2.  General Procedure for the Synthesis of <b>Ac6</b>–<b>Ac11</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>)</h4><div class="NLM_p last">Excess KOH (3 M solution in 96% EtOH, 3–4 equiv) was added to a mixture of 4-(hex-5-yn-1-yloxy)benzaldehyde (<b>Ac33</b>) (1.0 equiv) and the substituted 2′-hydroxyacetophenone <b>3a</b>–<b>e</b> (1.0 equiv). The mixture was stirred at room temperature for 16 h. When TLC indicated complete consumption of starting material, the reaction mixture was acidified to pH 5 with 1 M HCl at ice-bath temperature. The yellow precipitate formed was collected by suction filtration. The yellow solid was washed with <i>n</i>-hexane and subjected to crystallization from MeOH to afford the desired chalcones. If no precipitate was formed after the addition of 1 M HCl, then the mixture was continuously extracted with DCM. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and evaporated under reduced pressure to give a crude mixture, which was subjected to flash column chromatography using 15% EtOAc in hexane as eluent to furnish the desired chalcones.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">4.2.3.  Synthesis of 2-(4-(Pent-4-yn-1-yloxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac1</b>)</h4><div class="NLM_p last">This compound (0.53 g, 82%) was obtained from 2-(4-hydroxyphenyl)-4<i>H</i>-chromen-4-one (<b>1a</b>) and 5-chloropent-1-yne according to the general procedure <a class="ref internalNav" href="#sec4_2_1" aria-label="4.2.1">4.2.1</a> described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.21 (dd, <i>J</i> = 7.60, 1.60 Hz, 1H), 7.85 (d, <i>J</i> = 8.80 Hz, 2H), 7.65 (ddd, <i>J</i> = 7.60, 7.20, 1.60 Hz, 1H), 7.52 (d, <i>J</i> = 8.40 Hz, 1H), 7.38 (dd, <i>J</i> = 7.60, 7.20 Hz, 1H), 7.00 (d, <i>J</i> = 8.80 Hz, 2H), 6.71 (s, 1H), 4.13 (t, <i>J</i> = 6.40 Hz, 2H), 2.40–2.44 (m, 2H), 1.98–2.06 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 178.3, 163.3, 161.6, 156.1, 133.5, 127.9, 125.5, 125.0, 123.9, 123.8, 117.9, 114.8, 106.0, 83.1, 69.1, 66.3, 27.9, 15.0; LRMS (ESI) <i>m</i>/<i>z</i> 305 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>20</sub>H<sub>17</sub>O<sub>3</sub> [M + H]<sup>+</sup> 305.1178, found 305.1180.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">4.2.4.  Synthesis of 7-(Pent-4-yn-1-yloxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Ac2</b>)</h4><div class="NLM_p last">This compound (0.33 g, 79%) was obtained from 7-hydroxy-2-phenyl-4<i>H</i>-chromen-4-one (<b>1e</b>) and 5-chloropent-1-yne according to the general procedure <a class="ref internalNav" href="#sec4_2_1" aria-label="4.2.1">4.2.1</a> described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.09 (dd, <i>J</i> = 7.20, 2.80 Hz, 1H), 7.84–7.86 (m, 2H), 7.47–7.49 (m, 3H), 6.93–6.95 (m, 2H), 6.71 (s, 1H), 4.16 (t, <i>J</i> = 6.40 Hz, 2H), 2.40–2.44 (m, 2H), 1.99–2.07 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.7, 163.3, 162.9, 157.8, 131.7, 131.3, 128.9, 126.9, 126.0, 117.7, 114.6, 107.3, 100.8, 82.9, 69.2, 66.7, 27.7, 15.0; LRMS (ESI) <i>m</i>/<i>z</i> 305 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>20</sub>H<sub>17</sub>O<sub>3</sub> [M + H]<sup>+</sup> 305.1178, found 305.1181.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38">4.2.5.  Synthesis of 7-Fluoro-2-(4-(pent-4-yn-1-yloxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac3</b>)</h4><div class="NLM_p last">This compound (0.31 g, 89%) was obtained from 7-fluoro-2-(4-hydroxyphenyl)-4<i>H</i>-chromen-4-one (<b>1b</b>) and 5-chloropent-1-yne according to the general procedure <a class="ref internalNav" href="#sec4_2_1" aria-label="4.2.1">4.2.1</a> described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.20 (dd, <i>J</i> = 6.40, 6.40 Hz, 1H), 7.81 (t, <i>J</i> = 8.80 Hz, 2H), 7.20 (dd, <i>J</i> = 9.20, 2.40 Hz, 1H), 7.08–7.13 (m, 1H), 6.99 (d, <i>J</i> = 8.80 Hz, 2H), 6.68 (s, 1H), 4.14 (t, <i>J</i> = 6.00 Hz, 2H), 2.40–2.44 (m, 2H), 1.98–2.06 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.2, 166.7, 164.2, 163.6, 161.8, 157.1, 156.9, 127.8, 123.5, 120.7, 114.9, 113.7, 113.5, 106.0, 104.7, 104.5, 83.0, 69.1, 66.3, 27.9, 15.0; LRMS (ESI) <i>m</i>/<i>z</i> 323 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>20</sub>H<sub>16</sub>FO<sub>3</sub> [M + H]<sup>+</sup> 323.1083, found 323.1086.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39">4.2.6.  Synthesis of 5-(Benzyloxy)-7-(methoxymethoxy)-2-(4-(pent-4-yn-1-yloxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac4</b>)</h4><div class="NLM_p last">This compound (0.11 g, 71%) was obtained from 5-(benzyloxy)-2-(4-hydroxyphenyl)-7-(methoxymethoxy)-4<i>H</i>-chromen-4-one (<b>1c</b>) and 5-chloropent-1-yne according to the general procedure <a class="ref internalNav" href="#sec4_2_1" aria-label="4.2.1">4.2.1</a> described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.77 (d, <i>J</i> = 8.40 Hz, 2H), 7.62 (d, <i>J</i> = 7.20 Hz, 2H), 7.26–7.40 (m, 3H), 6.95 (d, <i>J</i> = 8.80 Hz, 2H), 6.73 (d, <i>J</i> = 1.60 Hz, 1H), 6.54 (s, 1H), 6.47 (d, <i>J</i> = 1.60 Hz, 1H), 5.21 (s, 2H), 5.20 (s, 2H), 4.09 (t, <i>J</i> = 6.00 Hz, 2H), 3.47 (s, 3H), 2.38–2.42 (m, 2H), 1.97–2.03 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.3, 161.3, 161.1, 160.6, 159.5, 159.3, 136.4, 128.5, 127.5, 126.6, 123.7, 114.7, 110.1, 107.4, 98.6, 95.9, 94.2, 83.1, 70.6, 69.1, 66.2, 56.3, 27.9, 15.0; LRMS (ESI) <i>m</i>/<i>z</i> 471 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>29</sub>H<sub>27</sub>O<sub>6</sub> [M + H]<sup>+</sup> 471.1808, found 471.1815.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40">4.2.7.  Synthesis of 2-(4-(Hex-5-yn-1-yloxy)phenyl)-6-methyl-4<i>H</i>-chromen-4-one (<b>Ac5</b>)</h4><div class="NLM_p last">This compound (0.22 g, 73%) was obtained from 2-(4-hydroxyphenyl)-6-methyl-4<i>H</i>-chromen-4-one (<b>1d</b>) and 6-chloropent-1-yne according to the general procedure <a class="ref internalNav" href="#sec4_2_1" aria-label="4.2.1">4.2.1</a> described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.95 (s, 1 H), 7.80 (d, <i>J</i> = 8.79 Hz, 2 H), 7.37–7.46 (m, 2 H), 6.95 (d, <i>J</i> = 8.30 Hz, 2 H), 6.67 (s, 1 H), 4.02 (t, <i>J</i> = 6.10 Hz, 2 H), 2.41 (s, 3 H), 2.23–2.31 (m, 2 H), 1.97 (br s, 1 H), 1.86–1.96 (m, 2 H), 1.67–1.76 (m, 2 H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 178.3, 163.1, 161.6, 154.3, 134.8, 134.6, 127.8, 124.8, 123.8, 123.4, 117.6, 114.7, 105.8, 83.8, 68.7, 67.4, 28.0, 24.8, 20.8, 18.0; LRMS (ESI) <i>m</i>/<i>z</i> 333 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>22</sub>H<sub>21</sub>O<sub>3</sub> [M + H]<sup>+</sup> 333.1491, found 333.1495.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">4.2.8.  Synthesis of (<i>E</i>)-3-(4-(Hex-5-yn-1-yloxy)phenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one (<b>Ac6</b>)</h4><div class="NLM_p last">This compound (0.36 g, 75%) was obtained from 4-(hex-5-yn-1-yloxy)benzaldehyde (<b>Ac33</b>) and 2′-hydroxyacetophenone (<b>3a</b>) according to the general procedure <a class="ref internalNav" href="#sec4_2_2" aria-label="4.2.2">4.2.2</a> described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.97 (s, 1H), 7.64–7.95 (m, 2H), 7.48–7.62 (m, 2H), 6.94–7.05 (m, 3H), 4.09 (t, <i>J</i> = 6.00 Hz, 2H), 2.31–2.35 (m, 2H), 1.93–2.01 (m, 3H), 1.82–1.85 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 193.6, 163.5, 161.5, 145.4, 136.1, 131.9, 130.5, 129.5, 127.2, 120.1, 118.7, 118.5, 117.5, 114.9, 114.7, 83.9, 68.8, 67.7, 28.1, 24.9, 18.1; LRMS (ESI) <i>m</i>/<i>z</i> 321 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>21</sub>H<sub>21</sub>O<sub>3</sub> [M + H]<sup>+</sup> 321.1491, found 321.1492.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42">4.2.9.  Synthesis of (<i>E</i>)-1-(5-Ethyl-2-hydroxyphenyl)-3-(4-(hex-5-yn-1-yloxy)phenyl)prop-2-en-1-one (<b>Ac7</b>)</h4><div class="NLM_p last">This compound (0.23 g, 61%) was obtained from 4-(hex-5-yn-1-yloxy)benzaldehyde (<b>Ac33</b>) and 2′-hydroxy-5′-ethylacetophenone (<b>3b</b>) according to the general procedure <a class="ref internalNav" href="#sec4_2_2" aria-label="4.2.2">4.2.2</a> described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.84 (s, 1H), 7.91 (d, <i>J</i> = 7.20 Hz,1H), 7.53–7.71 (m, 3H), 7.35 (dd, <i>J</i> = 2.00, 7.20 Hz, 1H), 6.94–6.98 (m, 3H), 4.09 (t, <i>J</i> = 6.00 Hz, 2H), 2.63–2.69 (m, 2H), 1.93–2.01 (m, 3H), 1.74–1.78 (m, 2H), 1.26 (t, <i>J</i> = 6.00 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 193.5, 161.6, 161.4, 145.1, 136.0, 134.3, 130.5, 128.1, 127.3, 119.8, 118.4, 117.6, 114.9, 83.9, 68.8, 67.5, 28 0.1, 24.9, 18.1, 15.9; LRMS (ESI) <i>m</i>/<i>z</i> 349 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>23</sub>H<sub>25</sub>O<sub>3</sub> [M + H]<sup>+</sup> 349.1804, found 349.1806.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">4.2.10.  Synthesis of (<i>E</i>)-3-(4-(Hex-5-yn-1-yloxy)phenyl)-1-(2-hydroxy-5-methylphenyl)prop-2-en-1-one (<b>Ac8</b>)</h4><div class="NLM_p last">This compound (0.25 g, 70%) was obtained from 4-(hex-5-yn-1-yloxy)benzaldehyde (<b>Ac33</b>) and 2′-hydroxy-5′-methylacetophenone (<b>3c</b>) according to the general procedure <a class="ref internalNav" href="#sec4_2_2" aria-label="4.2.2">4.2.2</a> described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.75–1.79 (m, 2H), 1.94–2.01 (m, 3H), 2.29 (t, <i>J</i> = 6.00 Hz, 2H), 2.43 (s, 3H), 4.08 (t, <i>J</i> = 6.00 Hz, 2H), 6.95 (d, <i>J</i> = 8.70 Hz, 2H), 7.46 (d, <i>J</i> = 15.40 Hz, 1H), 7.64 (d, <i>J</i> = 8.70 Hz, 2H), 7.89–8.01 (m, 3H), 13.45 (s, 1H);<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a>C NMR (100 MHz, CDCl<sub>3</sub>) δ 192.3, 161.9, 154.7, 146.9, 137.2, 136.0, 131.0, 130.9, 128.0, 126.8, 124.2, 118.0, 115.0, 83.9, 68.8, 67.5, 28.1, 24.9, 20.3, 18.1; LRMS (ESI) <i>m</i>/<i>z</i> 335 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>22</sub>H<sub>23</sub>O<sub>3</sub> [M + H]<sup>+</sup> 335.1647, found 335.1649.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44">4.2.11.  Synthesis of (<i>E</i>)-3-(4-(Hex-5-yn-1-yloxy)phenyl)-1-(2-hydroxy-4-methylphenyl)prop-2-en-1-one (<b>Ac9</b>)</h4><div class="NLM_p last">This compound (0.31 g, 65%) was obtained from 4-(hex-5-yn-1-yloxy)benzaldehyde (<b>Ac33</b>) and 2′-hydroxy-4′-methylacetophenone (<b>3d</b>) according to the general procedure <a class="ref internalNav" href="#sec4_2_2" aria-label="4.2.2">4.2.2</a> described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 13.02 (s, 1H), 7.92 (d, <i>J</i> = 7.20 Hz, 2H), 7.82 (d, <i>J</i> = 7.20 Hz, 1H), 7.64 (d, <i>J</i> = 8.00 Hz, 2H), 7.55 (d, <i>J</i> = 7.20 Hz, 1H), 6.97 (d, <i>J</i> = 8.00 Hz, 2H), 6.85 (s, 1H), 6.78 (d, <i>J</i> = 7.20 Hz, 1H), 4.08 (t, <i>J</i> = 6.00 Hz, 2H), 2.39 (s, 3H), 2.30–2.34 (m, 2H), 1.93–2.01 (m, 3H), 1.74–1.78 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 193.1, 163.7, 161.3, 147.7, 144.8, 130.4, 129.4, 127.4, 120.0, 118.6, 117.9, 117.7, 114.9, 83.9, 68.7, 67.5, 28.1, 24.9, 21.9, 18.1; LRMS (ESI) <i>m</i>/<i>z</i> 335 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>22</sub>H<sub>23</sub>O<sub>3</sub> [M + H]<sup>+</sup> 335.1647, found 335.1650.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45">4.2.12.  Synthesis of (<i>E</i>)-1-(4-Fluoro-2-hydroxyphenyl)-3-(4-(hex-5-yn-1-yloxy)phenyl)prop-2-en-1-one (<b>Ac10</b>)</h4><div class="NLM_p last">This compound (0.33 g, 69%) was obtained from 4-(hex-5-yn-1-yloxy)benzaldehyde (<b>Ac33</b>) and 2′-hydroxy-5′-fluoroacetophenone (<b>3e</b>) according to the general procedure <a class="ref internalNav" href="#sec4_2_2" aria-label="4.2.2">4.2.2</a> described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 13.37 (s, 1H), 7.89–7.96 (m, 2H), 7.63 (d, <i>J</i> = 8.00 Hz, 2H), 7.47 (d, <i>J</i> = 15.40 Hz, 1H), 6.94 (d, <i>J</i> = 8.00 Hz, 2H), 6.64–6.73 (m, 4H), 4.07 (t, <i>J</i> = 6.00 Hz, 2H), 2.30–2.33 (m, 2H), 1.93–2.01 (m, 3H), 1.74–1.78 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 192.4, 166.2, 166.1, 166.0, 161.6, 145.7, 131.9, 131.7, 130.6, 127.1, 117.2, 115.0, 114.7, 107.1, 106.9, 105.2, 105.0, 84.0, 68.8, 67.6, 28.1, 25.0, 18.2; LRMS (ESI) <i>m</i>/<i>z</i> 339 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>21</sub>H<sub>20</sub>FO<sub>3</sub> [M + H]<sup>+</sup> 339.1396, found 339.1398.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46">4.2.13.  Synthesis of 2-(4-(Pent-4-yn-1-yloxy)phenyl)quinazolin-4(3<i>H</i>)-one (<b>Ac11</b>)</h4><div class="NLM_p last">To a well stirred solution of 4-(pent-4-yn-1-yloxy)benzaldehyde (<b>2a</b>) and 2-aminobenzamide (<b>4</b>) in DMSO at 150 °C was added catalytic amount of iodine. The reaction mixture was further heated for 3 h. When TLC indicated complete consumption of starting material, the reaction mixture was poured into a beaker containing water ice-bath temperature. The white precipitate formed was collected by suction filtration. The white solid was washed with <i>n</i>-hexane and subjected to crystallization from MeOH to afford the desired compound <b>Ac11</b> (0.33 g, 65%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.38 (s, 1H), 8.10–8.17 (m, 3H), 7.78 (dd, <i>J</i> = 7.60, 7.60 Hz, 1H), 7.68 (d, <i>J</i> = 7.60 Hz, 1H), 7.46 (dd, <i>J</i> = 7.60, 7.60 Hz, 1H), 7.06 (d, <i>J</i> = 8.80 Hz, 2H), 4.10 (t, <i>J</i> = 6.00 Hz, 2H), 2.81 (s, 1H), 2.31–2.35 (m, 2H), 1.87–1.93 (m, 2H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.8, 161.5, 152.3, 134.9, 129.9, 127.6, 126.5, 126.2, 125.3, 121.1, 114.8, 84.0, 72.1, 66.7, 28.0, 14.9; LRMS (ESI) <i>m</i>/<i>z</i> 305 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>19</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 305.1290, found 305.1296.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">4.2.14.  Synthesis of 7-(Hex-5-yn-1-yloxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Ac12</b>)</h4><div class="NLM_p last">This compound (0.13 g, 69%) was obtained from 7-hydroxy-2-phenyl-4<i>H</i>-chromen-4-one (<b>1e</b>) and 6-chloropent-1-yne according to the general procedure <a class="ref internalNav" href="#sec4_2_1" aria-label="4.2.1">4.2.1</a> described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.13 (d, <i>J</i> = 8.79 Hz, 1 H), 7.89–7.94 (m, 2 H), 7.49–7.55 (m, 3 H), 6.95–7.01 (m, 2 H), 6.77 (s, 1 H), 4.12 (t, <i>J</i> = 6.34 Hz, 3 H), 2.31 (td, <i>J</i> = 7.08, 2.44 Hz, 2 H), 1.95–2.04 (m, 3 H), 1.71–1.81 (m, 3 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 177.63, 163.44, 162.78, 157.81, 131.72, 131.25, 128.86, 126.83, 125.99, 117.63, 114.58, 107.34, 100.78, 83.71, 68.81, 67.91, 27.87, 24.79, 18.01; LRMS (ESI) <i>m</i>/<i>z</i> 319 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>21</sub>H<sub>19</sub>O<sub>3</sub> [M + H]<sup>+</sup> 319.1334, found 319.1328.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48">4.2.15.  Synthesis of 2-Phenyl-7-(2-(prop-2-yn-1-yloxy)ethoxy)-4<i>H</i>-chromen-4-one (<b>Ac13</b>)</h4><div class="NLM_p last">A round-bottom flask was charged with corresponding 7-hydroxyflavones <b>1e</b> (0.021 mol, 5 g), 2-bromoethanol (0.022 mol, 1.6 mL), K<sub>2</sub>CO<sub>3</sub> (0.021 mol, 2.9 g), and anhydrous DMF (20 mL). The reaction mixture was stirred at refluxing temperature for 3 h. The reaction mixture was poured into a beaker containing ice–water followed by filtration and washing (50 mL hexane). This (3.2 g, 54%) was used without further purification. The obtained compound (7.1 mmol, 2 g) was then dissolved in anhydrous THF (10 mL). To this solution at room temperature was added excess sodium hydride (8.5 mmol, 0.2 g) and propargyl bromide (80% in xylene) (7.1 mmol, 0.79 mL) solution successively at 0 °C for 1 h. The reaction mixture was then stirred for 3 h at rt. When TLC indicated complete consumption of starting material, the reaction mixture was poured into a separating funnel containing water. The mixture was continuously extracted with DCM. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and evaporated to give a brown crude reaction mixture. Purification was performed by flash column chromatography on silica gel with acetone in DCM (1:10) as eluent to furnish titled compound (1.7 g, 75%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.15 (d, <i>J</i> = 8.79 Hz, 1 H), 7.88–7.94 (m, 2 H), 7.49–7.57 (m, 3 H), 7.03 (dd, <i>J</i> = 8.79, 2.44 Hz, 1 H), 7.00 (d, <i>J</i> = 2.44 Hz, 1 H), 6.78 (s, 1 H), 4.24–4.33 (m, 4 H), 3.97–3.99 (m, 2 H), 2.49 (t, <i>J</i> = 2.44 Hz, 1 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 177.5, 163.1, 162.8, 157.7, 131.6, 131.2, 128.8, 126.8, 126.0, 117.8, 114.6, 107.3, 101.0, 79.1, 74.9, 67.7, 58.5; LRMS (ESI) <i>m</i>/<i>z</i> 321 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>20</sub>H<sub>17</sub>O<sub>4</sub> [M + H]<sup>+</sup> 321.1127, found 321.1121.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">4.2.16.  <i>N</i>-Benzyl-<i>N,N</i>-di(prop-2-yn-1-yl)amine (<b>Ac15</b>)</h4><div class="NLM_p last">This compound was commercially available.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50">4.2.17.  Synthesis of 7-(2-(Benzyl(prop-2-yn-1-yl)amino)ethoxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Ac16</b>)</h4><div class="NLM_p last">To a well stirred solution of 7-hydroxyflavones <b>1e</b> (2.9 mmol, 0.7 g), 2-(benzyl(prop-2-yn-1-yl)amino)ethanol (2.9 mmol, 0.56 g), and PPh<sub>3</sub> (0.77 g, 1 equiv) in THF (10 mL) at room temperature was added DIAD (0.58 mL, 1 equiv) dropwise. The reaction mixture was then stirred for 12 h. The reaction mixture was evaporated to give a brown crude reaction mixture. Purification was performed by flash column chromatography on silica gel with acetone in DCM (1:50) as eluent to furnish the titled compound (0.42g, 35%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.13 (d, <i>J</i> = 8.78 Hz, 1 H), 7.88–7.93 (m, 2 H), 7.50–7.55 (m, 3 H), 7.37–7.40 (m, 2 H), 7.31–7.35 (m, 2 H), 7.27–7.29 (m, 1 H), 6.95–7.01 (m, 2 H), 6.77 (s, 1 H), 4.21 (t, <i>J</i> = 5.61 Hz, 2 H), 3.79 (s, 2 H), 3.48 (d, <i>J</i> = 2.44 Hz, 2 H), 3.07 (t, <i>J</i> = 5.61 Hz, 2 H), 2.30 (t, <i>J</i> = 2.20 Hz, 1 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 177.8, 163.2, 163.0, 157.9, 131.8, 131.3, 129.1, 128.9, 128.4, 127.4, 127.0, 126.1, 117.9, 114.7, 107.5, 101.1, 70.0, 67.2, 58.5, 51.7, 42.6; LRMS (ESI) <i>m</i>/<i>z</i> 410 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>27</sub>H<sub>24</sub>NO<sub>3</sub> [M + H]<sup>+</sup> 410.1756, found 410.1750.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51">4.2.18.  Tris(prop-2-yn-1-yl)amine (<b>Ac17</b>)</h4><div class="NLM_p last">This compound was commercially available.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52">4.2.19.  2-(But-3-yn-1-yl)isoindoline-1,3-dione (<b>Ac19</b>)</h4><div class="NLM_p last">This compound was commercially available.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53">4.2.20.  1,3-Diethynylbenzene (<b>Ac22</b>)</h4><div class="NLM_p last">This compound was commercially available.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54">4.2.21.  1,4-Diethynylbenzene (<b>Ac23</b>)</h4><div class="NLM_p last">This compound was commercially available.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55">4.2.22.  <i>N</i>-(Prop-2-yn-1-yl)aniline (<b>Ac27</b>)</h4><div class="NLM_p last">This compound was obtained from aniline (<b>4a</b>) as described.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56">4.2.23.  1,4-Di(prop-2-yn-1-yl)piperazine (<b>Ac29</b>)</h4><div class="NLM_p last">This compound was obtained from piperazine (<b>4b</b>) as described.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57">4.2.24.  <i>N</i><sup>1</sup>,<i>N</i><sup>2</sup>-Dimethyl-<i>N</i><sup>1</sup>,<i>N</i><sup>2</sup>-di(prop-2-yn-1-yl)ethane-1,2-diamine (<b>Ac31</b>)</h4><div class="NLM_p last">This compound was obtained from <i>N</i><sup>1</sup><i>,N</i><sup>2</sup>-dimethylethane-1,2-diamine (<b>4c</b>) as described.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58">4.2.25.  4-(Hex-5-yn-1-yloxy)benzaldehyde (<b>Ac33</b>)</h4><div class="NLM_p last">This compound was obtained from 4-hydroxybenzaldehyde (<b>4d</b>) as described.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59">4.2.26.  Synthesis of 2-(4-(Hex-5-yn-1-yloxy)phenyl)-3-((3-methoxybenzyl)oxy)-4<i>H</i>-chromen-4-one (<b>Ac35</b>)</h4><div class="NLM_p last">This compound (0.84 g, 54%) was obtained from 2-(4-hydroxyphenyl)-3-((3-methoxybenzyl)oxy)-4<i>H</i>-chromen-4-one (<b>1g</b>) according to the general procedure <a class="ref internalNav" href="#sec4_2_1" aria-label="4.2.1">4.2.1</a> described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.27 (dd, <i>J</i> = 7.95, 1.35 Hz, 1 H), 7.99–8.06 (m, 2 H), 7.59–7.68 (m, 1 H), 7.49 (d, <i>J</i> = 8.56 Hz, 1 H), 7.38 (t, <i>J</i> = 7.58 Hz, 1 H), 7.13–7.21 (m, 1 H), 6.89–6.98 (m, 4 H), 6.77–6.83 (m, 1 H), 5.10 (s, 2 H), 4.04 (t, <i>J</i> = 6.24 Hz, 2 H), 3.71 (s, 3 H), 2.29 (td, <i>J</i> = 7.03, 2.57 Hz, 2 H), 2.00 (t, <i>J</i> = 2.69 Hz, 1 H), 1.90–1.98 (m, 2 H), 1.68–1.79 (m, 2 H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 174.8, 160.8, 159.4, 156.2, 155.0, 139.1, 138.2, 133.1, 130.4, 129.1, 125.6, 124.4, 124.1, 123.1, 120.9, 117.8, 114.2, 114.1, 113.5, 83.8, 73.7, 68.7, 67.3, 55.0, 28.1, 24.9,18.0; LRMS (ESI) <i>m</i>/<i>z</i> 455 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>29</sub>H<sub>26</sub>O<sub>5</sub> [M + H]<sup>+</sup> 455.1858, found 455.1853.</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60">4.2.27.  Synthesis of 6-Fluoro-2-(4-(pent-4-yn-1-yloxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac42</b>)</h4><div class="NLM_p last">This compound (0.11 g, 29%) was obtained from 6-fluoro-2-(4-hydroxyphenyl)-4<i>H</i>-chromen-4-one (<b>1c</b>) and 5-chlorohex-1-yne according to the general procedure <a class="ref internalNav" href="#sec4_2_1" aria-label="4.2.1">4.2.1</a> described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78–7.87 (m, 3H), 7.53 (dd, <i>J</i> = 4.16, 9.05 Hz, 1H), 7.33–7.43 (m, 1H), 7.00 (d, <i>J</i> = 8.80 Hz, 2H), 6.70 (s, 1H), 4.14 (t, <i>J</i> = 6.11 Hz, 2H), 2.43 (dt, <i>J</i> = 2.45, 6.85 Hz, 2H), 2.01–2.07 (m, 2H), 2.00 (d, <i>J</i> = 2.45 Hz, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 177.5, 177.4, 163.6, 161.8, 160.7, 158.2, 152.4, 152.3, 128.0, 125.1, 125.0, 123.6, 121.7, 121.5, 120.0, 119.9, 114.9, 110.6, 110.4, 105.4, 83.1, 69.1, 66.4, 27.9, 15.1; LRMS (ESI) <i>m</i>/<i>z</i> 323 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>20</sub>H<sub>16</sub>FO<sub>3</sub> [M + H]<sup>+</sup> 323.1005, found 323.1007.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61">4.3.  General Procedure for Synthesis of <b>Az1</b>–<b>Az5</b>, <b>Az7</b>, <b>Az10</b>, <b>Az11</b>–<b>Az13</b>, <b>Az17</b>, and <b>Az18</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>)</h3><div class="NLM_p">To a round-bottom flask was charged with 4′-hydroxyflavones (<b>1a</b>,<b>d</b>,<b>f</b>–<b>i</b>) or 7-hydroxyflavones (<b>1e</b>) (1 equiv), 2-bromoethanol or 2-(2-chloroethoxy)ethanol or 2-(2-(2-chloroethoxy)ethoxy)ethanol (1.2 equiv), K<sub>2</sub>CO<sub>3</sub> (1.5 equiv) and DMF (3 mL per equiv). The reaction mixture was stirred at refluxing temperature. When TLC indicated complete consumption of starting material, the reaction mixture was poured into a separating funnel containing water. The mixture was continuously extracted with DCM. If the mixture could not be separated into two layers, small amount of 1 M HCl was added. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and evaporated to give a brown crude reaction mixture. Purification was performed by flash column chromatography on silica gel with acetone in DCM as eluent to furnish desired product.</div><div class="NLM_p">The hydroxylated flavone obtained from above was then dissolved in a solution of DCM (1 mL per equiv) and triethylamine (1 mL per equiv) at 0 °C. Methanesulfonyl chloride (1.2 equiv) was then added dropwise and stirred for 1 h at room temperature. When TLC indicated complete consumption of the starting material, the white precipitate formed was removed by passing through a short pad of silica gel to furnish the mesylated product which was sufficiently pure for the next step. To a solution of the mesylate in ACN (2 mL per equiv) was added excess of sodium azide (3 equiv). The solution was kept for reflux at 80 °C for 15 h. The resulting solution was treated with water and then extracted with DCM. The combined organic layer was dried over MgSO<sub>4</sub> and concentrated at reduced pressure to give pale yellow viscous liquid. Purification was performed by flash column chromatography on silica gel with acetone in DCM as eluent to furnish desired product.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62">4.3.1.  Synthesis of 2-(4-(2-(2-Azidoethoxy)ethoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Az1</b>)</h4><div class="NLM_p last">This compound (0.62 g, 45%) was obtained from 2-(4-hydroxyphenyl)-4<i>H</i>-chromen-4-one (<b>1a</b>) and 2-(2-chloroethoxy)ethanol according to the general procedure <a class="ref internalNav" href="#sec4_3" aria-label="4.3">4.3</a> described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.05 (dd, <i>J</i> = 7.60, 1.60 Hz, 1H), 7.68 (d, <i>J</i> = 8.80 Hz, 2H), 7.53 (ddd, <i>J</i> = 7.60, 7.20, 1.60 Hz, 1H), 7.37 (d, <i>J</i> = 8.40 Hz, 1H), 7.26 (dd, <i>J</i> = 7.60, 7.20 Hz, 1H), 6.86 (d, <i>J</i> = 8.80 Hz, 2H), 6.56 (s, 1H), 4.06 (t, <i>J</i> = 4.80 Hz, 2H), 3.77 (t, <i>J</i> = 4.80 Hz, 2H), 3.65 (t, <i>J</i> = 4.80 Hz, 2H), 3.32 (t, <i>J</i> = 4.80 Hz, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 178.0, 163.0, 161.4, 155.9, 133.4, 127.7, 125.3, 124.9, 123.8, 123.6, 117.8, 114.8, 105.8, 70.1, 69.3, 67.4, 50.5; LRMS (ESI) <i>m</i>/<i>z</i> 352 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>19</sub>H<sub>18</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 352.1297, found 352.1295.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63">4.3.2.  Synthesis of 2-(4-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Az2</b>)</h4><div class="NLM_p last">This compound (0.36 g, 41%) was obtained from 2-(4-hydroxyphenyl)-4<i>H</i>-chromen-4-one (<b>1a</b>) and 2-(2-(2-chloroethoxy)ethoxy)ethanol according to the general procedure <a class="ref internalNav" href="#sec4_3" aria-label="4.3">4.3</a> described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.23 (d, <i>J</i> = 7.81 Hz, 1 H), 7.88 (d, <i>J</i> = 10 Hz, 2 H), 7.66–7.71 (m, 1 H), 7.55 (d, <i>J</i> = 8.30 Hz, 1 H), 7.41 (t, <i>J</i> = 7.57 Hz, 1 H), 7.05 (d, <i>J</i> = 10 Hz, 2 H), 6.75 (s, 1 H), 4.20–4.25 (m, 2 H), 3.91–3.93 (m, 2 H), 3.74–3.78 (m, 2 H), 3.68–3.73 (m, 4 H), 3.40 (t, <i>J</i> = 5.12 Hz, 2 H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 178.1, 163.2, 163.1, 161.5, 156.0, 133.4, 127.8, 125.4, 124.9, 123.9, 123.7, 117.8, 114.9, 106.0, 70.7, 70.6, 69.9, 69.5, 67.5, 50.5; LRMS (ESI) <i>m</i>/<i>z</i> 396 [M + H]<sup>+</sup>, 418 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 396.1559, found 396.1544; calcd for C<sub>21</sub>H<sub>21</sub>N<sub>3</sub>O<sub>5</sub>Na [M + Na]<sup>+</sup> 418.1379, found 418.1378.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64">4.3.3.  Synthesis of 2-(4-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)phenyl)-6-methyl-4<i>H</i>-chromen-4-one (<b>Az3</b>)</h4><div class="NLM_p last">This compound (0.21 g, 36%) was obtained from 2-(4-hydroxyphenyl)-6-methyl-4<i>H</i>-chromen-4-one (<b>1d</b>) and 2-(2-(2-chloroethoxy)ethoxy)ethanol according to the general procedure <a class="ref internalNav" href="#sec4_3" aria-label="4.3">4.3</a> described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.85 (s, 1 H), 7.71 (d, <i>J</i> = 10.0 Hz, 2 H), 7.26–7.38 (m, 2 H), 6.90 (d, <i>J</i> = 10.0 Hz, 2 H), 6.57 (s, 1 H), 4.09 (t, <i>J</i> = 4.64 Hz, 2 H), 3.80 (t, <i>J</i> = 4.64 Hz, 2 H), 3.64–3.69 (m, 2 H), 3.58–3.64 (m, 4 H), 3.30 (t, <i>J</i> = 4.88 Hz, 2 H), 2.33 (s, 3 H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 177.9, 162.7, 161.2, 154.0, 134.6, 134.3, 127.5, 124.5, 123.8, 123.1, 117.4, 114.6, 105.5, 77.2, 76.9, 76.7, 70.5, 70.4, 69.7, 69.3, 67.3, 50.3, 20.5; LRMS (ESI) <i>m</i>/<i>z</i> 410 [M + H]<sup>+</sup>, 432 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>22</sub>H<sub>24</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 410.1716, found 410.1709; calcd for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub>Na [M + Na]<sup>+</sup> 432.1535, found 432.1544.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65">4.3.4.  Synthesis of 2-(4-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)phenyl)-6-fluoro-4<i>H</i>-chromen-4-one (<b>Az4</b>)</h4><div class="NLM_p last">This compound (0.23 g, 31%) was obtained from 6-fluoro-2-(4-hydroxyphenyl)-4<i>H</i>-chromen-4-one (<b>1f</b>) and 2-(2-(2-chloroethoxy)ethoxy)ethanol according to the general procedure <a class="ref internalNav" href="#sec4_3" aria-label="4.3">4.3</a> described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.84–7.89 (m, 3 H), 7.53–7.58 (m, 1 H), 7.40 (ddd, <i>J</i> = 9.03, 7.57, 2.93 Hz, 1 H), 7.05 (d, <i>J</i> = 10.0 Hz, 2 H), 4.20–4.24 (m, 2 H), 6.73 (s, 1 H), 3.90–3.93 (m, 2 H), 3.74–3.78 (m, 2 H), 3.67–3.72 (m, 4 H), 3.39 (t, <i>J</i> = 4.88 Hz, 2 H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 176.8 (d, <i>J</i> = 2.50 Hz, C4), 163.1, 161.4, 159.6 (d, <i>J</i> = 244.88 Hz, C6), 151.9 (d, <i>J</i> = 1.25 Hz, C9), 127.5, 124.7 (d, <i>J</i> = 7.25 Hz, C10), 123.2, 121.2 (d, <i>J</i> = 25.63 Hz, C7), 119.7 (d, <i>J</i> = 8.25 Hz, C8), 114.7, 110.0 (d, <i>J</i> = 23.25 Hz, C5), 104.9, 70.5, 70.3, 69.7, 69.7, 69.2, 67.3, 50.3; LRMS (ESI) <i>m</i>/<i>z</i> 414 [M + H]<sup>+</sup>, 436 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>21</sub>H<sub>21</sub>N<sub>3</sub>O<sub>5</sub>F [M + H]<sup>+</sup> 414.1465, found 414.1472; calcd for C<sub>21</sub>H<sub>20</sub>N<sub>3</sub>O<sub>5</sub>FNa [M + Na]<sup>+</sup> 436.1285, found 436.1299.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66">4.3.5.  Synthesis of 2-(4-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)phenyl)-3-(benzyloxy)-4<i>H</i>-chromen-4-one (<b>Az5</b>)</h4><div class="NLM_p last">This compound (0.17 g, 32%) was obtained from 3-(benzyloxy)-2-(4-hydroxyphenyl)-4<i>H</i>-chromen-4-one (<b>1g</b>) and 2-(2-(2-chloroethoxy)ethoxy)ethanol according to the general procedure <a class="ref internalNav" href="#sec4_3" aria-label="4.3">4.3</a> described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.18 (d, <i>J</i> = 10.0 Hz, 1 H), 7.95 (d, <i>J</i> = 10.0 Hz, 2 H), 7.50–7.55 (m, 1 H), 7.38 (d, <i>J</i> = 8.30 Hz, 1 H), 7.32–7.34 (m, 2 H), 7.28 (t, <i>J</i> = 7.50 Hz, 1 H), 7.17–7.24 (m, 3 H), 6.89 (d, <i>J</i> = 10.0 Hz, 2 H), 5.05 (s, 2 H), 4.06–4.12 (m, 2 H), 3.77–3.83 (m, 2 H), 3.64–3.69 (m, 2 H), 3.56–3.64 (m, 4 H), 3.29 (t, <i>J</i> = 4.88 Hz, 2 H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 174.3, 160.2, 155.6, 154.6, 138.8, 136.4, 132.7, 130.0, 128.3, 127.8, 127.6, 125.1, 124.1, 123.7, 122.9, 117.4, 113.9, 73.3, 70.4, 70.2, 69.6, 69.1, 67.1, 50.2; LRMS (ESI) <i>m</i>/<i>z</i> 502 [M + H]<sup>+</sup>, 524 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>28</sub>H<sub>28</sub>N<sub>3</sub>O<sub>6</sub> [M + H]<sup>+</sup> 502.1978, found 502.1989; calcd for C<sub>28</sub>H<sub>27</sub>N<sub>3</sub>O<sub>6</sub>Na [M + Na]<sup>+</sup> 524.1798, found 524.1797.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67">4.3.6.  Synthesis of 2-(4-(2-(2-Azidoethoxy)ethoxy)phenyl)-6-fluoro-4<i>H</i>-chromen-4-one (<b>Az7</b>)</h4><div class="NLM_p last">This compound (0.18 g, 37%) was obtained from 6-fluoro-2-(4-hydroxyphenyl)-4<i>H</i>-chromen-4-one (<b>1f</b>) and 2-(2-chloroethoxy)ethanol according to the general procedure <a class="ref internalNav" href="#sec4_3" aria-label="4.3">4.3</a> described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.81–7.88 (m, 3 H), 7.54 (dd, <i>J</i> = 9.03, 4.15 Hz, 1 H), 7.35–7.42 (m, 1 H), 7.03 (d, <i>J</i> = 9.0, 2 H), 6.71 (s, 1 H), 4.19–4.24 (m, 2 H), 3.88–3.93 (m, 2 H), 3.73–3.79 (m, 2 H), 3.42 (t, <i>J</i> = 4.88 Hz, 2 H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 177.1, 177.0, 163.2, 161.4, 159.2 (d, <i>J</i> = 244.88 Hz, C6), 152.0, 127.7, 124.8 (d, <i>J</i> = 7.83 Hz, C10), 123.5, 121.3 (d, <i>J</i> = 25.13 Hz, C7), 119.8 (d, <i>J</i> = 8.25 Hz, C8), 114.8, 110.2 (d, <i>J</i> = 23.75 Hz, C5), 105.1, 70.0, 69.3, 67.4, 50.4; LRMS (ESI) <i>m</i>/<i>z</i> 370 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>19</sub>H<sub>17</sub>N<sub>3</sub>O<sub>4</sub>F [M + H]<sup>+</sup> 370.1203, found 370.1218.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68">4.3.7.  Synthesis of 2-(4-(2-(2-Azidoethoxy)ethoxy)phenyl)-3-(benzyloxy)-4<i>H</i>-chromen-4-one (<b>Az10</b>)</h4><div class="NLM_p last">This compound (0.23 g, 31%) was obtained from 3-(benzyloxy)-2-(4-hydroxyphenyl)-4<i>H</i>-chromen-4-one (<b>1g</b>) and 2-(2-chloroethoxy)ethanol according to the general procedure <a class="ref internalNav" href="#sec4_3" aria-label="4.3">4.3</a> described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.29 (d, <i>J</i> = 7.81 Hz, 1 H), 8.04 (d, <i>J</i> = 8.79 Hz, 2 H), 7.67 (t, <i>J</i> = 7.81 Hz, 1 H), 7.52 (d, <i>J</i> = 8.30 Hz, 1 H), 7.34–7.44 (m, 3 H), 7.26–7.28 (m, 3 H), 6.99 (d, <i>J</i> = 8.79 Hz, 2 H), 5.12 (s, 2 H), 4.22–4.24 (m, 2 H), 3.91–3.93 (m, 2 H), 3.77–3.79 (m, 2 H), 3.43–3.45 (m, 2 H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 174.6, 160.3, 155.9, 154.9, 139.1, 136.6, 133.0, 130.3, 128.6, 128.0, 127.8, 125.4, 124.3, 123.9, 123.3, 117.7, 114.1, 73.7, 70.0, 69.3, 67.3, 50.4; LRMS (ESI) <i>m</i>/<i>z</i> 458 [M + H]<sup>+</sup>, 480 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>26</sub>H<sub>24</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 458.1716, found 458.1738; calcd for C<sub>26</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub>Na [M + Na]<sup>+</sup> 480.1535, found 480.1527.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69">4.3.8.  Synthesis of 7-(2-(2-Azidoethoxy)ethoxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Az11</b>)</h4><div class="NLM_p last">This compound (0.12 g, 32%) was obtained from 7-hydroxy-2-phenyl-4<i>H</i>-chromen-4-one (<b>1e</b>) and 2-(2-chloroethoxy)ethanol according to the general procedure <a class="ref internalNav" href="#sec4_3" aria-label="4.3">4.3</a> described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.14 (d, <i>J</i> = 8.30 Hz, 1 H), 7.88–7.93 (m, 2 H), 7.49–7.56 (m, 3 H), 6.99–7.04 (m, 2 H), 6.79 (s, 1 H), 4.27 (t, <i>J</i> = 5.0 Hz, 2 H), 3.93 (t, <i>J</i> = 5.0 Hz, 2 H), 3.78 (t, <i>J</i> = 5.0 Hz, 2 H), 3.43 (t, <i>J</i> = 5.0 Hz, 2 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 177.2, 162.8, 162.5, 157.3, 131.2, 131.0, 128.6, 126.4, 125.6, 117.5, 114.3, 106.9, 100.7, 69.9, 69.0, 67.6, 50.3; LRMS (ESI) <i>m</i>/<i>z</i> 352 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>19</sub>H<sub>18</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 352.1297, found 352.1288.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70">4.3.9.  Synthesis of 7-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Az12</b>)</h4><div class="NLM_p last">This compound (0.14 g, 38%) was obtained from 7-hydroxy-2-phenyl-4<i>H</i>-chromen-4-one (<b>1e</b>) and 2-(2-(2-chloroethoxy)ethoxy)ethanol according to the general procedure <a class="ref internalNav" href="#sec4_3" aria-label="4.3">4.3</a> described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.13 (d, <i>J</i> = 8.78 Hz, 1 H), 7.88–7.93 (m, 2 H), 7.49–7.56 (m, 3 H), 6.98–7.04 (m, 2 H), 6.77 (s, 1 H), 4.26 (t, <i>J</i> = 5.0 Hz, 2 H), 3.93–3.95 (m, 2 H), 3.75–3.78 (m, 2 H), 3.67–3.72 (m, 4 H), 3.39 (t, <i>J</i> = 4.88 Hz, 2 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 177.6, 163.2, 162.8, 157.7, 131.6, 131.2, 128.8, 126.8, 125.9, 117.7, 114.6, 107.2, 101.0, 70.7, 70.5, 69.9, 69.3, 67.9, 50.5; LRMS (ESI) <i>m</i>/<i>z</i> 396 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 396.1559, found 396.1544.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71">4.3.10.  Synthesis of 7-(2-Azidoethoxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Az13</b>)</h4><div class="NLM_p last">This compound (0.11 g, 29%) was obtained from 7-hydroxy-2-phenyl-4<i>H</i>-chromen-4-one (<b>1e</b>) and 2-bromoethanol according to the general procedure <a class="ref internalNav" href="#sec4_3" aria-label="4.3">4.3</a> described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.11–8.19 (m, 1 H), 7.85–7.93 (m, 2 H), 7.47–7.56 (m, 3 H), 6.96–7.05 (m, 2 H), 6.74–6.80 (m, 1 H), 4.26 (t, <i>J</i> = 4.64 Hz, 2 H), 3.68 (t, <i>J</i> = 4.88 Hz, 2 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 177.7, 163.1, 162.6, 157.8, 131.7, 131.4, 129.0, 127.3, 126.1, 118.3, 114.3, 107.5, 101.3, 67.4, 49.9; LRMS (ESI) <i>m</i>/<i>z</i> 308 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>17</sub>H<sub>14</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 308.1035, found 308.1037.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72">4.3.11.  Synthesis of 2-(4-(2-(2-Azidoethoxy)ethoxy)phenyl)-3-((3-methoxybenzyl)oxy)-4<i>H</i>-chromen-4-one (<b>Az17</b>)</h4><div class="NLM_p last">The titled compound (0.84 g, 54%) was obtained from 2-(4-hydroxyphenyl)-3-((3-methoxybenzyl)oxy)-4<i>H</i>-chromen-4-one (<b>1g</b>) and 2-(2-chloroethoxy)ethanol according to the general procedure <a class="ref internalNav" href="#sec4_3" aria-label="4.3">4.3</a> described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.28 (dd, <i>J</i> = 1.71, 8.05 Hz, 1H), 8.00–8.06 (m, 2H), 7.66 (ddd, <i>J</i> = 1.95, 7.08, 8.54 Hz, 1H), 7.51 (d, <i>J</i> = 8.79 Hz, 1H), 7.40 (ddd, <i>J</i> = 0.98, 7.08, 8.05 Hz, 1H), 7.18 (t, <i>J</i> = 7.81 Hz, 1H), 6.99–7.01 (m, 1H), 6.97–6.99 (m, 1H), 6.90–6.94 (m, 2H), 6.78–6.83 (m, 1H), 5.11 (s, 2H), 4.20–4.23 (m, 2H), 3.91 (dd, <i>J</i> = 4.15, 5.61 Hz, 2H), 3.75–3.79 (m, 2H), 3.72 (s, 3H), 3.44 (t, <i>J</i> = 4.88 Hz, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 174.8, 160.4, 159.4, 156.1, 155.0, 139.1, 138.1, 133.1, 130.4, 129.0, 125.5, 124.4, 124.0, 123.4, 120.9, 117.8, 114.2, 114.1, 113.6, 73.7, 70.2, 69.5, 67.4, 55.0, 50.6; LRMS (ESI) <i>m</i>/<i>z</i> 488 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>27</sub>H<sub>26</sub>N<sub>3</sub>O<sub>6</sub> [M + H]<sup>+</sup> 488.1822, found 488.1819.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73">4.3.12.  Synthesis of 2-(3-(2-(2-Azidoethoxy)ethoxy)phenyl)-3-(benzyloxy)-4<i>H</i>-chromen-4-one (<b>Az18</b>)</h4><div class="NLM_p last">This compound (0.26 g, 26%) was obtained from 3-(benzyloxy)-2-(3-hydroxyphenyl)-4<i>H</i>-chromen-4-one (<b>1i</b>) and 2-(2-chloroethoxy)ethanol according to the general procedure <a class="ref internalNav" href="#sec4_3" aria-label="4.3">4.3</a> described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.29 (dd, <i>J</i> = 7.81, 1.46 Hz, 1 H), 7.66–7.72 (m, 1 H), 7.63 (dt, <i>J</i> = 8.05, 1.10 Hz, 1 H), 7.60 (dd, <i>J</i> = 2.44, 1.46 Hz, 1 H), 7.53 (d, <i>J</i> = 7.81 Hz, 1 H), 7.39–7.45 (m, 1 H), 7.36–7.39 (m, 1 H), 7.31–7.36 (m, 2 H), 7.24–7.28 (m, 4 H), 7.06 (dt, <i>J</i> = 8.30, 1.46 Hz, 1 H), 5.14 (s, 2 H), 4.03–4.06 (m, 2 H), 3.82–3.85 (m, 2 H), 3.73–3.76 (m, 2 H), 3.40–3.44 (m, 2 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 175.0, 158.4, 155.8, 155.1, 140.0, 136.6, 133.3, 132.0, 129.2, 128.7, 128.1, 128.0, 128.0, 125.6, 124.6, 124.0, 121.3, 117.9, 117.5, 114.5, 74.1, 70.1, 69.5, 67.4, 50.6; LRMS (ESI) <i>m</i>/<i>z</i> 458 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>26</sub>H<sub>24</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup> 458.1716, found 458.1731.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74">4.4.  General Procedure for the Synthesis of Triazole Bridged Flavonoid Dimers Catalyzed by Cu(I)</h3><div class="NLM_p">The Cu(PPh<sub>3</sub>)<sub>3</sub>Br catalyst (MW = 929) (0.05 mmol), prepared according to literature,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> was added to a THF solution (2 mL) containing the azide (<b>Az</b>, 0.1 mmol) and the alkyne (<b>Ac</b>, 0.1 mmol). The reaction mixture was stirred overnight under reflux condition. The crude residue was purified by flash chromatography on silica gel using gradient of 10–50% of acetone with CH<sub>2</sub>Cl<sub>2</sub> to afford the desired compound.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75">4.4.1.  Synthesis of 2-(4-(3-(1-(2-(2-(4-(4-Oxo-4<i>H</i>-chromen-2-yl)phenoxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)propoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac1Az1</b>)</h4><div class="NLM_p last">This compound (90 mg) was obtained from <b>Ac1</b> and <b>Az1</b> in 81% yield according to the general procedure described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.08 (dd, <i>J</i> = 7.20, 7.20 Hz, 2H), 7.74 (d, <i>J</i> = 8.40 Hz, 2H), 7.69 (d, <i>J</i> = 8.40 Hz, 2H), 7.55–7.56 (m, 2H), 7.48 (s, 1H), 7.39 (dd, <i>J</i> = 7.20, 7.20 Hz, 2H), 7.25–7.28 (m, 2H), 6.89 (d, <i>J</i> = 8.40 Hz, 2H), 6.85 (d, <i>J</i> = 8.40 Hz, 2H), 6.60 (s, 1H), 6.57 (s, 1H), 4.50 (t, <i>J</i> = 6.40 Hz, 2H), 4.04 (t, <i>J</i> = 6.40 Hz, 2H), 3.87–3.96 (m, 4H), 3.75 (t, <i>J</i> = 6.40 Hz, 2H), 2.82 (t, <i>J</i> = 6.40 Hz, 2H), 2.08 (t, <i>J</i> = 6.40 Hz, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 178.1, 178.0, 163.1, 162.9, 161.6, 161.2, 155.9, 146.8, 133.4, 127.8, 127.8, 125.3, 124.9, 124.0, 123.7, 123.5, 122.1, 117.8, 117.8, 114.8, 114.7, 105.9, 105.8, 69.7, 69.4, 67.3, 67.0, 50.0, 28.6, 21.9; LRMS (ESI) <i>m</i>/<i>z</i> 656 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>39</sub>H<sub>34</sub>N<sub>3</sub>O<sub>7</sub> [M + H]<sup>+</sup> 656.2397, found 656.2394.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76">4.4.2.  Synthesis of 7-(3-(1-(2-(2-(4-(4-Oxo-4<i>H</i>-chromen-2-yl)phenoxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)propoxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Ac2Az1</b>)</h4><div class="NLM_p last">This compound (82 mg) was obtained from <b>Ac2</b> and <b>Az1</b> in 85% yield according to the general procedure described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.01 (d, <i>J</i> = 7.20 Hz, 1H), 7.99 (d, <i>J</i> = 7.20 Hz, 1H), 7.74–7.79 (m, 4H), 7.50 (dd, <i>J</i> = 7.20, 7.20 Hz, 1H), 7.49 (s, 1H), 7.38–7.42 (m, 4H), 7.28 (dd, <i>J</i> = 7.20, 7.20 Hz, 1H), 6.81–6.91 (m, 4H), 6.63 (s, 1H), 6.61 (s, 1H), 4.51 (t, <i>J</i> = 6.40 Hz, 2H), 3.99–4.06 (m, 4H), 3.89 (t, <i>J</i> = 6.40 Hz, 2H), 3.76 (t, <i>J</i> = 6.40 Hz, 2H), 2.84 (t, <i>J</i> = 6.40 Hz, 2H), 2.13 (t, <i>J</i> = 6.40 Hz, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 178.1, 177.6, 163.3, 162.9, 162.8, 161.2, 157.7, 155.9, 146.6, 133.5, 131.5, 131.3, 128.9, 127.8, 126.7, 125.9, 125.3, 125.0, 124.1, 123.7, 122.1, 117.8, 117.5, 114.8, 114.5, 107.2, 106.0, 100.8, 69.7, 69.4, 67.5, 67.3, 50.0, 28.5, 21.9; LRMS (ESI) <i>m</i>/<i>z</i> 656 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>39</sub>H<sub>34</sub>N<sub>3</sub>O<sub>7</sub> [M + H]<sup>+</sup> 656.2397, found 656.2401.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77">4.4.3.  Synthesis of 6-Fluoro-2-(4-(2-(2-(2-(4-(3-((4-oxo-2-phenyl-4<i>H</i>-chromen-7-yl)oxy)propyl)-1<i>H</i>-1,2,3-triazol-1-yl)ethoxy)ethoxy)ethoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac2Az4</b>)</h4><div class="NLM_p last">This compound (64 mg) was obtained from <b>Ac2</b> and <b>Az4</b> in 72% yield according to the general procedure described above. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.11 (d, <i>J</i> = 8.80 Hz, 1H), 7.88 (d, <i>J</i> = 5.87 Hz, 2H), 7.80–7.85 (m, 3H), 7.49–7.56 (m, 5H), 7.36–7.42 (m, 1H), 7.01 (d, <i>J</i> = 8.80 Hz, 2H), 6.90–6.98 (m, 2H), 6.75 (s, 1H), 6.70 (s, 1H), 4.57 (br s, 2H), 4.18 (br s, 2H), 4.11 (br s, 2H), 3.92 (br s, 2H), 3.82–3.87 (m, 2H), 3.68–3.72 (m, 2H), 3.62–3.68 (m, 3H), 2.94 (br s, 2H), 2.27 (br s, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 177.7, 177.4, 163.4, 163.4, 162.9, 161.5, 160.3, 158.6, 157.9, 152.2, 131.6, 131.4, 128.9, 128.0, 126.9, 126.1, 125.0, 125.0, 123.8, 121.7, 121.5, 120.0, 119.9, 117.7, 114.9, 114.7, 110.6, 110.4, 107.3, 105.4, 100.8, 70.7, 70.4, 69.4, 67.5, 53.7, 31.7, 30.9, 29.2, 21.9; LRMS (ESI) <i>m</i>/<i>z</i> 740 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>41</sub>H<sub>37</sub>N<sub>3</sub>O<sub>8</sub>F [M + H]<sup>+</sup> 718.2559, found 718.2556; calcd for C<sub>41</sub>H<sub>36</sub>N<sub>3</sub>O<sub>8</sub>Na [M + Na]<sup>+</sup> 740.2379, found 740.2381.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78">4.4.4.  Synthesis of 7-(3-(1-(2-(2-((4-Oxo-2-phenyl-4<i>H</i>-chromen-7-yl)oxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)propoxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Ac2Az11</b>)</h4><div class="NLM_p last">This compound (50 mg) was obtained from <b>Ac2</b> and <b>Az11</b> in 69% yield according to the general procedure described above. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.17 (d, <i>J</i> = 7.34 Hz, 1H), 8.11 (d, <i>J</i> = 8.80 Hz, 1H), 7.89 (d, <i>J</i> = 7.34 Hz, 4H), 7.49–7.66 (m, 7H), 7.00 (d, <i>J</i> = 7.34 Hz, 1H), 6.94 (s, 1H), 6.96 (s, 2H), 6.75–6.82 (m, 2H), 4.63 (br s, 2H), 4.21 (br s, 2H), 4.14 (br s, 2H), 4.02 (br s, 2H), 3.89 (br s, 2H), 3.00 (br s, 2H), 2.28 (br s, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 177.8, 177.7, 163.4, 163.1, 163.1, 163.0, 157.9, 157.8, 131.7, 131.7, 131.6, 131.6, 131.5, 131.5, 129.0, 127.3, 127.0, 126.2, 126.2, 126.1, 118.1, 117.7, 114.8, 114.8, 114.5, 107.5, 107.4, 101.2, 101.0, 101.0, 69.7, 69.5, 67.8, 67.6, 28.5, 21.8; LRMS (ESI) <i>m</i>/<i>z</i> 678 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>39</sub>H<sub>34</sub>N<sub>3</sub>O<sub>7</sub> [M + H]<sup>+</sup> 656.2390, found 656.2412; calcd for C<sub>39</sub>H<sub>33</sub>N<sub>3</sub>O<sub>7</sub>Na [M + Na]<sup>+</sup> 678.2216, found 678.2238.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79">4.4.5.  Synthesis of 7-Fluoro-2-(4-(3-(1-(2-(2-(4-(4-oxo-4<i>H</i>-chromen-2-yl)phenoxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)propoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac3Az1</b>)</h4><div class="NLM_p last">This compound (92 mg) was obtained from <b>Ac3</b> and <b>Az1</b> in 91% yield according to the general procedure described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.06–8.09 (m, 2H), 7.74 (d, <i>J</i> = 8.20 Hz, 2H), 7.65 (d, <i>J</i> = 8.20 Hz, 2H), 7.55 (dd, <i>J</i> = 7.20, 7.20 Hz, 1H), 7.48 (s, 1H), 7.48 (d, <i>J</i> = 7.40 Hz, 1H), 7.25–7.27 (m, 2H), 6.98–7.02 (m, 2H), 6.89 (d, <i>J</i> = 8.20 Hz, 2H), 6.84 (d, <i>J</i> = 8.20 Hz, 2H), 6.59 (s, 1H), 6.53 (s, 1H), 4.51 (t, <i>J</i> = 6.40 Hz, 2H), 4.05 (t, <i>J</i> = 6.40 Hz, 2H), 3.95 (t, <i>J</i> = 6.40 Hz, 2H), 3.89 (t, <i>J</i> = 4.80 Hz, 2H), 3.76 (t, <i>J</i> = 4.80 Hz, 2H), 2.82 (t, <i>J</i> = 6.40 Hz, 2H), 2.09 (t, <i>J</i> = 6.40 Hz, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 178.0, 177.1, 166.6, 164.1, 163.4, 162.9, 161.7, 161.2, 156.9, 156.8, 155.9, 146.8, 133.5, 127.8, 127.7, 125.3, 124.9, 124.0, 123.7, 123.1, 122.1, 120.5, 117.8, 114.8, 114.7, 105.9, 105.7, 69.7, 69.4, 67.3, 67.1, 50.0, 28.6, 21.9; LRMS (ESI) <i>m</i>/<i>z</i> 674 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>39</sub>H<sub>33</sub>N<sub>3</sub>O<sub>7</sub> [M + H]<sup>+</sup> 674.2303, found 674.2309.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80">4.4.6.  Synthesis of 7-Fluoro-2-(4-(3-(1-(2-(2-(2-(4-(4-oxo-4<i>H</i>-chromen-2-yl)phenoxy)ethoxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)propoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac3Az2</b>)</h4><div class="NLM_p last">This compound (70 mg) was obtained from <b>Ac3</b> and <b>Az2</b> in 90% yield according to the general procedure described above. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.22 (dd, <i>J</i> = 6.23, 8.72 Hz, 1H), 8.18 (d, <i>J</i> = 9.96 Hz, 1H), 7.86 (d, <i>J</i> = 8.72 Hz, 2H), 7.79 (d, <i>J</i> = 8.72 Hz, 3H), 7.65–7.69 (m, 1H), 7.53 (d, <i>J</i> = 8.72 Hz, 1H), 7.39 (t, <i>J</i> = 7.47 Hz, 1H), 7.23 (dd, <i>J</i> = 2.49, 8.72 Hz, 1H), 7.12–7.16 (m, 1H), 7.01–7.06 (m, <i>J</i> = 8.72 Hz, 2H), 6.94–6.98 (m, <i>J</i> = 8.72 Hz, 2H), 6.75 (s, 1H), 6.68 (s, 1H), 4.62 (br s, 2H), 4.19–4.24 (m, 2H), 4.03–4.07 (m, 2H), 3.94 (br s, 2H), 3.85–3.88 (m, 2H), 3.72 (d, <i>J</i> = 4.98 Hz, 2H), 3.69 (d, <i>J</i> = 4.98 Hz, 2H), 3.01 (br s, 2H), 2.26 (br s, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 178.3, 177.3, 166.4, 164.7, 163.5, 163.2, 161.7, 161.4, 157.0, 157.0, 156.0, 133.7, 129.5, 128.0, 127.9, 125.5, 125.1, 124.2, 123.7, 123.4, 120.6, 117.9, 115.4, 114.9, 114.9, 114.8, 113.8, 113.7, 106.1, 105.9, 104.8, 104.6, 70.6, 70.5, 69.5, 69.0, 67.6, 66.9, 61.8, 28.4, 21.4; LRMS (ESI) <i>m</i>/<i>z</i> 718 [M + H]<sup>+</sup>, 740 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>41</sub>H<sub>37</sub>N<sub>2</sub>O<sub>8</sub>F [M + H]<sup>+</sup> 718.2565, found 718.2588; calcd for C<sub>41</sub>H<sub>36</sub>N<sub>3</sub>O<sub>8</sub>FNa [M + Na]<sup>+</sup> 740.2384, found 740.2397.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81">4.4.7.  Synthesis of 7-Fluoro-2-(4-(3-(1-(2-(2-(2-(4-(6-methyl-4-oxo-4<i>H</i>-chromen-2-yl)phenoxy)ethoxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)propoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac3Az3</b>)</h4><div class="NLM_p last">This compound (55 mg) was obtained from <b>Ac3</b> and <b>Az3</b> in 79% yield according to the general procedure described above. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.15 (dd, <i>J</i> = 6.23, 8.72 Hz, 1H), 7.88 (s, 1H), 7.77 (d, <i>J</i> = 8.72 Hz, 2H), 7.68–7.73 (m, <i>J</i> = 8.72 Hz, 2H), 7.37–7.42 (m, 1H), 7.34 (d, <i>J</i> = 8.72 Hz, 1H), 7.15 (d, <i>J</i> = 7.47 Hz, 1H), 7.05–7.11 (m, 1H), 6.93–6.99 (m, <i>J</i> = 8.72 Hz, 2H), 6.89 (d, <i>J</i> = 8.72 Hz, 2H), 6.63 (s, 1H), 6.59 (s, 1H), 4.54 (br s, 2H), 4.12–4.16 (m, 2H), 3.97 (br s, 2H), 3.88 (br s, 2H), 3.82 (t, <i>J</i> = 4.36 Hz, 2H), 3.66–3.70 (m, 2H), 3.61–3.66 (m, 2H), 2.88 (br s, 2H), 2.36 (s, 3H), 2.15–2.21 (m, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 178.1, 177.1, 166.2, 164.5, 163.3, 162.8, 161.6, 161.2, 156.8, 156.7, 154.1, 134.8, 134.6, 127.8, 127.7, 127.7, 127.6, 124.7, 124.0, 123.2, 123.0, 120.5, 117.5, 114.7, 114.7, 113.6, 113.4, 105.7, 105.6, 104.6, 104.4, 70.5, 70.3, 69.3, 69.3, 67.4, 67.0, 53.7, 29.1, 28.5, 20.7; LRMS (ESI) <i>m</i>/<i>z</i> 732 [M + H]<sup>+</sup>, 754 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>42</sub>H<sub>39</sub>N<sub>3</sub>O<sub>8</sub>F [M + H]<sup>+</sup> 732.2721, found 732.2744; calcd for C<sub>42</sub>H<sub>38</sub>N<sub>3</sub>O<sub>8</sub>FNa [M + Na]<sup>+</sup> 754.2541, found 754.2554.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82">4.4.8.  Synthesis of 7-Fluoro-2-(4-(3-(1-(2-(2-(2-(4-(6-fluoro-4-oxo-4<i>H</i>-chromen-2-yl)phenoxy)ethoxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)propoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac3Az4</b>)</h4><div class="NLM_p last">This compound (60 mg) was obtained from <b>Ac3</b> and <b>Az4</b> in 86% yield according to the general procedure described above. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.21 (dd, <i>J</i> = 6.23, 8.72 Hz, 1H), 7.83 (d, <i>J</i> = 8.72 Hz, 2H), 7.77–7.82 (m, 4H), 7.53 (dd, <i>J</i> = 3.74, 8.72 Hz, 1H), 7.38 (dt, <i>J</i> = 3.11, 8.41 Hz, 1H), 7.19–7.24 (m, 1H), 7.14 (dt, <i>J</i> = 2.49, 8.72 Hz, 1H), 7.02 (d, <i>J</i> = 7.47 Hz, 2H), 6.96 (d, <i>J</i> = 8.72 Hz, 2H), 6.70 (s, 1H), 6.68 (s, 1H), 4.63 (br s, 2H), 4.20 (br s, 2H), 4.05 (br s, 2H), 3.94 (br s, 2H), 3.83–3.90 (m, 2H), 3.70 (dd, <i>J</i> = 4.36, 14.32 Hz, 4H), 3.01 (br s, 2H), 2.27 (br s, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 177.4, 177.4, 177.3, 166.4, 164.7, 163.5, 163.4, 161.6, 161.5, 160.2, 158.6, 157.0, 156.9, 152.2, 131.1, 131.0, 128.0, 128.0, 128.0, 127.9, 125.0, 124.9, 123.9, 123.4, 121.8, 121.6, 120.6, 120.6, 120.0, 119.9, 114.9, 114.8, 113.8, 113.7, 110.5, 110.4, 105.9, 105.4, 104.7, 104.6, 70.6, 70.4, 69.5, 68.9, 67.6, 66.9, 28.4, 21.4; LRMS (ESI) <i>m</i>/<i>z</i> 736 [M + H]<sup>+</sup>, 758 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>41</sub>H<sub>34</sub>N<sub>3</sub>O<sub>8</sub>F<sub>2</sub> [M + H]<sup>+</sup> 736.2392, found 736.2380; calcd for C<sub>41</sub>H<sub>35</sub>N<sub>3</sub>O<sub>8</sub>F<sub>2</sub>Na [M + Na]<sup>+</sup> 758.2290, found 758.2313.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83">4.4.9.  Synthesis of 7-Fluoro-2-(4-(3-(1-(2-(2-((4-oxo-2-phenyl-4<i>H</i>-chromen-7-yl)oxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)propoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac3Az11</b>)</h4><div class="NLM_p last">This compound (70 mg) was obtained from <b>Ac3</b> and <b>Az11</b> in 81% yield according to the general procedure described above. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.21 (dd, <i>J</i> = 6.85, 8.80 Hz, 1H), 8.13 (d, <i>J</i> = 8.80 Hz, 1H), 7.88 (d, <i>J</i> = 6.85 Hz, 2H), 7.79 (d, <i>J</i> = 8.80 Hz, 2H), 7.40–7.69 (m, 4H), 7.17–7.25 (m, 1H), 7.13 (t, <i>J</i> = 8.31 Hz, 1H), 6.92–7.00 (m, 4H), 6.75 (s, 1H), 6.68 (s, 1H), 4.60 (br s, 2H), 4.20 (br s, 2H), 4.07 (br s, 2H), 3.99 (br s, 2H), 3.87 (br s, 2H), 2.18–2.27 (m, 2H), 1.97 (br s, 2H);<sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 177.7, 177.3, 166.9, 164.3, 163.7, 163.1, 161.9, 157.9, 131.7, 131.5, 129.0, 128.1, 128.0, 127.9, 127.2, 126.1, 123.5, 115.0, 114.5, 113.9, 113.6 107.5, 106.0, 104.8, 104.6, 101.2, 77.4, 77.1, 76.7, 69.8, 69.4, 67.8, 67.2, 28.4, 22.0; LRMS (ESI) <i>m</i>/<i>z</i> 674 [M + H]<sup>+</sup>, 696 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>39</sub>H<sub>33</sub>N<sub>3</sub>O<sub>7</sub>F [M + H]<sup>+</sup> 674.6936, found 674.6842; calcd for C<sub>39</sub>H<sub>32</sub>N<sub>3</sub>O<sub>7</sub>FNa [M + Na]<sup>+</sup> 696.2122, found 696.2258. Compound <b>Ac3Az11·HCl</b> was prepared by adding excess conc hydrochloric acid to a solution of <b>Ac3Az11</b> in chloroform at room temperature and stirred for 30 min. The solvents were then evaporated to dryness under high vacuum to obtain <b>Ac3Az11·HCl</b> for PK study.</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84">4.4.10.  Synthesis of 6-Methyl-2-(4-(4-(1-(2-(2-(4-(4-oxo-4<i>H</i>-chromen-2-yl)phenoxy)-ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)butoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac5Az1</b>)</h4><div class="NLM_p last">This compound (52 mg) was obtained from <b>Ac5</b> and <b>Az1</b> in 76% yield according to the general procedure described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.11 (dd, <i>J</i> = 5.0 Hz, 1 H), 7.91 (s, 1 H), 7.78 (d, <i>J</i> = 10.0 Hz, 2 H), 7.73 (d, <i>J</i> = 10.0 Hz, 2 H), 7.59 (t, <i>J</i> = 7.5 Hz, 1 H), 7.47 (s, 1 H), 7.44 (d, <i>J</i> = 8.30 Hz, 1 H), 7.41 (dd, <i>J</i> = 8.54, 2.20 Hz, 1 H), 7.35 (d, <i>J</i> = 8.79 Hz, 1 H), 7.31 (t, <i>J</i> = 10.0 Hz,1 H), 6.94 (d, <i>J</i> = 10.0 Hz, 2 H), 6.87 (d, <i>J</i> = 10.0 Hz, 2 H), 6.65 (s, 1 H), 6.61 (s, 1 H), 4.52 (t, <i>J</i> = 5.12 Hz, 2 H), 4.08–4.14 (m, 2 H), 3.89–3.97 (m, 4 H), 3.77–3.82 (m, 2 H), 2.71–2.77 (m, 2 H), 2.39 (s, 3 H), 1.82 (br s, 4 H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 178.1, 178.0, 163.0, 162.9, 161.6, 161.2, 155.9, 154.2, 147.4, 134.7, 134.5, 133.4, 127.8, 127.7, 125.4, 124.9, 124.7, 124.1, 123.7, 123.3, 121.8, 117.7, 117.5, 114.8, 114.6, 106.0, 105.7, 69.7, 69.4, 67.6, 67.3, 49.9, 28.5, 25.7, 25.2, 20.7; LRMS (ESI) <i>m</i>/<i>z</i> 684 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>41</sub>H<sub>38</sub>N<sub>3</sub>O<sub>7</sub> [M + H]<sup>+</sup> 684.2710, found 684.2727.</div></div><div id="sec4_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85">4.4.11.  Synthesis of 6-Methyl-2-(4-(2-(2-(2-(4-(4-(4-(6-methyl-4-oxo-4<i>H</i>-chromen-2-yl)phenoxy)butyl)-1<i>H</i>-1,2,3-triazol-1-yl)ethoxy)ethoxy)ethoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac5Az3</b>)</h4><div class="NLM_p last">This compound (68 mg) was obtained from <b>Ac5</b> and <b>Az3</b> in 92% yield according to the general procedure described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.97 (s, 1 H), 7.97 (s, 1 H), 7.81 (d, <i>J</i> = 8.79 Hz, 2 H), 7.84 (d, <i>J</i> = 8.79 Hz, 2 H), 7.51 (s, 1 H), 7.47 (t, <i>J</i> = 8.79 Hz, 2 H), 7.41 (t, <i>J</i> = 9.03 Hz, 2 H), 7.00 (m, <i>J</i> = 7.81 Hz, 2 H), 6.94 (d, <i>J</i> = 8.79 Hz, 2 H), 6.70(s, 1 H), 6.69 (s, 1 H), 4.52 (t, <i>J</i> = 4.88 Hz, 2 H), 4.17 (t, <i>J</i> = 4.64 Hz, 2 H), 3.99–4.03 (m, 2 H), 3.88 (t, <i>J</i> = 4.88 Hz, 2 H), 3.85 (t, <i>J</i> = 4.39 Hz, 2 H), 3.67–3.72 (m, 2 H), 3.63–3.67 (m, 2 H), 2.77–2.79 (m, 2 H), 2.43 (s, 3 H), 2.45 (s, 3 H), 1.85–1.87 (m, 4 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 163.1, 162.9, 161.6, 161.3, 154.3, 134.9, 134.9, 134.7, 134.66, 127.8, 127.8, 124.9, 124.3, 123.8, 123.5, 121.8, 117.7, 117.6, 114.8, 114.7, 106.0, 105.8, 70.6, 70.5, 69.6, 69.5, 67.7, 67.5, 50.0, 29.2, 28.6, 25.9, 25.3, 20.8; LRMS (ESI) <i>m</i>/<i>z</i> 742 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>44</sub>H<sub>44</sub>N<sub>3</sub>O<sub>8</sub> [M + H]<sup>+</sup> 742.3128, found 742.3103.</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86">4.4.12.  Synthesis of 6-Fluoro-2-(4-(2-(2-(2-(4-(4-(4-(6-methyl-4-oxo-4<i>H</i>-chromen-2-yl)phenoxy)butyl)-1<i>H</i>-1,2,3-triazol-1-yl)ethoxy)ethoxy)ethoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac5Az4</b>)</h4><div class="NLM_p last">This compound (59 mg) was obtained from <b>Ac5</b> and <b>Az4</b> in 79% yield according to the general procedure described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.97 (s, 1 H), 7.78–7.85 (m, 5 H), 7.49–7.53 (m, 2 H), 7.47 (dd, <i>J</i> = 8.54, 2.20 Hz, 1 H), 7.41 (d, <i>J</i> = 8.30 Hz, 1 H), 7.37 (ddd, <i>J</i> = 9.15, 7.69, 3.17 Hz, 1 H), 6.70 (d, <i>J</i> = 10 Hz, 2 H), 6.94 (d, <i>J</i> = 10 Hz, 2 H), 6.69 (s, 1 H), 6.69 (s, 1 H), 4.52 (t, <i>J</i> = 5.12 Hz, 2 H), 4.13–4.18 (m, 2 H), 3.99–4.04 (m, 2 H), 3.88 (t, <i>J</i> = 5.12 Hz, 2 H), 3.82–3.86 (m, 2 H), 3.67–3.72 (m, 2 H), 3.62–3.67 (m, 2 H), 2.75–2.81 (m, 2 H), 2.44 (s, 3 H), 1.84–1.89 (m, 4 H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ178.1, 177.1, 163.2, 162.9, 161.5, 161.4, 159.3 (d, <i>J</i> = 244.88 Hz, C6), 154.1, 152.0, 147.3, 134.7, 134.5, 127.7, 127.6, 124.8 (d, <i>J</i> = 7.38 Hz, C10), 124.7, 123.6, 123.3, 121.7, 121.4 (d, <i>J</i> = 25.63 Hz, C7), 119.8 (d, <i>J</i> = 7.75 Hz, C8), 117.5, 114.8, 114.6, 110.2 (d, <i>J</i> = 23.38 Hz, C5), 105.6, 105.2, 70.5, 70.3, 69.4, 69.3, 67.6, 67.4, 49.9, 28.4, 25.7, 25.2, 20.7; LRMS (ESI) <i>m</i>/<i>z</i> 746 [M + H]<sup>+</sup>, 768 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>43</sub>H<sub>41</sub>N<sub>3</sub>O<sub>8</sub>F [M + H]<sup>+</sup> 746.2878, found 746.2845; calcd for C<sub>43</sub>H<sub>40</sub>N<sub>3</sub>O<sub>8</sub>FNa [M + Na]<sup>+</sup> 768.2697, found 768.2685.</div></div><div id="sec4_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87">4.4.13.  Synthesis of 6-Fluoro-2-(4-(2-(2-(4-(4-(4-(6-methyl-4-oxo-4<i>H</i>-chromen-2-yl)phenoxy)butyl)-1<i>H</i>-1,2,3-triazol-1-yl)ethoxy)ethoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac5Az7</b>)</h4><div class="NLM_p last">This compound (61 mg) was obtained from <b>Ac5</b> and <b>Az7</b> in 87% yield according to the general procedure described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.95 (s, 1 H), 7.74–7.82 (m, 5 H), 7.43–7.50 (m, 3 H), 7.37–7.41 (m, 1 H), 7.30–7.36 (m, 1 H), 6.97 (d, <i>J</i> = 8.79 Hz, 2 H), 6.91 (d, <i>J</i> = 8.79 Hz, 2 H), 6.67 (s, 1 H), 6.65 (s, 1 H), 4.54 (t, <i>J</i> = 4.88 Hz, 2 H), 4.11–4.16 (m, 2 H), 3.99 (br s, 2 H), 3.94 (t, <i>J</i> = 4.88 Hz, 2 H), 3.81–3.85 (m, 2 H), 2.77 (br s, 2 H), 2.43 (s, 3 H), 1.85 (br s, 4 H); <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 178.3, 177.2, 163.3, 163.0, 161.6, 161.4, 159.4 (d, <i>J</i> = 245.25 Hz, C6), 154.3, 152.2, 152.2, 147.6, 134.9, 134.6, 127.9, 127.8, 125.0 (d, <i>J</i> = 7.38 Hz, C10), 124.9, 124.0, 123.8, 123.4, 121.8, 121.5 (d, <i>J</i> = 25.75 Hz, C7), 119.8 (d, <i>J</i> = 7.75 Hz, C8), 117.6, 114.9, 114.7, 110.5 (d, <i>J</i> = 23.75 Hz, C5), 105.8, 105.4, 69.8, 69.4, 67.7, 67.4, 50.0, 28.5, 25.8, 25.2, 20.8; LRMS (ESI) <i>m</i>/<i>z</i> 702 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>42</sub>H<sub>37</sub>N<sub>3</sub>O<sub>8</sub>F [M + H]<sup>+</sup> 702.2503, found 702.2534.</div></div><div id="sec4_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88">4.4.14.  Synthesis of 6-Methyl-2-(4-(4-(1-(2-(2-((4-oxo-2-phenyl-4<i>H</i>-chromen-7-yl)oxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)butoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac5Az11</b>)</h4><div class="NLM_p last">This compound (40 mg) was obtained from <b>Ac5</b> and <b>Az11</b> in 59% yield according to the general procedure described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.13 (d, <i>J</i> = 8.79 Hz, 1 H), 7.97–8.00 (m, 1 H), 7.83–7.90 (m, 2 H), 7.81 (d, <i>J</i> = 9.0 Hz, 2 H), 7.40–7.54 (m, 6 H), 6.90–7.00 (m, 4 H), 6.75 (s, 1 H), 6.69 (s, 1 H), 4.55–4.75 (m, 2 H), 4.17–4.21 (m, 2 H), 3.95–4.01 (m, 4 H), 3.84–3.88 (m, 2 H), 2.78 (br s, 2 H), 2.45 (s, 3 H), 1.85 (br s, 4 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 178.3, 177.5, 163.1, 163.0, 162.9, 161.6, 157.7, 154.3, 134.8, 134.6, 131.5, 131.4, 128.9, 127.8, 127.0, 126.0, 124.8, 123.8, 123.4, 118.0, 117.6, 114.7, 114.4, 107.4, 105.7, 101.1, 69.7, 69.3, 67.8, 67.7, 50.1, 28.5, 25.7, 25.2, 20.8; LRMS (ESI) <i>m</i>/<i>z</i> 684 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>41</sub>H<sub>38</sub>N<sub>3</sub>O<sub>7</sub> [M + H]<sup>+</sup> 684.2710, found 684.2692.</div></div><div id="sec4_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89">4.4.15.  Synthesis of 7-(4-(1-(2-(2-(4-(4-Oxo-4<i>H</i>-chromen-2-yl)phenoxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)butoxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Ac12Az1</b>)</h4><div class="NLM_p last">This compound (63 mg) was obtained from <b>Ac12</b> and <b>Az1</b> in 91% yield according to the general procedure described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 1.79–1.91 (m, 4 H), 2.74–2.77 (m, 2 H), 3.77–3.83 (m, 2 H), 3.92 (t, <i>J</i> = 4.88 Hz, 2 H), 3.98–4.04 (m, 2 H), 4.08–4.15 (m, 2 H), 4.52 (t, <i>J</i> = 4.88 Hz, 2 H), 6.66 (s, 1 H), 6.67 (s, 1 H), 6.82–6.89 (m, 2 H), 6.92–6.98 (m, 2 H), 7.33 (t, <i>J</i> = 7.32 Hz, 1 H), 7.41–7.50 (m, 5 H), 7.59–7.62 (m, 1 H), 7.77–7.85 (m, 4 H), 8.03 (d, <i>J</i> = 8.75 Hz, 1 H), 8.13 (dd, <i>J</i> = 7.75, 1.45 Hz, 1 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 25.17, 25.74, 28.36, 50.00, 67.36, 68.17, 69.43, 69.73, 100.70, 106.08, 107.29, 114.58, 114.84, 117.57, 117.78, 121.84, 123.74, 124.23, 124.96, 125.45, 125.97, 126.76, 127.83, 128.84, 131.25, 131.66, 133.45, 147.41, 155.96, 157.79, 161.25, 162.77, 162.93, 163.42, 177.58, 178.04; LRMS (ESI) <i>m</i>/<i>z</i> 670 [M + H]<sup>+</sup>, 692 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>40</sub>H<sub>36</sub>N<sub>3</sub>O<sub>7</sub> [M + H]<sup>+</sup> 670.2553, found 670.2525; calcd for C<sub>40</sub>H<sub>35</sub>N<sub>3</sub>O<sub>7</sub>Na [M + Na]<sup>+</sup> 692.2373, found 692.2357.</div></div><div id="sec4_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90">4.4.16.  Synthesis of 7-(2-((1-(2-(2-(4-(4-Oxo-4<i>H</i>-chromen-2-yl)phenoxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)methoxy)ethoxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Ac13Az1</b>)</h4><div class="NLM_p last">This compound (56 mg) was obtained from <b>Ac13</b> and <b>Az1</b> in 84% yield according to the general procedure described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.17 (dd, <i>J</i> = 7.81, 1.46 Hz, 1 H), 8.07 (d, <i>J</i> = 8.79 Hz, 1 H), 7.80–7.87 (m, 4 H), 7.76 (s, 1 H), 7.64 (ddd, <i>J</i> = 8.42, 6.95, 1.71 Hz, 1 H), 7.44–7.53 (m, 4 H), 7.35–7.40 (m, 1 H), 6.96–7.00 (m, 2 H), 6.94 (dd, <i>J</i> = 8.79, 2.44 Hz, 1 H), 6.91 (d, <i>J</i> = 2.44 Hz, 1 H), 6.70 (d, <i>J</i> = 3.90 Hz, 2 H), 4.74 (s, 2 H), 4.57 (t, <i>J</i> = 4.88 Hz, 2 H), 4.18–4.23 (m, 2 H), 4.11–4.16 (m, 2 H), 3.92–3.96 (m, 4 H), 3.82–3.84 (m, 2 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 178.2, 177.6, 163.2, 163.0, 162.9, 161.3, 157.8, 156.1, 144.7, 133.5, 131.7, 131.3, 128.9, 127.9, 126.9, 126.0, 125.6, 125.0, 124.4, 123.8, 123.8, 117.9, 117.8, 114.9, 114.7, 107.4, 106.2, 101.0, 69.6, 69.5, 68.4, 67.9, 67.4, 64.8, 50.2; LRMS (ESI) <i>m</i>/<i>z</i> 672 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>39</sub>H<sub>34</sub>N<sub>3</sub>O<sub>8</sub> [M + H]<sup>+</sup> 672.2346, found 672.2334.</div></div><div id="sec4_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91">4.4.17.  Synthesis of 3-(Benzyloxy)-2-(4-(2-(2-(2-(4-((2-((4-oxo-2-phenyl-4<i>H</i>-chromen-7-yl)oxy)ethoxy)methyl)-1<i>H</i>-1,2,3-triazol-1-yl)ethoxy)ethoxy)ethoxy)phenyl)-4<i>H</i>-chromen-4-one (<b>Ac13Az5</b>)</h4><div class="NLM_p last">This compound (54 mg) was obtained from <b>Ac13</b> and <b>Az5</b> in 66% yield according to the general procedure described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.25 (dd, <i>J</i> = 8.30, 1.46 Hz, 1 H), 8.09 (d, <i>J</i> = 8.79 Hz, 1 H), 7.99–8.03 (m, 2 H), 7.83–7.88 (m, 2 H), 7.78 (s, 1 H), 7.63 (ddd, <i>J</i> = 8.54, 7.08, 1.95 Hz, 1 H), 7.45–7.51 (m, 4 H), 7.34–7.40 (m, 3 H), 7.23–7.30 (m, 3 H), 6.91–6.99 (m, 4 H), 6.72 (s, 1 H), 5.10 (s, 2 H), 4.74 (s, 2 H), 4.54 (t, <i>J</i> = 5.12 Hz, 2 H), 4.18–4.24 (m, 2 H), 4.13–4.18 (m, 2 H), 3.90–3.95 (m, 2 H), 3.88 (t, <i>J</i> = 5.12 Hz, 2 H), 3.80–3.85 (m, 2 H), 3.61–3.71 (m, 4 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 177.6, 174.8, 163.2, 162.9, 160.5, 157.8, 155.9, 155.1, 144.5, 139.2, 136.7, 133.1, 131.7, 131.3, 130.4, 128.9, 128.7, 128.1, 128.0, 126.9, 126.0, 125.7, 124.5, 124.1, 123.7, 123.5, 117.9, 117.8, 114.6, 114.2, 107.4, 101.1, 73.8, 70.7, 70.5, 69.5, 69.4, 68.4, 67.9, 67.4, 64.7, 50.2; LRMS (ESI) <i>m</i>/<i>z</i> 822 [M + H]<sup>+</sup>, 844 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>48</sub>H<sub>44</sub>N<sub>3</sub>O<sub>10</sub> [M + H]<sup>+</sup> 822.3027, found 822.3003; calcd for C<sub>48</sub>H<sub>44</sub>N<sub>3</sub>O<sub>10</sub>Na [M + Na]<sup>+</sup> 844.2846, found 844.2825.</div></div><div id="sec4_4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92">4.4.18.  Synthesis of 7-(2-(Benzyl((1-(2-(2-(4-(4-oxo-4<i>H</i>-chromen-2-yl)phenoxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)methyl)amino)ethoxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Ac16Az1</b>)</h4><div class="NLM_p last">This compound (69 mg) was obtained from <b>Ac16</b> and <b>Az1</b> in 90% yield according to the general procedure described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.14–8.20 (m, 1 H), 8.06 (d, <i>J</i> = 8.79, 1 H), 7.82–7.87 (m, 2 H), 7.75–7.81 (m, 2 H), 7.71 (br s, 1 H), 7.62–7.67 (m, 1 H), 7.43–7.52 (m, 4 H), 7.36–7.39 (m, 3 H), 7.29 (t, <i>J</i> = 7.32 Hz, 2 H), 7.20–7.25 (m, 1 H), 6.83–6.95 (m, 4 H), 6.71 (s, 1 H), 6.67 (s, 1 H), 4.57 (t, <i>J</i> = 5.12 Hz, 2 H), 4.14 (br s, 2 H), 4.06–4.12 (m, 2 H), 3.95 (t, <i>J</i> = 5.12 Hz, 4 H), 3.71–3.85 (m, 4 H), 2.98 (br s, 2 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 178.1, 177.6, 163.2, 163.0, 162.8, 161.2, 157.8, 156.0, 133.5, 131.6, 131.3, 128.9, 128.7, 128.3, 127.8, 127.2, 126.9, 126.0, 125.5, 125.0, 124.3, 123.8, 117.8, 117.7, 114.8, 114.6, 107.3, 106.1, 100.9, 69.7, 69.5, 67.4, 67.1, 58.8, 51.6, 50.2, 49.3; LRMS (ESI) <i>m</i>/<i>z</i> 761 [M + H]<sup>+</sup>, 783 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>46</sub>H<sub>41</sub>N<sub>4</sub>O<sub>7</sub> [M + H]<sup>+</sup> 761.2975, found 761.2980; calcd for C<sub>46</sub>H<sub>40</sub>N<sub>4</sub>O<sub>7</sub>Na [M + Na]<sup>+</sup> 783.2795, found 783.2794.</div></div><div id="sec4_4_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93">4.4.19.  Synthesis of 7-(2-(Benzyl((1-(2-(2-(2-(4-(4-oxo-4<i>H</i>-chromen-2-yl)phenoxy)ethoxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)methyl)amino)ethoxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Ac16Az2</b>)</h4><div class="NLM_p last">This compound (19 mg) was obtained from <b>Ac16</b> and <b>Az2</b> in 24% yield according to the general procedure described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.19 (dd, <i>J</i> = 7.81, 1.46 Hz, 1 H), 8.08 (d, <i>J</i> = 8.79 Hz, 1 H), 7.85–7.90 (m, 2 H), 7.81 (d, <i>J</i> = 9.25 Hz, 2 H), 7.74 (br s, 1 H), 7.66 (ddd, <i>J</i> = 8.66, 6.95, 1.46 Hz, 1 H), 7.45–7.54 (m, 4 H), 7.35–7.44 (m, 3 H), 7.32 (t, <i>J</i> = 7.57 Hz, 2 H), 7.22–7.28 (m, 1 H), 6.88–6.98 (m, 4 H), 6.73 (s, 1 H), 6.70 (s, 1 H), 4.54 (t, <i>J</i> = 5.12 Hz, 2 H), 4.19 (br s, 2 H), 4.07–4.14 (m, 2 H), 3.96 (br s, 2 H), 3.88 (t, <i>J</i> = 5.0 Hz, 2 H), 3.73–3.84 (m, 4 H), 3.59–3.69 (m, 4 H), 3.02 (br s, 2 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 178.2, 177.7, 163.2, 163.1, 162.9, 161.4, 157.8, 156.1, 133.5, 131.7, 131.3, 128.9, 128.8, 128.3, 127.9, 127.2, 126.9, 126.1, 125.6, 125.0, 124.2, 123.8, 117.8, 117.8, 114.9, 114.6, 107.4, 106.1, 100.9, 70.7, 70.5, 69.5, 69.5, 67.5, 67.2, 58.8, 51.6, 50.2, 49.2; LRMS (ESI) <i>m</i>/<i>z</i> 805 [M + H]<sup>+</sup>, 827 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>48</sub>H<sub>45</sub>N<sub>4</sub>O<sub>8</sub> [M + H]<sup>+</sup> 805.3237, found 805.3260; calcd for C<sub>48</sub>H<sub>44</sub>N<sub>4</sub>O<sub>8</sub>Na [M + Na]<sup>+</sup> 827.3057, found 827.3070.</div></div><div id="sec4_4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94">4.4.20.  Synthesis of 7-(2-(Benzyl((1-(2-(2-(2-(4-(6-fluoro-4-oxo-4<i>H</i>-chromen-2-yl)phenoxy)ethoxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)methyl)amino)ethoxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Ac16Az4</b>)</h4><div class="NLM_p last">This compound (57 mg) was obtained from <b>Ac16</b> and <b>Az4</b> in 75% yield according to the general procedure described above. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.10 (d, <i>J</i> = 8.80 Hz, 1H), 7.89 (d, <i>J</i> = 8.80 Hz, 2H), 7.81–7.85 (m, 3H), 7.50–7.55 (m, 5H), 7.42 (t, <i>J</i> = 8.80 Hz, 3H), 7.34 (t, <i>J</i> = 8.07 Hz, 2H), 7.25–7.28 (m, 1H), 6.90–7.00 (m, 5H), 6.76 (s, 1H), 6.71 (s, 1H), 4.57 (t, <i>J</i> = 5.14 Hz, 2H), 4.18–4.25 (m, 2H), 4.11–4.16 (m, 2H), 3.99 (br s, 2H), 3.91 (t, <i>J</i> = 5.14 Hz, 2H), 3.82 (br s, 2H), 3.67–3.71 (m, 3H), 3.64–3.67 (m, 2H), 3.04 (br s, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 177.8, 177.4, 163.4, 163.0, 161.5, 160.3, 158.6, 157.8, 152.2, 131.6, 131.4, 128.9, 128.4, 127.9, 126.9, 126.1, 125.0, 124.9, 123.8, 121.7, 121.5, 120.0, 119.9, 114.9, 114.7, 110.6, 110.4, 107.3, 105.4, 100.9, 70.7, 70.5, 69.5, 69.4, 67.5, 58.7, 53.7, 51.5, 50.2, 49.1; LRMS (ESI) <i>m</i>/<i>z</i> 823 [M + H]<sup>+</sup>, 845 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>48</sub>H<sub>44</sub>N<sub>4</sub>O<sub>8</sub>F [M + H]<sup>+</sup> 823.3143, found 823.3166; calcd for C<sub>48</sub>H<sub>43</sub>N<sub>4</sub>O<sub>8</sub>FNa [M + Na]<sup>+</sup> 845.2963, found 845.2976.</div></div><div id="sec4_4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95">4.4.21.  Synthesis of 7-(2-(Benzyl((1-(2-(2-(4-(6-fluoro-4-oxo-4<i>H</i>-chromen-2-yl)phenoxy)ethoxy)ethyl)-1<i>H</i>-1,2,3-triazol-4-yl)methyl)amino)ethoxy)-2-phenyl-4<i>H</i>-chromen-4-one (<b>Ac16Az7</b>)</h4><div class="NLM_p last">This compound (20 mg) was obtained from <b>Ac16</b> and <b>Az7</b> in 25% yield according to the general procedure described above. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.07 (d, <i>J</i> = 8.79 Hz, 1 H), 7.82–7.88 (m, 2 H), 7.80 (dd, <i>J</i> = 8.05, 3.17 Hz, 1 H), 7.77 (d, <i>J</i> = 8.79 Hz, 2 H), 7.45–7.53 (m, 4 H), 7.21–7.44 (m, 7 H), 6.85–6.96 (m, 4 H), 6.72 (s, 1 H), 6.66 (s, 1 H), 4.58 (br s, 2 H), 4.08–4.27 (m, 4 H), 3.92–4.05 (m, 4 H), 3.68–3.92 (m, 4 H), 2.99 (br s, 2 H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 177.6, 177.3, 163.3, 162.9, 161.4, 159.5 (d, <i>J</i> = 247.45 Hz, C6), 157.8, 152.2, 152.2, 131.6, 131.4, 128.9, 127.9, 127.0, 126.0, 124.0, 121.6 (d, <i>J</i> = 25.25 Hz, C7), 119.9 (d, <i>J</i> = 8.08 Hz, C8), 114.9, 114.6, 110.5 (d, <i>J</i> = 24.24 Hz, C5), 107.4, 105.5, 101.0, 69.7, 69.5, 67.5; LRMS (ESI) <i>m</i>/<i>z</i> 779 [M + H]<sup>+</sup>, 801 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>46</sub>H<sub>40</sub>N<sub>4</sub>O<sub>7</sub>F [M + H]<sup>+</sup> 799.2881, found 799.2916; calcd for C<sub>46</sub>H<sub>39</sub>N<sub>4</sub>O<sub>7</sub>FNa [M + Na]<sup>+</sup> 801.2700, found 801.2738.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96">4.5.  Purity Determination by HPLC</h3><div class="NLM_p last">HPLC equipped with an Agilent Prep-Sil Scalar column 4.6 mm × 250 mm, 5 μm; flow rate, 1 mL/min; detection 254 or 365 nm with reference at 450 nm. The compounds were weighed and dissolved in DCM solution. An amount of 5 μL of the samples was injected into the HPLC system. The chromatographic separation was performed using a linear gradient (1% dichloromethane + 99% methanol changed to 10% dichloromethane + 90% methanol in 20 min).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97">4.6.  Construction of Clicked Flavonoid Dimers Library</h3><div class="NLM_p last">In a 96-well PCR-plate, 1 mM alkyne monomer, 1 mM azide (AzM) monomer, and 1 mM Cu(I) catalyst were added into each well. For diacetylenes <b>Ac15</b>, <b>Ac22</b>, <b>Ac23</b>, <b>Ac29</b>, <b>Ac 31</b> and triacetylene <b>Ac17</b>, 2 mM and 3 mM azides (AzM) were used, respectively. Each reaction was topped up with THF to a final volume of 100 μL. The plate was capped and an ice pad was placed on the top of the plate in order to reduce evaporation of reagents. The plate was placed over 96-well hot plate and heated overnight at 70 °C. In the next morning, the lid of 96-well plate was removed and the reagents inside the well were completely removed by incubating at 70 °C for 1 h. After drying up, each clicked product in each well was dissolved in 100 μL of 100% DMSO. The concentration of clicked product was around 1 mM because the clicked reaction has been reported to be highly efficient (∼100% reaction yield).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98">4.7.  Materials for Biological Studies</h3><div class="NLM_p last">Dimethyl sulfoxide (DMSO), paclitaxel, topotecan, DOX, verapamil, MK571, cyclosporine A, Ko143, and phenazine methosulfate (PMS) were purchased from Sigma-Aldrich. Dulbecco’s modified Eagle’s medium (DMEM), trypsin–ethylenediaminetetraacetic acid (EDTA), and penicillin/streptomycin were purchased from Gibco BRL. Roswell Park Memorial Institute (RPMI) 1640 medium and fetal bovine serum (FBS) was purchased from HyClone Laboratories. 3-(4,5-Dimethylthiazol-2-yl)-5-[3-(carboxymethoxy)phenyl]-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium (MTS) was purchased from Promega. The human breast cancer cell lines LCC6 and P-gp transfectant LCC6MDR were kindly provided by Prof. R. Clarke (Georgetown University Medical School, USA). The human ovarian carcinoma cell lines 2008 and 2008/MRP1 were generous gift from Prof. P. Borst (The Netherlands Cancer Institute, Amsterdam, The Netherlands). The human embryonic kidney cell lines HEK293/pcDNA3.1 and BCRP-transfectant HEK293/R2 were generously provided by Dr. Kenneth To (The Chinese University of Hong Kong, Hong Kong). L929 was purchased from ATCC.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99">4.8.  Cell Culture</h3><div class="NLM_p last">2008/MRP1 was the stable MRP1 transfectant generated by retroviral transduction using pCMV-Neo-MRP1.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> pCMV-Neo-MRP1 was constructed by inserting a <i>Sal</i>I-<i>Not</i>I DNA fragment containing the complete human MRP1 cDNA as a blunt-end fragment in pCMVneo.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> 2008/MRP1 and 2008/P, HEK293/R2 and HEK293/pcDNA3.1 cells were cultured in RPMI 1640 medium with 10% FBS and 100 U/mL penicillin and 100 μg/mL streptomycin and maintained at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub>. The LCC6 and LCC6MDR cells were cultured in DMEM supplemented with 10% FBS and 100 U/mL penicillin and 100 μg/mL of streptomycin and maintained at 37 °C in a humidified atmosphere with 5% CO<sub>2.</sub> The cells were split constantly after a confluent monolayer has been formed. To split cells, the plate was washed briefly with phosphate buffered saline (PBS), treated with 0.05% trypsin–EDTA, and harvested by centrifugation.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100">4.9.  High Throughput Screening of MRP1 Modulating Activity</h3><div class="NLM_p last">4000 cells of 2008/MRP1 and 100 nM doxorubicin (DOX) were mixed with 2 μM (primary screening) or 1 μM (secondary screening) of crude clicked products to a final volume of 200 μL in each well of 96-well plates. The plates were then incubated for 5 days at 37 °C. Three controls were involved in which (1) cancer cells incubated with 2 μM of each pure alkyne and DOX, (2) cancer cells incubated with 2 μM of each pure azide and DOX, and (3) cancer cells incubated with Cu(I) catalyst and DOX. The CellTiter 96 AQ<sub>ueous</sub> assay (Promega) was used to measure the cell proliferation according to the manufacturer’s instructions. MTS (2 mg/mL) and PMS (0.92 mg/mL) were mixed in a ratio of 20:1. An aliquot (10 μL) of the freshly prepared MTS/PMS mixture was added into each well, and the plate was incubated for 2 h at 37 °C. Optical absorbance at 490 nm was recorded with microplate absorbance reader (Bio-Rad). The % of survivors was calculated: [(OD<sub>490nm</sub> in the presence of DOX and dimers)/(OD<sub>490nm</sub> in the absence of DOX and dimers)] × 100. All experiments were performed in triplicate and repeated at least thrice, and the results were represented as mean ± standard error of mean.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101">4.10.  Cell Proliferation Assay of LCC6MDR and HEK293/R2</h3><div class="NLM_p last">6500 cells of LCC6MDR or 5000 cells of HEK293/R2 were seeded into each well of 96-well plate in a total volume of 200 μL. LCC6MDR cells were incubated with a range of paclitaxel (0, 4.1, 12, 37, 111, 333, and 400 nM) and 1 μM of modulator. HEK293/R2 cells were incubated with different concentrations of topotecan (0, 12, 37, 111, 333, 1000, 3000 nM) and 1 μM modulator. The plates were incubated at 37 °C with 5% CO<sub>2</sub> for 5 days. After incubation, the cell survival in each well was determined by MTS assay as described above.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102">4.11.  DOX Accumulation Assay</h3><div class="NLM_p last">DOX accumulation assay was done in 1 mL volume. 5 × 10<sup>5</sup> 2008/MRP1 cells were added in an Eppendorf tube and incubated with 5 μM DOX and 2 μM modulators (<b>Ac3Az11</b>, <b>Ac12Az1</b>, <b>Ac16Az1</b>, verapamil, and MK571) at 37 °C for 120 min. A 0.2% DMSO was used as a negative control. After incubation, the cells were spun down and washed with cold PBS, pH 7.4, 2 times and finally resuspended with 300 μL of cold PBS, pH 7.4. The intracellular DOX level was analyzed by BD C6 Accuri flow cytometer using FL2 channel at EX 480 nm and EM 590 nm. For each sample, a total of 20 000 events was collected.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103">4.12.  Determination of MRP1 Protein Expression</h3><div class="NLM_p last">20 000 cells of 2008/P and 2008/MRP1 cells were seeded in a 6-well plate and incubated with 0, 1, 2, 5 μM <b>Ac3Az11</b> for 3 days, respectively. After 3 days, the cells were trypsinized and washed once with 1× PBS. After spinning down the cells, they were fixed with 4% paraformaldehyde at room temperature for 15 min and then permeabilized with 0.5% Tween 20 at room temperature for 15 min. The cells were resuspended in 100 μL of FACS buffer (1% BSA, 1 mM EDTA, 0.1% Tween 20 in PBS) and stained with 2.5 μL of FITC mouse anti-human MRP1 antibody (BD bioscience) at 4 °C for 45 min. After staining, the cells were washed once with 500 μL of cold FACS buffer and resuspended in 200 μL of FACS buffer. The MRP1-FITC level was analyzed by BD C6 Accuri flow cytometer using FL1 channel at EX 480 nm and EM 533/30 nm. For each sample, a total of 20 000 events was collected.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104">4.13.  Dox Influx and Efflux Studies</h3><div class="NLM_p last">To measure the DOX influx, 2008/P and 2008/MRP1 cells were coincubated with DOX (5 μM) and <b>Ac3Az11</b> (2 μM) in the supplemented RPMI1640 medium at 37 °C. 0.25% of DMSO acted as a negative control. The cells were harvested after 0, 15, 30, 45, and 60 min for determining the intracellular DOX concentration as described previously. The DOX level was determined by C6 Accuri flow cytometer as described previously. The % of DOX increase was calculated as [(DOX level at final time point – DOX level at 0 min)/DOX level at 0 min] × 100. To measure DOX efflux, 2008/P and 2008/MRP1 cells were incubated in supplemented RPMI1640 containing 20 μM DOX for 1 h at 37 °C. Then the cells were washed and further incubated with or without compound <b>Ac3Az11</b> (2 μM). At 0, 15, 30, 45, 60, 75, 90, and 105 min, the cells were harvested for measuring the intracellular DOX concentration. The % of DOX reduction was calculated as [(DOX level at final time point/DOX level at 0 min)] × 100.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105">4.14.  Pharmacokinetic Studies</h3><div class="NLM_p last">This animal study was conducted in full compliance with the standard protocol approved by the Animal Subjects Ethics Subcommittee (ASESC) of The Hong Kong Polytechnic University (ASESC Case No. 14-15/02-ABCT-R-GRF). Female Balb/c mice of weight 18–23 g were obtained from the Centralised Animal Facilities of The Hong Kong Polytechnic University. They were kept in a temperature and humidity controlled environment with 12 h light–dark cycle with the provision of standard diet and water throughout the experiment. A <b>Ac3Az11·HCl</b> solution was prepared in a formulation (NMP/Cremorphol/Tween80/ H<sub>2</sub>O = 5:5:4.5:85.5). <b>Ac3Az11·HCl</b> at dosage of 10 mg/kg was administered to female Balb/c mice through the intravenous (iv) injection by using a 25G needle. Blood samples were collected in heparinized tubes by cardiac puncture after deep anesthesia by ethyl ether at 15, 30, 60, 90, 120, 240, and 360 min postadministration of <b>Ac3Az11·HCl</b>. Blood samples were centrifuged at 16 000<i>g</i> for 10 min immediately after collection to obtain blood plasma. Blood plasma was stored at −20 °C until analysis.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106">4.15.  Liquid Chromatography Tandem Mass Spectrometry (LC–MS/MS)</h3><div class="NLM_p">Plasma samples collected were thawed in room temperature. 10 μL of internal standard ([<sup>13</sup>C6] paclitaxel, 10 μg/mL) was spiked into 90 μL of each plasma samples.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> 300 μL of methanol was added, followed by strong vortex for 30 s. After a centrifugation at 7500 rpm for 10 min at 4 °C, supernatant of each tube was collected and filtered. Filtered supernatants were transferred into glass vials with microvolume inserts for LC–MS/MS analysis.</div><div class="NLM_p last">The concentration of <b>Ac3Az11</b> was determined by LC–MS/MS. 10 μL of each sample was injected into liquid chromatography system (AcQuity, Waters) by autosampler (4 °C), separated by a BEH C18 column (2.1 mm × 50 mm, 1.7 μm; AcQuity UPLC, Waters) fitted with a BEH C18 guard column (2.1 mm × 5 mm, 1.7 μm; VanGuard, AcQuity UPLC, Waters). The mobile phase was composed of Milli-Q water (containing 0.1% formic acid) (A) and methanol (containing 0.1% formic acid) (B). The flow rate of mobile phase was 0.3 mL/min. And the gradient elution program is at 0 min 90% A/10% B, at 1 min 90% A/10% B, at 6 min 15% A/85% B, at 7 min 15% A/85% B, at 8 min 90% A/10% B, at 9 min 90% A/10% B. Effluent was detected by a triple-quadrupole mass spectrometer (Waters Quattro Ultima). For data acquisition, the capillary voltage was set as 3.0 kV, and the cone voltage was set at 30 V. After the electrospray ionization (ESI), <b>Ac3Az11</b> was ionized to a precursor ion with positive charge ([<b>Ac3Az11·H</b>]<sup>+</sup>). [<b>Ac3Az11·H</b>]<sup>+</sup> (<i>m</i>/<i>z</i> 674) was allowed to pass the first quadrupole (Q1) to get into the collision cell (Q2). Precursor ions were derived into many fragment ions under a collision energy of 34 eV. Only desired product ion (<i>m</i>/<i>z</i> 418) was detected and recorded through third quadrupole (Q3). The analysis of quantification was processed by Mass Lynx Mass Spectrometry Software (Waters).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107">4.16.  In Silico Docking Study</h3><div class="NLM_p last">CLC Drug Discovery Workbench (version 2.5, QIAGEN) software was used to predict how a ligand binds to its target protein of bMRP1. The ligands were flavonoid dimers <b>Ac3Az11</b> and <b>FD-4e</b> as well as MRP1 substrates LTC<sub>4</sub> and DOX. The 2D structures of these ligands were generated from SIMLES and imported into the software for docking study. The electron cryomicroscopy structure of bMRP1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UJA">5UJA</a>) bound to LTC<sub>4</sub> was downloaded from Protein Data Bank (<a href="https://www.rcsb.org/" class="extLink">https://www.rcsb.org/</a>) and used directly for docking without any changes. Using the software function of “Find Binding Pockets”, the software was able to identify the central translocation pathway of MRP1 as one of the potential binding pockets. The identification of ligand binding modes was done iteratively by evaluating 10 000 ligand conformations and estimating the binding energy of their interactions with the binding pocket. The binding pose with the top 5% highest scores were returned for further visual inspection. The highest scores positioned the ligands <b>Ac3Az11</b>, <b>FD-4e</b>, and DOX into the binding site of LTC<sub>4</sub>. Amino acid residues involved in the interaction with ligands are shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>. All ligands are surrounded by the similar residues in the central translocation pathway of MRP1; therefore it can be concluded that these residues play an important functional role.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i108"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00834" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00834" class="ext-link">10.1021/acs.jmedchem.8b00834</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HPLC chromatograms of compounds <b>Ac3Az11</b>, <b>Ac3Az2</b>, <b>Ac3Az4</b>, and <b>Ac16Az4</b>; <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra of representative compounds listed in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>; superimposition of reported cocomplex structure of LTC4 (green) and its predicted binding pose; alignment of hMRP1 and bMRP1 (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES molecular strings formulas and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Binding LTC<sub>4</sub>, <b>Ac3Az11</b>, <b>FD-4e</b>, and DOX to bMRP1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UJA">5UJA</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_003.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_001.pdf">jm8b00834_si_001.pdf (3.82 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_002.csv">jm8b00834_si_002.csv (2.68 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_003.pdb">jm8b00834_si_003.pdb (1.59 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00834" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35740" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35740" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Larry M. C. Chow</span> - <span class="hlFld-Affiliation affiliation">Department
of Applied Biology and Chemical Technology and State Key Laboratory
of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7915180b0b00571a11160e39091615000c571c1d0c571112"><span class="__cf_email__" data-cfemail="5f333e2d2d26713c3730281f2f3033262a713a3b2a713734">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tak Hang Chan</span> - <span class="hlFld-Affiliation affiliation">Department
of Applied Biology and Chemical Technology and State Key Laboratory
of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, McGill University, Montreal, Quebec H3A 2K6, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8702-4499" title="Orcid link">http://orcid.org/0000-0002-8702-4499</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#621603094f0a030c054c010a030c22120d0e1b174c0706174c0a09"><span class="__cf_email__" data-cfemail="5622373d7b3e37383178353e37381626393a2f2378333223783e3d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Iris L.
K. Wong</span> - <span class="hlFld-Affiliation affiliation">Department
of Applied Biology and Chemical Technology and State Key Laboratory
of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xuezhen Zhu</span> - <span class="hlFld-Affiliation affiliation">Department
of Applied Biology and Chemical Technology and State Key Laboratory
of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kin-Fai Chan</span> - <span class="hlFld-Affiliation affiliation">Department
of Applied Biology and Chemical Technology and State Key Laboratory
of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1475-288X" title="Orcid link">http://orcid.org/0000-0003-1475-288X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Man Chun Law</span> - <span class="hlFld-Affiliation affiliation">Department
of Applied Biology and Chemical Technology and State Key Laboratory
of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aya M. Y. Lo</span> - <span class="hlFld-Affiliation affiliation">Department
of Applied Biology and Chemical Technology and State Key Laboratory
of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xuesen Hu</span> - <span class="hlFld-Affiliation affiliation">Department
of Applied Biology and Chemical Technology and State Key Laboratory
of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong SAR, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>I.L.K.W., X.Z., and K.-F.C. contributed equally to this work. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">Authors will release the atomic coordinates upon article publication.</p></div></li></ul></div><div class="ack" id="ACK-d7e9087-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i111">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73214" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73214" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the funding support from the Hong Kong Polytechnic University (Grant 1-ZE22), NSFC-RGC (Grant 3-ZG4F), and the Research Grants Council of Hong Kong (Grant 25100014). We thank University Research Facilities of Life Science (ULS) of The Hong Kong Polytechnic University for providing the flow cytometry service.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">MRP1</td><td class="NLM_def"><p class="first last">multidrug resistance-associated protein 1</p></td></tr><tr><td class="NLM_term">TMD</td><td class="NLM_def"><p class="first last">transmembrane domain</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein</p></td></tr><tr><td class="NLM_term">ABC</td><td class="NLM_def"><p class="first last">ATP-binding cassette</p></td></tr><tr><td class="NLM_term">CuAAC</td><td class="NLM_def"><p class="first last">copper-catalyzed alkyne–azide cycloaddition</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">DOX</td><td class="NLM_def"><p class="first last">doxorubicin</p></td></tr><tr><td class="NLM_term">LTC<sub>4</sub></td><td class="NLM_def"><p class="first last">leukotriene C<sub>4</sub></p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-2-pyrrolidone</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i113">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span> <span> </span><span class="NLM_article-title">Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-011613-135959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1146%2Fannurev-pharmtox-011613-135959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=24050699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVSqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=95-117&author=S.+P.+Cole&title=Targeting+multidrug+resistance+protein+1+%28MRP1%2C+ABCC1%29%3A+past%2C+present%2C+and+future&doi=10.1146%2Fannurev-pharmtox-011613-135959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future</span></div><div class="casAuthors">Cole, Susan P. C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-117</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The human ATP-binding cassette transporter multidrug resistance protein 1 (MRP1), encoded by ABCC1, was initially identified because of its ability to confer multidrug resistance in lung cancer cells.  It is now established that MRP1 plays a role in protecting certain tissues from xenobiotic insults and that it mediates the cellular efflux of the proinflammatory cysteinyl leukotriene C4 as well as a vast array of other endo- and xenobiotic org. anions.  Many of these are glutathione (GSH) or glucuronide conjugates, the products of Phase II drug metab.  MRP1 also plays a role in the cellular efflux of the reduced and oxidized forms of GSH and thus contributes to the many physiol. and pathophysiol. processes influenced by these small peptides, including oxidative stress.  In this review, the pharmacol. and physiol. aspects of MRP1 are considered in the context of the current status and future prospects of pharmacol. and genetic modulation of MRP1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPGrLhUsWuhLVg90H21EOLACvtfcHk0lje3djPyAF8-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVSqtrw%253D&md5=4bceae9b2334a70a1856f78b65f6208b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-011613-135959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-011613-135959%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BP.%26atitle%3DTargeting%2520multidrug%2520resistance%2520protein%25201%2520%2528MRP1%252C%2520ABCC1%2529%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2014%26volume%3D54%26spage%3D95%26epage%3D117%26doi%3D10.1146%2Fannurev-pharmtox-011613-135959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhardwaj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almquist, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, E. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeley, R. G.</span></span> <span> </span><span class="NLM_article-title">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">1650</span>– <span class="NLM_lpage">1654</span>, <span class="refDoi"> DOI: 10.1126/science.1360704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1126%2Fscience.1360704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1360704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1650-1654&author=S.+P.+Coleauthor=G.+Bhardwajauthor=J.+H.+Gerlachauthor=J.+E.+Mackieauthor=C.+E.+Grantauthor=K.+C.+Almquistauthor=A.+J.+Stewartauthor=E.+U.+Kurzauthor=A.+M.+Duncanauthor=R.+G.+Deeley&title=Overexpression+of+a+transporter+gene+in+a+multidrug-resistant+human+lung+cancer+cell+line&doi=10.1126%2Fscience.1360704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span></div><div class="casAuthors">Cole, S. P. C.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M. V.; Deeley, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5088</span>),
    <span class="NLM_cas:pages">1650-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents.  However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on ATP and is assocd. with multidrug resistance.  CDNA clones corresponding to mRNAs overexpressed in H69AR cells were isolated.  One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells.  Overexpression was assocd. with amplification of the cognate gene located on chromosome 16 at band p13.1.  Reversion to drug sensitivity was assocd. with loss of gene amplification and a marked decrease in mRNA expression.  The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogS-PschUsW7Vg90H21EOLACvtfcHk0lje3djPyAF8-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D&md5=7002d3f14cd64c4f39e44d938db665f7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1360704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1360704%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BP.%26aulast%3DBhardwaj%26aufirst%3DG.%26aulast%3DGerlach%26aufirst%3DJ.%2BH.%26aulast%3DMackie%26aufirst%3DJ.%2BE.%26aulast%3DGrant%26aufirst%3DC.%2BE.%26aulast%3DAlmquist%26aufirst%3DK.%2BC.%26aulast%3DStewart%26aufirst%3DA.%2BJ.%26aulast%3DKurz%26aufirst%3DE.%2BU.%26aulast%3DDuncan%26aufirst%3DA.%2BM.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26atitle%3DOverexpression%2520of%2520a%2520transporter%2520gene%2520in%2520a%2520multidrug-resistant%2520human%2520lung%2520cancer%2520cell%2520line%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1650%26epage%3D1654%26doi%3D10.1126%2Fscience.1360704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bakos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szakacs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tusnady, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Deemter, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span> <span> </span><span class="NLM_article-title">Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">32167</span>– <span class="NLM_lpage">32175</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.48.32167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1074%2Fjbc.273.48.32167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=9822694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADyaK1cXnvVeltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=32167-32175&author=E.+Bakosauthor=R.+Eversauthor=G.+Szakacsauthor=G.+E.+Tusnadyauthor=E.+Welkerauthor=K.+Szaboauthor=M.+de+Haasauthor=L.+van+Deemterauthor=P.+Borstauthor=A.+Varadiauthor=B.+Sarkadi&title=Functional+multidrug+resistance+protein+%28MRP1%29+lacking+the+N-terminal+transmembrane+domain&doi=10.1074%2Fjbc.273.48.32167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain</span></div><div class="casAuthors">Bakos, Eva; Evers, Raymond; Szakacs, Gergely; Tusnady, Gabor E.; Welker, Ervin; Szabo, Katalin; De Haas, Marcel; Van Deemter, Liesbeth; Borst, Piet; Varadi, Andras; Sarkadi, Balazs</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">32167-32175</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The human multidrug resistance protein (MRP1) causes drug resistance by extruding drugs from tumor cells.  In addn. to an MDR-like core, MRP1 contains an N-terminal membrane-bound region (TMD0) connected to the core by a cytoplasmic linker (L0).  We have studied truncated MRP1 versions contg. either the MDR-like core alone or the core plus linker L0, produced in the baculovirus-insect (Sf9) cell system.  Their function was examd. in isolated membrane vesicles.  Fulllength MRP1 showed ATP-dependent, vanadate-sensitive accumulation of leukotriene C4 and N-ethylmaleimide glutathione.  In addn., leukotriene C4-stimulated, vanadate-dependent nucleotide occlusion was detected.  The MDR-like core was virtually inactive.  Co-expression of the core with the N-terminal region including L0 fully restored MRP1 function.  Unexpectedly, a truncated MRP1 mutant lacking the entire TMD0 region but still contg. L0 behaved like wild-type MRP1 in vesicle uptake and nucleotide trapping expts.  We also expressed the MRP1 constructs in polarized canine kidney derived MDCKII cells.  Like wild-type MRP1, the MRP1 protein without the TMD0 region was routed to the lateral plasma membrane and transported dinitrophenyl glutathione and daunorubicin.  The TMD0L0 and the MRP1 minus TMD0L0 remained in an intracellular compartment.  Taken together, these expts. strongly suggest that the TMD0 region is neither required for the transport function of MRP1 nor for its proper routing to the plasma membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18Lik7T68gbVg90H21EOLACvtfcHk0lje3djPyAF8-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvVeltbY%253D&md5=6e88d283ab8cfd2a4627e114b06cf991</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.48.32167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.48.32167%26sid%3Dliteratum%253Aachs%26aulast%3DBakos%26aufirst%3DE.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DSzakacs%26aufirst%3DG.%26aulast%3DTusnady%26aufirst%3DG.%2BE.%26aulast%3DWelker%26aufirst%3DE.%26aulast%3DSzabo%26aufirst%3DK.%26aulast%3Dde%2BHaas%26aufirst%3DM.%26aulast%3Dvan%2BDeemter%26aufirst%3DL.%26aulast%3DBorst%26aufirst%3DP.%26aulast%3DVaradi%26aufirst%3DA.%26aulast%3DSarkadi%26aufirst%3DB.%26atitle%3DFunctional%2520multidrug%2520resistance%2520protein%2520%2528MRP1%2529%2520lacking%2520the%2520N-terminal%2520transmembrane%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D32167%26epage%3D32175%26doi%3D10.1074%2Fjbc.273.48.32167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bakos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegedus, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tusnady, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flens, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span> <span> </span><span class="NLM_article-title">Membrane topology and glycosylation of the human multidrug resistance-associated protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">12322</span>– <span class="NLM_lpage">12326</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.21.12322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1074%2Fjbc.271.21.12322" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=12322-12326&author=E.+Bakosauthor=T.+Hegedusauthor=Z.+Holloauthor=E.+Welkerauthor=G.+E.+Tusnadyauthor=G.+J.+Zamanauthor=M.+J.+Flensauthor=A.+Varadiauthor=B.+Sarkadi&title=Membrane+topology+and+glycosylation+of+the+human+multidrug+resistance-associated+protein&doi=10.1074%2Fjbc.271.21.12322"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.21.12322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.21.12322%26sid%3Dliteratum%253Aachs%26aulast%3DBakos%26aufirst%3DE.%26aulast%3DHegedus%26aufirst%3DT.%26aulast%3DHollo%26aufirst%3DZ.%26aulast%3DWelker%26aufirst%3DE.%26aulast%3DTusnady%26aufirst%3DG.%2BE.%26aulast%3DZaman%26aufirst%3DG.%2BJ.%26aulast%3DFlens%26aufirst%3DM.%2BJ.%26aulast%3DVaradi%26aufirst%3DA.%26aulast%3DSarkadi%26aufirst%3DB.%26atitle%3DMembrane%2520topology%2520and%2520glycosylation%2520of%2520the%2520human%2520multidrug%2520resistance-associated%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D12322%26epage%3D12326%26doi%3D10.1074%2Fjbc.271.21.12322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeley, R. G.</span></span> <span> </span><span class="NLM_article-title">Transport of glutathione and glutathione conjugates by MRP1</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2006.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.tips.2006.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=16820223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVyls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=438-446&author=S.+P.+Coleauthor=R.+G.+Deeley&title=Transport+of+glutathione+and+glutathione+conjugates+by+MRP1&doi=10.1016%2Fj.tips.2006.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Transport of glutathione and glutathione conjugates by MRP1</span></div><div class="casAuthors">Cole, Susan P. C.; Deeley, Roger G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">438-446</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Glutathione (GSH)-conjugated xenobiotics and GSH-conjugated metabolites (e.g. the cysteinyl leukotriene C4) must be exported from the cells in which they are formed before they can be eliminated from the body or act on their cellular targets.  This efflux is often mediated by the multidrug resistance protein 1 (MRP1) transporter, which also confers drug resistance to tumor cells and can protect normal cells from toxic insults.  In addn. to drugs and GSH conjugates, MRP1 exports GSH and GSH disulfide, and might thus have a role in cellular responses to oxidative stress.  The transport of several drugs and conjugated org. anions by MRP1 requires the presence of GSH, but it is not well understood how GSH (and its analogs) enhances transport.  Site-directed mutagenesis studies and biophys. analyses have provided important insights into the structural determinants of MRP1 that influence GSH and GSH conjugate binding and transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIwmhqAP55ALVg90H21EOLACvtfcHk0lhkV0UNoXAWpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVyls74%253D&md5=2628cc48a4972feb4d9bea4715d27cad</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BP.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26atitle%3DTransport%2520of%2520glutathione%2520and%2520glutathione%2520conjugates%2520by%2520MRP1%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D438%26epage%3D446%26doi%3D10.1016%2Fj.tips.2006.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deeley, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westlake, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span> <span> </span><span class="NLM_article-title">Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">899</span>, <span class="refDoi"> DOI: 10.1152/physrev.00035.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1152%2Fphysrev.00035.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=16816140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFGgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2006&pages=849-899&author=R.+G.+Deeleyauthor=C.+Westlakeauthor=S.+P.+Cole&title=Transmembrane+transport+of+endo-+and+xenobiotics+by+mammalian+ATP-binding+cassette+multidrug+resistance+proteins&doi=10.1152%2Fphysrev.00035.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins</span></div><div class="casAuthors">Deeley, Roger G.; Westlake, Christopher; Cole, Susan P. C.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">849-899</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Multidrug Resistance Proteins (MRPs), together with the cystic fibrosis conductance regulator (CFTR/ABCC7) and the sulfonylurea receptors (SUR1/ABCC8 and SUR2/ABCC9) comprise the 13 members of the human "C" branch of the ATP binding cassette (ABC) superfamily.  All C branch proteins share conserved structural features in their nucleotide binding domains (NBDs) that distinguish them from other ABC proteins.  The MRPs can be further divided into 2 subfamilies "long" (MRP1, -2, -3, -6, and -7) and "short" (MRP4, -5, -8, -9, and -10).  The short MRPs have a typical ABC transporter structure with 2 polytropic membrane spanning domains (MSDs) and 2 NBDs, while the long MRPs have an addnl. NH2-terminal MSD.  In vitro, the MRPs can collectively confer resistance to natural product drugs and their conjugated metabolites, platinum compds., folate antimetabolites, nucleoside and nucleotide analogs, arsenical and antimonial oxyanions, peptide-based agents, and, under certain circumstances, alkylating agents.  The MRPs are also primary active transporters of other structurally diverse compds., including glutathione, glucuronide, and sulfate conjugates of a large no. of xeno- and endobiotics.  In vivo, several MRPs are major contributors to the distribution and elimination of a wide range of both anticancer and non-anticancer drugs and metabolites.  In this review, the authors describe what is known of the structure of the MRPs and the mechanisms by which they recognize and transport their diverse substrates.  The authors also summarize knowledge of their possible physiol. functions and evidence that they may be involved in the clin. drug resistance of various forms of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofKpMSkBDdL7Vg90H21EOLACvtfcHk0lhkV0UNoXAWpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFGgtb4%253D&md5=2aaa146afc7d5ac878d937ea8c630f72</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00035.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00035.2005%26sid%3Dliteratum%253Aachs%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26aulast%3DWestlake%26aufirst%3DC.%26aulast%3DCole%26aufirst%3DS.%2BP.%26atitle%3DTransmembrane%2520transport%2520of%2520endo-%2520and%2520xenobiotics%2520by%2520mammalian%2520ATP-binding%2520cassette%2520multidrug%2520resistance%2520proteins%26jtitle%3DPhysiol.%2520Rev.%26date%3D2006%26volume%3D86%26spage%3D849%26epage%3D899%26doi%3D10.1152%2Fphysrev.00035.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hipfner, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almquist, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeley, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span> <span> </span><span class="NLM_article-title">Membrane topology of the multidrug resistance protein (MRP). A study of glycosylation-site mutants reveals an extracytosolic NH2 terminus</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">23623</span>– <span class="NLM_lpage">23630</span>, <span class="refDoi"> DOI: 10.1074/jbc.272.38.23623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1074%2Fjbc.272.38.23623" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=23623-23630&author=D.+R.+Hipfnerauthor=K.+C.+Almquistauthor=E.+M.+Leslieauthor=J.+H.+Gerlachauthor=C.+E.+Grantauthor=R.+G.+Deeleyauthor=S.+P.+Cole&title=Membrane+topology+of+the+multidrug+resistance+protein+%28MRP%29.+A+study+of+glycosylation-site+mutants+reveals+an+extracytosolic+NH2+terminus&doi=10.1074%2Fjbc.272.38.23623"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.38.23623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.38.23623%26sid%3Dliteratum%253Aachs%26aulast%3DHipfner%26aufirst%3DD.%2BR.%26aulast%3DAlmquist%26aufirst%3DK.%2BC.%26aulast%3DLeslie%26aufirst%3DE.%2BM.%26aulast%3DGerlach%26aufirst%3DJ.%2BH.%26aulast%3DGrant%26aufirst%3DC.%2BE.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26aulast%3DCole%26aufirst%3DS.%2BP.%26atitle%3DMembrane%2520topology%2520of%2520the%2520multidrug%2520resistance%2520protein%2520%2528MRP%2529.%2520A%2520study%2520of%2520glycosylation-site%2520mutants%2520reveals%2520an%2520extracytosolic%2520NH2%2520terminus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D23623%26epage%3D23630%26doi%3D10.1074%2Fjbc.272.38.23623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raab-Graham, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirilo, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boettcher, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radeke, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberg, C. A.</span></span> <span> </span><span class="NLM_article-title">Membrane topology of the amino-terminal region of the sulfonylurea receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">29122</span>– <span class="NLM_lpage">29129</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.41.29122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1074%2Fjbc.274.41.29122" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=29122-29129&author=K.+F.+Raab-Grahamauthor=L.+J.+Ciriloauthor=A.+A.+Boettcherauthor=C.+M.+Radekeauthor=C.+A.+Vandenberg&title=Membrane+topology+of+the+amino-terminal+region+of+the+sulfonylurea+receptor&doi=10.1074%2Fjbc.274.41.29122"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.41.29122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.41.29122%26sid%3Dliteratum%253Aachs%26aulast%3DRaab-Graham%26aufirst%3DK.%2BF.%26aulast%3DCirilo%26aufirst%3DL.%2BJ.%26aulast%3DBoettcher%26aufirst%3DA.%2BA.%26aulast%3DRadeke%26aufirst%3DC.%2BM.%26aulast%3DVandenberg%26aufirst%3DC.%2BA.%26atitle%3DMembrane%2520topology%2520of%2520the%2520amino-terminal%2520region%2520of%2520the%2520sulfonylurea%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D29122%26epage%3D29129%26doi%3D10.1074%2Fjbc.274.41.29122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagnoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beretta, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarantino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbareschi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezzanzanica, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perego, P.</span></span> <span> </span><span class="NLM_article-title">Clinicopathological impact of ABCC1/MRP1 and ABCC4/MRP4 in epithelial ovarian carcinoma</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">143202</span>, <span class="refDoi"> DOI: 10.1155/2013/143202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1155%2F2013%2F143202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=143202&author=M.+Bagnoliauthor=G.+L.+Berettaauthor=L.+Gattiauthor=S.+Pilottiauthor=P.+Albertiauthor=E.+Tarantinoauthor=M.+Barbareschiauthor=S.+Canevariauthor=D.+Mezzanzanicaauthor=P.+Perego&title=Clinicopathological+impact+of+ABCC1%2FMRP1+and+ABCC4%2FMRP4+in+epithelial+ovarian+carcinoma&doi=10.1155%2F2013%2F143202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1155%2F2013%2F143202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F143202%26sid%3Dliteratum%253Aachs%26aulast%3DBagnoli%26aufirst%3DM.%26aulast%3DBeretta%26aufirst%3DG.%2BL.%26aulast%3DGatti%26aufirst%3DL.%26aulast%3DPilotti%26aufirst%3DS.%26aulast%3DAlberti%26aufirst%3DP.%26aulast%3DTarantino%26aufirst%3DE.%26aulast%3DBarbareschi%26aufirst%3DM.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DMezzanzanica%26aufirst%3DD.%26aulast%3DPerego%26aufirst%3DP.%26atitle%3DClinicopathological%2520impact%2520of%2520ABCC1%252FMRP1%2520and%2520ABCC4%252FMRP4%2520in%2520epithelial%2520ovarian%2520carcinoma%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2013%26volume%3D2013%26spage%3D143202%26doi%3D10.1155%2F2013%2F143202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordow, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flemming, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, M. D.</span></span> <span> </span><span class="NLM_article-title">Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1546</span>– <span class="NLM_lpage">1553</span>, <span class="refDoi"> DOI: 10.1200/JCO.2005.01.6196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1200%2FJCO.2005.01.6196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=16575006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFyktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=1546-1553&author=M.+Haberauthor=J.+Smithauthor=S.+B.+Bordowauthor=C.+Flemmingauthor=S.+L.+Cohnauthor=W.+B.+Londonauthor=G.+M.+Marshallauthor=M.+D.+Norris&title=Association+of+high-level+MRP1+expression+with+poor+clinical+outcome+in+a+large+prospective+study+of+primary+neuroblastoma&doi=10.1200%2FJCO.2005.01.6196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma</span></div><div class="casAuthors">Haber, Michelle; Smith, Janice; Bordow, Sharon B.; Flemming, Claudia; Cohn, Susan L.; London, Wendy B.; Marshall, Glenn M.; Norris, Murray D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1546-1553</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">We have previously shown in a retrospective study that expression of the multidrug transporter gene MRP1 (ABCC1) is assocd. with outcome in neuroblastoma.  We have now undertaken a prospective anal. to examine the independent prognostic significance of MRP1 expression in a large cohort of primary untreated neuroblastomas.  Two hundred nine diagnostic neuroblastoma samples from patients prospectively enrolled onto the Pediatric Oncol. Group biol. protocol 9047 were analyzed for expression of the MRP1, MDR1, MYCN, and TRKA genes using real-time polymerase chain reaction.  Expression levels were correlated with established prognostic indicators and disease outcome.  MRP1 expression was detected in all tumors analyzed, and levels were significantly higher in tumors with vs. without MYCN amplification (P < .0001).  High levels of MRP1 were highly predictive of both event-free survival (EFS; P < .001) and overall survival (OS; P < .001).  High-level MYCN and low-level TRKA were also predictive of poor outcome.  MDR1 expression demonstrated no prognostic significance.  After adjustment for the effect of statistically significant prognostic indicators in multivariate models, MRP1 expression retained significant prognostic value for both EFS (hazard ratio = 3.0; P = .0011) and OS (hazard ratio = 2.5; P = .0095), whereas MYCN amplification did not have prognostic significance.  The results of this prospective study confirm our earlier findings and support a clin. relevant role for MRP1 gene expression in neuroblastoma.  These findings have implications for the biol., prognosis, and treatment of this disease and provide evidence that MRP1 is a bone fide mol. target for reversing chemotherapy resistance in aggressive drug-refractory neuroblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0oXxz7DUGtLVg90H21EOLACvtfcHk0liF7Lkr44sXoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFyktrc%253D&md5=70096f4a8d71db43984319386e3df92c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.01.6196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.01.6196%26sid%3Dliteratum%253Aachs%26aulast%3DHaber%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DBordow%26aufirst%3DS.%2BB.%26aulast%3DFlemming%26aufirst%3DC.%26aulast%3DCohn%26aufirst%3DS.%2BL.%26aulast%3DLondon%26aufirst%3DW.%2BB.%26aulast%3DMarshall%26aufirst%3DG.%2BM.%26aulast%3DNorris%26aufirst%3DM.%2BD.%26atitle%3DAssociation%2520of%2520high-level%2520MRP1%2520expression%2520with%2520poor%2520clinical%2520outcome%2520in%2520a%2520large%2520prospective%2520study%2520of%2520primary%2520neuroblastoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D1546%26epage%3D1553%26doi%3D10.1200%2FJCO.2005.01.6196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hlavac, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brynychova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaclavikova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlichova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecha, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozevnikovova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trnkova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopperova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gut, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucek, P.</span></span> <span> </span><span class="NLM_article-title">The expression profile of ATP-binding cassette transporter genes in breast carcinoma</span>. <i>Pharmacogenomics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.2217/pgs.13.26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.2217%2Fpgs.13.26" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=515-529&author=V.+Hlavacauthor=V.+Brynychovaauthor=R.+Vaclavikovaauthor=M.+Ehrlichovaauthor=D.+Vranaauthor=V.+Pechaauthor=R.+Kozevnikovovaauthor=M.+Trnkovaauthor=J.+Gatekauthor=D.+Kopperovaauthor=I.+Gutauthor=P.+Soucek&title=The+expression+profile+of+ATP-binding+cassette+transporter+genes+in+breast+carcinoma&doi=10.2217%2Fpgs.13.26"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2217%2Fpgs.13.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fpgs.13.26%26sid%3Dliteratum%253Aachs%26aulast%3DHlavac%26aufirst%3DV.%26aulast%3DBrynychova%26aufirst%3DV.%26aulast%3DVaclavikova%26aufirst%3DR.%26aulast%3DEhrlichova%26aufirst%3DM.%26aulast%3DVrana%26aufirst%3DD.%26aulast%3DPecha%26aufirst%3DV.%26aulast%3DKozevnikovova%26aufirst%3DR.%26aulast%3DTrnkova%26aufirst%3DM.%26aulast%3DGatek%26aufirst%3DJ.%26aulast%3DKopperova%26aufirst%3DD.%26aulast%3DGut%26aufirst%3DI.%26aulast%3DSoucek%26aufirst%3DP.%26atitle%3DThe%2520expression%2520profile%2520of%2520ATP-binding%2520cassette%2520transporter%2520genes%2520in%2520breast%2520carcinoma%26jtitle%3DPharmacogenomics%26date%3D2013%26volume%3D14%26spage%3D515%26epage%3D529%26doi%3D10.2217%2Fpgs.13.26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Q.</span></span> <span> </span><span class="NLM_article-title">Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy</span>. <i>Lung Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/j.lungcan.2009.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.lungcan.2009.09.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2010&pages=116-122&author=J.+Liauthor=Z.+N.+Liauthor=L.+C.+Yuauthor=Q.+L.+Baoauthor=J.+R.+Wuauthor=S.+B.+Shiauthor=X.+Q.+Li&title=Association+of+expression+of+MRP1%2C+BCRP%2C+LRP+and+ERCC1+with+outcome+of+patients+with+locally+advanced+non-small+cell+lung+cancer+who+received+neoadjuvant+chemotherapy&doi=10.1016%2Fj.lungcan.2009.09.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.lungcan.2009.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lungcan.2009.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%2BN.%26aulast%3DYu%26aufirst%3DL.%2BC.%26aulast%3DBao%26aufirst%3DQ.%2BL.%26aulast%3DWu%26aufirst%3DJ.%2BR.%26aulast%3DShi%26aufirst%3DS.%2BB.%26aulast%3DLi%26aufirst%3DX.%2BQ.%26atitle%3DAssociation%2520of%2520expression%2520of%2520MRP1%252C%2520BCRP%252C%2520LRP%2520and%2520ERCC1%2520with%2520outcome%2520of%2520patients%2520with%2520locally%2520advanced%2520non-small%2520cell%2520lung%2520cancer%2520who%2520received%2520neoadjuvant%2520chemotherapy%26jtitle%3DLung%2520Cancer%26date%3D2010%26volume%3D69%26spage%3D116%26epage%3D122%26doi%3D10.1016%2Fj.lungcan.2009.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baumert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgeroth, A.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the development of P-gp inhibitors</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">436</span>, <span class="refDoi"> DOI: 10.2174/1871520610909040415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.2174%2F1871520610909040415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=19442042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlslOlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=415-436&author=C.+Baumertauthor=A.+Hilgeroth&title=Recent+advances+in+the+development+of+P-gp+inhibitors&doi=10.2174%2F1871520610909040415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of P-gp inhibitors</span></div><div class="casAuthors">Baumert, Christiane; Hilgeroth, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">415-436</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  During the last decades multidrug resistance (MDR) emerged as main problem in the anti-cancer therapy with cytostatically active agents.  Classical as well as recently developed cytostatics develop the phenomenon of loosing activity in former drug-sensitive cells.  Although MDR is a multifactorial process, the main obstacle is the expression of multidrug-efflux pumps that lowers the intracellular drug levels.  P-glycoprotein (P-gp) is the longest identified efflux pump.  As the attempt to overcome MDR by the use of inhibitors of the efflux pump activities turned out as most promising effect, the development of P-gp inhibitors has been a challenge for medicinal chemists.  The article reviews the advances in P-gp inhibitor development by focusing on structure-activity relationships in the different compd. classes to document improvements.  The success has been the redn. of cytotoxic properties.  The undesired activities could be much lowered in the case of compd. classes that were derived from pharmacol. active drugs.  Undesired drug interactions and limited in vivo activities are still a problem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlDTzTIfZNCLVg90H21EOLACvtfcHk0lhovxXdHyDldg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlslOlsrg%253D&md5=38025eb41e3e56b959e0dc90b7bf9af7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1871520610909040415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520610909040415%26sid%3Dliteratum%253Aachs%26aulast%3DBaumert%26aufirst%3DC.%26aulast%3DHilgeroth%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520P-gp%2520inhibitors%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D415%26epage%3D436%26doi%3D10.2174%2F1871520610909040415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eckford, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharom, F. J.</span></span> <span> </span><span class="NLM_article-title">ABC efflux pump-based resistance to chemotherapy drugs</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">2989</span>– <span class="NLM_lpage">3011</span>, <span class="refDoi"> DOI: 10.1021/cr9000226</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr9000226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlslSmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2989-3011&author=P.+D.+Eckfordauthor=F.+J.+Sharom&title=ABC+efflux+pump-based+resistance+to+chemotherapy+drugs&doi=10.1021%2Fcr9000226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">ABC Efflux Pump-Based Resistance to Chemotherapy Drugs</span></div><div class="casAuthors">Eckford, Paul D. W.; Sharom, Frances J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2989-3011</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over 1 million new cases of all types of cancer are diagnosed each year in the United States alone, and 559, 650 cancer-related deaths were expected to occur in 2007.  Chemotherapeutic treatment of cancers is an important tool to combat this devastating disease.  However, chemotherapy can fail due to the development of tumor cell resistance to multiple drugs, a phenomenon known as multidrug resistance (MDR), and essentially all cancer-related deaths are considered to be a result of chemotherapy failure.  MDR can have many causes, but one important mechanism of drug resistance is the expression of active drug efflux pumps in the membranes of cancer cells.  The efflux pump proteins mediating MDR in human cancers belong to the ATP-Binding Cassette (ABC) superfamily of proteins.  This is a diverse group of (primarily) active membrane transporters and is one of the largest known protein families.  Its members include proteins that mediate a variety of transport processes, in both prokaryotes (e.g., membrane-embedded importers for sugars and amino acids, and drug exporters) and eukaryotes, where only ABC exporters are known.  The 49 ABC proteins identified in the human genome (there appear to be 48 functional proteins) are involved in the efflux of substrates such as phospholipids, sterols, bile salts, and amphipathic drugs.  While as many as 15 ABC transporters have been obsd. to export chemotherapy drugs using in vitro exptl. systems, only 3 transporters have thus far been implicated as major contributors to MDR in cancer.  Discovered over 30 years ago, P-glycoprotein (Pgp; MDR1; ABCB1), was the first mammalian ABC protein to be identified.  Multidrug resistance-assocd. protein 1 (MRP1 or ABCC1) and more recently ABCG2 (also termed the breast cancer resistance protein, BCRP, or mitoxantrone resistance protein, MXR) also appear to function as clin. relevant drug efflux pumps.  All three proteins were discovered as factors over-expressed in MDR cell lines in culture, and they have since been detected in MDR tumors in patients.  Considerable effort has been made to understand the structure and function of these three drug pumps, which possess a unique ability to recognize and transport a broad array of structurally diverse compds. out of the cell.  The development of compds. known as modulators, which are able to reverse MDR by blocking or inhibiting the ATP-dependent transport function of these proteins, is also an important goal of researchers in this field.  This review will summarize our understanding of the substrate specificity of the mammalian drug efflux pumps, their structure, the mol. mechanisms by which they exert their function, and the progress made to date in reversing pump-mediated MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZIkwCqe_qg7Vg90H21EOLACvtfcHk0lhovxXdHyDldg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlslSmtbg%253D&md5=5009e7a7cac6977a296fd5bbf97d7df7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fcr9000226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9000226%26sid%3Dliteratum%253Aachs%26aulast%3DEckford%26aufirst%3DP.%2BD.%26aulast%3DSharom%26aufirst%3DF.%2BJ.%26atitle%3DABC%2520efflux%2520pump-based%2520resistance%2520to%2520chemotherapy%2520drugs%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2989%26epage%3D3011%26doi%3D10.1021%2Fcr9000226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, N.</span></span> <span> </span><span class="NLM_article-title">New multidrug resistance reversal agents</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.2174/1389450033347064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.2174%2F1389450033347064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=12528988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvVGmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=31-43&author=M.+Kawaseauthor=N.+Motohashi&title=New+multidrug+resistance+reversal+agents&doi=10.2174%2F1389450033347064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New multidrug resistance reversal agents</span></div><div class="casAuthors">Kawase, Masami; Motohashi, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-43</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance (MDR) to antitumor agents represents a significant challenge to effective chemotherapy.  The use of MDR modulators is a promising approach to overcome the undesired MDR phenotype.  The more effective MDR modulators are urgently needed for clin. use.  This review focuses on literatures published in 1998-2001.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVpCj9RsHpwrVg90H21EOLACvtfcHk0lhovxXdHyDldg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvVGmsg%253D%253D&md5=9e35cb90204fcc277e30e4db729ea39c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1389450033347064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450033347064%26sid%3Dliteratum%253Aachs%26aulast%3DKawase%26aufirst%3DM.%26aulast%3DMotohashi%26aufirst%3DN.%26atitle%3DNew%2520multidrug%2520resistance%2520reversal%2520agents%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2003%26volume%3D4%26spage%3D31%26epage%3D43%26doi%3D10.2174%2F1389450033347064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinkel, A. H.</span></span> <span> </span><span class="NLM_article-title">Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2)</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=12477055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=427-434&author=J.+D.+Allenauthor=A.+H.+Schinkel&title=Multidrug+resistance+and+pharmacological+protection+mediated+by+the+breast+cancer+resistance+protein+%28BCRP%2FABCG2%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2)</span></div><div class="casAuthors">Allen, John D.; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">427-434</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review discusses the current insights in the structure, function, and pharmacol. impact of breast cancer resistance protein (BCRP).  Topics discussed include subcellular localization of BCRP/Bcrp1; specificity and mechanism of drug resistance mediated by BCRP/Bcrp1; inhibitors of BCRP/Bcrp1; tissue distribution of BCRP and Bcrp1; and the clin. significance of BCRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJg9bHS6xUHLVg90H21EOLACvtfcHk0lg3WphBaHeO4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7k%253D&md5=5e4b4272efacd570866fe13c1a38c7ad</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BD.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DMultidrug%2520resistance%2520and%2520pharmacological%2520protection%2520mediated%2520by%2520the%2520breast%2520cancer%2520resistance%2520protein%2520%2528BCRP%252FABCG2%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D427%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Durmus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparidans, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagenaar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinkel, A. H.</span></span> <span> </span><span class="NLM_article-title">Oral availability and brain penetration of the B-RAFV600E inhibitor vemurafenib can be enhanced by the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3236</span>– <span class="NLM_lpage">3245</span>, <span class="refDoi"> DOI: 10.1021/mp3003144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp3003144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVamt7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=3236-3245&author=S.+Durmusauthor=R.+W.+Sparidansauthor=E.+Wagenaarauthor=J.+H.+Beijnenauthor=A.+H.+Schinkel&title=Oral+availability+and+brain+penetration+of+the+B-RAFV600E+inhibitor+vemurafenib+can+be+enhanced+by+the+P-glycoprotein+%28ABCB1%29+and+breast+cancer+resistance+protein+%28ABCG2%29+inhibitor+elacridar&doi=10.1021%2Fmp3003144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Oral Availability and Brain Penetration of the B-RAFV600E Inhibitor Vemurafenib Can Be Enhanced by the P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Inhibitor Elacridar</span></div><div class="casAuthors">Durmus, Selvi; Sparidans, Rolf W.; Wagenaar, Els; Beijnen, Jos H.; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3236-3245</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Vemurafenib (PLX4032) is a novel tyrosine kinase inhibitor that has clin. efficacy against metastatic melanoma harboring a BRAFV600E mutation.  We aimed to establish whether oral availability and brain penetration of vemurafenib could be restricted by the multidrug efflux transporters P-glycoprotein (P-gp/ABCB1) and breast cancer resistance protein (BCRP/ABCG2), as these might limit therapeutic efficacy, esp. against brain metastases.  In vitro, vemurafenib was efficiently transported by both human ABCB1 and ABCG2, and very efficiently by mouse Abcg2, but not by mouse Abcc2.  Upon oral administration of vemurafenib (5 mg/kg), Abcb1a/1b-/- mice had a 1.6-fold increased, Abcg2-/- mice a 2.3-fold increased, and Abcb1a/1b-/-;Abcg2-/- mice a 6.6-fold increased plasma AUC, resp., compared to wild-type (WT) mice, indicating a marked and additive role of these transporters in limiting vemurafenib oral availability.  Brain-to-plasma ratios of vemurafenib (oral, 25 mg/kg) were not increased in Abcg2-/- mice, only 1.7-fold in Abcb1a/1b-/- mice, but 21.4-fold in Abcb1a/1b-/-;Abcg2-/- mice, indicating pronounced overlapping functions of these transporters in reducing vemurafenib brain accumulation.  Oral coadministration of the dual ABCB1 and ABCG2 inhibitor elacridar almost completely eliminated the roles of Abcb1 and Abcg2 in restricting oral availability and brain accumulation of vemurafenib.  As predicted by previously described pharmacokinetic modeling, halving the amt. of active efflux transport at the WT blood-brain barrier by testing heterozygous Abcb1a/1b+/-;Abcg2+/- mice had little impact on vemurafenib brain accumulation.  Our data suggest that elacridar coadministration may be considered to improve the therapeutic efficacy of vemurafenib, esp. for brain metastases located behind a functional blood-brain barrier.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHem6ZUi3pJ7Vg90H21EOLACvtfcHk0lg3WphBaHeO4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVamt7bL&md5=af368d47ddc76fbd3d3e9ce6be97c29d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fmp3003144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp3003144%26sid%3Dliteratum%253Aachs%26aulast%3DDurmus%26aufirst%3DS.%26aulast%3DSparidans%26aufirst%3DR.%2BW.%26aulast%3DWagenaar%26aufirst%3DE.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DOral%2520availability%2520and%2520brain%2520penetration%2520of%2520the%2520B-RAFV600E%2520inhibitor%2520vemurafenib%2520can%2520be%2520enhanced%2520by%2520the%2520P-glycoprotein%2520%2528ABCB1%2529%2520and%2520breast%2520cancer%2520resistance%2520protein%2520%2528ABCG2%2529%2520inhibitor%2520elacridar%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D3236%26epage%3D3245%26doi%3D10.1021%2Fmp3003144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, K. K.</span></span> <span> </span><span class="NLM_article-title">Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.06.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.ejmech.2015.06.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=26197160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCqsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=560-572&author=X.+Q.+Liauthor=L.+Wangauthor=Y.+Leiauthor=T.+Huauthor=F.+L.+Zhangauthor=C.+H.+Choauthor=K.+K.+To&title=Reversal+of+P-gp+and+BCRP-mediated+MDR+by+tariquidar+derivatives&doi=10.1016%2Fj.ejmech.2015.06.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives</span></div><div class="casAuthors">Li, Xu-Qin; Wang, Lin; Lei, Yan; Hu, Tao; Zhang, Fei-Long; Cho, Chi-Hin; To, Kenneth K. W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">560-572</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">With an aim to generate non-toxic, specific and highly potent multidrug resistance (MDR) modulators, a novel series of anthranilic acid amide-substituted tariquidar derivs., e.g., I, were synthesized.  The new compds. were evaluated for their cytotoxicity toward normal human colon fibroblasts (CCD18-Co), human gastric epithelial cell line (HFE) and primary rat liver cells, and for their ability to inhibit P-gp/BCRP-mediated drug efflux and reversal of P-gp and BCRP-mediated MDR in parental and drug-resistant cancer cell lines (LCC6 MDR1, MCF-7 FLV1000, R-HepG2, SW620-Ad300).  While tariquidar is highly toxic to normal cells, the new derivs. exhibited much lower or negligible cytotoxicity.  Some of the new tariquidar derivs. inhibited both P-gp and BCRP-mediated drug efflux whereas a few of them bearing a sulfonamide functional group are specific to P-gp.  The new compds. were also found to potentiate the anticancer activity of the transporter substrate anticancer drugs in the corresponding transporter-overexpressing cell lines.  The extent of resistance reversal was found to be consistent with the transporter inhibitory effect of the new derivs.  To further understand the mechanism of P-gp and BCRP inhibition, the tariquidar derivs. were found to interact with the transporters using an antibody-based UIC2 or 5D3 shift assay.  Moreover, the transporters-inhibiting derivs. were found to modulate the ATPase activities of the two MDR transporters.  Our data thus advocate further development of the new compds. for the circumvention of MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMlzPe_laaA7Vg90H21EOLACvtfcHk0lg3WphBaHeO4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCqsb3E&md5=21de31591293a5f5b7b4039822940dfb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.06.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.06.049%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%2BQ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DF.%2BL.%26aulast%3DCho%26aufirst%3DC.%2BH.%26aulast%3DTo%26aufirst%3DK.%2BK.%26atitle%3DReversal%2520of%2520P-gp%2520and%2520BCRP-mediated%2520MDR%2520by%2520tariquidar%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D101%26spage%3D560%26epage%3D572%26doi%3D10.1016%2Fj.ejmech.2015.06.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minderman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Loughlin, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendyala, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baer, M. R.</span></span> <span> </span><span class="NLM_article-title">VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1826</span>– <span class="NLM_lpage">1834</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-0914-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1158%2F1078-0432.CCR-0914-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=15014037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFClt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1826-1834&author=H.+Mindermanauthor=K.+L.+O%E2%80%99Loughlinauthor=L.+Pendyalaauthor=M.+R.+Baer&title=VX-710+%28biricodar%29+increases+drug+retention+and+enhances+chemosensitivity+in+resistant+cells+overexpressing+P-glycoprotein%2C+multidrug+resistance+protein%2C+and+breast+cancer+resistance+protein&doi=10.1158%2F1078-0432.CCR-0914-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">VX-710 (Biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein</span></div><div class="casAuthors">Minderman, Hans; O'Loughlin, Kieran L.; Pendyala, Lakshmi; Baer, Maria R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1826-1834</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The pipecolinate deriv. VX-710 (Biricodar; Incel) is a clin. applicable modulator of P-glycoprotein (Pgp) and multidrug resistance protein (MRP-1); we studied its activity against the third multidrug resistance (MDR)-assocd. drug efflux protein, breast cancer resistance protein (BCRP).  VX-710 modulation of uptake, retention, and cytotoxicity of mitoxantrone, daunorubicin, doxorubicin, topotecan, and SN38 was studied in cell lines overexpressing Pgp, MRP-1 and wild-type (BCRPR482) and mutant (BCRPR482T) BCRP.  In 8226/Dox6 cells (Pgp), VX-710 increased mitoxantrone and daunorubicin uptake by 55 and 100%, resp., increased their retention by 100 and 60%, resp., and increased their cytotoxicity 3.1- and 6.9-fold, resp.  In HL60/Adr cells (MRP-1), VX-710 increased mitoxantrone and daunorubicin uptake by 43 and 130%, increased their retention by 90 and 60%, and increased their cytotoxicity 2.4- and 3.3-fold.  In 8226/MR20 cells (BCRPR482), VX-710 increased mitoxantrone uptake and retention by 60 and 40%, resp., and increased cytotoxicity 2.4-fold.  VX-710 increased daunorubicin uptake and retention by only 10% in 8226/MR20 cells, consistent with the fact that daunorubicin is not a substrate for BCRPR482, but, nevertheless, it increased daunorubicin cytotoxicity 3.6-fold, and this increase was not assocd. with intracellular drug redistribution.  VX-710 had little effect on uptake, retention, or cytotoxicity of mitoxantrone, daunorubicin, doxorubicin, topotecan, or SN38 in MCF7 AdVP3000 cells (BCRPR482T).  VX-710 modulates Pgp, MRP-1, and BCRPR482, and has potential as a clin. broad-spectrum MDR modulator in malignancies such as the acute leukemias in which these proteins are expressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLqnEIAu5oU7Vg90H21EOLACvtfcHk0li8veRyV7rC1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFClt7c%253D&md5=1848eb4d4dae0e2affe41e1f3d6adda6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-0914-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-0914-3%26sid%3Dliteratum%253Aachs%26aulast%3DMinderman%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Loughlin%26aufirst%3DK.%2BL.%26aulast%3DPendyala%26aufirst%3DL.%26aulast%3DBaer%26aufirst%3DM.%2BR.%26atitle%3DVX-710%2520%2528biricodar%2529%2520increases%2520drug%2520retention%2520and%2520enhances%2520chemosensitivity%2520in%2520resistant%2520cells%2520overexpressing%2520P-glycoprotein%252C%2520multidrug%2520resistance%2520protein%252C%2520and%2520breast%2520cancer%2520resistance%2520protein%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D1826%26epage%3D1834%26doi%3D10.1158%2F1078-0432.CCR-0914-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Loevezijn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinkel, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koomen, G. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(00)00588-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2FS0960-894X%2800%2900588-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=29-32&author=A.+van%0ALoevezijnauthor=J.+D.+Allenauthor=A.+H.+Schinkelauthor=G.+J.+Koomen&title=Inhibition+of+BCRP-mediated+drug+efflux+by+fumitremorgin-type+indolyl+diketopiperazines&doi=10.1016%2FS0960-894X%2800%2900588-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900588-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900588-6%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BLoevezijn%26aufirst%3DA.%26aulast%3DAllen%26aufirst%3DJ.%2BD.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26aulast%3DKoomen%26aufirst%3DG.%2BJ.%26atitle%3DInhibition%2520of%2520BCRP-mediated%2520drug%2520efflux%2520by%2520fumitremorgin-type%2520indolyl%2520diketopiperazines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D29%26epage%3D32%26doi%3D10.1016%2FS0960-894X%2800%2900588-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gekeler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ise, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, J.</span></span> <span> </span><span class="NLM_article-title">The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>208</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1995.1344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1006%2Fbbrc.1995.1344" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=1995&pages=345-352&author=V.+Gekelerauthor=W.+Iseauthor=K.+H.+Sandersauthor=W.+R.+Ulrichauthor=J.+Beck&title=The+leukotriene+LTD4+receptor+antagonist+MK571+specifically+modulates+MRP+associated+multidrug+resistance&doi=10.1006%2Fbbrc.1995.1344"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1995.1344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1995.1344%26sid%3Dliteratum%253Aachs%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DIse%26aufirst%3DW.%26aulast%3DSanders%26aufirst%3DK.%2BH.%26aulast%3DUlrich%26aufirst%3DW.%2BR.%26aulast%3DBeck%26aufirst%3DJ.%26atitle%3DThe%2520leukotriene%2520LTD4%2520receptor%2520antagonist%2520MK571%2520specifically%2520modulates%2520MRP%2520associated%2520multidrug%2520resistance%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1995%26volume%3D208%26spage%3D345%26epage%3D352%26doi%3D10.1006%2Fbbrc.1995.1344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gollapudi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span> <span> </span><span class="NLM_article-title">Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">150</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1007/s002800050640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1007%2Fs002800050640" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=9182837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADyaK2sXjsFKhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=150-158&author=S.+Gollapudiauthor=C.+H.+Kimauthor=B.+N.+Tranauthor=S.+Sanghaauthor=S.+Gupta&title=Probenecid+reverses+multidrug+resistance+in+multidrug+resistance-associated+protein-overexpressing+HL60%2FAR+and+H69%2FAR+cells+but+not+in+P-glycoprotein-overexpressing+HL60%2FTax+and+P388%2FADR+cells&doi=10.1007%2Fs002800050640"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells</span></div><div class="casAuthors">Gollapudi, Sastry; Kim, Choong H.; Tran, Bich Ngoc; Sangha, Soni; Gupta, Sudhir</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">150-158</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">To det. whether probenecid, an inhibitor of org. anion transport, is able to reverse multidrug resistance (MDR) through modulation of the drug transport function of MDR-assocd. protein (MRP) and P-glycoprotein (P-gP).  MRP-overexpressing cell lines and P-gP-overexpressing cell lines were cultured with different concns. of daunorubicin (DNR) or vincristine (VCR) in the presence or absence of various concns. of probenecid.  Drug sensitivity was detd. using an MTT assay.  DNR accumulation and subcellular distribution were detd. by flow cytometry and confocal microscopy, resp.  VCR accumulation was detd. by scintillation spectrometry.  Probenecid, in a concn.-dependent manner, reversed resistance to DNR and VCR in HL60/AR and H69/AR tumor cell lines.  This effect of probenecid on MDR was assocd. with an increased accumulation of DNR and VCR and correction of the altered subcellular distribution of DNR.  The concns. of probenecid that reversed MDR are clin. achievable in vivo.  In contrast, probenecid did not reverse MDR in either HL60/Tax or P388/ADR tumor cell lines that overexpress P-gP.  Probenecid is an effective chemosensitizer of MRP-assocd. MDR tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojobukUNaar7Vg90H21EOLACvtfcHk0li8veRyV7rC1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsFKhtL4%253D&md5=f2a909b0d5f55a20548932aae3172a7c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs002800050640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800050640%26sid%3Dliteratum%253Aachs%26aulast%3DGollapudi%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DC.%2BH.%26aulast%3DTran%26aufirst%3DB.%2BN.%26aulast%3DSangha%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DS.%26atitle%3DProbenecid%2520reverses%2520multidrug%2520resistance%2520in%2520multidrug%2520resistance-associated%2520protein-overexpressing%2520HL60%252FAR%2520and%2520H69%252FAR%2520cells%2520but%2520not%2520in%2520P-glycoprotein-overexpressing%2520HL60%252FTax%2520and%2520P388%252FADR%2520cells%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1997%26volume%3D40%26spage%3D150%26epage%3D158%26doi%3D10.1007%2Fs002800050640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span> <span> </span><span class="NLM_article-title">Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1999</span>– <span class="NLM_lpage">2014</span>, <span class="refDoi"> DOI: 10.1021/jm201121b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201121b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVeksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1999-2014&author=K.+F.+Chanauthor=I.+L.+Wongauthor=J.+W.+Kanauthor=C.+S.+Yanauthor=L.+M.+Chowauthor=T.+H.+Chan&title=Amine+linked+flavonoid+dimers+as+modulators+for+P-glycoprotein-based+multidrug+resistance%3A+structure-activity+relationship+and+mechanism+of+modulation&doi=10.1021%2Fjm201121b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Amine Linked Flavonoid Dimers as Modulators for P-Glycoprotein-Based Multidrug Resistance: Structure-Activity Relationship and Mechanism of Modulation</span></div><div class="casAuthors">Chan, Kin-Fai; Wong, Iris L. K.; Kan, Jason W. Y.; Yan, Clare S. W.; Chow, Larry M. C.; Chan, Tak Hang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1999-2014</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here we report a great improvement in reversal potency of cancer drug resistance when flavonoid dimers possess a functionally substituted aminopolyethylene glycol linker.  The most potent compd., (I), contains a N-benzyl group at the linker.  It has many advantages including (1) high potencies in reversing P-glycoprotein (P-gp) mediated resistance in LCC6MDR cells to various anticancer drugs with EC50 in the nanomolar range, (2) low toxicity and high therapeutic index, and (3) preferential inhibition of P-gp over multidrug resistance protein 1 and breast cancer resistance protein.  I stimulates P-gp-ATPase activity by 2.7-fold and mediates a dose-dependent inhibition of doxorubicin (DOX) transport activity.  Lineweaver-Burk and Dixon plots suggest that I is a competitive inhibitor to DOX in binding to P-gp with a Ki of 0.28-0.34 μM and a Hill coeff. of 1.17.  Moreover, the LCC6MDR cell displays about 2.1-fold lower intracellular accumulation of 18 compared to the wild type, suggesting that 18 is a P-gp substrate as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzkFyzfv4ZzrVg90H21EOLACvtfcHk0lic0FXn_ro4PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVeksbY%253D&md5=dee53ec7b3b8651b85dad6d833df4691</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm201121b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201121b%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DK.%2BF.%26aulast%3DWong%26aufirst%3DI.%2BL.%26aulast%3DKan%26aufirst%3DJ.%2BW.%26aulast%3DYan%26aufirst%3DC.%2BS.%26aulast%3DChow%26aufirst%3DL.%2BM.%26aulast%3DChan%26aufirst%3DT.%2BH.%26atitle%3DAmine%2520linked%2520flavonoid%2520dimers%2520as%2520modulators%2520for%2520P-glycoprotein-based%2520multidrug%2520resistance%253A%2520structure-activity%2520relationship%2520and%2520mechanism%2520of%2520modulation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1999%26epage%3D2014%26doi%3D10.1021%2Fjm201121b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkett, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span> <span> </span><span class="NLM_article-title">Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6742</span>– <span class="NLM_lpage">6759</span>, <span class="refDoi"> DOI: 10.1021/jm060593+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060593%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOqsLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6742-6759&author=K.+F.+Chanauthor=Y.+Zhaoauthor=B.+A.+Burkettauthor=I.+L.+Wongauthor=L.+M.+Chowauthor=T.+H.+Chan&title=Flavonoid+dimers+as+bivalent+modulators+for+P-glycoprotein-based+multidrug+resistance%3A+synthetic+apigenin+homodimers+linked+with+defined-length+poly%28ethylene+glycol%29+spacers+increase+drug+retention+and+enhance+chemosensitivity+in+resistant+cancer+cells&doi=10.1021%2Fjm060593%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Flavonoid Dimers as Bivalent Modulators for P-Glycoprotein-Based Multidrug Resistance: Synthetic Apigenin Homodimers Linked with Defined-Length Poly(ethylene glycol) Spacers Increase Drug Retention and Enhance Chemosensitivity in Resistant Cancer Cells</span></div><div class="casAuthors">Chan, Kin-Fai; Zhao, Yunzhe; Burkett, Brendan A.; Wong, Iris L. K.; Chow, Larry M. C.; Chan, Tak Hang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6742-6759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Much effort has been spent on searching for better P-glycoprotein- (P-gp-) based multidrug resistance (MDR) modulators.  Our approach was to target the binding sites of P-gp using dimers of dietary flavonoids.  A series of apigenin-based flavonoid dimers, linked by poly(ethylene glycol) chains of various lengths, have been synthesized.  These flavonoid dimers modulate drug chemosensitivity and retention in breast and leukemic MDR cells with the optimal no. of ethylene glycol units equal to 2-4.  Compd. 9d bearing four ethylene glycol units increased drug accumulation in drug-resistant cells and enhanced cytotoxicity of paclitaxel, doxorubicin, daunomycin, vincristine, and vinblastine in drug-resistant breast cancer and leukemia cells in vitro, resulting in redn. of IC50 by 5-50 times.  This compd. also stimulated P-gp's ATPase activity by 3.3-fold.  Its modulating activity was presumably by binding to the substrate binding sites of P-gp and disrupting drug efflux.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAs5cv1zQgVLVg90H21EOLACvtfcHk0lic0FXn_ro4PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOqsLfM&md5=236d3561a062922ed3656b61abafd0bb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm060593%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060593%252B%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DK.%2BF.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DBurkett%26aufirst%3DB.%2BA.%26aulast%3DWong%26aufirst%3DI.%2BL.%26aulast%3DChow%26aufirst%3DL.%2BM.%26aulast%3DChan%26aufirst%3DT.%2BH.%26atitle%3DFlavonoid%2520dimers%2520as%2520bivalent%2520modulators%2520for%2520P-glycoprotein-based%2520multidrug%2520resistance%253A%2520synthetic%2520apigenin%2520homodimers%2520linked%2520with%2520defined-length%2520poly%2528ethylene%2520glycol%2529%2520spacers%2520increase%2520drug%2520retention%2520and%2520enhance%2520chemosensitivity%2520in%2520resistant%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6742%26epage%3D6759%26doi%3D10.1021%2Fjm060593%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkett, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span> <span> </span><span class="NLM_article-title">Flavonoid dimers as bivalent modulators for p-glycoprotein-based multidrug resistance: structure-activity relationships</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">594</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200800413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1002%2Fcmdc.200800413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=19288491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlCgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=594-614&author=K.+F.+Chanauthor=Y.+Zhaoauthor=T.+W.+Chowauthor=C.+S.+Yanauthor=D.+L.+Maauthor=B.+A.+Burkettauthor=I.+L.+Wongauthor=L.+M.+Chowauthor=T.+H.+Chan&title=Flavonoid+dimers+as+bivalent+modulators+for+p-glycoprotein-based+multidrug+resistance%3A+structure-activity+relationships&doi=10.1002%2Fcmdc.200800413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Flavonoid Dimers as Bivalent Modulators for P-Glycoprotein-Based Multidrug Resistance: Structure-Activity Relationships</span></div><div class="casAuthors">Chan, Kin-Fai; Zhao, Yunzhe; Chow, Toby W. S.; Yan, Clare S. W.; Ma, Dik Lung; Burkett, Brendan A.; Wong, Iris L. K.; Chow, Larry M. C.; Chan, Tak Hang</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">594-614</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sym. and unsym. tetra(ethylene glycol)-linked dimers of flavonoids such as I are prepd. as potential multidrug resistance-reversing agents; their abilities to potential the cytotoxicity of paclitaxel in a multidrug resistant human breast cancer cell line and their lipophilicities are detd., while the abilities of selected compds. to potentiate the toxicities of doxorubicin, vincristine, and vinblastine in a human breast cancer cell line are detd.  Tetra(ethylene glycol)-linked flavanoid dimers with nonpolar, hydrophobic, and less bulky substituents generally show more potent reversing activities than those with other substituents.  Flavonoid dimers with nonpolar and hydrophobic substituents such as Me and Et groups are more potent resistance-reversing agents than dimers with polar and hydrophilic substituents such as hydroxy groups at the C3, C6, and C7 positions of the flavone moieties, but not at C5.  I, contg. Me groups at C6 of the flavone moieties, is optimal, with dimers contg. bulkier substituents at C6 leading to lower multidrug reversing activity.  Comparison of unsym. flavanoid dimers with the corresponding sym. dimers revealed that the two binding sites on P-gp for flavonoid moieties are similar to each other.  The compds. are not cytotoxic towards normal or multidrug resistant cancer cells at 1, 2, or 5 μM concns. (no data).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEk32GHrRA67Vg90H21EOLACvtfcHk0lic0FXn_ro4PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlCgtr8%253D&md5=eea708b2cbb50b5f7c703760d1e7a1fc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800413%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DK.%2BF.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChow%26aufirst%3DT.%2BW.%26aulast%3DYan%26aufirst%3DC.%2BS.%26aulast%3DMa%26aufirst%3DD.%2BL.%26aulast%3DBurkett%26aufirst%3DB.%2BA.%26aulast%3DWong%26aufirst%3DI.%2BL.%26aulast%3DChow%26aufirst%3DL.%2BM.%26aulast%3DChan%26aufirst%3DT.%2BH.%26atitle%3DFlavonoid%2520dimers%2520as%2520bivalent%2520modulators%2520for%2520p-glycoprotein-based%2520multidrug%2520resistance%253A%2520structure-activity%2520relationships%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D594%26epage%3D614%26doi%3D10.1002%2Fcmdc.200800413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span> <span> </span><span class="NLM_article-title">Novel classes of dimer antitumour drug candidates</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.2174/138161209787315576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.2174%2F138161209787315576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=19199989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=659-674&author=L.+M.+Chowauthor=T.+H.+Chan&title=Novel+classes+of+dimer+antitumour+drug+candidates&doi=10.2174%2F138161209787315576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Novel classes of dimer antitumour drug candidates</span></div><div class="casAuthors">Chow, Larry M. C.; Chan, Tak Hang</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">659-674</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Polyvalency in the biol. world is defined as the simultaneous binding of multiple ligands to one receptor.  Polyvalency can increase the affinity of the polyvalent ligand by 100-1000 fold over the monovalent ligand.  Such phenomenon has been employed to design polyvalent toxin inhibitors.  Bivalency is a similar approach where two ligands are joined together with a linker to form a homo- or hetero-dimer with an increase in affinity by up to several hundred fold over the monovalent ligand.  This review will summarize the recent advancement in designing bivalent inhibitors to be used as antitumor agents.  Some dimers (e.g. artemisinin homo-dimer) simply increase the affinity of the monovalent ligands without detailed knowledge of the target.  Other dimers are designed with well-characterized targets, for example, jesterone dimer (inhibiting Rel/NF-κB) and 3,3'-diindolymethane and their derivs. (inhibiting Akt and NFκB).  Some dimers are designed based on the high definition structure between ligand and target (e.g. benzodiazepine and daunorubicin interacting with DNA).  Heterodimers have also been produced by combining either two different antitumor drugs (e.g. cis-platin/acridine or cis-platin/naphthalimide) or combining one antitumor candidate (artemisinin) with a mol. which can increase the efficacy of the former (transferrin receptor).  Finally we will discuss the design of bivalent inhibitors of the P-glycoprotein (ABCB1; MDR or P-gp) to overcome the problem of antitumor resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUXhqOSnGxmLVg90H21EOLACvtfcHk0lgDg2EYQo4fcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSns7k%253D&md5=00d01b4aafa8cef596a8bce572c757f8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F138161209787315576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209787315576%26sid%3Dliteratum%253Aachs%26aulast%3DChow%26aufirst%3DL.%2BM.%26aulast%3DChan%26aufirst%3DT.%2BH.%26atitle%3DNovel%2520classes%2520of%2520dimer%2520antitumour%2520drug%2520candidates%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D659%26epage%3D674%26doi%3D10.2174%2F138161209787315576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M.</span></span> <span> </span><span class="NLM_article-title">Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5311</span>– <span class="NLM_lpage">5322</span>, <span class="refDoi"> DOI: 10.1021/jm900194w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900194w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWntb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5311-5322&author=I.+L.+Wongauthor=K.+F.+Chanauthor=K.+H.+Tsangauthor=C.+Y.+Lamauthor=Y.+Zhaoauthor=T.+H.+Chanauthor=L.+M.+Chow&title=Modulation+of+multidrug+resistance+protein+1+%28MRP1%2FABCC1%29-mediated+multidrug+resistance+by+bivalent+apigenin+homodimers+and+their+derivatives&doi=10.1021%2Fjm900194w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Multidrug Resistance Protein 1 (MRP1/ABCC1)-Mediated Multidrug Resistance by Bivalent Apigenin Homodimers and Their Derivatives</span></div><div class="casAuthors">Wong, Iris L. K.; Chan, Kin-Fai; Tsang, Ka Hing; Lam, Chi Yin; Zhao, Yunzhe; Chan, Tak Hang; Chow, Larry Ming Cheung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5311-5322</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here it is showed that bivalency approach is effective in modulating multidrug resistance protein 1 (MRP1/ABCC1)-mediated doxorubicin (DOX) and etoposide (VP16) resistance in human 2008/MRP1 ovarian carcinoma cells.  Flavonoid dimers bearing five or six ethylene glycol (EG) units with 6-Me or 7-Me substitution on the ring A of flavonoid dimers have the highest modulating activity for DOX against MRP1 with an EC50 ranging from 73 to 133 nM.  At 0.5 μM, the flavonoid dimer I was sufficient to restore DOX accumulation in 2008/MRP1 to parental 2008/P level.  Lineweaver-Burk and Dixon plot suggested that it is likely a competitive inhibitor of DOX transport with a Ki = 0.2 μM.  The data suggest that flavonoid dimers have a high affinity toward binding to DOX recognition site of MRP1.  This results in inhibiting DOX transport, increasing intracellular DOX retention, and finally resensitizing 2008/MRP1 to DOX.  The present study demonstrates that flavonoid dimers can be employed as an effective modulator of MRP1-mediated drug resistance in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM2E1QnkQ3jrVg90H21EOLACvtfcHk0lgDg2EYQo4fcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWntb3E&md5=5acb996cd44f205b7344d2b91e34e9f2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900194w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900194w%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DI.%2BL.%26aulast%3DChan%26aufirst%3DK.%2BF.%26aulast%3DTsang%26aufirst%3DK.%2BH.%26aulast%3DLam%26aufirst%3DC.%2BY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DT.%2BH.%26aulast%3DChow%26aufirst%3DL.%2BM.%26atitle%3DModulation%2520of%2520multidrug%2520resistance%2520protein%25201%2520%2528MRP1%252FABCC1%2529-mediated%2520multidrug%2520resistance%2520by%2520bivalent%2520apigenin%2520homodimers%2520and%2520their%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5311%26epage%3D5322%26doi%3D10.1021%2Fjm900194w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M.</span></span> <span> </span><span class="NLM_article-title">A new class of safe, potent, and specific P-gp modulator: flavonoid dimer FD18 reverses P-gp-mediated multidrug resistance in human breast xenograft in vivo</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3507</span>– <span class="NLM_lpage">3517</span>, <span class="refDoi"> DOI: 10.1021/mp500770e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp500770e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlKnsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=3507-3517&author=C.+S.+Yanauthor=I.+L.+Wongauthor=K.+F.+Chanauthor=J.+W.+Kanauthor=T.+C.+Chongauthor=M.+C.+Lawauthor=Y.+Zhaoauthor=S.+W.+Chanauthor=T.+H.+Chanauthor=L.+M.+Chow&title=A+new+class+of+safe%2C+potent%2C+and+specific+P-gp+modulator%3A+flavonoid+dimer+FD18+reverses+P-gp-mediated+multidrug+resistance+in+human+breast+xenograft+in+vivo&doi=10.1021%2Fmp500770e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A New Class of Safe, Potent, and Specific P-gp Modulator: Flavonoid Dimer FD18 Reverses P-gp-Mediated Multidrug Resistance in Human Breast Xenograft in Vivo</span></div><div class="casAuthors">Yan, Clare S. W.; Wong, Iris L. K.; Chan, Kin-Fai; Kan, Jason W. Y.; Chong, Tsz Cheung; Law, Man Chun; Zhao, Yunzhe; Chan, Shun Wan; Chan, Tak Hang; Chow, Larry M. C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3507-3517</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Flavonoid dimer FD18 is a new class of dimeric P-gp modulator that can reverse cancer drug resistance.  FD18 is a potent (EC50 = 148 nM for paclitaxel), safe (selective index = 574), and selective P-glycoprotein (P-gp) modulator.  FD18 can modulate multidrug resistance toward paclitaxel, vinblastine, vincristine, doxorubicin, daunorubicin, and mitoxantrone in human breast cancer LCC6MDR in vitro.  FD18 (1 μM) can revert chemosensitivity of LCC6MDR back to parental LCC6 level.  FD18 was 11- to 46-fold more potent than verapamil.  FD18 (1 μM) can increase accumulation of doxorubicin by 2.7-fold, daunorubicin (2.1-fold), and rhodamine 123 (5.2-fold) in LCC6MDR.  FD18 inhibited P-gp-mediated doxorubicin efflux and has no effect on influx.  FD18 at 1 μM did not affect the protein expression level of P-gp.  Pharmacokinetics studies indicated that i.p. administration of 45 mg/kg FD18 was enough to maintain a plasma level above EC50 (148 nM) for more than 600 min.  Acute toxicity studies with FD18 (90 mg/kg, i.p. for 12 times in 22 days) with paclitaxel (12 mg/kg, i.v. for 12 times in 22 days) revealed no obvious toxicity or death in mice.  In vivo efficacy studies indicated that FD18 (45 mg/kg, i.p. for 12 times in 22 days) together with paclitaxel (12 mg/kg, i.v. for 12 times in 22 days) resulted in a 46% redn. in LCC6MDR xenograft vol. (n = 11; 648 ± 84 mm3) compared to paclitaxel control (n = 8; 1201 ± 118 mm3).  There were no animal deaths or significant drop in body wt. and vital organ wet wt.  FD18 can increase paclitaxel accumulation in LCC6MDR xenograft by 1.8- to 2.2-fold.  The present study suggests that FD18 represents a new class of safe and potent P-gp modulator in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGV4jlyRZZHbVg90H21EOLACvtfcHk0lgDg2EYQo4fcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlKnsL7L&md5=ae0ce196912ba2739030b31213c7d7fe</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fmp500770e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp500770e%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DC.%2BS.%26aulast%3DWong%26aufirst%3DI.%2BL.%26aulast%3DChan%26aufirst%3DK.%2BF.%26aulast%3DKan%26aufirst%3DJ.%2BW.%26aulast%3DChong%26aufirst%3DT.%2BC.%26aulast%3DLaw%26aufirst%3DM.%2BC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DS.%2BW.%26aulast%3DChan%26aufirst%3DT.%2BH.%26aulast%3DChow%26aufirst%3DL.%2BM.%26atitle%3DA%2520new%2520class%2520of%2520safe%252C%2520potent%252C%2520and%2520specific%2520P-gp%2520modulator%253A%2520flavonoid%2520dimer%2520FD18%2520reverses%2520P-gp-mediated%2520multidrug%2520resistance%2520in%2520human%2520breast%2520xenograft%2520in%2520vivo%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D3507%26epage%3D3517%26doi%3D10.1021%2Fmp500770e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span> <span> </span><span class="NLM_article-title">The growing impact of click chemistry on drug discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1128</span>– <span class="NLM_lpage">1137</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(03)02933-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2FS1359-6446%2803%2902933-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=14678739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVWkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=1128-1137&author=H.+C.+Kolbauthor=K.+B.+Sharpless&title=The+growing+impact+of+click+chemistry+on+drug+discovery&doi=10.1016%2FS1359-6446%2803%2902933-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The growing impact of click chemistry on drug discovery</span></div><div class="casAuthors">Kolb, Hartmuth C.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">1128-1137</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Click chem. is a modular approach that uses only the most practical and reliable chem. transformations.  Its applications are increasingly found in all aspects of drug discovery, ranging from lead finding through combinatorial chem. and target-templated in situ chem., to proteomics and DNA research, using bioconjugation reactions.  The copper-(I)-catalyzed 1,2,3-triazole formation from azides and terminal acetylenes is a particularly powerful linking reaction, due to its high degree of dependability, complete specificity, and the bio-compatibility of the reactants.  The triazole products are more than just passive linkers; they readily assoc. with biol. targets, through hydrogen bonding and dipole interactions.  Click chem., a modular approach based on highly reliable chem. transformations, is being applied in all aspects of drug discovery, ranging from lead finding to proteomics and DNA research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqEB1hjIBNhbVg90H21EOLACvtfcHk0lhtqljX0FNaKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVWkuro%253D&md5=f0042f3a8f153d1c1192533d90699d19</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902933-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902933-7%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DThe%2520growing%2520impact%2520of%2520click%2520chemistry%2520on%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D1128%26epage%3D1137%26doi%3D10.1016%2FS1359-6446%2803%2902933-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasini, D.</span></span> <span> </span><span class="NLM_article-title">The click reaction as an efficient tool for the construction of macrocyclic structures</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">9512</span>– <span class="NLM_lpage">9530</span>, <span class="refDoi"> DOI: 10.3390/molecules18089512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.3390%2Fmolecules18089512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=23966075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWgtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=9512-9530&author=D.+Pasini&title=The+click+reaction+as+an+efficient+tool+for+the+construction+of+macrocyclic+structures&doi=10.3390%2Fmolecules18089512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The click reaction as an efficient tool for the construction of macrocyclic structures</span></div><div class="casAuthors">Pasini, Dario</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9512-9530</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The Cu(I)-catalyzed azide-alkyne cycloaddn. (CuAAC, known as the click reaction) is an established tool used for the construction of complex mol. architectures.  Given its efficiency it has been widely applied for bioconjugation, polymer and dendrimer synthesis.  More recently, this reaction has been utilized for the efficient formation of rigid or shape-persistent, preorganized macrocyclic species.  This strategy also allows the installment of useful functionalities, in the form of polar and function-rich 1,2,3-triazole moieties, directly embedded in the macrocyclic structures.  This review analyzes the state of the art in this context, and provides some elements of perspective for future applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvopsXeQjNJbVg90H21EOLACvtfcHk0lhtqljX0FNaKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWgtbnL&md5=bfd78e7f1ea10ea51f48e21ab87449e6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18089512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18089512%26sid%3Dliteratum%253Aachs%26aulast%3DPasini%26aufirst%3DD.%26atitle%3DThe%2520click%2520reaction%2520as%2520an%2520efficient%2520tool%2520for%2520the%2520construction%2520of%2520macrocyclic%2520structures%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D9512%26epage%3D9530%26doi%3D10.3390%2Fmolecules18089512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.drudis.2015.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=26315392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVOnt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=118-132&author=X.+Wangauthor=B.+Huangauthor=X.+Liuauthor=P.+Zhan&title=Discovery+of+bioactive+molecules+from+CuAAC+click-chemistry-based+combinatorial+libraries&doi=10.1016%2Fj.drudis.2015.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries</span></div><div class="casAuthors">Wang, Xueshun; Huang, Boshi; Liu, Xinyong; Zhan, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">118-132</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The rapid assembly and in situ screening of focused combinatorial fragment libraries using CuAAC click chem. is a highly robust and efficient strategy for establishing SAR and for discovering bioactive mols.  This review outlines the current status of this methodol. in drug discovery application.  The inherent limitations, challenges and prospects are critically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGricX1HNgromLVg90H21EOLACvtfcHk0lhtqljX0FNaKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVOnt7%252FN&md5=57314fbcbf2e16e2267a8c9513a39b13</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhan%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520bioactive%2520molecules%2520from%2520CuAAC%2520click-chemistry-based%2520combinatorial%2520libraries%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D118%26epage%3D132%26doi%3D10.1016%2Fj.drudis.2015.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levental, I.</span></span> <span> </span><span class="NLM_article-title">Click-chemistry based high throughput screening platform for modulators of ras palmitoylation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">41147</span>, <span class="refDoi"> DOI: 10.1038/srep41147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1038%2Fsrep41147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=28112226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFaks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=41147&author=L.+Ganesanauthor=P.+Shiehauthor=C.+R.+Bertozziauthor=I.+Levental&title=Click-chemistry+based+high+throughput+screening+platform+for+modulators+of+ras+palmitoylation&doi=10.1038%2Fsrep41147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Click-Chemistry Based High Throughput Screening Platform for Modulators of Ras Palmitoylation</span></div><div class="casAuthors">Ganesan, Lakshmi; Shieh, Peyton; Bertozzi, Carolyn R.; Levental, Ilya</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">41147</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Palmitoylation is a widespread, reversible lipid modification that has been implicated in regulating a variety of cellular processes.  Approx. one thousand proteins are annotated as being palmitoylated, and for some of these, including several oncogenes of the Ras and Src families, palmitoylation is indispensable for protein function.  Despite this wealth of disease-relevant targets, there are currently few effective pharmacol. tools to interfere with protein palmitoylation.  One reason for this lack of development is the dearth of assays to efficiently screen for small mol. inhibitors of palmitoylation.  To address this shortcoming, we have developed a robust, high-throughput compatible, click chem.-based approach to identify small mols. that interfere with the palmitoylation of Ras, a high value therapeutic target that is mutated in up to a third of human cancers.  This assay design shows excellent performance in 384-well format and is sensitive to known, non-specific palmitoylation inhibitors.  Further, we demonstrate an ideal counter-screening strategy, which relies on a target peptide from an unrelated protein, the Src-family kinase Fyn.  The screening approach described here provides an integrated platform to identify specific modulators of palmitoylated proteins, demonstrated here for Ras and Fyn, but potentially applicable to pharmaceutical targets involved in a variety of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_WhXLki_41rVg90H21EOLACvtfcHk0lh7Dk1pfrdGNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFaks70%253D&md5=080c253e699f7b7d012ad19c0b1c0eaa</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fsrep41147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep41147%26sid%3Dliteratum%253Aachs%26aulast%3DGanesan%26aufirst%3DL.%26aulast%3DShieh%26aufirst%3DP.%26aulast%3DBertozzi%26aufirst%3DC.%2BR.%26aulast%3DLevental%26aufirst%3DI.%26atitle%3DClick-chemistry%2520based%2520high%2520throughput%2520screening%2520platform%2520for%2520modulators%2520of%2520ras%2520palmitoylation%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D41147%26doi%3D10.1038%2Fsrep41147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabbrizzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabocchi, A.</span></span> <span> </span><span class="NLM_article-title">Use of click-chemistry in the development of peptidomimetic enzyme inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1467</span>– <span class="NLM_lpage">1477</span>, <span class="refDoi"> DOI: 10.2174/0929867321666131218093611</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.2174%2F0929867321666131218093611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=24350850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1Cns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1467-1477&author=P.+Fabbrizziauthor=G.+Menchiauthor=A.+Guarnaauthor=A.+Trabocchi&title=Use+of+click-chemistry+in+the+development+of+peptidomimetic+enzyme+inhibitors&doi=10.2174%2F0929867321666131218093611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Click-Chemistry in the Development of Peptidomimetic Enzyme Inhibitors</span></div><div class="casAuthors">Fabbrizzi, P.; Menchi, G.; Guarna, A.; Trabocchi, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1467-1477</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cu(I)-catalyzed Azide-Alkyne Cycloaddn. (CuAAC) is often utilized in medicinal chem. to make the triazole moiety as it acts as a non-classical bioisostere of the peptide bond.  This useful technique can also be applied in the fragment-based assembly of mol. libraries for high-throughput screening.  This minireview outlines the application of click-chem. in the synthesis of enzyme inhibitors with the triazole moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2LYh2dI8jLVg90H21EOLACvtfcHk0lh7Dk1pfrdGNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1Cns78%253D&md5=38e8fba08390d4dccf4d2e588e231ac2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F0929867321666131218093611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666131218093611%26sid%3Dliteratum%253Aachs%26aulast%3DFabbrizzi%26aufirst%3DP.%26aulast%3DMenchi%26aufirst%3DG.%26aulast%3DGuarna%26aufirst%3DA.%26aulast%3DTrabocchi%26aufirst%3DA.%26atitle%3DUse%2520of%2520click-chemistry%2520in%2520the%2520development%2520of%2520peptidomimetic%2520enzyme%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1467%26epage%3D1477%26doi%3D10.2174%2F0929867321666131218093611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalesh, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S. Q.</span></span> <span> </span><span class="NLM_article-title">Methods of using click chemistry in the discovery of enzyme inhibitors</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2655</span>– <span class="NLM_lpage">2664</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1038%2Fnprot.2007.323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=18007601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSlsrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=2655-2664&author=R.+Srinivasanauthor=J.+Liauthor=S.+L.+Ngauthor=K.+A.+Kaleshauthor=S.+Q.+Yao&title=Methods+of+using+click+chemistry+in+the+discovery+of+enzyme+inhibitors&doi=10.1038%2Fnprot.2007.323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Methods of using click chemistry in the discovery of enzyme inhibitors</span></div><div class="casAuthors">Srinivasan, Rajavel; Li, Junqi; Ng, Su Ling; Kalesh, Karunakaran A.; Yao, Shao Q.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2655-2664</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">This protocol describes the step-by-step procedures for the efficient assembly of bidentate inhibitor libraries of a target enzyme, using the so-called 'click chem.' between an alkyne-bearing core group and an azide-modified peripheral group, followed by direct biol. screening for the identification of potential 'hits'.  The reaction is highlighted by its modularity, high efficiency (∼100% yield in most cases) and tolerance toward many functional groups present in the fragments, as well as biocompatibility (typically carried out in aq. conditions with small amts. of biocompatible catalysts).  The approach consists of three steps: (i) chem. synthesis of alkyne-bearing protein tyrosine phosphatase or matrix metalloprotease core groups and diverse azide-modified peripheral groups; (ii) click chem. to assemble the bidentate inhibitor libraries; and (iii) direct screening of the libraries with target enzymes using 384-well microplate assays.  Following the chem. synthesis of the core and peripheral groups and optimization of the click chem. conditions (∼1 wk), steps (ii) and (iii) take 3 d to complete (∼1-2 d for library assembly and 1 d for inhibitor screening).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvVU_E7kmG4rVg90H21EOLACvtfcHk0lh7Dk1pfrdGNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSlsrrJ&md5=21306eca61966c0d8d1bbb504a17fdf4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.323%26sid%3Dliteratum%253Aachs%26aulast%3DSrinivasan%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DNg%26aufirst%3DS.%2BL.%26aulast%3DKalesh%26aufirst%3DK.%2BA.%26aulast%3DYao%26aufirst%3DS.%2BQ.%26atitle%3DMethods%2520of%2520using%2520click%2520chemistry%2520in%2520the%2520discovery%2520of%2520enzyme%2520inhibitors%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D2655%26epage%3D2664%26doi%3D10.1038%2Fnprot.2007.323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalesh, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S. Q.</span></span> <span> </span><span class="NLM_article-title">High-throughput synthesis of azide libraries suitable for direct “click” chemistry and in situ screening</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1821</span>– <span class="NLM_lpage">1828</span>, <span class="refDoi"> DOI: 10.1039/b902338k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1039%2Fb902338k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=19590777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksV2iurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=1821-1828&author=R.+Srinivasanauthor=L.+P.+Tanauthor=H.+Wuauthor=P.+Y.+Yangauthor=K.+A.+Kaleshauthor=S.+Q.+Yao&title=High-throughput+synthesis+of+azide+libraries+suitable+for+direct+%E2%80%9Cclick%E2%80%9D+chemistry+and+in+situ+screening&doi=10.1039%2Fb902338k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput synthesis of azide libraries suitable for direct "click" chemistry and in situ screening</span></div><div class="casAuthors">Srinivasan, Rajavel; Tan, Lay Pheng; Wu, Hao; Yang, Peng-Yu; Kalesh, Karunakaran A.; Yao, Shao Q.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1821-1828</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A key challenge in current drug discovery is the development of high-throughput (HT) amenable chem. reactions that allow rapid synthesis of diverse chem. libraries of enzyme inhibitors.  The Cu(I)-catalyzed, 1,3-dipolar cycloaddn. between an azide and an alkyne, better known as "click chem.", is one such method that has received the most attention in recent years.  Despite its popularity, there is still a lack of robust and efficient chem. strategies that give access to diverse libraries of azide-contg. building blocks (key components in click chem.).  A highly robust and efficient strategy for high-throughput synthesis of a 325-member azide library is reported here.  The method is highlighted by its simplicity and product purity.  The utility of the library is demonstrated with the subsequent "click" synthesis of the corresponding bidentate inhibitors against PTP1B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTPQK-e7mMZrVg90H21EOLACvtfcHk0lh7Dk1pfrdGNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksV2iurk%253D&md5=5165664e64901ea28c120dcd573de2d4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2Fb902338k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb902338k%26sid%3Dliteratum%253Aachs%26aulast%3DSrinivasan%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DL.%2BP.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DP.%2BY.%26aulast%3DKalesh%26aufirst%3DK.%2BA.%26aulast%3DYao%26aufirst%3DS.%2BQ.%26atitle%3DHigh-throughput%2520synthesis%2520of%2520azide%2520libraries%2520suitable%2520for%2520direct%2520%25E2%2580%259Cclick%25E2%2580%259D%2520chemistry%2520and%2520in%2520situ%2520screening%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D1821%26epage%3D1828%26doi%3D10.1039%2Fb902338k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalesh, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S. Q.</span></span> <span> </span><span class="NLM_article-title">High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">5102</span>– <span class="NLM_lpage">5105</span>, <span class="refDoi"> DOI: 10.1021/ol9023419</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9023419" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=5102-5105&author=L.+P.+Tanauthor=H.+Wuauthor=P.+Y.+Yangauthor=K.+A.+Kaleshauthor=X.+Zhangauthor=M.+Huauthor=R.+Srinivasanauthor=S.+Q.+Yao&title=High-throughput+discovery+of+Mycobacterium+tuberculosis+protein+tyrosine+phosphatase+B+%28MptpB%29+inhibitors+using+click+chemistry&doi=10.1021%2Fol9023419"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fol9023419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9023419%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%2BP.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DP.%2BY.%26aulast%3DKalesh%26aufirst%3DK.%2BA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DSrinivasan%26aufirst%3DR.%26aulast%3DYao%26aufirst%3DS.%2BQ.%26atitle%3DHigh-throughput%2520discovery%2520of%2520Mycobacterium%2520tuberculosis%2520protein%2520tyrosine%2520phosphatase%2520B%2520%2528MptpB%2529%2520inhibitors%2520using%2520click%2520chemistry%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D5102%26epage%3D5105%26doi%3D10.1021%2Fol9023419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M. C.</span>; <span class="NLM_string-name">Chan, T. H.</span>; <span class="NLM_string-name">Chan, K. F.</span>; <span class="NLM_string-name">Wong, I. L. K.</span>; <span class="NLM_string-name">Law, M. C.</span></span> <span> </span><span class="NLM_article-title">Alkyne-, Azide- and Triazole-containing Flavonoids as Modulators for Multidrug Resistance in Cancers</span>. Patent <span class="NLM_patent">US 9,611,256</span>, April 4, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+M.+C.+Chow&author=T.+H.+Chan&author=K.+F.+Chan&author=I.+L.+K.+Wong&author=M.+C.+Law&title=Alkyne-%2C+Azide-+and+Triazole-containing+Flavonoids+as+Modulators+for+Multidrug+Resistance+in+Cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChow%26aufirst%3DL.%2BM.%2BC.%26atitle%3DAlkyne-%252C%2520Azide-%2520and%2520Triazole-containing%2520Flavonoids%2520as%2520Modulators%2520for%2520Multidrug%2520Resistance%2520in%2520Cancers%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuriakose, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrycyna, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chmielewski, J.</span></span> <span> </span><span class="NLM_article-title">Click chemistry-derived bivalent quinine inhibitors of P-glycoprotein-mediated cellular efflux</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4410</span>– <span class="NLM_lpage">4412</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.04.125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.bmcl.2012.04.125" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4410-4412&author=J.+Kuriakoseauthor=C.+A.+Hrycynaauthor=J.+Chmielewski&title=Click+chemistry-derived+bivalent+quinine+inhibitors+of+P-glycoprotein-mediated+cellular+efflux&doi=10.1016%2Fj.bmcl.2012.04.125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.04.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.04.125%26sid%3Dliteratum%253Aachs%26aulast%3DKuriakose%26aufirst%3DJ.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DChmielewski%26aufirst%3DJ.%26atitle%3DClick%2520chemistry-derived%2520bivalent%2520quinine%2520inhibitors%2520of%2520P-glycoprotein-mediated%2520cellular%2520efflux%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4410%26epage%3D4412%26doi%3D10.1016%2Fj.bmcl.2012.04.125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel P-glycoprotein-mediated multidrug resistance inhibitors bearing triazole core via click chemistry</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1111%2Fcbdd.12301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=24750961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWjt7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=182-191&author=B.+Liuauthor=Q.+Qiuauthor=T.+Zhaoauthor=L.+Jiaoauthor=J.+Houauthor=Y.+Liauthor=H.+Qianauthor=W.+Huang&title=Discovery+of+novel+P-glycoprotein-mediated+multidrug+resistance+inhibitors+bearing+triazole+core+via+click+chemistry&doi=10.1111%2Fcbdd.12301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel P-Glycoprotein-Mediated Multidrug Resistance Inhibitors Bearing Triazole Core via Click Chemistry</span></div><div class="casAuthors">Liu, Baomin; Qiu, Qianqian; Zhao, Tianxiao; Jiao, Lei; Hou, Jianyu; Li, Yunman; Qian, Hai; Huang, Wenlong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-191</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A novel series of P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) inhibitors bearing a triazol-phenethyl-tetrahydroisoquinoline scaffold were designed and synthesized via click chem.  Most of the synthesized compds. showed higher reversal activity than verapamil (VRP).  Among them, the most potent compd. 5 showed a comparable activity with the known potent P-gp inhibitor WK-X-34 with lower cytotoxicity (IC50s > 100 μm).  Compared with VRP, compd. 5 exhibited more potency in increasing drug accumulation in K562/A02 MDR cells.  Moreover, compd. 5 persisted longer chemo-sensitizing effect (>24 h) than VRP (<6 h) with reversibility.  Given the low intrinsic cytotoxicity and the potent reversal activity, compd. 5 may represent a promising candidate for developing P-gp-mediated MDR inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkvTZmqaVku7Vg90H21EOLACvtfcHk0li2RaIG5Fr7Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWjt7jI&md5=bad1c7bfc4fc1cf9c5eecce9d3182be5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12301%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DQiu%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DJiao%26aufirst%3DL.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520novel%2520P-glycoprotein-mediated%2520multidrug%2520resistance%2520inhibitors%2520bearing%2520triazole%2520core%2520via%2520click%2520chemistry%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2014%26volume%3D84%26spage%3D182%26epage%3D191%26doi%3D10.1111%2Fcbdd.12301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of substrate recognition by the multidrug resistance protein MRP1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">1075</span>– <span class="NLM_lpage">1085</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.01.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.cell.2017.01.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=28238471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlGrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=1075-1085&author=Z.+L.+Johnsonauthor=J.+Chen&title=Structural+basis+of+substrate+recognition+by+the+multidrug+resistance+protein+MRP1&doi=10.1016%2Fj.cell.2017.01.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Substrate Recognition by the Multidrug Resistance Protein MRP1</span></div><div class="casAuthors">Johnson, Zachary Lee; Chen, Jue</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1075-1085.e9</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The multidrug resistance protein MRP1 is an ATP-binding cassette (ABC) transporter that confers resistance to many anticancer drugs and plays a role in the disposition and efficacy of several opiates, antidepressants, statins, and antibiotics.  In addn., MRP1 regulates redox homeostasis, inflammation, and hormone secretion.  Using electron cryomicroscopy, we detd. the mol. structures of bovine MRP1 in two conformations: an apo form at 3.5 Å without any added substrate and a complex form at 3.3 Å with one of its physiol. substrates, leukotriene C4.  These structures show that by forming a single bipartite binding site, MRP1 can recognize a spectrum of substrates with different chem. structures.  We also obsd. large conformational changes induced by leukotriene C4, explaining how substrate binding primes the transporter for ATP hydrolysis.  Structural comparison of MRP1 and P-glycoprotein advances our understanding of the common and unique properties of these two important mols. in multidrug resistance to chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo87MmRBg2HsbVg90H21EOLACvtfcHk0li2RaIG5Fr7Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlGrurg%253D&md5=1799bd0d0180f8c524ebe97271a08c85</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.01.041%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DZ.%2BL.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520substrate%2520recognition%2520by%2520the%2520multidrug%2520resistance%2520protein%2520MRP1%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D1075%26epage%3D1085%26doi%3D10.1016%2Fj.cell.2017.01.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">ATP binding enables substrate release from multidrug resistance protein 1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.cell.2017.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=29290467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Ogsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=81-89&author=Z.+L.+Johnsonauthor=J.+Chen&title=ATP+binding+enables+substrate+release+from+multidrug+resistance+protein+1&doi=10.1016%2Fj.cell.2017.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">ATP Binding Enables Substrate Release from Multidrug Resistance Protein 1</span></div><div class="casAuthors">Johnson, Zachary Lee; Chen, Jue</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">81-89.e10</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The multidrug resistance protein MRP1 is an ATP-driven pump that confers resistance to chemotherapy.  Previously, we have shown that intracellular substrates are recruited to a bipartite binding site when the transporter rests in an inward-facing conformation.  A key question remains: how are high-affinity substrates transferred across the membrane and released outside the cell.  Using electron cryomicroscopy, we show here that ATP binding opens the transport pathway to the extracellular space and reconfigures the substrate-binding site such that it relinquishes its affinity for substrate.  Thus, substrate is released prior to ATP hydrolysis.  With this result, we now have a complete description of the conformational cycle that enables substrate transfer in a eukaryotic ABC exporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR-gP8vhWQC7Vg90H21EOLACvtfcHk0lhQGsUL4m4sQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Ogsg%253D%253D&md5=16b3ad685ad58f31c1db6ca3aad4b4ab</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DZ.%2BL.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DATP%2520binding%2520enables%2520substrate%2520release%2520from%2520multidrug%2520resistance%2520protein%25201%26jtitle%3DCell%26date%3D2018%26volume%3D172%26spage%3D81%26epage%3D89%26doi%3D10.1016%2Fj.cell.2017.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganai, S.</span></span> <span> </span><span class="NLM_article-title">An expedient approach to substituted triazolo[1,5-a][1,4]benzodiazepines via Cu-catalyzed tandem Ullmann C–N coupling/azide-alkyne cycloaddition</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6192</span>– <span class="NLM_lpage">6195</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2013.08.125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.tetlet.2013.08.125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFaksLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=6192-6195&author=K.+C.+Majumdarauthor=S.+Ganai&title=An+expedient+approach+to+substituted+triazolo%5B1%2C5-a%5D%5B1%2C4%5Dbenzodiazepines+via+Cu-catalyzed+tandem+Ullmann+C%E2%80%93N+coupling%2Fazide-alkyne+cycloaddition&doi=10.1016%2Fj.tetlet.2013.08.125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An expedient approach to substituted triazolo[1,5-a][1,4]benzodiazepines via Cu-catalyzed tandem Ullmann C-N coupling/azide-alkyne cycloaddition</span></div><div class="casAuthors">Majumdar, K. C.; Ganai, Sintu</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">6192-6195</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">An approach to the synthesis of triazolo[1,5-a][1,4]benzodiazepines comprising copper catalyzed tandem Ullmann C-N coupling followed by azide-alkyne cycloaddn. was described.  The reaction of o-azidobenzylbromide and N-propargylated aniline derivs. in the presence of CuI and base leads to the formation of triazolo[1,5-a][1,4]benzodiazepines.  The reaction was successfully generalized by synthesizing a no. of triazolo[1,5-a][1,4]benzodiazepine derivs. in good to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_6UFhyhclELVg90H21EOLACvtfcHk0lhQGsUL4m4sQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFaksLbP&md5=807c13927d0c779614571251b96a2e63</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2013.08.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2013.08.125%26sid%3Dliteratum%253Aachs%26aulast%3DMajumdar%26aufirst%3DK.%2BC.%26aulast%3DGanai%26aufirst%3DS.%26atitle%3DAn%2520expedient%2520approach%2520to%2520substituted%2520triazolo%255B1%252C5-a%255D%255B1%252C4%255Dbenzodiazepines%2520via%2520Cu-catalyzed%2520tandem%2520Ullmann%2520C%25E2%2580%2593N%2520coupling%252Fazide-alkyne%2520cycloaddition%26jtitle%3DTetrahedron%2520Lett.%26date%3D2013%26volume%3D54%26spage%3D6192%26epage%3D6195%26doi%3D10.1016%2Fj.tetlet.2013.08.125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paitandi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, D. S.</span></span> <span> </span><span class="NLM_article-title">Triazole-appended BODIPY-piperazine conjugates and their efficacy toward mercury sensing</span>. <i>New J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2233</span>– <span class="NLM_lpage">2239</span>, <span class="refDoi"> DOI: 10.1039/C4NJ01625D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1039%2FC4NJ01625D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2015&pages=2233-2239&author=R.+S.+Singhauthor=R.+K.+Guptaauthor=R.+P.+Paitandiauthor=A.+Misraauthor=D.+S.+Pandey&title=Triazole-appended+BODIPY-piperazine+conjugates+and+their+efficacy+toward+mercury+sensing&doi=10.1039%2FC4NJ01625D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1039%2FC4NJ01625D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NJ01625D%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%2BS.%26aulast%3DGupta%26aufirst%3DR.%2BK.%26aulast%3DPaitandi%26aufirst%3DR.%2BP.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DD.%2BS.%26atitle%3DTriazole-appended%2520BODIPY-piperazine%2520conjugates%2520and%2520their%2520efficacy%2520toward%2520mercury%2520sensing%26jtitle%3DNew%2520J.%2520Chem.%26date%3D2015%26volume%3D39%26spage%3D2233%26epage%3D2239%26doi%3D10.1039%2FC4NJ01625D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">“Click” tetradentate ligands</span>. <i>Dalton Transactions</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2660</span>– <span class="NLM_lpage">2666</span>, <span class="refDoi"> DOI: 10.1039/b922043g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1039%2Fb922043g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=20179861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlentbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=2660-2666&author=E.+Haoauthor=Z.+Wangauthor=L.+Jiaoauthor=S.+Wang&title=%E2%80%9CClick%E2%80%9D+tetradentate+ligands&doi=10.1039%2Fb922043g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">"Click" tetradentate ligands</span></div><div class="casAuthors">Hao, Erhong; Wang, Zhaoyun; Jiao, Lijuan; Wang, Shaowu</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2660-2666</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Triazole-based N4 tetradentate ligands I (Ar = Ph, 2,6-dimethylphenyl, 4-nitrophenyl, 4-methoxyphenyl) are efficiently synthesized using CuI-catalyzed azide-alkyne click strategy and are readily coordinated to many metal ions (e.g. MnII, NiII, ZnII and FeII).  The x-ray structures of the resultant metal-complexes reveal an octahedral mononuclear structure with two co-ligands bonded in cis sites and the two triazoles as N-donors to the metal center.  The MnII-complexes show efficient catalytic activities in the epoxidn. of various aliph. terminal olefins with peracetic acid, and feature with low catalyst loading, fast conversion and high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ7lzcRlk2mrVg90H21EOLACvtfcHk0lhQGsUL4m4sQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlentbc%253D&md5=c3cbe52ffb76160bed7ff8114a769549</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2Fb922043g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb922043g%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DJiao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DS.%26atitle%3D%25E2%2580%259CClick%25E2%2580%259D%2520tetradentate%2520ligands%26jtitle%3DDalton%2520Transactions%26date%3D2010%26volume%3D39%26spage%3D2660%26epage%3D2666%26doi%3D10.1039%2Fb922043g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koynov, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auernhammer, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, T.</span></span> <span> </span><span class="NLM_article-title">Supramolecular organogel based on crown ether and secondary ammoniumion functionalized glycidyl triazole polymers</span>. <i>Macromolecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4617</span>– <span class="NLM_lpage">4625</span>, <span class="refDoi"> DOI: 10.1021/ma400407a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ma400407a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVeisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2013&pages=4617-4625&author=D.+Liuauthor=D.+Wangauthor=M.+Wangauthor=Y.+Zhengauthor=K.+Koynovauthor=G.+K.+Auernhammerauthor=H.-J.+Buttauthor=T.+Ikeda&title=Supramolecular+organogel+based+on+crown+ether+and+secondary+ammoniumion+functionalized+glycidyl+triazole+polymers&doi=10.1021%2Fma400407a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Supramolecular Organogel Based on Crown Ether and Secondary Ammoniumion Functionalized Glycidyl Triazole Polymers</span></div><div class="casAuthors">Liu, Dian; Wang, Dapeng; Wang, Miao; Zheng, Yijun; Koynov, Kaloian; Auernhammer, Guenter K.; Butt, Hans-Juergen; Ikeda, Taichi</div><div class="citationInfo"><span class="NLM_cas:title">Macromolecules (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4617-4625</span>CODEN:
                <span class="NLM_cas:coden">MAMOBX</span>;
        ISSN:<span class="NLM_cas:issn">0024-9297</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A supramol. organogel was prepd. by mixing the glycidyl triazole polymers (GTP) functionalized with crown ether and secondary ammoniumion at the side groups.  The polymers form an organogel above a concn. of 3 wt. % via phys. crosslinks of the inclusion complex.  The organogel responds to multiple stimuli, e.g., temp., acid/base, and chem. species.  The no. of the effective crosslinks estd. from the storage modulus and the affine network model suggests that some part of the binding sites could not work as the phys. crosslinks.  Rheol. measurement under large deformation showed that the storage modulus was const. up to 250% strain and larger than the loss modulus up to 600% strain.  The high elasticity of the gel is attributable to the material design based on the high-mol.-wt. flexible glycidyl polymers with many binding sites in the single polymer chain.  The organogel also showed nice self-healing behavior.  The mol. diffusion in the gel network was characterized by fluorescence correlation spectroscopy.  Although the crosslink of the organogel has dynamic nature due to inclusion complexation, the diffusion behavior of the low-mol.-wt. fluorescence tracer was similar to that obsd. in chem. crosslinked gels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqIVjmwtZENLVg90H21EOLACvtfcHk0lhnwHSoUPmaAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVeisr0%253D&md5=22d9cde9421d0c49fbaf3171a99f5694</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fma400407a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fma400407a%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DKoynov%26aufirst%3DK.%26aulast%3DAuernhammer%26aufirst%3DG.%2BK.%26aulast%3DButt%26aufirst%3DH.-J.%26aulast%3DIkeda%26aufirst%3DT.%26atitle%3DSupramolecular%2520organogel%2520based%2520on%2520crown%2520ether%2520and%2520secondary%2520ammoniumion%2520functionalized%2520glycidyl%2520triazole%2520polymers%26jtitle%3DMacromolecules%26date%3D2013%26volume%3D46%26spage%3D4617%26epage%3D4625%26doi%3D10.1021%2Fma400407a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gujadhur, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataraman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kintigh, J. T.</span></span> <span> </span><span class="NLM_article-title">Formation of aryl-nitrogen bonds using a soluble copper (I) catalyst</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">4791</span>– <span class="NLM_lpage">4793</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)00888-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2FS0040-4039%2801%2900888-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslyjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=4791-4793&author=R.+Gujadhurauthor=D.+Venkataramanauthor=J.+T.+Kintigh&title=Formation+of+aryl-nitrogen+bonds+using+a+soluble+copper+%28I%29+catalyst&doi=10.1016%2FS0040-4039%2801%2900888-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Formation of aryl-nitrogen bonds using a soluble copper(I) catalyst</span></div><div class="casAuthors">Gujadhur, R.; Venkataraman, D.; Kintigh, J. T.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">4791-4793</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The authors report a synthetic protocol for the synthesis of functionalized diaryl- and triarylamines under mild conditions, using a sol., air-stable copper(I) complex, Cu(PPh3)3Br, as the catalyst and cesium carbonate as the base.  Using this protocol, the authors were able to synthesize a tri-ortho-ester functionalized triphenylamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocJ1A-IU0r_bVg90H21EOLACvtfcHk0lhnwHSoUPmaAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslyjtrc%253D&md5=aff77a492ae6c96b786f8416184c5dab</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2900888-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252900888-7%26sid%3Dliteratum%253Aachs%26aulast%3DGujadhur%26aufirst%3DR.%26aulast%3DVenkataraman%26aufirst%3DD.%26aulast%3DKintigh%26aufirst%3DJ.%2BT.%26atitle%3DFormation%2520of%2520aryl-nitrogen%2520bonds%2520using%2520a%2520soluble%2520copper%2520%2528I%2529%2520catalyst%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D4791%26epage%3D4793%26doi%3D10.1016%2FS0040-4039%2801%2900888-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleschuk, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeley, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span> <span> </span><span class="NLM_article-title">Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1171</span>– <span class="NLM_lpage">1180</span>, <span class="refDoi"> DOI: 10.1124/mol.59.5.1171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1124%2Fmol.59.5.1171" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=1171-1180&author=E.+M.+Leslieauthor=Q.+Maoauthor=C.+J.+Oleschukauthor=R.+G.+Deeleyauthor=S.+P.+Cole&title=Modulation+of+multidrug+resistance+protein+1+%28MRP1%2FABCC1%29+transport+and+atpase+activities+by+interaction+with+dietary+flavonoids&doi=10.1124%2Fmol.59.5.1171"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fmol.59.5.1171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.59.5.1171%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DE.%2BM.%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DOleschuk%26aufirst%3DC.%2BJ.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26aulast%3DCole%26aufirst%3DS.%2BP.%26atitle%3DModulation%2520of%2520multidrug%2520resistance%2520protein%25201%2520%2528MRP1%252FABCC1%2529%2520transport%2520and%2520atpase%2520activities%2520by%2520interaction%2520with%2520dietary%2520flavonoids%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D1171%26epage%3D1180%26doi%3D10.1124%2Fmol.59.5.1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiser, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McChesney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zygmunt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, S. J.</span></span> <span> </span><span class="NLM_article-title">Measurement of paclitaxel in biological matrices: high-throughput liquid chromatographic-tandem mass spectrometric quantification of paclitaxel and metabolites in human and dog plasma</span>. <i>J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>785</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/S1570-0232(02)00913-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2FS1570-0232%2802%2900913-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=12554138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtVaksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=785&publication_year=2003&pages=253-261&author=M.+S.+Alexanderauthor=M.+M.+Kiserauthor=T.+Culleyauthor=J.+R.+Kernauthor=J.+W.+Dolanauthor=J.+D.+McChesneyauthor=J.+Zygmuntauthor=S.+J.+Bannister&title=Measurement+of+paclitaxel+in+biological+matrices%3A+high-throughput+liquid+chromatographic-tandem+mass+spectrometric+quantification+of+paclitaxel+and+metabolites+in+human+and+dog+plasma&doi=10.1016%2FS1570-0232%2802%2900913-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of Paclitaxel in biological matrices: High-throughput liquid chromatographic-tandem mass spectrometric quantification of Paclitaxel and metabolites in human and dog plasma</span></div><div class="casAuthors">Alexander, Michael S.; Kiser, Melissa M.; Culley, Travis; Kern, John R.; Dolan, John W.; McChesney, James D.; Zygmunt, Jan; Bannister, Steve J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">785</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">253-261</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A GLP-validated, sensitive, and specific LC-MS-MS method for the quantification of Paclitaxel and its 6-α- and 3'-p-hydroxy metabolites is presented.  A 0.400-mL plasma aliquot is spiked with a 13C6-labeled Paclitaxel internal std. and extd. with 1 mL methyl-tert.-Bu ether.  The ether is evapd. and the residue is reconstituted in 130 μL of 30% aq. acetonitrile (ACN) contg. 0.1% trifluoroacetic acid.  Isocratic HPLC anal. is performed by injecting 50 μL of the reconstituted material onto a 50×2.1 mm C18 column with an ACN-water-acetic acid (50:50:0.1) mobile phase at 200 μL/min flow.  Detection is by pos. ion electrospray followed by multiple reaction monitoring of the following transitions: Paclitaxel (854>509 u), 6-α-hydroxy Paclitaxel (870>525 u), 3'-p-hydroxy Paclitaxel (870>509 u), and internal std. (860>509 u).  Quantification is by peak area ratio against the 13C6 internal std.  The method range is 0.117-117 nM (0.1-100 ng/mL) for Paclitaxel and both metabolites using a 0.400-mL human or dog plasma sample.  Anal. time per sample is <5 min.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL2LKq-BmEHLVg90H21EOLACvtfcHk0lhnwHSoUPmaAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtVaksbY%253D&md5=2106d89103bf7b02caec280c4755f5cd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS1570-0232%2802%2900913-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1570-0232%252802%252900913-3%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DM.%2BS.%26aulast%3DKiser%26aufirst%3DM.%2BM.%26aulast%3DCulley%26aufirst%3DT.%26aulast%3DKern%26aufirst%3DJ.%2BR.%26aulast%3DDolan%26aufirst%3DJ.%2BW.%26aulast%3DMcChesney%26aufirst%3DJ.%2BD.%26aulast%3DZygmunt%26aufirst%3DJ.%26aulast%3DBannister%26aufirst%3DS.%2BJ.%26atitle%3DMeasurement%2520of%2520paclitaxel%2520in%2520biological%2520matrices%253A%2520high-throughput%2520liquid%2520chromatographic-tandem%2520mass%2520spectrometric%2520quantification%2520of%2520paclitaxel%2520and%2520metabolites%2520in%2520human%2520and%2520dog%2520plasma%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2003%26volume%3D785%26spage%3D253%26epage%3D261%26doi%3D10.1016%2FS1570-0232%2802%2900913-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weidner, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambudkar, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innis, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span> <span> </span><span class="NLM_article-title">The inhibitor Ko143 is not specific for ABCG2</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">384</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.225482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1124%2Fjpet.115.225482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=26148857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGrtb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2015&pages=384-393&author=L.+D.+Weidnerauthor=S.+S.+Zoghbiauthor=S.+Luauthor=S.+Shuklaauthor=S.+V.+Ambudkarauthor=V.+W.+Pikeauthor=J.+Mulderauthor=M.+M.+Gottesmanauthor=R.+B.+Innisauthor=M.+D.+Hall&title=The+inhibitor+Ko143+is+not+specific+for+ABCG2&doi=10.1124%2Fjpet.115.225482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibitor Ko143 is not specific for ABCG2</span></div><div class="casAuthors">Weidner, Lora D.; Zoghbi, Sami S.; Lu, Shuiyu; Shukla, Suneet; Ambudkar, Suresh V.; Pike, Victor W.; Mulder, Jan; Gottesman, Michael M.; Innis, Robert B.; Hall, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">384-393</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Imaging ATP-binding cassette (ABC) transporter activity in vivo with positron emission tomog. requires both a substrate and a transporter inhibitor.  However, for ABCG2, there is no inhibitor proven to be specific to that transporter alone at the blood-brain barrier.  Ko143 [(3S,6S,12aS)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester], a nontoxic analog of fungal toxin fumitremorgin C, is a potent inhibitor of ABCG2, although its specificity in mouse and human systems is unclear.  This study examd. the selectivity of Ko143 using human embryonic kidney cell lines transfected with ABCG2, ABCB1, or ABCC1 in several in vitro assays.  The stability of Ko143 in rat plasma was measured using high performance liq. chromatog.  Our results show that, in addn. to being a potent inhibitor of ABCG2, at higher concns. (≥1 μM) Ko143 also has an effect on the transport activity of both ABCB1 and ABCC1.  Furthermore, Ko143 was found to be unstable in rat plasma.  These findings indicate that Ko143 lacks specificity for ABCG2 and this should be taken into consideration when using Ko143 for both in vitro and in vivo expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqWjvTByDwbLVg90H21EOLACvtfcHk0ljGXMjuwEFZ0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGrtb7L&md5=4336228ff99f608f6452dca312e78a5a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.225482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.225482%26sid%3Dliteratum%253Aachs%26aulast%3DWeidner%26aufirst%3DL.%2BD.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DShukla%26aufirst%3DS.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DMulder%26aufirst%3DJ.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DHall%26aufirst%3DM.%2BD.%26atitle%3DThe%2520inhibitor%2520Ko143%2520is%2520not%2520specific%2520for%2520ABCG2%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D354%26spage%3D384%26epage%3D393%26doi%3D10.1124%2Fjpet.115.225482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Köhler, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">HM30181 derivatives as novel potent and selective inhibitors of the breast cancer resistance protein (BCRP/ABCG2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3910</span>– <span class="NLM_lpage">3921</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00188</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00188" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A280%3ADC%252BC2Mjitlelsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3910-3921&author=S.+C.+K%C3%B6hlerauthor=M.+Wiese&title=HM30181+derivatives+as+novel+potent+and+selective+inhibitors+of+the+breast+cancer+resistance+protein+%28BCRP%2FABCG2%29&doi=10.1021%2Facs.jmedchem.5b00188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2)</span></div><div class="casAuthors">Kohler Sebastian C; Wiese Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3910-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The breast cancer resistance protein (BCRP, ABCG2) belongs to the superfamily of ATP binding-cassette (ABC) proteins.  In addition to other physiological functions, it transports potentially cell-damaging compounds out of the cell using the energy from ATP hydrolysis.  Certain tumors overexpressing BCRP were found to become resistant against various anticancer drugs.  In previous work, we found that tariquidar analogues lacking the tetrahydroisoquinoline moiety selectively inhibit BCRP.  In the present study, we synthesized 21 derivatives of the third-generation P-gp inhibitor HM30181, which is structurally related to tariquidar.  The compounds were tested for their inhibitory activities against BCRP and screened against P-glycoprotein (P-gp, ABCB1) and multidrug resistance protein 1 (MRP1, ABCC1) to confirm the selectivity toward BCRP.  The most potent compounds are selective toward BCRP and 2-fold more potent than the reference Ko143.  Qualitative structure-activity relationship (SAR) analysis revealed that the presence of a methoxy group in the ortho or para position of at least one phenyl ring is beneficial for inhibitory activity.  Furthermore, the cytotoxicity and multidrug resistance (MDR)-reversal ability of selected compounds were investigated.  It was shown that they have a low cytotoxicity and the ability to reverse the BCRP-mediated SN-38 resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_-1BYW7HmO9-cVm4E2RlLfW6udTcc2eZL_ZIc2ZHAq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mjitlelsg%253D%253D&md5=777b13f427105e8909ae751d11e8c7b4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00188%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6hler%26aufirst%3DS.%2BC.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DHM30181%2520derivatives%2520as%2520novel%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520breast%2520cancer%2520resistance%2520protein%2520%2528BCRP%252FABCG2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3910%26epage%3D3921%26doi%3D10.1021%2Facs.jmedchem.5b00188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xuezhen Zhu, Iris L. K. Wong, Kin-Fai Chan, Jiahua Cui, Man Chun Law, Tsz Cheung Chong, Xuesen Hu, Larry M. C. Chow, <span class="NLM_string-name hlFld-ContribAuthor">Tak Hang Chan</span>. </span><span class="cited-content_cbyCitation_article-title">Triazole Bridged Flavonoid Dimers as Potent, Nontoxic, and Highly Selective Breast Cancer Resistance Protein (BCRP/ABCG2) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (18)
                                     , 8578-8608. <a href="https://doi.org/10.1021/acs.jmedchem.9b00963" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00963</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00963%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTriazole%252BBridged%252BFlavonoid%252BDimers%252Bas%252BPotent%25252C%252BNontoxic%25252C%252Band%252BHighly%252BSelective%252BBreast%252BCancer%252BResistance%252BProtein%252B%252528BCRP%25252FABCG2%252529%252BInhibitors%26aulast%3DZhu%26aufirst%3DXuezhen%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17062019%26date%3D12092019%26date%3D29082019%26volume%3D62%26issue%3D18%26spage%3D8578%26epage%3D8608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alena  Liskova</span>, <span class="hlFld-ContribAuthor ">Marek  Samec</span>, <span class="hlFld-ContribAuthor ">Lenka  Koklesova</span>, <span class="hlFld-ContribAuthor ">Aranka  Brockmueller</span>, <span class="hlFld-ContribAuthor ">Kevin  Zhai</span>, <span class="hlFld-ContribAuthor ">Basma  Abdellatif</span>, <span class="hlFld-ContribAuthor ">Manaal  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Kamil  Biringer</span>, <span class="hlFld-ContribAuthor ">Erik  Kudela</span>, <span class="hlFld-ContribAuthor ">Martin  Pec</span>, <span class="hlFld-ContribAuthor ">Laura Kate  Gadanec</span>, <span class="hlFld-ContribAuthor ">Miroslava  Šudomová</span>, <span class="hlFld-ContribAuthor ">Sherif T. S.  Hassan</span>, <span class="hlFld-ContribAuthor ">Anthony  Zulli</span>, <span class="hlFld-ContribAuthor ">Mehdi  Shakibaei</span>, <span class="hlFld-ContribAuthor ">Frank A.  Giordano</span>, <span class="hlFld-ContribAuthor ">Dietrich  Büsselberg</span>, <span class="hlFld-ContribAuthor ">Olga  Golubnitschaja</span>, <span class="hlFld-ContribAuthor ">Peter  Kubatka</span>. </span><span class="cited-content_cbyCitation_article-title">Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles. </span><span class="cited-content_cbyCitation_journal-name">EPMA Journal</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     , 155-176. <a href="https://doi.org/10.1007/s13167-021-00242-5" title="DOI URL">https://doi.org/10.1007/s13167-021-00242-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13167-021-00242-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13167-021-00242-5%26sid%3Dliteratum%253Aachs%26jtitle%3DEPMA%2520Journal%26atitle%3DFlavonoids%252Bas%252Ban%252Beffective%252Bsensitizer%252Bfor%252Banti-cancer%252Btherapy%25253A%252Binsights%252Binto%252Bmulti-faceted%252Bmechanisms%252Band%252Bapplicability%252Btowards%252Bindividualized%252Bpatient%252Bprofiles%26aulast%3DLiskova%26aufirst%3DAlena%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D2%26spage%3D155%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. P.  Kaushik</span>, <span class="hlFld-ContribAuthor ">Manisha  Chahal</span>, <span class="hlFld-ContribAuthor ">Raj  Luxmi</span>, <span class="hlFld-ContribAuthor ">Devinder  Kumar</span>, <span class="hlFld-ContribAuthor ">Ashwani  Kumar</span>, <span class="hlFld-ContribAuthor ">Mukesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Dharmendra  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization and biological activities of sulfonamide tagged 1,2,3-triazoles. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2020,</strong> <em>50 </em>
                                    (22)
                                     , 3443-3461. <a href="https://doi.org/10.1080/00397911.2020.1802758" title="DOI URL">https://doi.org/10.1080/00397911.2020.1802758</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2020.1802758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2020.1802758%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSynthesis%25252C%252Bcharacterization%252Band%252Bbiological%252Bactivities%252Bof%252Bsulfonamide%252Btagged%252B1%25252C2%25252C3-triazoles%26aulast%3DKaushik%26aufirst%3DC.%2BP.%26date%3D2020%26date%3D2020%26volume%3D50%26issue%3D22%26spage%3D3443%26epage%3D3461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno  M. F. Gonçalves</span>, <span class="hlFld-ContribAuthor ">David  S. P. Cardoso</span>, <span class="hlFld-ContribAuthor ">Maria-José  U. Ferreira</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (15)
                                     , 3364. <a href="https://doi.org/10.3390/molecules25153364" title="DOI URL">https://doi.org/10.3390/molecules25153364</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25153364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25153364%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DOvercoming%252BMultidrug%252BResistance%25253A%252BFlavonoid%252Band%252BTerpenoid%252BNitrogen-Containing%252BDerivatives%252Bas%252BABC%252BTransporter%252BModulators%26aulast%3DM.%2BF.%2BGon%25C3%25A7alves%26aufirst%3DBruno%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D15%26spage%3D3364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingpei  Huo</span>, <span class="hlFld-ContribAuthor ">Chong  Lin</span>, <span class="hlFld-ContribAuthor ">Jinming  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">A brief minireview of poly-triazole: Alkyne and azide substrate selective, metal-catalyst expansion. </span><span class="cited-content_cbyCitation_journal-name">Reactive and Functional Polymers</span><span> <strong>2020,</strong> <em>152 </em>, 104531. <a href="https://doi.org/10.1016/j.reactfunctpolym.2020.104531" title="DOI URL">https://doi.org/10.1016/j.reactfunctpolym.2020.104531</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.reactfunctpolym.2020.104531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.reactfunctpolym.2020.104531%26sid%3Dliteratum%253Aachs%26jtitle%3DReactive%2520and%2520Functional%2520Polymers%26atitle%3DA%252Bbrief%252Bminireview%252Bof%252Bpoly-triazole%25253A%252BAlkyne%252Band%252Bazide%252Bsubstrate%252Bselective%25252C%252Bmetal-catalyst%252Bexpansion%26aulast%3DHuo%26aufirst%3DJingpei%26date%3D2020%26volume%3D152%26spage%3D104531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ajay G.  Namdeo</span>, <span class="hlFld-ContribAuthor ">Sai H.S.  Boddu</span>, <span class="hlFld-ContribAuthor ">Haneen  Amawi</span>, <span class="hlFld-ContribAuthor ">Charles R.  Ashby</span>, <span class="hlFld-ContribAuthor ">Diwakar B.  Tukaramrao</span>, <span class="hlFld-ContribAuthor ">Piyush  Trivedi</span>, <span class="hlFld-ContribAuthor ">R. Jayachandra  Babu</span>, <span class="hlFld-ContribAuthor ">Amit K.  Tiwari</span>. </span><span class="cited-content_cbyCitation_article-title">Flavonoids as Multi-Target Compounds: A Special Emphasis on their Potential as Chemo-adjuvants in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2020,</strong> <em>26 </em>
                                    (15)
                                     , 1712-1728. <a href="https://doi.org/10.2174/1381612826666200128095248" title="DOI URL">https://doi.org/10.2174/1381612826666200128095248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612826666200128095248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612826666200128095248%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DFlavonoids%252Bas%252BMulti-Target%252BCompounds%25253A%252BA%252BSpecial%252BEmphasis%252Bon%252Btheir%252BPotential%252Bas%252BChemo-adjuvants%252Bin%252BCancer%252BTherapy%26aulast%3DNamdeo%26aufirst%3DAjay%2BG.%26date%3D2020%26volume%3D26%26issue%3D15%26spage%3D1712%26epage%3D1728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingqiu  Wang</span>, <span class="hlFld-ContribAuthor ">Jing-Quan  Wang</span>, <span class="hlFld-ContribAuthor ">Chao-Yun  Cai</span>, <span class="hlFld-ContribAuthor ">Qingbin  Cui</span>, <span class="hlFld-ContribAuthor ">Yuqi  Yang</span>, <span class="hlFld-ContribAuthor ">Zhuo-Xun  Wu</span>, <span class="hlFld-ContribAuthor ">Xingduo  Dong</span>, <span class="hlFld-ContribAuthor ">Leli  Zeng</span>, <span class="hlFld-ContribAuthor ">Linguo  Zhao</span>, <span class="hlFld-ContribAuthor ">Dong-Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Zhe-Sheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.00228" title="DOI URL">https://doi.org/10.3389/fonc.2020.00228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.00228%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DReversal%252BEffect%252Bof%252BALK%252BInhibitor%252BNVP-TAE684%252Bon%252BABCG2-Overexpressing%252BCancer%252BCells%26aulast%3DWang%26aufirst%3DJingqiu%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mi-Zhuan  Li</span>, <span class="hlFld-ContribAuthor ">Qi  Tong</span>, <span class="hlFld-ContribAuthor ">Wen-Yong  Han</span>, <span class="hlFld-ContribAuthor ">Si-Yi  Yang</span>, <span class="hlFld-ContribAuthor ">Bao-Dong  Cui</span>, <span class="hlFld-ContribAuthor ">Nan-Wei  Wan</span>, <span class="hlFld-ContribAuthor ">Yong-Zheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of chromone-containing polycyclic compounds
              via
              palladium-catalyzed [2 + 2 + 1] annulation. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (6)
                                     , 1112-1116. <a href="https://doi.org/10.1039/C9OB02690H" title="DOI URL">https://doi.org/10.1039/C9OB02690H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB02690H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB02690H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bchromone-containing%252Bpolycyclic%252Bcompounds%252Bvia%252Bpalladium-catalyzed%252B%25255B2%252B%25252B%252B2%252B%25252B%252B1%25255D%252Bannulation%26aulast%3DLi%26aufirst%3DMi-Zhuan%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D6%26spage%3D1112%26epage%3D1116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Zeng</span>, <span class="hlFld-ContribAuthor ">Chen  Xu</span>, <span class="hlFld-ContribAuthor ">Qipeng  Cheng</span>, <span class="hlFld-ContribAuthor ">Jun  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Gao</span>, <span class="hlFld-ContribAuthor ">Xuemei  Yang</span>, <span class="hlFld-ContribAuthor ">Kwok‐Yin  Wong</span>, <span class="hlFld-ContribAuthor ">Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Kin‐Fai  Chan</span>. </span><span class="cited-content_cbyCitation_article-title">Phenol‐Soluble‐Modulin‐Inspired Amphipathic Peptides Have Bactericidal Activity against Multidrug‐Resistant Bacteria. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (16)
                                     , 1547-1559. <a href="https://doi.org/10.1002/cmdc.201900364" title="DOI URL">https://doi.org/10.1002/cmdc.201900364</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900364%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DPhenol%2525E2%252580%252590Soluble%2525E2%252580%252590Modulin%2525E2%252580%252590Inspired%252BAmphipathic%252BPeptides%252BHave%252BBactericidal%252BActivity%252Bagainst%252BMultidrug%2525E2%252580%252590Resistant%252BBacteria%26aulast%3DZeng%26aufirst%3DPing%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D16%26spage%3D1547%26epage%3D1559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyi  Jiang</span>, <span class="hlFld-ContribAuthor ">Xia  Hao</span>, <span class="hlFld-ContribAuthor ">Lanlan  Jing</span>, <span class="hlFld-ContribAuthor ">Gaochan  Wu</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent applications of click chemistry in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (8)
                                     , 779-789. <a href="https://doi.org/10.1080/17460441.2019.1614910" title="DOI URL">https://doi.org/10.1080/17460441.2019.1614910</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1614910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1614910%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DRecent%252Bapplications%252Bof%252Bclick%252Bchemistry%252Bin%252Bdrug%252Bdiscovery%26aulast%3DJiang%26aufirst%3DXiangyi%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D8%26spage%3D779%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of <b>FD-4e</b>, MK571, and verapamil used in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of various alkynes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of various azides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Acetylenes <b>Ac1</b>–<b>5</b>, <b>Ac12</b>, and <b>Ac42</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and condition: (i) K<sub>2</sub>CO<sub>3</sub>, 6-chloro-1-hexyne or 5-chloro-1-pentyne, DMF, reflux.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Acetylenes <b>Ac6</b>–<b>Ac11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and condition: (i) KOH, EtOH, rt; (ii) I<sub>2</sub>, DMSO, 150 °C.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Acetylenes <b>Ac13</b> and <b>Ac16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and condition: (i) (a) K<sub>2</sub>CO<sub>3</sub>, 2-bromoethanol, DMF, reflux; (b) NaH, propargyl bromide solution, THF; (ii) 2-(benzyl(prop-2-yn-1-yl)amino)ethanol, PPh<sub>3</sub>, DIAD, THF.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Acetylenes <b>Ac27</b>, <b>Ac29</b>, <b>Ac31</b>, and <b>Ac33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and condition: (i) K<sub>2</sub>CO<sub>3</sub>, propargyl bromide, DMF, rt; (ii) K<sub>2</sub>CO<sub>3</sub>, propargyl bromide, acetone, rt; (iii) K<sub>2</sub>CO<sub>3</sub>, propargyl bromide, DMF, 10 °C; (iv) K<sub>2</sub>CO<sub>3</sub>, 6-chloro-1-hexyne, KI, DMF, 80 °C.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Azides <b>Az1</b>–<b>5</b>, <b>Az7</b>–<b>13</b>, <b>Az17</b>, and <b>Az18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and condition: (i) K<sub>2</sub>CO<sub>3</sub>, 2-bromoethanol (<i>n</i> = 0) or 2-(2-chloroethoxy)ethanol (<i>n</i> = 1) or 2-(2-(2-chloroethoxy)ethoxy)ethanol (<i>n</i> = 2), DMF, reflux; (ii) (a) methanesulfonyl chloride, NEt<sub>3</sub>, DCM, 0 °C; (b) NaN<sub>3</sub>, ACN.</p></p></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. EC<sub>50</sub> of <b>Ac3Az11</b> for reversing DOX resistance in 2008/MRP1 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of pure clicked flavonoid dimers on intracellular DOX accumulation in 2008/MRP1 cells. 2008/MRP1 cells were incubated with 5 μM DOX for 120 min at 37 °C with or without 2 μM <b>Ac3Az11</b>, <b>Ac12Az1</b>, <b>Ac16Az1</b>, <b>FD</b>-4e, verapamil, or MK571. 0.2% of DMSO was used as negative control. After incubation, cells were washed and intracellular accumulation of DOX was measured by flow cytometry. Experiments were performed in duplicate and repeated thrice. The florescence level of each sample was normalized to the 0.2% DMSO negative control and presented as a fold-difference. The results were presented as mean ± standard error of mean. Student paired <i>t</i> test was conducted relative to 2008/MRP1 cells incubated with 0.2% DMSO: (∗) <i>P</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of <b>Ac3Az11</b> on MRP1 protein expression. The 2008/MRP1 cells were incubated with 1, 2, or 5 μM <b>Ac3Az11</b> for 3 days. Total MRP1 level was measured by flow cytometer at FL1 channel. (A) Flow cytometry result of total MRP1 protein expression in 2008/P or 2008/MRP1 cells after incubating with 0.25% DMSO. (B) Total MRP1 protein level of 2008/MRP1 cells after incubating with 1, 2, or 5 μM <b>Ac3Az11</b> for 3 days. <i>N</i> = 3 independent experiments. The fluorescence units were presented as the mean ± standard error of the mean. 0.25% DMSO was used as a solvent control. Student paired <i>t</i> test was conducted between 2008/P and 2008/MRP1 cells after incubating with 0.25% of DMSO for 3 days: (∗∗) <i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0007.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of <b>Ac3Az11</b> on DOX influx and DOX efflux in 2008/MRP1 cells. In the influx experiments (A), cells were co-incubated with DOX (5 μM) and <b>Ac3Az11</b> (2 μM) in supplemented RPMI1640 medium at 37 °C. 0.25% of DMSO was used as a negative control. The cells were harvested after 0, 15, 30, 45, and 60 min for determining the intracellular DOX concentration. To measure DOX efflux (B), cells were incubated in supplemented RPMI1640 containing 20 μM DOX for 1 h at 37 °C. Cells were then washed and further incubated with or without compound <b>Ac3Az11</b> (2 μM). At 0, 15, 30, 45, 60, 75, 90, and 105 min, cells were harvested and intracellular DOX concentration was measured. The values were presented as the mean ± standard error of the mean. Student paired <i>t</i> test was conducted at each time point in 2008/MRP1 cells after incubating with or without <b>Ac3Az11</b>: (∗∗∗) <i>P</i> < 0.0001 and (∗) <i>P</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0008.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Pharmacokinetics study of <b>Ac3Az11·HCl</b> in Balb/c mice. <b>Ac3Az11.2·HCl</b> at 10 mg/kg was injected intravenously to the Balb/c mice. At each time point indicated (15, 30, 60, 120, 240, and 360 min), three mice were sacrificed and blood was collected. The plasma level of <b>Ac3Az11</b> was quantified by LC–MS/MS. The data were presented as the mean ± standard error of the mean. In vitro EC<sub>50</sub> (nM) for reversing DOX resistance was 53 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/medium/jm-2018-00834a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0009.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. In silico docking. (A1) Representation of bovine MRP1 with labeled TMD0, TMD1, TMD2, NBD1, and NBD2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UJA">5UJA</a>). The red square indicates the bipartite binding site with zoomed in view of (A2) <b>Ac3Az11</b> (violet color), (A3) <b>FD-4e</b> (blue color), and (A4) DOX (brown color) in the same binding site with important amino acids highlighted in black and hydrogen bonding interactions indicated as dotted blue lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b00834/20181119/images/large/jm-2018-00834a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00834&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i113">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86060" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86060" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span> <span> </span><span class="NLM_article-title">Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-011613-135959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1146%2Fannurev-pharmtox-011613-135959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=24050699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVSqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=95-117&author=S.+P.+Cole&title=Targeting+multidrug+resistance+protein+1+%28MRP1%2C+ABCC1%29%3A+past%2C+present%2C+and+future&doi=10.1146%2Fannurev-pharmtox-011613-135959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future</span></div><div class="casAuthors">Cole, Susan P. C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-117</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  The human ATP-binding cassette transporter multidrug resistance protein 1 (MRP1), encoded by ABCC1, was initially identified because of its ability to confer multidrug resistance in lung cancer cells.  It is now established that MRP1 plays a role in protecting certain tissues from xenobiotic insults and that it mediates the cellular efflux of the proinflammatory cysteinyl leukotriene C4 as well as a vast array of other endo- and xenobiotic org. anions.  Many of these are glutathione (GSH) or glucuronide conjugates, the products of Phase II drug metab.  MRP1 also plays a role in the cellular efflux of the reduced and oxidized forms of GSH and thus contributes to the many physiol. and pathophysiol. processes influenced by these small peptides, including oxidative stress.  In this review, the pharmacol. and physiol. aspects of MRP1 are considered in the context of the current status and future prospects of pharmacol. and genetic modulation of MRP1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPGrLhUsWuhLVg90H21EOLACvtfcHk0lh9nzGxg5Vqdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVSqtrw%253D&md5=4bceae9b2334a70a1856f78b65f6208b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-011613-135959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-011613-135959%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BP.%26atitle%3DTargeting%2520multidrug%2520resistance%2520protein%25201%2520%2528MRP1%252C%2520ABCC1%2529%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2014%26volume%3D54%26spage%3D95%26epage%3D117%26doi%3D10.1146%2Fannurev-pharmtox-011613-135959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhardwaj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almquist, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, E. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeley, R. G.</span></span> <span> </span><span class="NLM_article-title">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">1650</span>– <span class="NLM_lpage">1654</span>, <span class="refDoi"> DOI: 10.1126/science.1360704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1126%2Fscience.1360704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1360704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1650-1654&author=S.+P.+Coleauthor=G.+Bhardwajauthor=J.+H.+Gerlachauthor=J.+E.+Mackieauthor=C.+E.+Grantauthor=K.+C.+Almquistauthor=A.+J.+Stewartauthor=E.+U.+Kurzauthor=A.+M.+Duncanauthor=R.+G.+Deeley&title=Overexpression+of+a+transporter+gene+in+a+multidrug-resistant+human+lung+cancer+cell+line&doi=10.1126%2Fscience.1360704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span></div><div class="casAuthors">Cole, S. P. C.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M. V.; Deeley, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5088</span>),
    <span class="NLM_cas:pages">1650-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents.  However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on ATP and is assocd. with multidrug resistance.  CDNA clones corresponding to mRNAs overexpressed in H69AR cells were isolated.  One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells.  Overexpression was assocd. with amplification of the cognate gene located on chromosome 16 at band p13.1.  Reversion to drug sensitivity was assocd. with loss of gene amplification and a marked decrease in mRNA expression.  The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogS-PschUsW7Vg90H21EOLACvtfcHk0lh9nzGxg5Vqdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D&md5=7002d3f14cd64c4f39e44d938db665f7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1360704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1360704%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BP.%26aulast%3DBhardwaj%26aufirst%3DG.%26aulast%3DGerlach%26aufirst%3DJ.%2BH.%26aulast%3DMackie%26aufirst%3DJ.%2BE.%26aulast%3DGrant%26aufirst%3DC.%2BE.%26aulast%3DAlmquist%26aufirst%3DK.%2BC.%26aulast%3DStewart%26aufirst%3DA.%2BJ.%26aulast%3DKurz%26aufirst%3DE.%2BU.%26aulast%3DDuncan%26aufirst%3DA.%2BM.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26atitle%3DOverexpression%2520of%2520a%2520transporter%2520gene%2520in%2520a%2520multidrug-resistant%2520human%2520lung%2520cancer%2520cell%2520line%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1650%26epage%3D1654%26doi%3D10.1126%2Fscience.1360704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bakos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szakacs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tusnady, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Deemter, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span> <span> </span><span class="NLM_article-title">Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">32167</span>– <span class="NLM_lpage">32175</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.48.32167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1074%2Fjbc.273.48.32167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=9822694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADyaK1cXnvVeltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=32167-32175&author=E.+Bakosauthor=R.+Eversauthor=G.+Szakacsauthor=G.+E.+Tusnadyauthor=E.+Welkerauthor=K.+Szaboauthor=M.+de+Haasauthor=L.+van+Deemterauthor=P.+Borstauthor=A.+Varadiauthor=B.+Sarkadi&title=Functional+multidrug+resistance+protein+%28MRP1%29+lacking+the+N-terminal+transmembrane+domain&doi=10.1074%2Fjbc.273.48.32167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain</span></div><div class="casAuthors">Bakos, Eva; Evers, Raymond; Szakacs, Gergely; Tusnady, Gabor E.; Welker, Ervin; Szabo, Katalin; De Haas, Marcel; Van Deemter, Liesbeth; Borst, Piet; Varadi, Andras; Sarkadi, Balazs</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">32167-32175</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The human multidrug resistance protein (MRP1) causes drug resistance by extruding drugs from tumor cells.  In addn. to an MDR-like core, MRP1 contains an N-terminal membrane-bound region (TMD0) connected to the core by a cytoplasmic linker (L0).  We have studied truncated MRP1 versions contg. either the MDR-like core alone or the core plus linker L0, produced in the baculovirus-insect (Sf9) cell system.  Their function was examd. in isolated membrane vesicles.  Fulllength MRP1 showed ATP-dependent, vanadate-sensitive accumulation of leukotriene C4 and N-ethylmaleimide glutathione.  In addn., leukotriene C4-stimulated, vanadate-dependent nucleotide occlusion was detected.  The MDR-like core was virtually inactive.  Co-expression of the core with the N-terminal region including L0 fully restored MRP1 function.  Unexpectedly, a truncated MRP1 mutant lacking the entire TMD0 region but still contg. L0 behaved like wild-type MRP1 in vesicle uptake and nucleotide trapping expts.  We also expressed the MRP1 constructs in polarized canine kidney derived MDCKII cells.  Like wild-type MRP1, the MRP1 protein without the TMD0 region was routed to the lateral plasma membrane and transported dinitrophenyl glutathione and daunorubicin.  The TMD0L0 and the MRP1 minus TMD0L0 remained in an intracellular compartment.  Taken together, these expts. strongly suggest that the TMD0 region is neither required for the transport function of MRP1 nor for its proper routing to the plasma membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18Lik7T68gbVg90H21EOLACvtfcHk0lir979U96Q2vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvVeltbY%253D&md5=6e88d283ab8cfd2a4627e114b06cf991</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.48.32167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.48.32167%26sid%3Dliteratum%253Aachs%26aulast%3DBakos%26aufirst%3DE.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DSzakacs%26aufirst%3DG.%26aulast%3DTusnady%26aufirst%3DG.%2BE.%26aulast%3DWelker%26aufirst%3DE.%26aulast%3DSzabo%26aufirst%3DK.%26aulast%3Dde%2BHaas%26aufirst%3DM.%26aulast%3Dvan%2BDeemter%26aufirst%3DL.%26aulast%3DBorst%26aufirst%3DP.%26aulast%3DVaradi%26aufirst%3DA.%26aulast%3DSarkadi%26aufirst%3DB.%26atitle%3DFunctional%2520multidrug%2520resistance%2520protein%2520%2528MRP1%2529%2520lacking%2520the%2520N-terminal%2520transmembrane%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D32167%26epage%3D32175%26doi%3D10.1074%2Fjbc.273.48.32167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bakos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegedus, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tusnady, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flens, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkadi, B.</span></span> <span> </span><span class="NLM_article-title">Membrane topology and glycosylation of the human multidrug resistance-associated protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">12322</span>– <span class="NLM_lpage">12326</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.21.12322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1074%2Fjbc.271.21.12322" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=12322-12326&author=E.+Bakosauthor=T.+Hegedusauthor=Z.+Holloauthor=E.+Welkerauthor=G.+E.+Tusnadyauthor=G.+J.+Zamanauthor=M.+J.+Flensauthor=A.+Varadiauthor=B.+Sarkadi&title=Membrane+topology+and+glycosylation+of+the+human+multidrug+resistance-associated+protein&doi=10.1074%2Fjbc.271.21.12322"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.21.12322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.21.12322%26sid%3Dliteratum%253Aachs%26aulast%3DBakos%26aufirst%3DE.%26aulast%3DHegedus%26aufirst%3DT.%26aulast%3DHollo%26aufirst%3DZ.%26aulast%3DWelker%26aufirst%3DE.%26aulast%3DTusnady%26aufirst%3DG.%2BE.%26aulast%3DZaman%26aufirst%3DG.%2BJ.%26aulast%3DFlens%26aufirst%3DM.%2BJ.%26aulast%3DVaradi%26aufirst%3DA.%26aulast%3DSarkadi%26aufirst%3DB.%26atitle%3DMembrane%2520topology%2520and%2520glycosylation%2520of%2520the%2520human%2520multidrug%2520resistance-associated%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D12322%26epage%3D12326%26doi%3D10.1074%2Fjbc.271.21.12322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeley, R. G.</span></span> <span> </span><span class="NLM_article-title">Transport of glutathione and glutathione conjugates by MRP1</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2006.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.tips.2006.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=16820223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVyls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=438-446&author=S.+P.+Coleauthor=R.+G.+Deeley&title=Transport+of+glutathione+and+glutathione+conjugates+by+MRP1&doi=10.1016%2Fj.tips.2006.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Transport of glutathione and glutathione conjugates by MRP1</span></div><div class="casAuthors">Cole, Susan P. C.; Deeley, Roger G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">438-446</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Glutathione (GSH)-conjugated xenobiotics and GSH-conjugated metabolites (e.g. the cysteinyl leukotriene C4) must be exported from the cells in which they are formed before they can be eliminated from the body or act on their cellular targets.  This efflux is often mediated by the multidrug resistance protein 1 (MRP1) transporter, which also confers drug resistance to tumor cells and can protect normal cells from toxic insults.  In addn. to drugs and GSH conjugates, MRP1 exports GSH and GSH disulfide, and might thus have a role in cellular responses to oxidative stress.  The transport of several drugs and conjugated org. anions by MRP1 requires the presence of GSH, but it is not well understood how GSH (and its analogs) enhances transport.  Site-directed mutagenesis studies and biophys. analyses have provided important insights into the structural determinants of MRP1 that influence GSH and GSH conjugate binding and transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIwmhqAP55ALVg90H21EOLACvtfcHk0lir979U96Q2vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVyls74%253D&md5=2628cc48a4972feb4d9bea4715d27cad</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BP.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26atitle%3DTransport%2520of%2520glutathione%2520and%2520glutathione%2520conjugates%2520by%2520MRP1%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D438%26epage%3D446%26doi%3D10.1016%2Fj.tips.2006.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deeley, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westlake, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span> <span> </span><span class="NLM_article-title">Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">899</span>, <span class="refDoi"> DOI: 10.1152/physrev.00035.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1152%2Fphysrev.00035.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=16816140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFGgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2006&pages=849-899&author=R.+G.+Deeleyauthor=C.+Westlakeauthor=S.+P.+Cole&title=Transmembrane+transport+of+endo-+and+xenobiotics+by+mammalian+ATP-binding+cassette+multidrug+resistance+proteins&doi=10.1152%2Fphysrev.00035.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins</span></div><div class="casAuthors">Deeley, Roger G.; Westlake, Christopher; Cole, Susan P. C.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">849-899</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Multidrug Resistance Proteins (MRPs), together with the cystic fibrosis conductance regulator (CFTR/ABCC7) and the sulfonylurea receptors (SUR1/ABCC8 and SUR2/ABCC9) comprise the 13 members of the human "C" branch of the ATP binding cassette (ABC) superfamily.  All C branch proteins share conserved structural features in their nucleotide binding domains (NBDs) that distinguish them from other ABC proteins.  The MRPs can be further divided into 2 subfamilies "long" (MRP1, -2, -3, -6, and -7) and "short" (MRP4, -5, -8, -9, and -10).  The short MRPs have a typical ABC transporter structure with 2 polytropic membrane spanning domains (MSDs) and 2 NBDs, while the long MRPs have an addnl. NH2-terminal MSD.  In vitro, the MRPs can collectively confer resistance to natural product drugs and their conjugated metabolites, platinum compds., folate antimetabolites, nucleoside and nucleotide analogs, arsenical and antimonial oxyanions, peptide-based agents, and, under certain circumstances, alkylating agents.  The MRPs are also primary active transporters of other structurally diverse compds., including glutathione, glucuronide, and sulfate conjugates of a large no. of xeno- and endobiotics.  In vivo, several MRPs are major contributors to the distribution and elimination of a wide range of both anticancer and non-anticancer drugs and metabolites.  In this review, the authors describe what is known of the structure of the MRPs and the mechanisms by which they recognize and transport their diverse substrates.  The authors also summarize knowledge of their possible physiol. functions and evidence that they may be involved in the clin. drug resistance of various forms of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofKpMSkBDdL7Vg90H21EOLACvtfcHk0lgEqCOe21c4rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFGgtb4%253D&md5=2aaa146afc7d5ac878d937ea8c630f72</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00035.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00035.2005%26sid%3Dliteratum%253Aachs%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26aulast%3DWestlake%26aufirst%3DC.%26aulast%3DCole%26aufirst%3DS.%2BP.%26atitle%3DTransmembrane%2520transport%2520of%2520endo-%2520and%2520xenobiotics%2520by%2520mammalian%2520ATP-binding%2520cassette%2520multidrug%2520resistance%2520proteins%26jtitle%3DPhysiol.%2520Rev.%26date%3D2006%26volume%3D86%26spage%3D849%26epage%3D899%26doi%3D10.1152%2Fphysrev.00035.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hipfner, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almquist, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeley, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span> <span> </span><span class="NLM_article-title">Membrane topology of the multidrug resistance protein (MRP). A study of glycosylation-site mutants reveals an extracytosolic NH2 terminus</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">23623</span>– <span class="NLM_lpage">23630</span>, <span class="refDoi"> DOI: 10.1074/jbc.272.38.23623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1074%2Fjbc.272.38.23623" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=23623-23630&author=D.+R.+Hipfnerauthor=K.+C.+Almquistauthor=E.+M.+Leslieauthor=J.+H.+Gerlachauthor=C.+E.+Grantauthor=R.+G.+Deeleyauthor=S.+P.+Cole&title=Membrane+topology+of+the+multidrug+resistance+protein+%28MRP%29.+A+study+of+glycosylation-site+mutants+reveals+an+extracytosolic+NH2+terminus&doi=10.1074%2Fjbc.272.38.23623"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.38.23623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.38.23623%26sid%3Dliteratum%253Aachs%26aulast%3DHipfner%26aufirst%3DD.%2BR.%26aulast%3DAlmquist%26aufirst%3DK.%2BC.%26aulast%3DLeslie%26aufirst%3DE.%2BM.%26aulast%3DGerlach%26aufirst%3DJ.%2BH.%26aulast%3DGrant%26aufirst%3DC.%2BE.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26aulast%3DCole%26aufirst%3DS.%2BP.%26atitle%3DMembrane%2520topology%2520of%2520the%2520multidrug%2520resistance%2520protein%2520%2528MRP%2529.%2520A%2520study%2520of%2520glycosylation-site%2520mutants%2520reveals%2520an%2520extracytosolic%2520NH2%2520terminus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D23623%26epage%3D23630%26doi%3D10.1074%2Fjbc.272.38.23623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raab-Graham, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirilo, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boettcher, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radeke, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberg, C. A.</span></span> <span> </span><span class="NLM_article-title">Membrane topology of the amino-terminal region of the sulfonylurea receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">29122</span>– <span class="NLM_lpage">29129</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.41.29122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1074%2Fjbc.274.41.29122" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=29122-29129&author=K.+F.+Raab-Grahamauthor=L.+J.+Ciriloauthor=A.+A.+Boettcherauthor=C.+M.+Radekeauthor=C.+A.+Vandenberg&title=Membrane+topology+of+the+amino-terminal+region+of+the+sulfonylurea+receptor&doi=10.1074%2Fjbc.274.41.29122"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.41.29122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.41.29122%26sid%3Dliteratum%253Aachs%26aulast%3DRaab-Graham%26aufirst%3DK.%2BF.%26aulast%3DCirilo%26aufirst%3DL.%2BJ.%26aulast%3DBoettcher%26aufirst%3DA.%2BA.%26aulast%3DRadeke%26aufirst%3DC.%2BM.%26aulast%3DVandenberg%26aufirst%3DC.%2BA.%26atitle%3DMembrane%2520topology%2520of%2520the%2520amino-terminal%2520region%2520of%2520the%2520sulfonylurea%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D29122%26epage%3D29129%26doi%3D10.1074%2Fjbc.274.41.29122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagnoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beretta, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarantino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbareschi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezzanzanica, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perego, P.</span></span> <span> </span><span class="NLM_article-title">Clinicopathological impact of ABCC1/MRP1 and ABCC4/MRP4 in epithelial ovarian carcinoma</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">143202</span>, <span class="refDoi"> DOI: 10.1155/2013/143202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1155%2F2013%2F143202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=143202&author=M.+Bagnoliauthor=G.+L.+Berettaauthor=L.+Gattiauthor=S.+Pilottiauthor=P.+Albertiauthor=E.+Tarantinoauthor=M.+Barbareschiauthor=S.+Canevariauthor=D.+Mezzanzanicaauthor=P.+Perego&title=Clinicopathological+impact+of+ABCC1%2FMRP1+and+ABCC4%2FMRP4+in+epithelial+ovarian+carcinoma&doi=10.1155%2F2013%2F143202"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1155%2F2013%2F143202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F143202%26sid%3Dliteratum%253Aachs%26aulast%3DBagnoli%26aufirst%3DM.%26aulast%3DBeretta%26aufirst%3DG.%2BL.%26aulast%3DGatti%26aufirst%3DL.%26aulast%3DPilotti%26aufirst%3DS.%26aulast%3DAlberti%26aufirst%3DP.%26aulast%3DTarantino%26aufirst%3DE.%26aulast%3DBarbareschi%26aufirst%3DM.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DMezzanzanica%26aufirst%3DD.%26aulast%3DPerego%26aufirst%3DP.%26atitle%3DClinicopathological%2520impact%2520of%2520ABCC1%252FMRP1%2520and%2520ABCC4%252FMRP4%2520in%2520epithelial%2520ovarian%2520carcinoma%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2013%26volume%3D2013%26spage%3D143202%26doi%3D10.1155%2F2013%2F143202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordow, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flemming, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, M. D.</span></span> <span> </span><span class="NLM_article-title">Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1546</span>– <span class="NLM_lpage">1553</span>, <span class="refDoi"> DOI: 10.1200/JCO.2005.01.6196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1200%2FJCO.2005.01.6196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=16575006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFyktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=1546-1553&author=M.+Haberauthor=J.+Smithauthor=S.+B.+Bordowauthor=C.+Flemmingauthor=S.+L.+Cohnauthor=W.+B.+Londonauthor=G.+M.+Marshallauthor=M.+D.+Norris&title=Association+of+high-level+MRP1+expression+with+poor+clinical+outcome+in+a+large+prospective+study+of+primary+neuroblastoma&doi=10.1200%2FJCO.2005.01.6196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma</span></div><div class="casAuthors">Haber, Michelle; Smith, Janice; Bordow, Sharon B.; Flemming, Claudia; Cohn, Susan L.; London, Wendy B.; Marshall, Glenn M.; Norris, Murray D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1546-1553</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">We have previously shown in a retrospective study that expression of the multidrug transporter gene MRP1 (ABCC1) is assocd. with outcome in neuroblastoma.  We have now undertaken a prospective anal. to examine the independent prognostic significance of MRP1 expression in a large cohort of primary untreated neuroblastomas.  Two hundred nine diagnostic neuroblastoma samples from patients prospectively enrolled onto the Pediatric Oncol. Group biol. protocol 9047 were analyzed for expression of the MRP1, MDR1, MYCN, and TRKA genes using real-time polymerase chain reaction.  Expression levels were correlated with established prognostic indicators and disease outcome.  MRP1 expression was detected in all tumors analyzed, and levels were significantly higher in tumors with vs. without MYCN amplification (P < .0001).  High levels of MRP1 were highly predictive of both event-free survival (EFS; P < .001) and overall survival (OS; P < .001).  High-level MYCN and low-level TRKA were also predictive of poor outcome.  MDR1 expression demonstrated no prognostic significance.  After adjustment for the effect of statistically significant prognostic indicators in multivariate models, MRP1 expression retained significant prognostic value for both EFS (hazard ratio = 3.0; P = .0011) and OS (hazard ratio = 2.5; P = .0095), whereas MYCN amplification did not have prognostic significance.  The results of this prospective study confirm our earlier findings and support a clin. relevant role for MRP1 gene expression in neuroblastoma.  These findings have implications for the biol., prognosis, and treatment of this disease and provide evidence that MRP1 is a bone fide mol. target for reversing chemotherapy resistance in aggressive drug-refractory neuroblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0oXxz7DUGtLVg90H21EOLACvtfcHk0lhXjAxPWuPQBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFyktrc%253D&md5=70096f4a8d71db43984319386e3df92c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.01.6196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.01.6196%26sid%3Dliteratum%253Aachs%26aulast%3DHaber%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DBordow%26aufirst%3DS.%2BB.%26aulast%3DFlemming%26aufirst%3DC.%26aulast%3DCohn%26aufirst%3DS.%2BL.%26aulast%3DLondon%26aufirst%3DW.%2BB.%26aulast%3DMarshall%26aufirst%3DG.%2BM.%26aulast%3DNorris%26aufirst%3DM.%2BD.%26atitle%3DAssociation%2520of%2520high-level%2520MRP1%2520expression%2520with%2520poor%2520clinical%2520outcome%2520in%2520a%2520large%2520prospective%2520study%2520of%2520primary%2520neuroblastoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D1546%26epage%3D1553%26doi%3D10.1200%2FJCO.2005.01.6196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hlavac, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brynychova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaclavikova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlichova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecha, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozevnikovova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trnkova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopperova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gut, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucek, P.</span></span> <span> </span><span class="NLM_article-title">The expression profile of ATP-binding cassette transporter genes in breast carcinoma</span>. <i>Pharmacogenomics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.2217/pgs.13.26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.2217%2Fpgs.13.26" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=515-529&author=V.+Hlavacauthor=V.+Brynychovaauthor=R.+Vaclavikovaauthor=M.+Ehrlichovaauthor=D.+Vranaauthor=V.+Pechaauthor=R.+Kozevnikovovaauthor=M.+Trnkovaauthor=J.+Gatekauthor=D.+Kopperovaauthor=I.+Gutauthor=P.+Soucek&title=The+expression+profile+of+ATP-binding+cassette+transporter+genes+in+breast+carcinoma&doi=10.2217%2Fpgs.13.26"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2217%2Fpgs.13.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fpgs.13.26%26sid%3Dliteratum%253Aachs%26aulast%3DHlavac%26aufirst%3DV.%26aulast%3DBrynychova%26aufirst%3DV.%26aulast%3DVaclavikova%26aufirst%3DR.%26aulast%3DEhrlichova%26aufirst%3DM.%26aulast%3DVrana%26aufirst%3DD.%26aulast%3DPecha%26aufirst%3DV.%26aulast%3DKozevnikovova%26aufirst%3DR.%26aulast%3DTrnkova%26aufirst%3DM.%26aulast%3DGatek%26aufirst%3DJ.%26aulast%3DKopperova%26aufirst%3DD.%26aulast%3DGut%26aufirst%3DI.%26aulast%3DSoucek%26aufirst%3DP.%26atitle%3DThe%2520expression%2520profile%2520of%2520ATP-binding%2520cassette%2520transporter%2520genes%2520in%2520breast%2520carcinoma%26jtitle%3DPharmacogenomics%26date%3D2013%26volume%3D14%26spage%3D515%26epage%3D529%26doi%3D10.2217%2Fpgs.13.26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Q.</span></span> <span> </span><span class="NLM_article-title">Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy</span>. <i>Lung Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/j.lungcan.2009.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.lungcan.2009.09.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2010&pages=116-122&author=J.+Liauthor=Z.+N.+Liauthor=L.+C.+Yuauthor=Q.+L.+Baoauthor=J.+R.+Wuauthor=S.+B.+Shiauthor=X.+Q.+Li&title=Association+of+expression+of+MRP1%2C+BCRP%2C+LRP+and+ERCC1+with+outcome+of+patients+with+locally+advanced+non-small+cell+lung+cancer+who+received+neoadjuvant+chemotherapy&doi=10.1016%2Fj.lungcan.2009.09.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.lungcan.2009.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lungcan.2009.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%2BN.%26aulast%3DYu%26aufirst%3DL.%2BC.%26aulast%3DBao%26aufirst%3DQ.%2BL.%26aulast%3DWu%26aufirst%3DJ.%2BR.%26aulast%3DShi%26aufirst%3DS.%2BB.%26aulast%3DLi%26aufirst%3DX.%2BQ.%26atitle%3DAssociation%2520of%2520expression%2520of%2520MRP1%252C%2520BCRP%252C%2520LRP%2520and%2520ERCC1%2520with%2520outcome%2520of%2520patients%2520with%2520locally%2520advanced%2520non-small%2520cell%2520lung%2520cancer%2520who%2520received%2520neoadjuvant%2520chemotherapy%26jtitle%3DLung%2520Cancer%26date%3D2010%26volume%3D69%26spage%3D116%26epage%3D122%26doi%3D10.1016%2Fj.lungcan.2009.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baumert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgeroth, A.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the development of P-gp inhibitors</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">436</span>, <span class="refDoi"> DOI: 10.2174/1871520610909040415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.2174%2F1871520610909040415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=19442042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlslOlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=415-436&author=C.+Baumertauthor=A.+Hilgeroth&title=Recent+advances+in+the+development+of+P-gp+inhibitors&doi=10.2174%2F1871520610909040415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of P-gp inhibitors</span></div><div class="casAuthors">Baumert, Christiane; Hilgeroth, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">415-436</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  During the last decades multidrug resistance (MDR) emerged as main problem in the anti-cancer therapy with cytostatically active agents.  Classical as well as recently developed cytostatics develop the phenomenon of loosing activity in former drug-sensitive cells.  Although MDR is a multifactorial process, the main obstacle is the expression of multidrug-efflux pumps that lowers the intracellular drug levels.  P-glycoprotein (P-gp) is the longest identified efflux pump.  As the attempt to overcome MDR by the use of inhibitors of the efflux pump activities turned out as most promising effect, the development of P-gp inhibitors has been a challenge for medicinal chemists.  The article reviews the advances in P-gp inhibitor development by focusing on structure-activity relationships in the different compd. classes to document improvements.  The success has been the redn. of cytotoxic properties.  The undesired activities could be much lowered in the case of compd. classes that were derived from pharmacol. active drugs.  Undesired drug interactions and limited in vivo activities are still a problem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlDTzTIfZNCLVg90H21EOLACvtfcHk0lhXjAxPWuPQBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlslOlsrg%253D&md5=38025eb41e3e56b959e0dc90b7bf9af7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1871520610909040415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520610909040415%26sid%3Dliteratum%253Aachs%26aulast%3DBaumert%26aufirst%3DC.%26aulast%3DHilgeroth%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520P-gp%2520inhibitors%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D415%26epage%3D436%26doi%3D10.2174%2F1871520610909040415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eckford, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharom, F. J.</span></span> <span> </span><span class="NLM_article-title">ABC efflux pump-based resistance to chemotherapy drugs</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">2989</span>– <span class="NLM_lpage">3011</span>, <span class="refDoi"> DOI: 10.1021/cr9000226</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr9000226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlslSmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2989-3011&author=P.+D.+Eckfordauthor=F.+J.+Sharom&title=ABC+efflux+pump-based+resistance+to+chemotherapy+drugs&doi=10.1021%2Fcr9000226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">ABC Efflux Pump-Based Resistance to Chemotherapy Drugs</span></div><div class="casAuthors">Eckford, Paul D. W.; Sharom, Frances J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2989-3011</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over 1 million new cases of all types of cancer are diagnosed each year in the United States alone, and 559, 650 cancer-related deaths were expected to occur in 2007.  Chemotherapeutic treatment of cancers is an important tool to combat this devastating disease.  However, chemotherapy can fail due to the development of tumor cell resistance to multiple drugs, a phenomenon known as multidrug resistance (MDR), and essentially all cancer-related deaths are considered to be a result of chemotherapy failure.  MDR can have many causes, but one important mechanism of drug resistance is the expression of active drug efflux pumps in the membranes of cancer cells.  The efflux pump proteins mediating MDR in human cancers belong to the ATP-Binding Cassette (ABC) superfamily of proteins.  This is a diverse group of (primarily) active membrane transporters and is one of the largest known protein families.  Its members include proteins that mediate a variety of transport processes, in both prokaryotes (e.g., membrane-embedded importers for sugars and amino acids, and drug exporters) and eukaryotes, where only ABC exporters are known.  The 49 ABC proteins identified in the human genome (there appear to be 48 functional proteins) are involved in the efflux of substrates such as phospholipids, sterols, bile salts, and amphipathic drugs.  While as many as 15 ABC transporters have been obsd. to export chemotherapy drugs using in vitro exptl. systems, only 3 transporters have thus far been implicated as major contributors to MDR in cancer.  Discovered over 30 years ago, P-glycoprotein (Pgp; MDR1; ABCB1), was the first mammalian ABC protein to be identified.  Multidrug resistance-assocd. protein 1 (MRP1 or ABCC1) and more recently ABCG2 (also termed the breast cancer resistance protein, BCRP, or mitoxantrone resistance protein, MXR) also appear to function as clin. relevant drug efflux pumps.  All three proteins were discovered as factors over-expressed in MDR cell lines in culture, and they have since been detected in MDR tumors in patients.  Considerable effort has been made to understand the structure and function of these three drug pumps, which possess a unique ability to recognize and transport a broad array of structurally diverse compds. out of the cell.  The development of compds. known as modulators, which are able to reverse MDR by blocking or inhibiting the ATP-dependent transport function of these proteins, is also an important goal of researchers in this field.  This review will summarize our understanding of the substrate specificity of the mammalian drug efflux pumps, their structure, the mol. mechanisms by which they exert their function, and the progress made to date in reversing pump-mediated MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZIkwCqe_qg7Vg90H21EOLACvtfcHk0lhXjAxPWuPQBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlslSmtbg%253D&md5=5009e7a7cac6977a296fd5bbf97d7df7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fcr9000226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9000226%26sid%3Dliteratum%253Aachs%26aulast%3DEckford%26aufirst%3DP.%2BD.%26aulast%3DSharom%26aufirst%3DF.%2BJ.%26atitle%3DABC%2520efflux%2520pump-based%2520resistance%2520to%2520chemotherapy%2520drugs%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2989%26epage%3D3011%26doi%3D10.1021%2Fcr9000226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motohashi, N.</span></span> <span> </span><span class="NLM_article-title">New multidrug resistance reversal agents</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.2174/1389450033347064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.2174%2F1389450033347064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=12528988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvVGmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=31-43&author=M.+Kawaseauthor=N.+Motohashi&title=New+multidrug+resistance+reversal+agents&doi=10.2174%2F1389450033347064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New multidrug resistance reversal agents</span></div><div class="casAuthors">Kawase, Masami; Motohashi, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-43</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multidrug resistance (MDR) to antitumor agents represents a significant challenge to effective chemotherapy.  The use of MDR modulators is a promising approach to overcome the undesired MDR phenotype.  The more effective MDR modulators are urgently needed for clin. use.  This review focuses on literatures published in 1998-2001.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVpCj9RsHpwrVg90H21EOLACvtfcHk0ljqK2zQmKKVBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvVGmsg%253D%253D&md5=9e35cb90204fcc277e30e4db729ea39c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1389450033347064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450033347064%26sid%3Dliteratum%253Aachs%26aulast%3DKawase%26aufirst%3DM.%26aulast%3DMotohashi%26aufirst%3DN.%26atitle%3DNew%2520multidrug%2520resistance%2520reversal%2520agents%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2003%26volume%3D4%26spage%3D31%26epage%3D43%26doi%3D10.2174%2F1389450033347064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinkel, A. H.</span></span> <span> </span><span class="NLM_article-title">Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2)</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=12477055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=427-434&author=J.+D.+Allenauthor=A.+H.+Schinkel&title=Multidrug+resistance+and+pharmacological+protection+mediated+by+the+breast+cancer+resistance+protein+%28BCRP%2FABCG2%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2)</span></div><div class="casAuthors">Allen, John D.; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">427-434</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review discusses the current insights in the structure, function, and pharmacol. impact of breast cancer resistance protein (BCRP).  Topics discussed include subcellular localization of BCRP/Bcrp1; specificity and mechanism of drug resistance mediated by BCRP/Bcrp1; inhibitors of BCRP/Bcrp1; tissue distribution of BCRP and Bcrp1; and the clin. significance of BCRP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJg9bHS6xUHLVg90H21EOLACvtfcHk0ljqK2zQmKKVBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1yqs7k%253D&md5=5e4b4272efacd570866fe13c1a38c7ad</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BD.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DMultidrug%2520resistance%2520and%2520pharmacological%2520protection%2520mediated%2520by%2520the%2520breast%2520cancer%2520resistance%2520protein%2520%2528BCRP%252FABCG2%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D427%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Durmus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparidans, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagenaar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinkel, A. H.</span></span> <span> </span><span class="NLM_article-title">Oral availability and brain penetration of the B-RAFV600E inhibitor vemurafenib can be enhanced by the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3236</span>– <span class="NLM_lpage">3245</span>, <span class="refDoi"> DOI: 10.1021/mp3003144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp3003144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVamt7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=3236-3245&author=S.+Durmusauthor=R.+W.+Sparidansauthor=E.+Wagenaarauthor=J.+H.+Beijnenauthor=A.+H.+Schinkel&title=Oral+availability+and+brain+penetration+of+the+B-RAFV600E+inhibitor+vemurafenib+can+be+enhanced+by+the+P-glycoprotein+%28ABCB1%29+and+breast+cancer+resistance+protein+%28ABCG2%29+inhibitor+elacridar&doi=10.1021%2Fmp3003144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Oral Availability and Brain Penetration of the B-RAFV600E Inhibitor Vemurafenib Can Be Enhanced by the P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Inhibitor Elacridar</span></div><div class="casAuthors">Durmus, Selvi; Sparidans, Rolf W.; Wagenaar, Els; Beijnen, Jos H.; Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3236-3245</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Vemurafenib (PLX4032) is a novel tyrosine kinase inhibitor that has clin. efficacy against metastatic melanoma harboring a BRAFV600E mutation.  We aimed to establish whether oral availability and brain penetration of vemurafenib could be restricted by the multidrug efflux transporters P-glycoprotein (P-gp/ABCB1) and breast cancer resistance protein (BCRP/ABCG2), as these might limit therapeutic efficacy, esp. against brain metastases.  In vitro, vemurafenib was efficiently transported by both human ABCB1 and ABCG2, and very efficiently by mouse Abcg2, but not by mouse Abcc2.  Upon oral administration of vemurafenib (5 mg/kg), Abcb1a/1b-/- mice had a 1.6-fold increased, Abcg2-/- mice a 2.3-fold increased, and Abcb1a/1b-/-;Abcg2-/- mice a 6.6-fold increased plasma AUC, resp., compared to wild-type (WT) mice, indicating a marked and additive role of these transporters in limiting vemurafenib oral availability.  Brain-to-plasma ratios of vemurafenib (oral, 25 mg/kg) were not increased in Abcg2-/- mice, only 1.7-fold in Abcb1a/1b-/- mice, but 21.4-fold in Abcb1a/1b-/-;Abcg2-/- mice, indicating pronounced overlapping functions of these transporters in reducing vemurafenib brain accumulation.  Oral coadministration of the dual ABCB1 and ABCG2 inhibitor elacridar almost completely eliminated the roles of Abcb1 and Abcg2 in restricting oral availability and brain accumulation of vemurafenib.  As predicted by previously described pharmacokinetic modeling, halving the amt. of active efflux transport at the WT blood-brain barrier by testing heterozygous Abcb1a/1b+/-;Abcg2+/- mice had little impact on vemurafenib brain accumulation.  Our data suggest that elacridar coadministration may be considered to improve the therapeutic efficacy of vemurafenib, esp. for brain metastases located behind a functional blood-brain barrier.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHem6ZUi3pJ7Vg90H21EOLACvtfcHk0ljqK2zQmKKVBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVamt7bL&md5=af368d47ddc76fbd3d3e9ce6be97c29d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fmp3003144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp3003144%26sid%3Dliteratum%253Aachs%26aulast%3DDurmus%26aufirst%3DS.%26aulast%3DSparidans%26aufirst%3DR.%2BW.%26aulast%3DWagenaar%26aufirst%3DE.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DOral%2520availability%2520and%2520brain%2520penetration%2520of%2520the%2520B-RAFV600E%2520inhibitor%2520vemurafenib%2520can%2520be%2520enhanced%2520by%2520the%2520P-glycoprotein%2520%2528ABCB1%2529%2520and%2520breast%2520cancer%2520resistance%2520protein%2520%2528ABCG2%2529%2520inhibitor%2520elacridar%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D3236%26epage%3D3245%26doi%3D10.1021%2Fmp3003144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, K. K.</span></span> <span> </span><span class="NLM_article-title">Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.06.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.ejmech.2015.06.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=26197160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCqsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=560-572&author=X.+Q.+Liauthor=L.+Wangauthor=Y.+Leiauthor=T.+Huauthor=F.+L.+Zhangauthor=C.+H.+Choauthor=K.+K.+To&title=Reversal+of+P-gp+and+BCRP-mediated+MDR+by+tariquidar+derivatives&doi=10.1016%2Fj.ejmech.2015.06.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives</span></div><div class="casAuthors">Li, Xu-Qin; Wang, Lin; Lei, Yan; Hu, Tao; Zhang, Fei-Long; Cho, Chi-Hin; To, Kenneth K. W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">560-572</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">With an aim to generate non-toxic, specific and highly potent multidrug resistance (MDR) modulators, a novel series of anthranilic acid amide-substituted tariquidar derivs., e.g., I, were synthesized.  The new compds. were evaluated for their cytotoxicity toward normal human colon fibroblasts (CCD18-Co), human gastric epithelial cell line (HFE) and primary rat liver cells, and for their ability to inhibit P-gp/BCRP-mediated drug efflux and reversal of P-gp and BCRP-mediated MDR in parental and drug-resistant cancer cell lines (LCC6 MDR1, MCF-7 FLV1000, R-HepG2, SW620-Ad300).  While tariquidar is highly toxic to normal cells, the new derivs. exhibited much lower or negligible cytotoxicity.  Some of the new tariquidar derivs. inhibited both P-gp and BCRP-mediated drug efflux whereas a few of them bearing a sulfonamide functional group are specific to P-gp.  The new compds. were also found to potentiate the anticancer activity of the transporter substrate anticancer drugs in the corresponding transporter-overexpressing cell lines.  The extent of resistance reversal was found to be consistent with the transporter inhibitory effect of the new derivs.  To further understand the mechanism of P-gp and BCRP inhibition, the tariquidar derivs. were found to interact with the transporters using an antibody-based UIC2 or 5D3 shift assay.  Moreover, the transporters-inhibiting derivs. were found to modulate the ATPase activities of the two MDR transporters.  Our data thus advocate further development of the new compds. for the circumvention of MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMlzPe_laaA7Vg90H21EOLACvtfcHk0lhiKLvml1nWhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCqsb3E&md5=21de31591293a5f5b7b4039822940dfb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.06.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.06.049%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%2BQ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DF.%2BL.%26aulast%3DCho%26aufirst%3DC.%2BH.%26aulast%3DTo%26aufirst%3DK.%2BK.%26atitle%3DReversal%2520of%2520P-gp%2520and%2520BCRP-mediated%2520MDR%2520by%2520tariquidar%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D101%26spage%3D560%26epage%3D572%26doi%3D10.1016%2Fj.ejmech.2015.06.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minderman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Loughlin, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendyala, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baer, M. R.</span></span> <span> </span><span class="NLM_article-title">VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1826</span>– <span class="NLM_lpage">1834</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-0914-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1158%2F1078-0432.CCR-0914-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=15014037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFClt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1826-1834&author=H.+Mindermanauthor=K.+L.+O%E2%80%99Loughlinauthor=L.+Pendyalaauthor=M.+R.+Baer&title=VX-710+%28biricodar%29+increases+drug+retention+and+enhances+chemosensitivity+in+resistant+cells+overexpressing+P-glycoprotein%2C+multidrug+resistance+protein%2C+and+breast+cancer+resistance+protein&doi=10.1158%2F1078-0432.CCR-0914-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">VX-710 (Biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein</span></div><div class="casAuthors">Minderman, Hans; O'Loughlin, Kieran L.; Pendyala, Lakshmi; Baer, Maria R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1826-1834</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The pipecolinate deriv. VX-710 (Biricodar; Incel) is a clin. applicable modulator of P-glycoprotein (Pgp) and multidrug resistance protein (MRP-1); we studied its activity against the third multidrug resistance (MDR)-assocd. drug efflux protein, breast cancer resistance protein (BCRP).  VX-710 modulation of uptake, retention, and cytotoxicity of mitoxantrone, daunorubicin, doxorubicin, topotecan, and SN38 was studied in cell lines overexpressing Pgp, MRP-1 and wild-type (BCRPR482) and mutant (BCRPR482T) BCRP.  In 8226/Dox6 cells (Pgp), VX-710 increased mitoxantrone and daunorubicin uptake by 55 and 100%, resp., increased their retention by 100 and 60%, resp., and increased their cytotoxicity 3.1- and 6.9-fold, resp.  In HL60/Adr cells (MRP-1), VX-710 increased mitoxantrone and daunorubicin uptake by 43 and 130%, increased their retention by 90 and 60%, and increased their cytotoxicity 2.4- and 3.3-fold.  In 8226/MR20 cells (BCRPR482), VX-710 increased mitoxantrone uptake and retention by 60 and 40%, resp., and increased cytotoxicity 2.4-fold.  VX-710 increased daunorubicin uptake and retention by only 10% in 8226/MR20 cells, consistent with the fact that daunorubicin is not a substrate for BCRPR482, but, nevertheless, it increased daunorubicin cytotoxicity 3.6-fold, and this increase was not assocd. with intracellular drug redistribution.  VX-710 had little effect on uptake, retention, or cytotoxicity of mitoxantrone, daunorubicin, doxorubicin, topotecan, or SN38 in MCF7 AdVP3000 cells (BCRPR482T).  VX-710 modulates Pgp, MRP-1, and BCRPR482, and has potential as a clin. broad-spectrum MDR modulator in malignancies such as the acute leukemias in which these proteins are expressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLqnEIAu5oU7Vg90H21EOLACvtfcHk0lhiKLvml1nWhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFClt7c%253D&md5=1848eb4d4dae0e2affe41e1f3d6adda6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-0914-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-0914-3%26sid%3Dliteratum%253Aachs%26aulast%3DMinderman%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Loughlin%26aufirst%3DK.%2BL.%26aulast%3DPendyala%26aufirst%3DL.%26aulast%3DBaer%26aufirst%3DM.%2BR.%26atitle%3DVX-710%2520%2528biricodar%2529%2520increases%2520drug%2520retention%2520and%2520enhances%2520chemosensitivity%2520in%2520resistant%2520cells%2520overexpressing%2520P-glycoprotein%252C%2520multidrug%2520resistance%2520protein%252C%2520and%2520breast%2520cancer%2520resistance%2520protein%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D1826%26epage%3D1834%26doi%3D10.1158%2F1078-0432.CCR-0914-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Loevezijn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinkel, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koomen, G. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(00)00588-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2FS0960-894X%2800%2900588-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=29-32&author=A.+van%0ALoevezijnauthor=J.+D.+Allenauthor=A.+H.+Schinkelauthor=G.+J.+Koomen&title=Inhibition+of+BCRP-mediated+drug+efflux+by+fumitremorgin-type+indolyl+diketopiperazines&doi=10.1016%2FS0960-894X%2800%2900588-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900588-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900588-6%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BLoevezijn%26aufirst%3DA.%26aulast%3DAllen%26aufirst%3DJ.%2BD.%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26aulast%3DKoomen%26aufirst%3DG.%2BJ.%26atitle%3DInhibition%2520of%2520BCRP-mediated%2520drug%2520efflux%2520by%2520fumitremorgin-type%2520indolyl%2520diketopiperazines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D29%26epage%3D32%26doi%3D10.1016%2FS0960-894X%2800%2900588-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gekeler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ise, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, J.</span></span> <span> </span><span class="NLM_article-title">The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>208</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1995.1344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1006%2Fbbrc.1995.1344" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=1995&pages=345-352&author=V.+Gekelerauthor=W.+Iseauthor=K.+H.+Sandersauthor=W.+R.+Ulrichauthor=J.+Beck&title=The+leukotriene+LTD4+receptor+antagonist+MK571+specifically+modulates+MRP+associated+multidrug+resistance&doi=10.1006%2Fbbrc.1995.1344"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1995.1344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1995.1344%26sid%3Dliteratum%253Aachs%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DIse%26aufirst%3DW.%26aulast%3DSanders%26aufirst%3DK.%2BH.%26aulast%3DUlrich%26aufirst%3DW.%2BR.%26aulast%3DBeck%26aufirst%3DJ.%26atitle%3DThe%2520leukotriene%2520LTD4%2520receptor%2520antagonist%2520MK571%2520specifically%2520modulates%2520MRP%2520associated%2520multidrug%2520resistance%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1995%26volume%3D208%26spage%3D345%26epage%3D352%26doi%3D10.1006%2Fbbrc.1995.1344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gollapudi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span> <span> </span><span class="NLM_article-title">Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">150</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1007/s002800050640</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1007%2Fs002800050640" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=9182837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADyaK2sXjsFKhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=150-158&author=S.+Gollapudiauthor=C.+H.+Kimauthor=B.+N.+Tranauthor=S.+Sanghaauthor=S.+Gupta&title=Probenecid+reverses+multidrug+resistance+in+multidrug+resistance-associated+protein-overexpressing+HL60%2FAR+and+H69%2FAR+cells+but+not+in+P-glycoprotein-overexpressing+HL60%2FTax+and+P388%2FADR+cells&doi=10.1007%2Fs002800050640"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells</span></div><div class="casAuthors">Gollapudi, Sastry; Kim, Choong H.; Tran, Bich Ngoc; Sangha, Soni; Gupta, Sudhir</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">150-158</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">To det. whether probenecid, an inhibitor of org. anion transport, is able to reverse multidrug resistance (MDR) through modulation of the drug transport function of MDR-assocd. protein (MRP) and P-glycoprotein (P-gP).  MRP-overexpressing cell lines and P-gP-overexpressing cell lines were cultured with different concns. of daunorubicin (DNR) or vincristine (VCR) in the presence or absence of various concns. of probenecid.  Drug sensitivity was detd. using an MTT assay.  DNR accumulation and subcellular distribution were detd. by flow cytometry and confocal microscopy, resp.  VCR accumulation was detd. by scintillation spectrometry.  Probenecid, in a concn.-dependent manner, reversed resistance to DNR and VCR in HL60/AR and H69/AR tumor cell lines.  This effect of probenecid on MDR was assocd. with an increased accumulation of DNR and VCR and correction of the altered subcellular distribution of DNR.  The concns. of probenecid that reversed MDR are clin. achievable in vivo.  In contrast, probenecid did not reverse MDR in either HL60/Tax or P388/ADR tumor cell lines that overexpress P-gP.  Probenecid is an effective chemosensitizer of MRP-assocd. MDR tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojobukUNaar7Vg90H21EOLACvtfcHk0lhiKLvml1nWhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsFKhtL4%253D&md5=f2a909b0d5f55a20548932aae3172a7c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs002800050640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800050640%26sid%3Dliteratum%253Aachs%26aulast%3DGollapudi%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DC.%2BH.%26aulast%3DTran%26aufirst%3DB.%2BN.%26aulast%3DSangha%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DS.%26atitle%3DProbenecid%2520reverses%2520multidrug%2520resistance%2520in%2520multidrug%2520resistance-associated%2520protein-overexpressing%2520HL60%252FAR%2520and%2520H69%252FAR%2520cells%2520but%2520not%2520in%2520P-glycoprotein-overexpressing%2520HL60%252FTax%2520and%2520P388%252FADR%2520cells%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1997%26volume%3D40%26spage%3D150%26epage%3D158%26doi%3D10.1007%2Fs002800050640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span> <span> </span><span class="NLM_article-title">Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1999</span>– <span class="NLM_lpage">2014</span>, <span class="refDoi"> DOI: 10.1021/jm201121b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201121b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVeksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1999-2014&author=K.+F.+Chanauthor=I.+L.+Wongauthor=J.+W.+Kanauthor=C.+S.+Yanauthor=L.+M.+Chowauthor=T.+H.+Chan&title=Amine+linked+flavonoid+dimers+as+modulators+for+P-glycoprotein-based+multidrug+resistance%3A+structure-activity+relationship+and+mechanism+of+modulation&doi=10.1021%2Fjm201121b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Amine Linked Flavonoid Dimers as Modulators for P-Glycoprotein-Based Multidrug Resistance: Structure-Activity Relationship and Mechanism of Modulation</span></div><div class="casAuthors">Chan, Kin-Fai; Wong, Iris L. K.; Kan, Jason W. Y.; Yan, Clare S. W.; Chow, Larry M. C.; Chan, Tak Hang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1999-2014</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here we report a great improvement in reversal potency of cancer drug resistance when flavonoid dimers possess a functionally substituted aminopolyethylene glycol linker.  The most potent compd., (I), contains a N-benzyl group at the linker.  It has many advantages including (1) high potencies in reversing P-glycoprotein (P-gp) mediated resistance in LCC6MDR cells to various anticancer drugs with EC50 in the nanomolar range, (2) low toxicity and high therapeutic index, and (3) preferential inhibition of P-gp over multidrug resistance protein 1 and breast cancer resistance protein.  I stimulates P-gp-ATPase activity by 2.7-fold and mediates a dose-dependent inhibition of doxorubicin (DOX) transport activity.  Lineweaver-Burk and Dixon plots suggest that I is a competitive inhibitor to DOX in binding to P-gp with a Ki of 0.28-0.34 μM and a Hill coeff. of 1.17.  Moreover, the LCC6MDR cell displays about 2.1-fold lower intracellular accumulation of 18 compared to the wild type, suggesting that 18 is a P-gp substrate as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzkFyzfv4ZzrVg90H21EOLACvtfcHk0lgHpDmUNl0ZYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVeksbY%253D&md5=dee53ec7b3b8651b85dad6d833df4691</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm201121b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201121b%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DK.%2BF.%26aulast%3DWong%26aufirst%3DI.%2BL.%26aulast%3DKan%26aufirst%3DJ.%2BW.%26aulast%3DYan%26aufirst%3DC.%2BS.%26aulast%3DChow%26aufirst%3DL.%2BM.%26aulast%3DChan%26aufirst%3DT.%2BH.%26atitle%3DAmine%2520linked%2520flavonoid%2520dimers%2520as%2520modulators%2520for%2520P-glycoprotein-based%2520multidrug%2520resistance%253A%2520structure-activity%2520relationship%2520and%2520mechanism%2520of%2520modulation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1999%26epage%3D2014%26doi%3D10.1021%2Fjm201121b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkett, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span> <span> </span><span class="NLM_article-title">Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6742</span>– <span class="NLM_lpage">6759</span>, <span class="refDoi"> DOI: 10.1021/jm060593+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060593%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOqsLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6742-6759&author=K.+F.+Chanauthor=Y.+Zhaoauthor=B.+A.+Burkettauthor=I.+L.+Wongauthor=L.+M.+Chowauthor=T.+H.+Chan&title=Flavonoid+dimers+as+bivalent+modulators+for+P-glycoprotein-based+multidrug+resistance%3A+synthetic+apigenin+homodimers+linked+with+defined-length+poly%28ethylene+glycol%29+spacers+increase+drug+retention+and+enhance+chemosensitivity+in+resistant+cancer+cells&doi=10.1021%2Fjm060593%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Flavonoid Dimers as Bivalent Modulators for P-Glycoprotein-Based Multidrug Resistance: Synthetic Apigenin Homodimers Linked with Defined-Length Poly(ethylene glycol) Spacers Increase Drug Retention and Enhance Chemosensitivity in Resistant Cancer Cells</span></div><div class="casAuthors">Chan, Kin-Fai; Zhao, Yunzhe; Burkett, Brendan A.; Wong, Iris L. K.; Chow, Larry M. C.; Chan, Tak Hang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6742-6759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Much effort has been spent on searching for better P-glycoprotein- (P-gp-) based multidrug resistance (MDR) modulators.  Our approach was to target the binding sites of P-gp using dimers of dietary flavonoids.  A series of apigenin-based flavonoid dimers, linked by poly(ethylene glycol) chains of various lengths, have been synthesized.  These flavonoid dimers modulate drug chemosensitivity and retention in breast and leukemic MDR cells with the optimal no. of ethylene glycol units equal to 2-4.  Compd. 9d bearing four ethylene glycol units increased drug accumulation in drug-resistant cells and enhanced cytotoxicity of paclitaxel, doxorubicin, daunomycin, vincristine, and vinblastine in drug-resistant breast cancer and leukemia cells in vitro, resulting in redn. of IC50 by 5-50 times.  This compd. also stimulated P-gp's ATPase activity by 3.3-fold.  Its modulating activity was presumably by binding to the substrate binding sites of P-gp and disrupting drug efflux.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAs5cv1zQgVLVg90H21EOLACvtfcHk0lgHpDmUNl0ZYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOqsLfM&md5=236d3561a062922ed3656b61abafd0bb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm060593%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060593%252B%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DK.%2BF.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DBurkett%26aufirst%3DB.%2BA.%26aulast%3DWong%26aufirst%3DI.%2BL.%26aulast%3DChow%26aufirst%3DL.%2BM.%26aulast%3DChan%26aufirst%3DT.%2BH.%26atitle%3DFlavonoid%2520dimers%2520as%2520bivalent%2520modulators%2520for%2520P-glycoprotein-based%2520multidrug%2520resistance%253A%2520synthetic%2520apigenin%2520homodimers%2520linked%2520with%2520defined-length%2520poly%2528ethylene%2520glycol%2529%2520spacers%2520increase%2520drug%2520retention%2520and%2520enhance%2520chemosensitivity%2520in%2520resistant%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6742%26epage%3D6759%26doi%3D10.1021%2Fjm060593%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkett, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span> <span> </span><span class="NLM_article-title">Flavonoid dimers as bivalent modulators for p-glycoprotein-based multidrug resistance: structure-activity relationships</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">594</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200800413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1002%2Fcmdc.200800413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=19288491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlCgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=594-614&author=K.+F.+Chanauthor=Y.+Zhaoauthor=T.+W.+Chowauthor=C.+S.+Yanauthor=D.+L.+Maauthor=B.+A.+Burkettauthor=I.+L.+Wongauthor=L.+M.+Chowauthor=T.+H.+Chan&title=Flavonoid+dimers+as+bivalent+modulators+for+p-glycoprotein-based+multidrug+resistance%3A+structure-activity+relationships&doi=10.1002%2Fcmdc.200800413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Flavonoid Dimers as Bivalent Modulators for P-Glycoprotein-Based Multidrug Resistance: Structure-Activity Relationships</span></div><div class="casAuthors">Chan, Kin-Fai; Zhao, Yunzhe; Chow, Toby W. S.; Yan, Clare S. W.; Ma, Dik Lung; Burkett, Brendan A.; Wong, Iris L. K.; Chow, Larry M. C.; Chan, Tak Hang</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">594-614</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sym. and unsym. tetra(ethylene glycol)-linked dimers of flavonoids such as I are prepd. as potential multidrug resistance-reversing agents; their abilities to potential the cytotoxicity of paclitaxel in a multidrug resistant human breast cancer cell line and their lipophilicities are detd., while the abilities of selected compds. to potentiate the toxicities of doxorubicin, vincristine, and vinblastine in a human breast cancer cell line are detd.  Tetra(ethylene glycol)-linked flavanoid dimers with nonpolar, hydrophobic, and less bulky substituents generally show more potent reversing activities than those with other substituents.  Flavonoid dimers with nonpolar and hydrophobic substituents such as Me and Et groups are more potent resistance-reversing agents than dimers with polar and hydrophilic substituents such as hydroxy groups at the C3, C6, and C7 positions of the flavone moieties, but not at C5.  I, contg. Me groups at C6 of the flavone moieties, is optimal, with dimers contg. bulkier substituents at C6 leading to lower multidrug reversing activity.  Comparison of unsym. flavanoid dimers with the corresponding sym. dimers revealed that the two binding sites on P-gp for flavonoid moieties are similar to each other.  The compds. are not cytotoxic towards normal or multidrug resistant cancer cells at 1, 2, or 5 μM concns. (no data).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEk32GHrRA67Vg90H21EOLACvtfcHk0lgHpDmUNl0ZYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlCgtr8%253D&md5=eea708b2cbb50b5f7c703760d1e7a1fc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800413%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DK.%2BF.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChow%26aufirst%3DT.%2BW.%26aulast%3DYan%26aufirst%3DC.%2BS.%26aulast%3DMa%26aufirst%3DD.%2BL.%26aulast%3DBurkett%26aufirst%3DB.%2BA.%26aulast%3DWong%26aufirst%3DI.%2BL.%26aulast%3DChow%26aufirst%3DL.%2BM.%26aulast%3DChan%26aufirst%3DT.%2BH.%26atitle%3DFlavonoid%2520dimers%2520as%2520bivalent%2520modulators%2520for%2520p-glycoprotein-based%2520multidrug%2520resistance%253A%2520structure-activity%2520relationships%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D594%26epage%3D614%26doi%3D10.1002%2Fcmdc.200800413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span> <span> </span><span class="NLM_article-title">Novel classes of dimer antitumour drug candidates</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.2174/138161209787315576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.2174%2F138161209787315576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=19199989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=659-674&author=L.+M.+Chowauthor=T.+H.+Chan&title=Novel+classes+of+dimer+antitumour+drug+candidates&doi=10.2174%2F138161209787315576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Novel classes of dimer antitumour drug candidates</span></div><div class="casAuthors">Chow, Larry M. C.; Chan, Tak Hang</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">659-674</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Polyvalency in the biol. world is defined as the simultaneous binding of multiple ligands to one receptor.  Polyvalency can increase the affinity of the polyvalent ligand by 100-1000 fold over the monovalent ligand.  Such phenomenon has been employed to design polyvalent toxin inhibitors.  Bivalency is a similar approach where two ligands are joined together with a linker to form a homo- or hetero-dimer with an increase in affinity by up to several hundred fold over the monovalent ligand.  This review will summarize the recent advancement in designing bivalent inhibitors to be used as antitumor agents.  Some dimers (e.g. artemisinin homo-dimer) simply increase the affinity of the monovalent ligands without detailed knowledge of the target.  Other dimers are designed with well-characterized targets, for example, jesterone dimer (inhibiting Rel/NF-κB) and 3,3'-diindolymethane and their derivs. (inhibiting Akt and NFκB).  Some dimers are designed based on the high definition structure between ligand and target (e.g. benzodiazepine and daunorubicin interacting with DNA).  Heterodimers have also been produced by combining either two different antitumor drugs (e.g. cis-platin/acridine or cis-platin/naphthalimide) or combining one antitumor candidate (artemisinin) with a mol. which can increase the efficacy of the former (transferrin receptor).  Finally we will discuss the design of bivalent inhibitors of the P-glycoprotein (ABCB1; MDR or P-gp) to overcome the problem of antitumor resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUXhqOSnGxmLVg90H21EOLACvtfcHk0lh09zbOOikA_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSns7k%253D&md5=00d01b4aafa8cef596a8bce572c757f8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F138161209787315576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209787315576%26sid%3Dliteratum%253Aachs%26aulast%3DChow%26aufirst%3DL.%2BM.%26aulast%3DChan%26aufirst%3DT.%2BH.%26atitle%3DNovel%2520classes%2520of%2520dimer%2520antitumour%2520drug%2520candidates%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D659%26epage%3D674%26doi%3D10.2174%2F138161209787315576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M.</span></span> <span> </span><span class="NLM_article-title">Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5311</span>– <span class="NLM_lpage">5322</span>, <span class="refDoi"> DOI: 10.1021/jm900194w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900194w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWntb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5311-5322&author=I.+L.+Wongauthor=K.+F.+Chanauthor=K.+H.+Tsangauthor=C.+Y.+Lamauthor=Y.+Zhaoauthor=T.+H.+Chanauthor=L.+M.+Chow&title=Modulation+of+multidrug+resistance+protein+1+%28MRP1%2FABCC1%29-mediated+multidrug+resistance+by+bivalent+apigenin+homodimers+and+their+derivatives&doi=10.1021%2Fjm900194w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Multidrug Resistance Protein 1 (MRP1/ABCC1)-Mediated Multidrug Resistance by Bivalent Apigenin Homodimers and Their Derivatives</span></div><div class="casAuthors">Wong, Iris L. K.; Chan, Kin-Fai; Tsang, Ka Hing; Lam, Chi Yin; Zhao, Yunzhe; Chan, Tak Hang; Chow, Larry Ming Cheung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5311-5322</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here it is showed that bivalency approach is effective in modulating multidrug resistance protein 1 (MRP1/ABCC1)-mediated doxorubicin (DOX) and etoposide (VP16) resistance in human 2008/MRP1 ovarian carcinoma cells.  Flavonoid dimers bearing five or six ethylene glycol (EG) units with 6-Me or 7-Me substitution on the ring A of flavonoid dimers have the highest modulating activity for DOX against MRP1 with an EC50 ranging from 73 to 133 nM.  At 0.5 μM, the flavonoid dimer I was sufficient to restore DOX accumulation in 2008/MRP1 to parental 2008/P level.  Lineweaver-Burk and Dixon plot suggested that it is likely a competitive inhibitor of DOX transport with a Ki = 0.2 μM.  The data suggest that flavonoid dimers have a high affinity toward binding to DOX recognition site of MRP1.  This results in inhibiting DOX transport, increasing intracellular DOX retention, and finally resensitizing 2008/MRP1 to DOX.  The present study demonstrates that flavonoid dimers can be employed as an effective modulator of MRP1-mediated drug resistance in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM2E1QnkQ3jrVg90H21EOLACvtfcHk0lh09zbOOikA_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWntb3E&md5=5acb996cd44f205b7344d2b91e34e9f2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900194w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900194w%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DI.%2BL.%26aulast%3DChan%26aufirst%3DK.%2BF.%26aulast%3DTsang%26aufirst%3DK.%2BH.%26aulast%3DLam%26aufirst%3DC.%2BY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DT.%2BH.%26aulast%3DChow%26aufirst%3DL.%2BM.%26atitle%3DModulation%2520of%2520multidrug%2520resistance%2520protein%25201%2520%2528MRP1%252FABCC1%2529-mediated%2520multidrug%2520resistance%2520by%2520bivalent%2520apigenin%2520homodimers%2520and%2520their%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5311%26epage%3D5322%26doi%3D10.1021%2Fjm900194w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M.</span></span> <span> </span><span class="NLM_article-title">A new class of safe, potent, and specific P-gp modulator: flavonoid dimer FD18 reverses P-gp-mediated multidrug resistance in human breast xenograft in vivo</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3507</span>– <span class="NLM_lpage">3517</span>, <span class="refDoi"> DOI: 10.1021/mp500770e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp500770e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlKnsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=3507-3517&author=C.+S.+Yanauthor=I.+L.+Wongauthor=K.+F.+Chanauthor=J.+W.+Kanauthor=T.+C.+Chongauthor=M.+C.+Lawauthor=Y.+Zhaoauthor=S.+W.+Chanauthor=T.+H.+Chanauthor=L.+M.+Chow&title=A+new+class+of+safe%2C+potent%2C+and+specific+P-gp+modulator%3A+flavonoid+dimer+FD18+reverses+P-gp-mediated+multidrug+resistance+in+human+breast+xenograft+in+vivo&doi=10.1021%2Fmp500770e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A New Class of Safe, Potent, and Specific P-gp Modulator: Flavonoid Dimer FD18 Reverses P-gp-Mediated Multidrug Resistance in Human Breast Xenograft in Vivo</span></div><div class="casAuthors">Yan, Clare S. W.; Wong, Iris L. K.; Chan, Kin-Fai; Kan, Jason W. Y.; Chong, Tsz Cheung; Law, Man Chun; Zhao, Yunzhe; Chan, Shun Wan; Chan, Tak Hang; Chow, Larry M. C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3507-3517</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Flavonoid dimer FD18 is a new class of dimeric P-gp modulator that can reverse cancer drug resistance.  FD18 is a potent (EC50 = 148 nM for paclitaxel), safe (selective index = 574), and selective P-glycoprotein (P-gp) modulator.  FD18 can modulate multidrug resistance toward paclitaxel, vinblastine, vincristine, doxorubicin, daunorubicin, and mitoxantrone in human breast cancer LCC6MDR in vitro.  FD18 (1 μM) can revert chemosensitivity of LCC6MDR back to parental LCC6 level.  FD18 was 11- to 46-fold more potent than verapamil.  FD18 (1 μM) can increase accumulation of doxorubicin by 2.7-fold, daunorubicin (2.1-fold), and rhodamine 123 (5.2-fold) in LCC6MDR.  FD18 inhibited P-gp-mediated doxorubicin efflux and has no effect on influx.  FD18 at 1 μM did not affect the protein expression level of P-gp.  Pharmacokinetics studies indicated that i.p. administration of 45 mg/kg FD18 was enough to maintain a plasma level above EC50 (148 nM) for more than 600 min.  Acute toxicity studies with FD18 (90 mg/kg, i.p. for 12 times in 22 days) with paclitaxel (12 mg/kg, i.v. for 12 times in 22 days) revealed no obvious toxicity or death in mice.  In vivo efficacy studies indicated that FD18 (45 mg/kg, i.p. for 12 times in 22 days) together with paclitaxel (12 mg/kg, i.v. for 12 times in 22 days) resulted in a 46% redn. in LCC6MDR xenograft vol. (n = 11; 648 ± 84 mm3) compared to paclitaxel control (n = 8; 1201 ± 118 mm3).  There were no animal deaths or significant drop in body wt. and vital organ wet wt.  FD18 can increase paclitaxel accumulation in LCC6MDR xenograft by 1.8- to 2.2-fold.  The present study suggests that FD18 represents a new class of safe and potent P-gp modulator in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGV4jlyRZZHbVg90H21EOLACvtfcHk0lh09zbOOikA_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlKnsL7L&md5=ae0ce196912ba2739030b31213c7d7fe</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fmp500770e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp500770e%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DC.%2BS.%26aulast%3DWong%26aufirst%3DI.%2BL.%26aulast%3DChan%26aufirst%3DK.%2BF.%26aulast%3DKan%26aufirst%3DJ.%2BW.%26aulast%3DChong%26aufirst%3DT.%2BC.%26aulast%3DLaw%26aufirst%3DM.%2BC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DS.%2BW.%26aulast%3DChan%26aufirst%3DT.%2BH.%26aulast%3DChow%26aufirst%3DL.%2BM.%26atitle%3DA%2520new%2520class%2520of%2520safe%252C%2520potent%252C%2520and%2520specific%2520P-gp%2520modulator%253A%2520flavonoid%2520dimer%2520FD18%2520reverses%2520P-gp-mediated%2520multidrug%2520resistance%2520in%2520human%2520breast%2520xenograft%2520in%2520vivo%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D3507%26epage%3D3517%26doi%3D10.1021%2Fmp500770e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span> <span> </span><span class="NLM_article-title">The growing impact of click chemistry on drug discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1128</span>– <span class="NLM_lpage">1137</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(03)02933-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2FS1359-6446%2803%2902933-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=14678739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVWkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=1128-1137&author=H.+C.+Kolbauthor=K.+B.+Sharpless&title=The+growing+impact+of+click+chemistry+on+drug+discovery&doi=10.1016%2FS1359-6446%2803%2902933-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The growing impact of click chemistry on drug discovery</span></div><div class="casAuthors">Kolb, Hartmuth C.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">1128-1137</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Click chem. is a modular approach that uses only the most practical and reliable chem. transformations.  Its applications are increasingly found in all aspects of drug discovery, ranging from lead finding through combinatorial chem. and target-templated in situ chem., to proteomics and DNA research, using bioconjugation reactions.  The copper-(I)-catalyzed 1,2,3-triazole formation from azides and terminal acetylenes is a particularly powerful linking reaction, due to its high degree of dependability, complete specificity, and the bio-compatibility of the reactants.  The triazole products are more than just passive linkers; they readily assoc. with biol. targets, through hydrogen bonding and dipole interactions.  Click chem., a modular approach based on highly reliable chem. transformations, is being applied in all aspects of drug discovery, ranging from lead finding to proteomics and DNA research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqEB1hjIBNhbVg90H21EOLACvtfcHk0lgExNkRpKFzKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVWkuro%253D&md5=f0042f3a8f153d1c1192533d90699d19</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902933-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902933-7%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DThe%2520growing%2520impact%2520of%2520click%2520chemistry%2520on%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D1128%26epage%3D1137%26doi%3D10.1016%2FS1359-6446%2803%2902933-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasini, D.</span></span> <span> </span><span class="NLM_article-title">The click reaction as an efficient tool for the construction of macrocyclic structures</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">9512</span>– <span class="NLM_lpage">9530</span>, <span class="refDoi"> DOI: 10.3390/molecules18089512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.3390%2Fmolecules18089512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=23966075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWgtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=9512-9530&author=D.+Pasini&title=The+click+reaction+as+an+efficient+tool+for+the+construction+of+macrocyclic+structures&doi=10.3390%2Fmolecules18089512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The click reaction as an efficient tool for the construction of macrocyclic structures</span></div><div class="casAuthors">Pasini, Dario</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9512-9530</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The Cu(I)-catalyzed azide-alkyne cycloaddn. (CuAAC, known as the click reaction) is an established tool used for the construction of complex mol. architectures.  Given its efficiency it has been widely applied for bioconjugation, polymer and dendrimer synthesis.  More recently, this reaction has been utilized for the efficient formation of rigid or shape-persistent, preorganized macrocyclic species.  This strategy also allows the installment of useful functionalities, in the form of polar and function-rich 1,2,3-triazole moieties, directly embedded in the macrocyclic structures.  This review analyzes the state of the art in this context, and provides some elements of perspective for future applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvopsXeQjNJbVg90H21EOLACvtfcHk0lgExNkRpKFzKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWgtbnL&md5=bfd78e7f1ea10ea51f48e21ab87449e6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18089512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18089512%26sid%3Dliteratum%253Aachs%26aulast%3DPasini%26aufirst%3DD.%26atitle%3DThe%2520click%2520reaction%2520as%2520an%2520efficient%2520tool%2520for%2520the%2520construction%2520of%2520macrocyclic%2520structures%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D9512%26epage%3D9530%26doi%3D10.3390%2Fmolecules18089512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.drudis.2015.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=26315392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVOnt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=118-132&author=X.+Wangauthor=B.+Huangauthor=X.+Liuauthor=P.+Zhan&title=Discovery+of+bioactive+molecules+from+CuAAC+click-chemistry-based+combinatorial+libraries&doi=10.1016%2Fj.drudis.2015.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries</span></div><div class="casAuthors">Wang, Xueshun; Huang, Boshi; Liu, Xinyong; Zhan, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">118-132</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The rapid assembly and in situ screening of focused combinatorial fragment libraries using CuAAC click chem. is a highly robust and efficient strategy for establishing SAR and for discovering bioactive mols.  This review outlines the current status of this methodol. in drug discovery application.  The inherent limitations, challenges and prospects are critically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGricX1HNgromLVg90H21EOLACvtfcHk0lgExNkRpKFzKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVOnt7%252FN&md5=57314fbcbf2e16e2267a8c9513a39b13</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhan%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520bioactive%2520molecules%2520from%2520CuAAC%2520click-chemistry-based%2520combinatorial%2520libraries%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D118%26epage%3D132%26doi%3D10.1016%2Fj.drudis.2015.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levental, I.</span></span> <span> </span><span class="NLM_article-title">Click-chemistry based high throughput screening platform for modulators of ras palmitoylation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">41147</span>, <span class="refDoi"> DOI: 10.1038/srep41147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1038%2Fsrep41147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=28112226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFaks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=41147&author=L.+Ganesanauthor=P.+Shiehauthor=C.+R.+Bertozziauthor=I.+Levental&title=Click-chemistry+based+high+throughput+screening+platform+for+modulators+of+ras+palmitoylation&doi=10.1038%2Fsrep41147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Click-Chemistry Based High Throughput Screening Platform for Modulators of Ras Palmitoylation</span></div><div class="casAuthors">Ganesan, Lakshmi; Shieh, Peyton; Bertozzi, Carolyn R.; Levental, Ilya</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">41147</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Palmitoylation is a widespread, reversible lipid modification that has been implicated in regulating a variety of cellular processes.  Approx. one thousand proteins are annotated as being palmitoylated, and for some of these, including several oncogenes of the Ras and Src families, palmitoylation is indispensable for protein function.  Despite this wealth of disease-relevant targets, there are currently few effective pharmacol. tools to interfere with protein palmitoylation.  One reason for this lack of development is the dearth of assays to efficiently screen for small mol. inhibitors of palmitoylation.  To address this shortcoming, we have developed a robust, high-throughput compatible, click chem.-based approach to identify small mols. that interfere with the palmitoylation of Ras, a high value therapeutic target that is mutated in up to a third of human cancers.  This assay design shows excellent performance in 384-well format and is sensitive to known, non-specific palmitoylation inhibitors.  Further, we demonstrate an ideal counter-screening strategy, which relies on a target peptide from an unrelated protein, the Src-family kinase Fyn.  The screening approach described here provides an integrated platform to identify specific modulators of palmitoylated proteins, demonstrated here for Ras and Fyn, but potentially applicable to pharmaceutical targets involved in a variety of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_WhXLki_41rVg90H21EOLACvtfcHk0lgExNkRpKFzKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFaks70%253D&md5=080c253e699f7b7d012ad19c0b1c0eaa</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fsrep41147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep41147%26sid%3Dliteratum%253Aachs%26aulast%3DGanesan%26aufirst%3DL.%26aulast%3DShieh%26aufirst%3DP.%26aulast%3DBertozzi%26aufirst%3DC.%2BR.%26aulast%3DLevental%26aufirst%3DI.%26atitle%3DClick-chemistry%2520based%2520high%2520throughput%2520screening%2520platform%2520for%2520modulators%2520of%2520ras%2520palmitoylation%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D41147%26doi%3D10.1038%2Fsrep41147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabbrizzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabocchi, A.</span></span> <span> </span><span class="NLM_article-title">Use of click-chemistry in the development of peptidomimetic enzyme inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1467</span>– <span class="NLM_lpage">1477</span>, <span class="refDoi"> DOI: 10.2174/0929867321666131218093611</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.2174%2F0929867321666131218093611" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=24350850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1Cns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1467-1477&author=P.+Fabbrizziauthor=G.+Menchiauthor=A.+Guarnaauthor=A.+Trabocchi&title=Use+of+click-chemistry+in+the+development+of+peptidomimetic+enzyme+inhibitors&doi=10.2174%2F0929867321666131218093611"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Click-Chemistry in the Development of Peptidomimetic Enzyme Inhibitors</span></div><div class="casAuthors">Fabbrizzi, P.; Menchi, G.; Guarna, A.; Trabocchi, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1467-1477</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cu(I)-catalyzed Azide-Alkyne Cycloaddn. (CuAAC) is often utilized in medicinal chem. to make the triazole moiety as it acts as a non-classical bioisostere of the peptide bond.  This useful technique can also be applied in the fragment-based assembly of mol. libraries for high-throughput screening.  This minireview outlines the application of click-chem. in the synthesis of enzyme inhibitors with the triazole moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2LYh2dI8jLVg90H21EOLACvtfcHk0lgW8m7Bd1phZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1Cns78%253D&md5=38e8fba08390d4dccf4d2e588e231ac2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F0929867321666131218093611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666131218093611%26sid%3Dliteratum%253Aachs%26aulast%3DFabbrizzi%26aufirst%3DP.%26aulast%3DMenchi%26aufirst%3DG.%26aulast%3DGuarna%26aufirst%3DA.%26aulast%3DTrabocchi%26aufirst%3DA.%26atitle%3DUse%2520of%2520click-chemistry%2520in%2520the%2520development%2520of%2520peptidomimetic%2520enzyme%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1467%26epage%3D1477%26doi%3D10.2174%2F0929867321666131218093611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalesh, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S. Q.</span></span> <span> </span><span class="NLM_article-title">Methods of using click chemistry in the discovery of enzyme inhibitors</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2655</span>– <span class="NLM_lpage">2664</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1038%2Fnprot.2007.323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=18007601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSlsrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=2655-2664&author=R.+Srinivasanauthor=J.+Liauthor=S.+L.+Ngauthor=K.+A.+Kaleshauthor=S.+Q.+Yao&title=Methods+of+using+click+chemistry+in+the+discovery+of+enzyme+inhibitors&doi=10.1038%2Fnprot.2007.323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Methods of using click chemistry in the discovery of enzyme inhibitors</span></div><div class="casAuthors">Srinivasan, Rajavel; Li, Junqi; Ng, Su Ling; Kalesh, Karunakaran A.; Yao, Shao Q.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2655-2664</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">This protocol describes the step-by-step procedures for the efficient assembly of bidentate inhibitor libraries of a target enzyme, using the so-called 'click chem.' between an alkyne-bearing core group and an azide-modified peripheral group, followed by direct biol. screening for the identification of potential 'hits'.  The reaction is highlighted by its modularity, high efficiency (∼100% yield in most cases) and tolerance toward many functional groups present in the fragments, as well as biocompatibility (typically carried out in aq. conditions with small amts. of biocompatible catalysts).  The approach consists of three steps: (i) chem. synthesis of alkyne-bearing protein tyrosine phosphatase or matrix metalloprotease core groups and diverse azide-modified peripheral groups; (ii) click chem. to assemble the bidentate inhibitor libraries; and (iii) direct screening of the libraries with target enzymes using 384-well microplate assays.  Following the chem. synthesis of the core and peripheral groups and optimization of the click chem. conditions (∼1 wk), steps (ii) and (iii) take 3 d to complete (∼1-2 d for library assembly and 1 d for inhibitor screening).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvVU_E7kmG4rVg90H21EOLACvtfcHk0lgW8m7Bd1phZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSlsrrJ&md5=21306eca61966c0d8d1bbb504a17fdf4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.323%26sid%3Dliteratum%253Aachs%26aulast%3DSrinivasan%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DNg%26aufirst%3DS.%2BL.%26aulast%3DKalesh%26aufirst%3DK.%2BA.%26aulast%3DYao%26aufirst%3DS.%2BQ.%26atitle%3DMethods%2520of%2520using%2520click%2520chemistry%2520in%2520the%2520discovery%2520of%2520enzyme%2520inhibitors%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D2655%26epage%3D2664%26doi%3D10.1038%2Fnprot.2007.323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalesh, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S. Q.</span></span> <span> </span><span class="NLM_article-title">High-throughput synthesis of azide libraries suitable for direct “click” chemistry and in situ screening</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1821</span>– <span class="NLM_lpage">1828</span>, <span class="refDoi"> DOI: 10.1039/b902338k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1039%2Fb902338k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=19590777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksV2iurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=1821-1828&author=R.+Srinivasanauthor=L.+P.+Tanauthor=H.+Wuauthor=P.+Y.+Yangauthor=K.+A.+Kaleshauthor=S.+Q.+Yao&title=High-throughput+synthesis+of+azide+libraries+suitable+for+direct+%E2%80%9Cclick%E2%80%9D+chemistry+and+in+situ+screening&doi=10.1039%2Fb902338k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput synthesis of azide libraries suitable for direct "click" chemistry and in situ screening</span></div><div class="casAuthors">Srinivasan, Rajavel; Tan, Lay Pheng; Wu, Hao; Yang, Peng-Yu; Kalesh, Karunakaran A.; Yao, Shao Q.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1821-1828</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A key challenge in current drug discovery is the development of high-throughput (HT) amenable chem. reactions that allow rapid synthesis of diverse chem. libraries of enzyme inhibitors.  The Cu(I)-catalyzed, 1,3-dipolar cycloaddn. between an azide and an alkyne, better known as "click chem.", is one such method that has received the most attention in recent years.  Despite its popularity, there is still a lack of robust and efficient chem. strategies that give access to diverse libraries of azide-contg. building blocks (key components in click chem.).  A highly robust and efficient strategy for high-throughput synthesis of a 325-member azide library is reported here.  The method is highlighted by its simplicity and product purity.  The utility of the library is demonstrated with the subsequent "click" synthesis of the corresponding bidentate inhibitors against PTP1B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTPQK-e7mMZrVg90H21EOLACvtfcHk0lgW8m7Bd1phZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksV2iurk%253D&md5=5165664e64901ea28c120dcd573de2d4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2Fb902338k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb902338k%26sid%3Dliteratum%253Aachs%26aulast%3DSrinivasan%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DL.%2BP.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DP.%2BY.%26aulast%3DKalesh%26aufirst%3DK.%2BA.%26aulast%3DYao%26aufirst%3DS.%2BQ.%26atitle%3DHigh-throughput%2520synthesis%2520of%2520azide%2520libraries%2520suitable%2520for%2520direct%2520%25E2%2580%259Cclick%25E2%2580%259D%2520chemistry%2520and%2520in%2520situ%2520screening%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D1821%26epage%3D1828%26doi%3D10.1039%2Fb902338k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalesh, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S. Q.</span></span> <span> </span><span class="NLM_article-title">High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">5102</span>– <span class="NLM_lpage">5105</span>, <span class="refDoi"> DOI: 10.1021/ol9023419</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9023419" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=5102-5105&author=L.+P.+Tanauthor=H.+Wuauthor=P.+Y.+Yangauthor=K.+A.+Kaleshauthor=X.+Zhangauthor=M.+Huauthor=R.+Srinivasanauthor=S.+Q.+Yao&title=High-throughput+discovery+of+Mycobacterium+tuberculosis+protein+tyrosine+phosphatase+B+%28MptpB%29+inhibitors+using+click+chemistry&doi=10.1021%2Fol9023419"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fol9023419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9023419%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%2BP.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DP.%2BY.%26aulast%3DKalesh%26aufirst%3DK.%2BA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DSrinivasan%26aufirst%3DR.%26aulast%3DYao%26aufirst%3DS.%2BQ.%26atitle%3DHigh-throughput%2520discovery%2520of%2520Mycobacterium%2520tuberculosis%2520protein%2520tyrosine%2520phosphatase%2520B%2520%2528MptpB%2529%2520inhibitors%2520using%2520click%2520chemistry%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D5102%26epage%3D5105%26doi%3D10.1021%2Fol9023419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chow, L. M. C.</span>; <span class="NLM_string-name">Chan, T. H.</span>; <span class="NLM_string-name">Chan, K. F.</span>; <span class="NLM_string-name">Wong, I. L. K.</span>; <span class="NLM_string-name">Law, M. C.</span></span> <span> </span><span class="NLM_article-title">Alkyne-, Azide- and Triazole-containing Flavonoids as Modulators for Multidrug Resistance in Cancers</span>. Patent <span class="NLM_patent">US 9,611,256</span>, April 4, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+M.+C.+Chow&author=T.+H.+Chan&author=K.+F.+Chan&author=I.+L.+K.+Wong&author=M.+C.+Law&title=Alkyne-%2C+Azide-+and+Triazole-containing+Flavonoids+as+Modulators+for+Multidrug+Resistance+in+Cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChow%26aufirst%3DL.%2BM.%2BC.%26atitle%3DAlkyne-%252C%2520Azide-%2520and%2520Triazole-containing%2520Flavonoids%2520as%2520Modulators%2520for%2520Multidrug%2520Resistance%2520in%2520Cancers%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuriakose, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrycyna, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chmielewski, J.</span></span> <span> </span><span class="NLM_article-title">Click chemistry-derived bivalent quinine inhibitors of P-glycoprotein-mediated cellular efflux</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4410</span>– <span class="NLM_lpage">4412</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.04.125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.bmcl.2012.04.125" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4410-4412&author=J.+Kuriakoseauthor=C.+A.+Hrycynaauthor=J.+Chmielewski&title=Click+chemistry-derived+bivalent+quinine+inhibitors+of+P-glycoprotein-mediated+cellular+efflux&doi=10.1016%2Fj.bmcl.2012.04.125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.04.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.04.125%26sid%3Dliteratum%253Aachs%26aulast%3DKuriakose%26aufirst%3DJ.%26aulast%3DHrycyna%26aufirst%3DC.%2BA.%26aulast%3DChmielewski%26aufirst%3DJ.%26atitle%3DClick%2520chemistry-derived%2520bivalent%2520quinine%2520inhibitors%2520of%2520P-glycoprotein-mediated%2520cellular%2520efflux%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4410%26epage%3D4412%26doi%3D10.1016%2Fj.bmcl.2012.04.125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel P-glycoprotein-mediated multidrug resistance inhibitors bearing triazole core via click chemistry</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1111%2Fcbdd.12301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=24750961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWjt7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=182-191&author=B.+Liuauthor=Q.+Qiuauthor=T.+Zhaoauthor=L.+Jiaoauthor=J.+Houauthor=Y.+Liauthor=H.+Qianauthor=W.+Huang&title=Discovery+of+novel+P-glycoprotein-mediated+multidrug+resistance+inhibitors+bearing+triazole+core+via+click+chemistry&doi=10.1111%2Fcbdd.12301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel P-Glycoprotein-Mediated Multidrug Resistance Inhibitors Bearing Triazole Core via Click Chemistry</span></div><div class="casAuthors">Liu, Baomin; Qiu, Qianqian; Zhao, Tianxiao; Jiao, Lei; Hou, Jianyu; Li, Yunman; Qian, Hai; Huang, Wenlong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-191</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A novel series of P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) inhibitors bearing a triazol-phenethyl-tetrahydroisoquinoline scaffold were designed and synthesized via click chem.  Most of the synthesized compds. showed higher reversal activity than verapamil (VRP).  Among them, the most potent compd. 5 showed a comparable activity with the known potent P-gp inhibitor WK-X-34 with lower cytotoxicity (IC50s > 100 μm).  Compared with VRP, compd. 5 exhibited more potency in increasing drug accumulation in K562/A02 MDR cells.  Moreover, compd. 5 persisted longer chemo-sensitizing effect (>24 h) than VRP (<6 h) with reversibility.  Given the low intrinsic cytotoxicity and the potent reversal activity, compd. 5 may represent a promising candidate for developing P-gp-mediated MDR inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkvTZmqaVku7Vg90H21EOLACvtfcHk0ljFFeUgBrghiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWjt7jI&md5=bad1c7bfc4fc1cf9c5eecce9d3182be5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12301%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DQiu%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DJiao%26aufirst%3DL.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520novel%2520P-glycoprotein-mediated%2520multidrug%2520resistance%2520inhibitors%2520bearing%2520triazole%2520core%2520via%2520click%2520chemistry%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2014%26volume%3D84%26spage%3D182%26epage%3D191%26doi%3D10.1111%2Fcbdd.12301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of substrate recognition by the multidrug resistance protein MRP1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">1075</span>– <span class="NLM_lpage">1085</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.01.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.cell.2017.01.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=28238471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlGrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=1075-1085&author=Z.+L.+Johnsonauthor=J.+Chen&title=Structural+basis+of+substrate+recognition+by+the+multidrug+resistance+protein+MRP1&doi=10.1016%2Fj.cell.2017.01.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Substrate Recognition by the Multidrug Resistance Protein MRP1</span></div><div class="casAuthors">Johnson, Zachary Lee; Chen, Jue</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1075-1085.e9</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The multidrug resistance protein MRP1 is an ATP-binding cassette (ABC) transporter that confers resistance to many anticancer drugs and plays a role in the disposition and efficacy of several opiates, antidepressants, statins, and antibiotics.  In addn., MRP1 regulates redox homeostasis, inflammation, and hormone secretion.  Using electron cryomicroscopy, we detd. the mol. structures of bovine MRP1 in two conformations: an apo form at 3.5 Å without any added substrate and a complex form at 3.3 Å with one of its physiol. substrates, leukotriene C4.  These structures show that by forming a single bipartite binding site, MRP1 can recognize a spectrum of substrates with different chem. structures.  We also obsd. large conformational changes induced by leukotriene C4, explaining how substrate binding primes the transporter for ATP hydrolysis.  Structural comparison of MRP1 and P-glycoprotein advances our understanding of the common and unique properties of these two important mols. in multidrug resistance to chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo87MmRBg2HsbVg90H21EOLACvtfcHk0ljFFeUgBrghiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlGrurg%253D&md5=1799bd0d0180f8c524ebe97271a08c85</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.01.041%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DZ.%2BL.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520substrate%2520recognition%2520by%2520the%2520multidrug%2520resistance%2520protein%2520MRP1%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D1075%26epage%3D1085%26doi%3D10.1016%2Fj.cell.2017.01.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">ATP binding enables substrate release from multidrug resistance protein 1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.cell.2017.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=29290467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Ogsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=81-89&author=Z.+L.+Johnsonauthor=J.+Chen&title=ATP+binding+enables+substrate+release+from+multidrug+resistance+protein+1&doi=10.1016%2Fj.cell.2017.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">ATP Binding Enables Substrate Release from Multidrug Resistance Protein 1</span></div><div class="casAuthors">Johnson, Zachary Lee; Chen, Jue</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">81-89.e10</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The multidrug resistance protein MRP1 is an ATP-driven pump that confers resistance to chemotherapy.  Previously, we have shown that intracellular substrates are recruited to a bipartite binding site when the transporter rests in an inward-facing conformation.  A key question remains: how are high-affinity substrates transferred across the membrane and released outside the cell.  Using electron cryomicroscopy, we show here that ATP binding opens the transport pathway to the extracellular space and reconfigures the substrate-binding site such that it relinquishes its affinity for substrate.  Thus, substrate is released prior to ATP hydrolysis.  With this result, we now have a complete description of the conformational cycle that enables substrate transfer in a eukaryotic ABC exporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR-gP8vhWQC7Vg90H21EOLACvtfcHk0ljFFeUgBrghiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Ogsg%253D%253D&md5=16b3ad685ad58f31c1db6ca3aad4b4ab</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DZ.%2BL.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DATP%2520binding%2520enables%2520substrate%2520release%2520from%2520multidrug%2520resistance%2520protein%25201%26jtitle%3DCell%26date%3D2018%26volume%3D172%26spage%3D81%26epage%3D89%26doi%3D10.1016%2Fj.cell.2017.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganai, S.</span></span> <span> </span><span class="NLM_article-title">An expedient approach to substituted triazolo[1,5-a][1,4]benzodiazepines via Cu-catalyzed tandem Ullmann C–N coupling/azide-alkyne cycloaddition</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6192</span>– <span class="NLM_lpage">6195</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2013.08.125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2Fj.tetlet.2013.08.125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFaksLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=6192-6195&author=K.+C.+Majumdarauthor=S.+Ganai&title=An+expedient+approach+to+substituted+triazolo%5B1%2C5-a%5D%5B1%2C4%5Dbenzodiazepines+via+Cu-catalyzed+tandem+Ullmann+C%E2%80%93N+coupling%2Fazide-alkyne+cycloaddition&doi=10.1016%2Fj.tetlet.2013.08.125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">An expedient approach to substituted triazolo[1,5-a][1,4]benzodiazepines via Cu-catalyzed tandem Ullmann C-N coupling/azide-alkyne cycloaddition</span></div><div class="casAuthors">Majumdar, K. C.; Ganai, Sintu</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">6192-6195</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">An approach to the synthesis of triazolo[1,5-a][1,4]benzodiazepines comprising copper catalyzed tandem Ullmann C-N coupling followed by azide-alkyne cycloaddn. was described.  The reaction of o-azidobenzylbromide and N-propargylated aniline derivs. in the presence of CuI and base leads to the formation of triazolo[1,5-a][1,4]benzodiazepines.  The reaction was successfully generalized by synthesizing a no. of triazolo[1,5-a][1,4]benzodiazepine derivs. in good to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_6UFhyhclELVg90H21EOLACvtfcHk0lg2M1grSSoCGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFaksLbP&md5=807c13927d0c779614571251b96a2e63</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2013.08.125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2013.08.125%26sid%3Dliteratum%253Aachs%26aulast%3DMajumdar%26aufirst%3DK.%2BC.%26aulast%3DGanai%26aufirst%3DS.%26atitle%3DAn%2520expedient%2520approach%2520to%2520substituted%2520triazolo%255B1%252C5-a%255D%255B1%252C4%255Dbenzodiazepines%2520via%2520Cu-catalyzed%2520tandem%2520Ullmann%2520C%25E2%2580%2593N%2520coupling%252Fazide-alkyne%2520cycloaddition%26jtitle%3DTetrahedron%2520Lett.%26date%3D2013%26volume%3D54%26spage%3D6192%26epage%3D6195%26doi%3D10.1016%2Fj.tetlet.2013.08.125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paitandi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, D. S.</span></span> <span> </span><span class="NLM_article-title">Triazole-appended BODIPY-piperazine conjugates and their efficacy toward mercury sensing</span>. <i>New J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2233</span>– <span class="NLM_lpage">2239</span>, <span class="refDoi"> DOI: 10.1039/C4NJ01625D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1039%2FC4NJ01625D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2015&pages=2233-2239&author=R.+S.+Singhauthor=R.+K.+Guptaauthor=R.+P.+Paitandiauthor=A.+Misraauthor=D.+S.+Pandey&title=Triazole-appended+BODIPY-piperazine+conjugates+and+their+efficacy+toward+mercury+sensing&doi=10.1039%2FC4NJ01625D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1039%2FC4NJ01625D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NJ01625D%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%2BS.%26aulast%3DGupta%26aufirst%3DR.%2BK.%26aulast%3DPaitandi%26aufirst%3DR.%2BP.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DD.%2BS.%26atitle%3DTriazole-appended%2520BODIPY-piperazine%2520conjugates%2520and%2520their%2520efficacy%2520toward%2520mercury%2520sensing%26jtitle%3DNew%2520J.%2520Chem.%26date%3D2015%26volume%3D39%26spage%3D2233%26epage%3D2239%26doi%3D10.1039%2FC4NJ01625D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">“Click” tetradentate ligands</span>. <i>Dalton Transactions</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2660</span>– <span class="NLM_lpage">2666</span>, <span class="refDoi"> DOI: 10.1039/b922043g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1039%2Fb922043g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=20179861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlentbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=2660-2666&author=E.+Haoauthor=Z.+Wangauthor=L.+Jiaoauthor=S.+Wang&title=%E2%80%9CClick%E2%80%9D+tetradentate+ligands&doi=10.1039%2Fb922043g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">"Click" tetradentate ligands</span></div><div class="casAuthors">Hao, Erhong; Wang, Zhaoyun; Jiao, Lijuan; Wang, Shaowu</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2660-2666</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Triazole-based N4 tetradentate ligands I (Ar = Ph, 2,6-dimethylphenyl, 4-nitrophenyl, 4-methoxyphenyl) are efficiently synthesized using CuI-catalyzed azide-alkyne click strategy and are readily coordinated to many metal ions (e.g. MnII, NiII, ZnII and FeII).  The x-ray structures of the resultant metal-complexes reveal an octahedral mononuclear structure with two co-ligands bonded in cis sites and the two triazoles as N-donors to the metal center.  The MnII-complexes show efficient catalytic activities in the epoxidn. of various aliph. terminal olefins with peracetic acid, and feature with low catalyst loading, fast conversion and high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ7lzcRlk2mrVg90H21EOLACvtfcHk0lg2M1grSSoCGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlentbc%253D&md5=c3cbe52ffb76160bed7ff8114a769549</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2Fb922043g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb922043g%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DJiao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DS.%26atitle%3D%25E2%2580%259CClick%25E2%2580%259D%2520tetradentate%2520ligands%26jtitle%3DDalton%2520Transactions%26date%3D2010%26volume%3D39%26spage%3D2660%26epage%3D2666%26doi%3D10.1039%2Fb922043g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koynov, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auernhammer, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, T.</span></span> <span> </span><span class="NLM_article-title">Supramolecular organogel based on crown ether and secondary ammoniumion functionalized glycidyl triazole polymers</span>. <i>Macromolecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4617</span>– <span class="NLM_lpage">4625</span>, <span class="refDoi"> DOI: 10.1021/ma400407a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ma400407a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVeisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2013&pages=4617-4625&author=D.+Liuauthor=D.+Wangauthor=M.+Wangauthor=Y.+Zhengauthor=K.+Koynovauthor=G.+K.+Auernhammerauthor=H.-J.+Buttauthor=T.+Ikeda&title=Supramolecular+organogel+based+on+crown+ether+and+secondary+ammoniumion+functionalized+glycidyl+triazole+polymers&doi=10.1021%2Fma400407a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Supramolecular Organogel Based on Crown Ether and Secondary Ammoniumion Functionalized Glycidyl Triazole Polymers</span></div><div class="casAuthors">Liu, Dian; Wang, Dapeng; Wang, Miao; Zheng, Yijun; Koynov, Kaloian; Auernhammer, Guenter K.; Butt, Hans-Juergen; Ikeda, Taichi</div><div class="citationInfo"><span class="NLM_cas:title">Macromolecules (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4617-4625</span>CODEN:
                <span class="NLM_cas:coden">MAMOBX</span>;
        ISSN:<span class="NLM_cas:issn">0024-9297</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A supramol. organogel was prepd. by mixing the glycidyl triazole polymers (GTP) functionalized with crown ether and secondary ammoniumion at the side groups.  The polymers form an organogel above a concn. of 3 wt. % via phys. crosslinks of the inclusion complex.  The organogel responds to multiple stimuli, e.g., temp., acid/base, and chem. species.  The no. of the effective crosslinks estd. from the storage modulus and the affine network model suggests that some part of the binding sites could not work as the phys. crosslinks.  Rheol. measurement under large deformation showed that the storage modulus was const. up to 250% strain and larger than the loss modulus up to 600% strain.  The high elasticity of the gel is attributable to the material design based on the high-mol.-wt. flexible glycidyl polymers with many binding sites in the single polymer chain.  The organogel also showed nice self-healing behavior.  The mol. diffusion in the gel network was characterized by fluorescence correlation spectroscopy.  Although the crosslink of the organogel has dynamic nature due to inclusion complexation, the diffusion behavior of the low-mol.-wt. fluorescence tracer was similar to that obsd. in chem. crosslinked gels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqIVjmwtZENLVg90H21EOLACvtfcHk0lg2M1grSSoCGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVeisr0%253D&md5=22d9cde9421d0c49fbaf3171a99f5694</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fma400407a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fma400407a%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DKoynov%26aufirst%3DK.%26aulast%3DAuernhammer%26aufirst%3DG.%2BK.%26aulast%3DButt%26aufirst%3DH.-J.%26aulast%3DIkeda%26aufirst%3DT.%26atitle%3DSupramolecular%2520organogel%2520based%2520on%2520crown%2520ether%2520and%2520secondary%2520ammoniumion%2520functionalized%2520glycidyl%2520triazole%2520polymers%26jtitle%3DMacromolecules%26date%3D2013%26volume%3D46%26spage%3D4617%26epage%3D4625%26doi%3D10.1021%2Fma400407a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gujadhur, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataraman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kintigh, J. T.</span></span> <span> </span><span class="NLM_article-title">Formation of aryl-nitrogen bonds using a soluble copper (I) catalyst</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">4791</span>– <span class="NLM_lpage">4793</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)00888-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2FS0040-4039%2801%2900888-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslyjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=4791-4793&author=R.+Gujadhurauthor=D.+Venkataramanauthor=J.+T.+Kintigh&title=Formation+of+aryl-nitrogen+bonds+using+a+soluble+copper+%28I%29+catalyst&doi=10.1016%2FS0040-4039%2801%2900888-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Formation of aryl-nitrogen bonds using a soluble copper(I) catalyst</span></div><div class="casAuthors">Gujadhur, R.; Venkataraman, D.; Kintigh, J. T.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">4791-4793</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The authors report a synthetic protocol for the synthesis of functionalized diaryl- and triarylamines under mild conditions, using a sol., air-stable copper(I) complex, Cu(PPh3)3Br, as the catalyst and cesium carbonate as the base.  Using this protocol, the authors were able to synthesize a tri-ortho-ester functionalized triphenylamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocJ1A-IU0r_bVg90H21EOLACvtfcHk0ligZRNW-xVi1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslyjtrc%253D&md5=aff77a492ae6c96b786f8416184c5dab</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2900888-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252900888-7%26sid%3Dliteratum%253Aachs%26aulast%3DGujadhur%26aufirst%3DR.%26aulast%3DVenkataraman%26aufirst%3DD.%26aulast%3DKintigh%26aufirst%3DJ.%2BT.%26atitle%3DFormation%2520of%2520aryl-nitrogen%2520bonds%2520using%2520a%2520soluble%2520copper%2520%2528I%2529%2520catalyst%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D4791%26epage%3D4793%26doi%3D10.1016%2FS0040-4039%2801%2900888-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oleschuk, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeley, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. P.</span></span> <span> </span><span class="NLM_article-title">Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1171</span>– <span class="NLM_lpage">1180</span>, <span class="refDoi"> DOI: 10.1124/mol.59.5.1171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1124%2Fmol.59.5.1171" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=1171-1180&author=E.+M.+Leslieauthor=Q.+Maoauthor=C.+J.+Oleschukauthor=R.+G.+Deeleyauthor=S.+P.+Cole&title=Modulation+of+multidrug+resistance+protein+1+%28MRP1%2FABCC1%29+transport+and+atpase+activities+by+interaction+with+dietary+flavonoids&doi=10.1124%2Fmol.59.5.1171"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fmol.59.5.1171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.59.5.1171%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DE.%2BM.%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DOleschuk%26aufirst%3DC.%2BJ.%26aulast%3DDeeley%26aufirst%3DR.%2BG.%26aulast%3DCole%26aufirst%3DS.%2BP.%26atitle%3DModulation%2520of%2520multidrug%2520resistance%2520protein%25201%2520%2528MRP1%252FABCC1%2529%2520transport%2520and%2520atpase%2520activities%2520by%2520interaction%2520with%2520dietary%2520flavonoids%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D1171%26epage%3D1180%26doi%3D10.1124%2Fmol.59.5.1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiser, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McChesney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zygmunt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, S. J.</span></span> <span> </span><span class="NLM_article-title">Measurement of paclitaxel in biological matrices: high-throughput liquid chromatographic-tandem mass spectrometric quantification of paclitaxel and metabolites in human and dog plasma</span>. <i>J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>785</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/S1570-0232(02)00913-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1016%2FS1570-0232%2802%2900913-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=12554138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtVaksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=785&publication_year=2003&pages=253-261&author=M.+S.+Alexanderauthor=M.+M.+Kiserauthor=T.+Culleyauthor=J.+R.+Kernauthor=J.+W.+Dolanauthor=J.+D.+McChesneyauthor=J.+Zygmuntauthor=S.+J.+Bannister&title=Measurement+of+paclitaxel+in+biological+matrices%3A+high-throughput+liquid+chromatographic-tandem+mass+spectrometric+quantification+of+paclitaxel+and+metabolites+in+human+and+dog+plasma&doi=10.1016%2FS1570-0232%2802%2900913-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of Paclitaxel in biological matrices: High-throughput liquid chromatographic-tandem mass spectrometric quantification of Paclitaxel and metabolites in human and dog plasma</span></div><div class="casAuthors">Alexander, Michael S.; Kiser, Melissa M.; Culley, Travis; Kern, John R.; Dolan, John W.; McChesney, James D.; Zygmunt, Jan; Bannister, Steve J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">785</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">253-261</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A GLP-validated, sensitive, and specific LC-MS-MS method for the quantification of Paclitaxel and its 6-α- and 3'-p-hydroxy metabolites is presented.  A 0.400-mL plasma aliquot is spiked with a 13C6-labeled Paclitaxel internal std. and extd. with 1 mL methyl-tert.-Bu ether.  The ether is evapd. and the residue is reconstituted in 130 μL of 30% aq. acetonitrile (ACN) contg. 0.1% trifluoroacetic acid.  Isocratic HPLC anal. is performed by injecting 50 μL of the reconstituted material onto a 50×2.1 mm C18 column with an ACN-water-acetic acid (50:50:0.1) mobile phase at 200 μL/min flow.  Detection is by pos. ion electrospray followed by multiple reaction monitoring of the following transitions: Paclitaxel (854>509 u), 6-α-hydroxy Paclitaxel (870>525 u), 3'-p-hydroxy Paclitaxel (870>509 u), and internal std. (860>509 u).  Quantification is by peak area ratio against the 13C6 internal std.  The method range is 0.117-117 nM (0.1-100 ng/mL) for Paclitaxel and both metabolites using a 0.400-mL human or dog plasma sample.  Anal. time per sample is <5 min.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL2LKq-BmEHLVg90H21EOLACvtfcHk0ligZRNW-xVi1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtVaksbY%253D&md5=2106d89103bf7b02caec280c4755f5cd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS1570-0232%2802%2900913-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1570-0232%252802%252900913-3%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DM.%2BS.%26aulast%3DKiser%26aufirst%3DM.%2BM.%26aulast%3DCulley%26aufirst%3DT.%26aulast%3DKern%26aufirst%3DJ.%2BR.%26aulast%3DDolan%26aufirst%3DJ.%2BW.%26aulast%3DMcChesney%26aufirst%3DJ.%2BD.%26aulast%3DZygmunt%26aufirst%3DJ.%26aulast%3DBannister%26aufirst%3DS.%2BJ.%26atitle%3DMeasurement%2520of%2520paclitaxel%2520in%2520biological%2520matrices%253A%2520high-throughput%2520liquid%2520chromatographic-tandem%2520mass%2520spectrometric%2520quantification%2520of%2520paclitaxel%2520and%2520metabolites%2520in%2520human%2520and%2520dog%2520plasma%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2003%26volume%3D785%26spage%3D253%26epage%3D261%26doi%3D10.1016%2FS1570-0232%2802%2900913-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weidner, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambudkar, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottesman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innis, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span> <span> </span><span class="NLM_article-title">The inhibitor Ko143 is not specific for ABCG2</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>354</i></span>,  <span class="NLM_fpage">384</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.225482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=10.1124%2Fjpet.115.225482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=26148857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGrtb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2015&pages=384-393&author=L.+D.+Weidnerauthor=S.+S.+Zoghbiauthor=S.+Luauthor=S.+Shuklaauthor=S.+V.+Ambudkarauthor=V.+W.+Pikeauthor=J.+Mulderauthor=M.+M.+Gottesmanauthor=R.+B.+Innisauthor=M.+D.+Hall&title=The+inhibitor+Ko143+is+not+specific+for+ABCG2&doi=10.1124%2Fjpet.115.225482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibitor Ko143 is not specific for ABCG2</span></div><div class="casAuthors">Weidner, Lora D.; Zoghbi, Sami S.; Lu, Shuiyu; Shukla, Suneet; Ambudkar, Suresh V.; Pike, Victor W.; Mulder, Jan; Gottesman, Michael M.; Innis, Robert B.; Hall, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">384-393</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Imaging ATP-binding cassette (ABC) transporter activity in vivo with positron emission tomog. requires both a substrate and a transporter inhibitor.  However, for ABCG2, there is no inhibitor proven to be specific to that transporter alone at the blood-brain barrier.  Ko143 [(3S,6S,12aS)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester], a nontoxic analog of fungal toxin fumitremorgin C, is a potent inhibitor of ABCG2, although its specificity in mouse and human systems is unclear.  This study examd. the selectivity of Ko143 using human embryonic kidney cell lines transfected with ABCG2, ABCB1, or ABCC1 in several in vitro assays.  The stability of Ko143 in rat plasma was measured using high performance liq. chromatog.  Our results show that, in addn. to being a potent inhibitor of ABCG2, at higher concns. (≥1 μM) Ko143 also has an effect on the transport activity of both ABCB1 and ABCC1.  Furthermore, Ko143 was found to be unstable in rat plasma.  These findings indicate that Ko143 lacks specificity for ABCG2 and this should be taken into consideration when using Ko143 for both in vitro and in vivo expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqWjvTByDwbLVg90H21EOLACvtfcHk0ligZRNW-xVi1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGrtb7L&md5=4336228ff99f608f6452dca312e78a5a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.225482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.225482%26sid%3Dliteratum%253Aachs%26aulast%3DWeidner%26aufirst%3DL.%2BD.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DShukla%26aufirst%3DS.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DMulder%26aufirst%3DJ.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DHall%26aufirst%3DM.%2BD.%26atitle%3DThe%2520inhibitor%2520Ko143%2520is%2520not%2520specific%2520for%2520ABCG2%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D354%26spage%3D384%26epage%3D393%26doi%3D10.1124%2Fjpet.115.225482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Köhler, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, M.</span></span> <span> </span><span class="NLM_article-title">HM30181 derivatives as novel potent and selective inhibitors of the breast cancer resistance protein (BCRP/ABCG2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3910</span>– <span class="NLM_lpage">3921</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00188</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00188" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;key=1%3ACAS%3A280%3ADC%252BC2Mjitlelsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3910-3921&author=S.+C.+K%C3%B6hlerauthor=M.+Wiese&title=HM30181+derivatives+as+novel+potent+and+selective+inhibitors+of+the+breast+cancer+resistance+protein+%28BCRP%2FABCG2%29&doi=10.1021%2Facs.jmedchem.5b00188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2)</span></div><div class="casAuthors">Kohler Sebastian C; Wiese Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3910-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The breast cancer resistance protein (BCRP, ABCG2) belongs to the superfamily of ATP binding-cassette (ABC) proteins.  In addition to other physiological functions, it transports potentially cell-damaging compounds out of the cell using the energy from ATP hydrolysis.  Certain tumors overexpressing BCRP were found to become resistant against various anticancer drugs.  In previous work, we found that tariquidar analogues lacking the tetrahydroisoquinoline moiety selectively inhibit BCRP.  In the present study, we synthesized 21 derivatives of the third-generation P-gp inhibitor HM30181, which is structurally related to tariquidar.  The compounds were tested for their inhibitory activities against BCRP and screened against P-glycoprotein (P-gp, ABCB1) and multidrug resistance protein 1 (MRP1, ABCC1) to confirm the selectivity toward BCRP.  The most potent compounds are selective toward BCRP and 2-fold more potent than the reference Ko143.  Qualitative structure-activity relationship (SAR) analysis revealed that the presence of a methoxy group in the ortho or para position of at least one phenyl ring is beneficial for inhibitory activity.  Furthermore, the cytotoxicity and multidrug resistance (MDR)-reversal ability of selected compounds were investigated.  It was shown that they have a low cytotoxicity and the ability to reverse the BCRP-mediated SN-38 resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_-1BYW7HmO9-cVm4E2RlLfW6udTcc2eY4TCgpHg8ChLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mjitlelsg%253D%253D&md5=777b13f427105e8909ae751d11e8c7b4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00188%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6hler%26aufirst%3DS.%2BC.%26aulast%3DWiese%26aufirst%3DM.%26atitle%3DHM30181%2520derivatives%2520as%2520novel%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520breast%2520cancer%2520resistance%2520protein%2520%2528BCRP%252FABCG2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3910%26epage%3D3921%26doi%3D10.1021%2Facs.jmedchem.5b00188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UJA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UJA','PDB','5UJA'); return false;">PDB: 5UJA</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i108"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00834">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_15027"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00834">10.1021/acs.jmedchem.8b00834</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HPLC chromatograms of compounds <b>Ac3Az11</b>, <b>Ac3Az2</b>, <b>Ac3Az4</b>, and <b>Ac16Az4</b>; <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra of representative compounds listed in <a class="ref showTableEvent internalNav" href="#tbl5">Table <a class="ref showTableEvent internalNav" href="#tbl5">5</a></a>; superimposition of reported cocomplex structure of LTC4 (green) and its predicted binding pose; alignment of hMRP1 and bMRP1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES molecular strings formulas and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_002.csv">CSV</a>)</p></li><li><p class="inline">Binding LTC<sub>4</sub>, <b>Ac3Az11</b>, <b>FD-4e</b>, and DOX to bMRP1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UJA">5UJA</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_003.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_001.pdf">jm8b00834_si_001.pdf (3.82 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_002.csv">jm8b00834_si_002.csv (2.68 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00834/suppl_file/jm8b00834_si_003.pdb">jm8b00834_si_003.pdb (1.59 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00834&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-22%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00834%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00834" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ac13d7eacd1ef","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
